archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,1.3909e-05,0.37482,0.40681,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,1.8524e-05,0.26399,0.31207,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00057531,0.23345,0.21034,1,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.024086,0.14255,0.13196,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.045233,0.12388,0.1132,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00054254,0.11832,0.14949,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00031664,0.6788,0.58172,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,5.6086e-05,0.66771,0.69044,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0021907,0.66339,0.55448,1,1
2,GO RESPONSE TO POTASSIUM ION,0.00024771,0.64682,0.52154,1,1
2,GO OPTIC NERVE DEVELOPMENT,0.0016767,0.63923,0.5256,1,1
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0015882,0.63061,0.47872,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00042807,0.61198,0.53397,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,8.3641e-05,0.60825,0.5794,1,1
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00054254,0.59893,0.50405,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00014989,0.58419,0.50284,1,1
2,GO DISTAL TUBULE DEVELOPMENT,0.0028457,0.57009,0.4761,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00012367,0.56853,0.60656,1,1
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.00014989,0.5636,0.52568,1,1
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00026348,0.55783,0.47928,1,1
2,GO PREPULSE INHIBITION,0.00024771,0.54593,0.54065,1,1
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00010866,0.53498,0.51352,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0017696,0.53317,0.42302,1,1
2,GO CENTRIOLE CENTRIOLE COHESION,4.2763e-05,0.53217,0.53708,1,1
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00091199,0.52928,0.52999,1,1
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0016767,0.52575,0.49748,1,1
2,GO SYNAPTIC VESICLE DOCKING,0.0011418,0.52087,0.4563,1,1
2,GO MEIOTIC CHROMOSOME SEPARATION,7.3279e-05,0.51966,0.49679,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0017696,0.51712,0.40221,1,1
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00068502,0.51538,0.5059,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0011418,0.51534,0.52655,1,1
2,GO POSTSYNAPSE ASSEMBLY,0.00017019,0.50919,0.48901,1,1
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00014989,0.50791,0.48134,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00076864,0.50494,0.456,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00013188,0.49886,0.57246,1,1
2,GO SYNAPSE MATURATION,0.00054254,0.49689,0.50741,1,1
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.0003797,0.49622,0.44771,1,1
2,GO KINETOCHORE ASSEMBLY,0.00017019,0.49564,0.42935,1,1
2,GO KINETOCHORE ORGANIZATION,5.2428e-05,0.48985,0.46319,1,1
2,GO MICROTUBULE DEPOLYMERIZATION,0.00013188,0.47855,0.44907,1,1
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0044907,0.47555,0.42399,1,1
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0015882,0.47507,0.4253,1,1
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.0042727,0.47279,0.45668,1,1
2,GO MRNA SPLICE SITE SELECTION,4.2763e-05,0.47064,0.45146,1,1
2,GO MALE SEX DETERMINATION,0.0042727,0.47058,0.36272,1,1
2,GO FOREBRAIN REGIONALIZATION,8.3641e-05,0.46744,0.52661,1,1
2,GO REPLICATION FORK PROCESSING,0.00024771,0.46568,0.42814,1,1
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00031664,0.46354,0.42289,1,1
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00028019,0.456,0.43297,1,1
2,GO REGULATION OF NEURON MIGRATION,0.00015974,0.45598,0.50077,1,1
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00017019,0.45544,0.41983,1,1
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.00031664,0.45517,0.47759,1,1
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0038653,0.45182,0.40489,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.021265,0.44724,0.33177,1,1
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.012106,0.44595,0.33611,1,1
2,GO DENDRITIC TRANSPORT,0.0012071,0.44437,0.44426,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0020776,0.4401,0.3644,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00045436,0.43533,0.39455,1,1
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.031957,0.43274,0.30288,1,1
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0003797,0.43265,0.44015,1,1
2,GO HISTONE H3 K36 METHYLATION,0.0003797,0.42971,0.439,1,1
2,GO NEURONAL ION CHANNEL CLUSTERING,0.00010866,0.42886,0.46452,1,1
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0021907,0.42824,0.35412,1,1
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.00048214,0.42727,0.40279,1,1
2,GO SPINAL CORD PATTERNING,0.0013481,0.42597,0.44487,1,1
2,GO DENTATE GYRUS DEVELOPMENT,0.00015974,0.42533,0.53385,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.01266,0.42439,0.33803,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00033648,0.42171,0.33473,1,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00040321,0.42145,0.40513,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.0042727,0.42095,0.33113,1,1
2,GO CENTRIOLE ASSEMBLY,4.2763e-05,0.41747,0.40494,1,1
2,GO HOMOLOGOUS RECOMBINATION,0.00017019,0.41557,0.36197,1,1
2,GO SYNAPTIC VESICLE CLUSTERING,0.00068502,0.41548,0.46256,1,1
2,GO URETER DEVELOPMENT,0.020391,0.41407,0.41664,1,1
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00014062,0.41273,0.4009,1,1
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00019306,0.41172,0.41191,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.0080134,0.41004,0.3208,1,1
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.0010209,0.40982,0.39879,1,1
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00028019,0.40885,0.42811,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.0020776,0.40768,0.41078,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.00064645,0.40552,0.45485,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00086166,0.40543,0.37191,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00045436,0.40495,0.3671,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0052065,0.40431,0.34059,1,1
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00024771,0.40355,0.42498,1,1
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00010866,0.4016,0.43114,1,1
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0003797,0.39842,0.41159,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,0.00017019,0.39725,0.41029,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0011418,0.3972,0.41303,1,1
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,4.5779e-05,0.39613,0.41673,1,1
2,GO HISTONE H3 K27 METHYLATION,0.00033648,0.39479,0.40476,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,0.0027019,0.39394,0.35523,1,1
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00045436,0.39278,0.41001,1,1
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.00010866,0.39255,0.34969,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,6.4139e-05,0.38962,0.38812,1,1
2,GO CEREBELLAR CORTEX DEVELOPMENT,8.9327e-05,0.38898,0.36974,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0012758,0.38846,0.40758,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.0027019,0.38781,0.37924,1,1
2,GO NEURON CELL CELL ADHESION,0.0012071,0.38702,0.39507,1,1
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0024341,0.38679,0.31467,1,1
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00048214,0.38619,0.36427,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00091199,0.38615,0.35036,1,1
2,GO MATING BEHAVIOR,0.00031664,0.38559,0.38521,1,1
2,GO LOOP OF HENLE DEVELOPMENT,0.0036751,0.38482,0.45578,1,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00096503,0.38268,0.36978,1,1
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00018128,0.38113,0.46488,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.010101,0.37915,0.49282,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00042807,0.37884,0.35601,1,1
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00019306,0.37584,0.36406,1,1
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.0047188,0.37532,0.33625,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0060238,0.37466,0.4203,1,1
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00076864,0.37459,0.37076,1,1
2,GO GROWTH HORMONE SECRETION,0.0010209,0.37305,0.39767,1,1
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00035748,0.37057,0.38401,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0010798,0.36962,0.36445,1,1
2,GO NOSE DEVELOPMENT,0.0060238,0.36949,0.36235,1,1
2,GO ADULT BEHAVIOR,0.00010181,0.36922,0.34347,1,1
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.010572,0.3687,0.34712,1,1
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0027019,0.36837,0.3418,1,1
2,GO REGULATION OF COLLATERAL SPROUTING,0.0044907,0.36818,0.31704,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.00064645,0.36817,0.34874,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.010572,0.36681,0.30985,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0003797,0.36549,0.34864,1,1
2,GO STARTLE RESPONSE,0.00020554,0.36335,0.41447,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00028019,0.36227,0.36337,1,1
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.00096503,0.36169,0.31953,1,1
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00029789,0.36006,0.37462,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0042727,0.35895,0.32107,1,1
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00096503,0.35867,0.31671,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.9888e-05,0.35813,0.52664,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00076864,0.35773,0.3516,1,1
2,GO NERVE DEVELOPMENT,0.0024341,0.35759,0.34488,1,1
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.0010798,0.35705,0.46892,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0028457,0.35692,0.31959,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.3279e-05,0.35638,0.44521,1,1
2,GO ACROSOME ASSEMBLY,0.0020776,0.3563,0.31021,1,1
2,GO NEURAL TUBE PATTERNING,0.0011418,0.35628,0.30043,1,1
2,GO CENTROMERE COMPLEX ASSEMBLY,7.3279e-05,0.35407,0.40122,1,1
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.00028019,0.35349,0.29493,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,0.008797,0.35341,0.30412,1,1
2,GO METENCEPHALON DEVELOPMENT,5.9985e-05,0.35324,0.35204,1,1
2,GO HISTONE H3 K9 METHYLATION,0.00086166,0.35306,0.3567,1,1
2,GO MEIOSIS I CELL CYCLE PROCESS,8.9327e-05,0.35157,0.31883,1,1
2,GO CENTROSOME DUPLICATION,0.00017019,0.35138,0.33631,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.010101,0.35114,0.31327,1,1
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.00045436,0.35072,0.33307,1,1
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00020554,0.35062,0.34212,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.0096484,0.35057,0.28303,1,1
2,GO PROTEIN LOCALIZATION TO CILIUM,0.00040321,0.34874,0.34708,1,1
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.00057531,0.34842,0.38761,1,1
2,GO RESPONSE TO COCAINE,6.8565e-05,0.34764,0.39024,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.00024771,0.34752,0.35287,1,1
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00086166,0.34699,0.32018,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0066311,0.34695,0.38183,1,1
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0028457,0.34685,0.33026,1,1
2,GO POSITIVE REGULATION OF BEHAVIOR,0.0021907,0.34658,0.29327,1,1
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00014062,0.34625,0.36809,1,1
2,GO REGULATION OF MICROTUBULE BINDING,0.00072571,0.34572,0.36602,1,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00045436,0.34509,0.31209,1,1
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,6.8565e-05,0.34434,0.37218,1,1
2,GO RESPONSE TO L GLUTAMATE,0.00029789,0.3439,0.33451,1,1
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.00081392,0.34373,0.41763,1,1
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.00026348,0.34364,0.52124,1,1
2,GO CHROMATIN REMODELING AT CENTROMERE,7.8298e-05,0.34332,0.39674,1,1
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.8298e-05,0.34331,0.36667,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0021907,0.342,0.35396,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00332,0.34172,0.30155,1,1
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00057531,0.34132,0.28913,1,1
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0011418,0.34037,0.38189,1,1
2,GO RETROGRADE AXONAL TRANSPORT,0.00057531,0.33901,0.40439,1,1
2,GO FOREBRAIN NEURON DEVELOPMENT,0.0019699,0.33825,0.31886,1,1
2,GO CARDIAC CHAMBER FORMATION,0.011063,0.33576,0.29779,1,1
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0019699,0.33571,0.34048,1,1
2,GO MICROTUBULE ANCHORING,0.00018128,0.33425,0.37307,1,1
2,GO REGULATION OF FEEDING BEHAVIOR,8.9327e-05,0.33319,0.31475,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00091199,0.33316,0.30199,1,1
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0021907,0.33202,0.31704,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00091199,0.33186,0.39081,1,1
2,GO RESPONSE TO INSECTICIDE,0.0038653,0.33135,0.30009,1,1
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.00028019,0.33133,0.34859,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0013481,0.33131,0.34502,1,1
2,GO SEX DETERMINATION,0.0172,0.3312,0.23621,1,1
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.6086e-05,0.33115,0.35627,1,1
2,GO CEREBELLAR CORTEX FORMATION,0.00035748,0.33043,0.3534,1,1
2,GO CHROMOSOME SEPARATION,5.9985e-05,0.33018,0.34681,1,1
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.008797,0.33017,0.27895,1,1
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0015882,0.32911,0.27124,1,1
2,GO MITOTIC SISTER CHROMATID COHESION,0.00021879,0.32849,0.34653,1,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.0012071,0.32734,0.31596,1,1
2,GO MITOTIC RECOMBINATION,0.0010209,0.32694,0.31374,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.0010798,0.32692,0.3228,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0012071,0.32652,0.3373,1,1
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0052065,0.3265,0.42137,1,1
2,GO SYNAPSE ASSEMBLY,0.00051151,0.32648,0.33937,1,1
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.00081392,0.32638,0.28958,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,8.3641e-05,0.32566,0.34756,1,1
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0014241,0.32529,0.28074,1,1
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0010798,0.32472,0.3256,1,1
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,5.2428e-05,0.32451,0.35471,1,1
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00060992,0.32375,0.33757,1,1
2,GO PRO B CELL DIFFERENTIATION,0.0034935,0.32366,0.35184,1,1
2,GO INNERVATION,0.0028457,0.32308,0.45099,1,1
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0003797,0.32289,0.34388,1,1
2,GO LONG TERM SYNAPTIC DEPRESSION,0.008797,0.32228,0.27049,1,1
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00020554,0.32195,0.34339,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0029965,0.32128,0.28928,1,1
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0028457,0.32127,0.2798,1,1
2,GO REGULATION OF RESPONSE TO FOOD,0.0003797,0.32106,0.3847,1,1
2,GO DENDRITE MORPHOGENESIS,0.00040321,0.32096,0.32902,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0019699,0.3206,0.38718,1,1
2,GO FEAR RESPONSE,0.0027019,0.31896,0.25685,1,1
2,GO HISTONE EXCHANGE,4.8997e-05,0.31856,0.34481,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,4.8997e-05,0.31798,0.36683,1,1
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0038653,0.31751,0.31044,1,1
2,GO NOREPINEPHRINE SECRETION,0.006955,0.31638,0.32744,1,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.00057531,0.31531,0.28258,1,1
2,GO PRESYNAPSE ORGANIZATION,0.00057531,0.3151,0.3316,1,1
2,GO CARNITINE SHUTTLE,0.00054254,0.31508,0.32655,1,1
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00064645,0.31421,0.36095,1,1
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.014457,0.31421,0.28498,1,1
2,GO DENDRITIC SPINE MORPHOGENESIS,0.00042807,0.31418,0.33337,1,1
2,GO REGULATION OF SISTER CHROMATID COHESION,0.00028019,0.31391,0.36418,1,1
2,GO MITOTIC CHROMOSOME CONDENSATION,0.00013188,0.31389,0.46232,1,1
2,GO SECRETORY GRANULE LOCALIZATION,0.0031545,0.31377,0.34152,1,1
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0015041,0.31361,0.33598,1,1
2,GO GLIAL CELL FATE COMMITMENT,0.0021907,0.31317,0.32952,1,1
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,5.2428e-05,0.31282,0.33231,1,1
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00057531,0.31265,0.32671,1,1
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00064645,0.31233,0.34753,1,1
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00091199,0.31058,0.31446,1,1
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,6.8565e-05,0.31055,0.38455,1,1
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,3.9936e-05,0.31032,0.33397,1,1
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,9.5377e-05,0.31025,0.32437,1,1
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.00010181,0.31003,0.30578,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.010572,0.30939,0.2574,1,1
2,GO MICROTUBULE BASED MOVEMENT,0.00024771,0.30913,0.30652,1,1
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00023283,0.30895,0.31022,1,1
2,GO RESPONSE TO AUDITORY STIMULUS,0.0028457,0.30891,0.35719,1,1
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00010866,0.30816,0.30452,1,1
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00057531,0.30603,0.31975,1,1
2,GO CATECHOLAMINE UPTAKE,0.0011418,0.30568,0.3552,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00076864,0.30566,0.34259,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0010798,0.3054,0.32024,1,1
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0011418,0.30538,0.31264,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0024341,0.30535,0.28676,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.020391,0.30522,0.23722,1,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00051151,0.30511,0.30967,1,1
2,GO BRAIN MORPHOGENESIS,0.00033648,0.30505,0.32843,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00020554,0.30409,0.34248,1,1
2,GO ANTEROGRADE AXONAL TRANSPORT,0.00042807,0.30407,0.30885,1,1
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,6.4139e-05,0.30404,0.33712,1,1
2,GO REGULATION OF CHROMOSOME SEGREGATION,5.2428e-05,0.30373,0.33289,1,1
2,GO UTERUS DEVELOPMENT,0.0034935,0.30333,0.35583,1,1
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00068502,0.3033,0.323,1,1
2,GO RETINAL ROD CELL DIFFERENTIATION,0.021265,0.30316,0.22177,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.00068502,0.30274,0.32653,1,1
2,GO UV DAMAGE EXCISION REPAIR,0.0018673,0.30273,0.26975,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0018673,0.3025,0.36865,1,1
2,GO RESPONSE TO FOOD,0.00017019,0.30195,0.32477,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0096484,0.30183,0.32297,1,1
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0024341,0.30107,0.28619,1,1
2,GO SYNAPTIC VESICLE PRIMING,0.0057394,0.30098,0.288,1,1
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0047188,0.30065,0.26914,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00051151,0.30039,0.3391,1,1
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00020554,0.3,0.32954,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0047188,0.29997,0.30958,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.0019699,0.29981,0.27834,1,1
2,GO G0 TO G1 TRANSITION,0.00018128,0.29974,0.35149,1,1
2,GO INOSITOL METABOLIC PROCESS,0.0080134,0.29904,0.26639,1,1
2,GO NEURON FATE SPECIFICATION,0.0031545,0.299,0.36581,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00060992,0.29879,0.30457,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00332,0.29783,0.2867,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0010798,0.29774,0.29946,1,1
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.00051151,0.29763,0.31015,1,1
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019306,0.29727,0.34007,1,1
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00028019,0.29722,0.30507,1,1
2,GO NOREPINEPHRINE TRANSPORT,0.0049572,0.29714,0.35024,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.0015041,0.29683,0.32153,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.0012758,0.29658,0.3105,1,1
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0010209,0.29641,0.30898,1,1
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0076456,0.29613,0.27659,1,1
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.034576,0.29601,0.33967,1,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00014062,0.29592,0.34468,1,1
2,GO CHROMOSOME SEGREGATION,0.00013188,0.29586,0.30249,1,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.00040321,0.29582,0.36511,1,1
2,GO NEUROTRANSMITTER SECRETION,0.00040321,0.29435,0.32481,1,1
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0028457,0.29396,0.42045,1,1
2,GO NUCLEAR PORE ORGANIZATION,0.0020776,0.29374,0.32416,1,1
2,GO REGULATION OF CHROMOSOME SEPARATION,3.9936e-05,0.29344,0.31753,1,1
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00057531,0.29326,0.28197,1,1
2,GO CHROMOSOME CONDENSATION,0.00020554,0.29312,0.37852,1,1
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.0096484,0.29311,0.29588,1,1
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0040644,0.29255,0.30924,1,1
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0016767,0.29248,0.31333,1,1
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.2428e-05,0.29201,0.31181,1,1
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.0003797,0.29198,0.33154,1,1
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,6.4139e-05,0.29171,0.32196,1,1
2,GO REGULATION OF CHROMATIN BINDING,0.00035748,0.2916,0.34402,1,1
2,GO CRANIAL NERVE DEVELOPMENT,0.0060238,0.29093,0.31996,1,1
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.010572,0.28895,0.24482,1,1
2,GO P BODY ASSEMBLY,0.00086166,0.2889,0.3369,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00068502,0.28861,0.33055,1,1
2,GO GOLGI RIBBON FORMATION,0.00064645,0.28761,0.35091,1,1
2,GO NEURAL RETINA DEVELOPMENT,0.00057531,0.28741,0.31286,1,1
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00072571,0.28698,0.32411,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00051151,0.28693,0.32365,1,1
2,GO EPITHELIAL CELL MATURATION,0.043559,0.28639,0.20885,1,1
2,GO NEURON MIGRATION,0.00018128,0.28622,0.36605,1,1
2,GO MEIOTIC SPINDLE ORGANIZATION,0.0015882,0.28564,0.3537,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.015104,0.28558,0.24806,1,1
2,GO SPINDLE ORGANIZATION,0.00014062,0.28539,0.31322,1,1
2,GO STRESS GRANULE ASSEMBLY,0.00033648,0.2853,0.31091,1,1
2,GO MICROTUBULE BASED TRANSPORT,0.00048214,0.28512,0.2921,1,1
2,GO DENDRITE DEVELOPMENT,0.00060992,0.28488,0.30514,1,1
2,GO MICROTUBULE POLYMERIZATION,0.0003797,0.28464,0.32383,1,1
2,GO MICROTUBULE BASED PROCESS,9.5377e-05,0.28428,0.3024,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00057531,0.28406,0.31957,1,1
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00051151,0.28406,0.29786,1,1
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0015882,0.28377,0.30776,1,1
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0057394,0.28367,0.27355,1,1
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.015776,0.28343,0.30057,1,1
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00091199,0.2832,0.32422,1,1
2,GO THALAMUS DEVELOPMENT,0.007293,0.28279,0.27372,1,1
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0014241,0.28247,0.32794,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00064645,0.28216,0.3527,1,1
2,GO PEPTIDYL LYSINE METHYLATION,0.00060992,0.28139,0.31444,1,1
2,GO MYOBLAST MIGRATION,0.02951,0.28093,0.2314,1,1
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.014457,0.28012,0.27188,1,1
2,GO REGULATION OF APPETITE,0.0044907,0.28004,0.26982,1,1
2,GO REGULATION OF DENDRITE MORPHOGENESIS,9.5377e-05,0.27997,0.3343,1,1
2,GO ATP DEPENDENT CHROMATIN REMODELING,7.8298e-05,0.2796,0.33694,1,1
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0023095,0.27947,0.27852,1,1
2,GO REGULATION OF CENTROSOME CYCLE,0.00023283,0.27929,0.28117,1,1
2,GO SISTER CHROMATID SEGREGATION,0.00010866,0.27927,0.30304,1,1
2,GO TRANSPORT ALONG MICROTUBULE,0.00023283,0.27876,0.29093,1,1
2,GO SPINAL CORD DEVELOPMENT,0.00019306,0.27872,0.38,1,1
2,GO REGULATION OF AXONOGENESIS,0.0015882,0.27868,0.30675,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.015776,0.2786,0.28691,1,1
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00048214,0.27848,0.29924,1,1
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,7.8298e-05,0.2782,0.32438,1,1
2,GO RECOMBINATIONAL REPAIR,0.00035748,0.27811,0.31047,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00042807,0.27768,0.30039,1,1
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00010181,0.27755,0.29886,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00033648,0.27747,0.30809,1,1
2,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.006955,0.27744,0.26861,1,1
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00048214,0.27729,0.27425,1,1
2,GO RESPONSE TO HYDROXYUREA,0.0014241,0.27706,0.28225,1,1
2,GO FEEDING BEHAVIOR,0.0016767,0.27689,0.25341,1,1
2,GO HISTONE H2A UBIQUITINATION,0.0013481,0.27659,0.27933,1,1
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0028457,0.2761,0.28892,1,1
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.0092139,0.27573,0.29711,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.00028019,0.27547,0.30565,1,1
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0019699,0.27543,0.28692,1,1
2,GO SMOOTHENED SIGNALING PATHWAY,0.00020554,0.27539,0.29677,1,1
2,GO MITOTIC SPINDLE ORGANIZATION,0.00011593,0.27527,0.32199,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.008797,0.27523,0.27665,1,1
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00018128,0.27515,0.30603,1,1
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0013481,0.27503,0.31969,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00057531,0.27494,0.31091,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0015882,0.27469,0.30466,1,1
2,GO HISTONE METHYLATION,0.00064645,0.27464,0.30417,1,1
2,GO MEMBRANE DISASSEMBLY,0.013235,0.27439,0.23965,1,1
2,GO HISTONE H3 K9 MODIFICATION,0.0015041,0.27395,0.30587,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0027019,0.27382,0.2604,1,1
2,GO SYNAPTIC VESICLE LOCALIZATION,0.0015882,0.2737,0.28496,1,1
2,GO MISMATCH REPAIR,0.00010866,0.27366,0.29834,1,1
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00096503,0.2735,0.29493,1,1
2,GO NEUROMUSCULAR PROCESS,0.0023095,0.2735,0.2588,1,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.00010866,0.27347,0.34121,1,1
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,8.3641e-05,0.27277,0.30252,1,1
2,GO MEIOTIC CELL CYCLE PROCESS,0.00011593,0.27235,0.29593,1,1
2,GO CILIUM ORGANIZATION,0.0003797,0.27231,0.30876,1,1
2,GO LEARNING,0.00029789,0.27227,0.30367,1,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.00072571,0.27197,0.32342,1,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.035953,0.27184,0.25279,1,1
2,GO SYNAPTIC SIGNALING,0.00057531,0.2718,0.2715,1,1
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00096503,0.27177,0.31047,1,1
2,GO POSTSYNAPSE ORGANIZATION,0.00045436,0.27167,0.30325,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00064645,0.27121,0.28879,1,1
2,GO PROTEIN METHYLATION,0.00054254,0.27071,0.29019,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0015882,0.26999,0.25106,1,1
2,GO DENDRITIC SPINE DEVELOPMENT,0.00033648,0.2697,0.31348,1,1
2,GO ASYMMETRIC CELL DIVISION,0.00332,0.26958,0.26242,1,1
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.00013188,0.26936,0.29704,1,1
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00072571,0.26913,0.2818,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00048214,0.26782,0.29544,1,1
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00029789,0.26767,0.33155,1,1
2,GO METHIONINE METABOLIC PROCESS,0.0012758,0.26752,0.26489,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0044907,0.2674,0.37378,1,1
2,GO NEUROBLAST PROLIFERATION,0.0015882,0.2671,0.29482,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00096503,0.26708,0.30265,1,1
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0034935,0.26624,0.32991,1,1
2,GO OOCYTE MATURATION,0.0054671,0.2662,0.29452,1,1
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0010209,0.26567,0.28512,1,1
2,GO SYNAPSE ORGANIZATION,0.00086166,0.26551,0.27937,1,1
2,GO HISTONE H3 DEACETYLATION,0.0038653,0.26521,0.25516,1,1
2,GO REGULATION OF MRNA PROCESSING,0.00042807,0.26407,0.27321,1,1
2,GO SISTER CHROMATID COHESION,0.00031664,0.26353,0.32248,1,1
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0013481,0.26342,0.25223,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.046961,0.26341,0.23254,1,1
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.0021907,0.26301,0.29103,1,1
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00076864,0.26299,0.29483,1,1
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0047188,0.26288,0.23608,1,1
2,GO DNA GEOMETRIC CHANGE,0.00033648,0.26259,0.2951,1,1
2,GO PHOTORECEPTOR CELL MAINTENANCE,7.8298e-05,0.26248,0.27773,1,1
2,GO GENITALIA MORPHOGENESIS,0.019548,0.26242,0.28284,1,1
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00010866,0.26222,0.28759,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,0.0024341,0.26152,0.33077,1,1
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0028457,0.26149,0.27222,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00048214,0.26144,0.28757,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00086166,0.26143,0.25721,1,1
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0025648,0.26133,0.29503,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.00042807,0.26081,0.28755,1,1
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0015882,0.25994,0.30745,1,1
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.031957,0.25973,0.19876,1,1
2,GO V D J RECOMBINATION,0.0018673,0.25967,0.28218,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00045436,0.25947,0.26091,1,1
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0023095,0.2593,0.2979,1,1
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0012758,0.25918,0.27133,1,1
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0015041,0.25909,0.29011,1,1
2,GO MEIOTIC CELL CYCLE,0.00010181,0.25864,0.2988,1,1
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00060992,0.25832,0.29375,1,1
2,GO SINGLE STRAND BREAK REPAIR,0.00026348,0.25819,0.30196,1,1
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0057394,0.25735,0.25654,1,1
2,GO MICROTUBULE NUCLEATION,0.0024341,0.25715,0.31322,1,1
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,5.2428e-05,0.25645,0.31714,1,1
2,GO HIPPO SIGNALING,0.0066311,0.25586,0.27704,1,1
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.00081392,0.25576,0.26335,1,1
2,GO RESPONSE TO LEUCINE,0.0027019,0.25573,0.31673,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,9.5377e-05,0.25512,0.29813,1,1
2,GO MITOCHONDRION LOCALIZATION,0.00064645,0.25497,0.28681,1,1
2,GO NEUROTRANSMITTER TRANSPORT,0.00076864,0.25466,0.29073,1,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0014241,0.25395,0.2825,1,1
2,GO LOCOMOTORY BEHAVIOR,0.00048214,0.25377,0.29449,1,1
2,GO DNA DEPENDENT DNA REPLICATION,0.00060992,0.2537,0.29404,1,1
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00064645,0.25317,0.35059,1,1
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00086166,0.25291,0.30872,1,1
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.0036751,0.25285,0.22161,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.018736,0.25238,0.26344,1,1
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.015776,0.2522,0.26738,1,1
2,GO HISTONE H4 K16 ACETYLATION,0.00051151,0.25209,0.30462,1,1
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.048745,0.25176,0.20126,1,1
2,GO AXONAL TRANSPORT,0.00057531,0.25176,0.30824,1,1
2,GO SPINDLE ASSEMBLY,0.00040321,0.25155,0.29347,1,1
2,GO RECEPTOR CLUSTERING,0.0092139,0.25106,0.25923,1,1
2,GO MITOTIC SPINDLE ASSEMBLY,0.00076864,0.25101,0.27484,1,1
2,GO NEURON MATURATION,0.0028457,0.25095,0.27855,1,1
2,GO BEHAVIOR,0.0011418,0.2507,0.24715,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00012367,0.25045,0.28008,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0025648,0.2503,0.27714,1,1
2,GO NEURON PROJECTION ARBORIZATION,0.0057394,0.25015,0.30642,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.0044907,0.24995,0.28147,1,1
2,GO HISTONE H3 K4 METHYLATION,0.00057531,0.2498,0.29741,1,1
2,GO CEREBRAL CORTEX DEVELOPMENT,0.00064645,0.24962,0.28679,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00091199,0.24953,0.27737,1,1
2,GO SPINDLE LOCALIZATION,0.0010209,0.24952,0.26441,1,1
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.0017696,0.2491,0.23943,1,1
2,GO DNA REPLICATION CHECKPOINT,0.0011418,0.24906,0.33389,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0076456,0.24889,0.26934,1,1
2,GO CHROMATIN REMODELING,0.00040321,0.24849,0.28641,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00024771,0.24836,0.30914,1,1
2,GO DNA RECOMBINATION,0.0010209,0.24783,0.245,1,1
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0010798,0.2476,0.30136,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00086166,0.24724,0.31801,1,1
2,GO CELL PART MORPHOGENESIS,0.0015041,0.24696,0.27832,1,1
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.011574,0.24663,0.25232,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,0.0028457,0.24636,0.25247,1,1
2,GO HINDBRAIN MORPHOGENESIS,0.00042807,0.24598,0.28089,1,1
2,GO LENS FIBER CELL DIFFERENTIATION,0.0036751,0.24547,0.24518,1,1
2,GO HINDBRAIN DEVELOPMENT,0.00023283,0.24539,0.28312,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.019548,0.24459,0.18542,1,1
2,GO EXTRACELLULAR TRANSPORT,0.018736,0.24444,0.27848,1,1
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00086166,0.24408,0.37059,1,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0060238,0.24398,0.26208,1,1
2,GO ORGANELLE FISSION,0.00015974,0.24378,0.25365,1,1
2,GO AXON DEVELOPMENT,0.0015041,0.24366,0.28283,1,1
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.010101,0.24343,0.31012,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0017696,0.24337,0.25402,1,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.00057531,0.24287,0.26547,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00026348,0.24262,0.2809,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0083971,0.24256,0.24703,1,1
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00028019,0.24235,0.2767,1,1
2,GO REGULATION OF CYTOKINESIS,0.00054254,0.24095,0.27784,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00091199,0.24094,0.24501,1,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.0034935,0.24071,0.22344,1,1
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0172,0.24044,0.33328,1,1
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.035953,0.24027,0.23697,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0083971,0.24022,0.2521,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00033648,0.23993,0.23909,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0066311,0.23982,0.30433,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.037377,0.23978,0.1865,1,1
2,GO HISTONE H3 K9 TRIMETHYLATION,0.0015882,0.23967,0.30563,1,1
2,GO CHROMOSOME LOCALIZATION,0.0003797,0.23962,0.25098,1,1
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0010209,0.23908,0.25122,1,1
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00040321,0.23898,0.28458,1,1
2,GO APICAL PROTEIN LOCALIZATION,0.013235,0.2389,0.26967,1,1
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0049572,0.23883,0.22533,1,1
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.01266,0.23881,0.24873,1,1
2,GO POST ANAL TAIL MORPHOGENESIS,0.0044907,0.23859,0.2995,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.0054671,0.23846,0.22379,1,1
2,GO HISTONE H4 DEACETYLATION,0.0025648,0.23774,0.22382,1,1
2,GO DOPAMINE TRANSPORT,0.007293,0.23773,0.29661,1,1
2,GO REGULATION OF RNA SPLICING,0.00060992,0.23769,0.25698,1,1
2,GO AXON EXTENSION,0.0038653,0.23762,0.26338,1,1
2,GO AXO DENDRITIC TRANSPORT,0.0023095,0.23716,0.28026,1,1
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0021907,0.23677,0.28985,1,1
2,GO NUCLEOSOME ORGANIZATION,0.00020554,0.2366,0.28792,1,1
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.014457,0.23602,0.23572,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.00040321,0.23583,0.25322,1,1
2,GO CELL CYCLE DNA REPLICATION,0.0012071,0.2354,0.2979,1,1
2,GO REGULATION OF CIRCADIAN RHYTHM,0.00029789,0.23536,0.27098,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0010209,0.23523,0.28301,1,1
2,GO ADULT LOCOMOTORY BEHAVIOR,0.007293,0.23517,0.22749,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0019699,0.23506,0.23728,1,1
2,GO DORSAL VENTRAL PATTERN FORMATION,0.0013481,0.23504,0.28592,1,1
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0047188,0.23484,0.30813,1,1
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.013235,0.23464,0.26866,1,1
2,GO DNA REPLICATION,0.00019306,0.23364,0.30122,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0019699,0.23339,0.31923,1,1
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0010209,0.23326,0.27779,1,1
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.0029965,0.23324,0.2931,1,1
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0017696,0.23315,0.29018,1,1
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0076456,0.23287,0.2937,1,1
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.0020776,0.23276,0.26049,1,1
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0019699,0.23274,0.24854,1,1
2,GO NEURON PROJECTION EXTENSION,0.00332,0.23261,0.25396,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00045436,0.23238,0.32451,1,1
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0052065,0.2321,0.28433,1,1
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0003797,0.23193,0.2908,1,1
2,GO ECTODERM DEVELOPMENT,0.0047188,0.23149,0.23002,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00332,0.23145,0.24809,1,1
2,GO POTASSIUM ION HOMEOSTASIS,0.015104,0.23141,0.18135,1,1
2,GO ESTROUS CYCLE,0.016475,0.23115,0.25914,1,1
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00076864,0.23061,0.26974,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0013481,0.23009,0.25092,1,1
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0047188,0.22998,0.28522,1,1
2,GO PALLIUM DEVELOPMENT,0.0003797,0.22971,0.26953,1,1
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.022172,0.22968,0.2142,1,1
2,GO SPERM MOTILITY,0.0040644,0.22929,0.23606,1,1
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00040321,0.22907,0.30069,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0040644,0.22881,0.23903,1,1
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0029965,0.22858,0.26478,1,1
2,GO METANEPHROS MORPHOGENESIS,0.010101,0.2285,0.24971,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.0036751,0.22845,0.27375,1,1
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0015041,0.22831,0.25457,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0028457,0.22814,0.2777,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.00042807,0.2281,0.27719,1,1
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00020554,0.22762,0.28129,1,1
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.00048214,0.22725,0.31902,1,1
2,GO MITOTIC NUCLEAR DIVISION,0.00014062,0.22679,0.27234,1,1
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0010209,0.2264,0.26811,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00012367,0.2264,0.24409,1,1
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.00332,0.22633,0.22301,1,1
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0012071,0.22599,0.26223,1,1
2,GO PANCREAS DEVELOPMENT,0.0013481,0.22567,0.30494,1,1
2,GO RNA INTERFERENCE,0.0031545,0.22566,0.22838,1,1
2,GO EMBRYONIC AXIS SPECIFICATION,0.00033648,0.22564,0.27255,1,1
2,GO MRNA 3 END PROCESSING,0.00040321,0.22543,0.25386,1,1
2,GO DNA CONFORMATION CHANGE,0.00026348,0.2254,0.30101,1,1
2,GO HISTONE UBIQUITINATION,0.0015041,0.22528,0.2518,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0029965,0.22449,0.22473,1,1
2,GO RNA POLYADENYLATION,0.0013481,0.22427,0.24741,1,1
2,GO METAPHASE PLATE CONGRESSION,0.00031664,0.22422,0.25232,1,1
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00029789,0.22375,0.20421,1,1
2,GO NEURON DEVELOPMENT,0.0011418,0.22336,0.25547,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.00072571,0.22324,0.26002,1,1
2,GO DNA REPLICATION INITIATION,0.0076456,0.22304,0.23853,1,1
2,GO MRNA METHYLATION,0.0029965,0.22273,0.26717,1,1
2,GO MAINTENANCE OF CELL POLARITY,0.010101,0.22225,0.23474,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.011063,0.2216,0.28486,1,1
2,GO REGULATION OF NEURON DIFFERENTIATION,0.0010798,0.22125,0.26425,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.008797,0.22086,0.24082,1,1
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00045436,0.22038,0.25101,1,1
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0023095,0.22026,0.24625,1,1
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0040644,0.22012,0.22428,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.00064645,0.22009,0.25566,1,1
2,GO MALE MEIOSIS I,0.0047188,0.21989,0.27047,1,1
2,GO NUCLEOSOME ASSEMBLY,0.00019306,0.21977,0.32103,1,1
2,GO HISTONE MONOUBIQUITINATION,0.0042727,0.21953,0.25175,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00051151,0.21951,0.26374,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.0028457,0.21834,0.249,1,1
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0052065,0.21829,0.2262,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0025648,0.21811,0.28031,1,1
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.008797,0.2181,0.23367,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING,0.0010209,0.2177,0.23398,1,1
2,GO ORGANIC CATION TRANSPORT,0.019548,0.21747,0.20631,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.043559,0.21726,0.21172,1,1
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.045233,0.21713,0.28314,1,1
2,GO MEMBRANE DOCKING,0.00068502,0.21697,0.25174,1,1
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0060238,0.21659,0.22943,1,1
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0027019,0.21658,0.24104,1,1
2,GO NEURON DIFFERENTIATION,0.00091199,0.21644,0.25325,1,1
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0016767,0.2164,0.20182,1,1
2,GO PATTERN SPECIFICATION PROCESS,0.0029965,0.21631,0.22016,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0025648,0.21615,0.30813,1,1
2,GO POSITIVE REGULATION OF RNA SPLICING,0.0018673,0.21584,0.23655,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00086166,0.21584,0.24977,1,1
2,GO POSITIVE REGULATION OF DNA REPAIR,0.00040321,0.21561,0.25543,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0042727,0.21555,0.24188,1,1
2,GO NEGATIVE CHEMOTAXIS,0.025096,0.21508,0.24356,1,1
2,GO DNA PACKAGING,0.00018128,0.21483,0.3153,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.023112,0.2147,0.21024,1,1
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.018736,0.21438,0.24176,1,1
2,GO CENTROSOME SEPARATION,0.00064645,0.21376,0.27669,1,1
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0083971,0.21345,0.24521,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.00081392,0.21335,0.2756,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0054671,0.2131,0.20127,1,1
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.006955,0.2125,0.25176,1,1
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00332,0.21224,0.23152,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0080134,0.21122,0.26645,1,1
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0083971,0.21097,0.18531,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0034935,0.21083,0.25861,1,1
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.0013481,0.21062,0.24869,1,1
2,GO EATING BEHAVIOR,0.006955,0.2104,0.23219,1,1
2,GO PROTEIN AUTOUBIQUITINATION,0.00035748,0.21022,0.23587,1,1
2,GO MRNA CLEAVAGE,0.0025648,0.2102,0.24106,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.0024341,0.21019,0.23751,1,1
2,GO TORC1 SIGNALING,0.0015041,0.20995,0.27642,1,1
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00054254,0.20985,0.28116,1,1
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00021879,0.20954,0.25279,1,1
2,GO ADHERENS JUNCTION ORGANIZATION,0.011574,0.20895,0.23246,1,1
2,GO RRNA CATABOLIC PROCESS,0.0172,0.20844,0.17002,1,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.015776,0.20785,0.27767,1,1
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0024341,0.20724,0.26659,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0057394,0.20713,0.19035,1,1
2,GO MOTOR NEURON AXON GUIDANCE,0.015104,0.20712,0.24319,1,1
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.006955,0.20711,0.24862,1,1
2,GO TELENCEPHALON DEVELOPMENT,0.00045436,0.20703,0.26076,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.00054254,0.2069,0.27501,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.048745,0.20677,0.1837,1,1
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0038653,0.20674,0.31349,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0031545,0.20624,0.20585,1,1
2,GO HEAD DEVELOPMENT,0.00091199,0.20624,0.24269,1,1
2,GO CYTOKINESIS,0.00057531,0.20564,0.23512,1,1
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00020554,0.20549,0.22888,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.008797,0.20544,0.20772,1,1
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0019699,0.20521,0.23356,1,1
2,GO CELL DIVISION,0.00019306,0.20505,0.24589,1,1
2,GO PROTEIN MANNOSYLATION,0.010101,0.20456,0.2073,1,1
2,GO CELL PROJECTION ORGANIZATION,0.0012758,0.20412,0.23255,1,1
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.010101,0.20403,0.18722,1,1
2,GO REGULATION OF MITOPHAGY,0.011063,0.20402,0.22906,1,1
2,GO SPERMATID DIFFERENTIATION,0.00054254,0.20392,0.22371,1,1
2,GO UV PROTECTION,0.033245,0.20387,0.20908,1,1
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0011418,0.20369,0.25667,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.00086166,0.2036,0.28468,1,1
2,GO REGULATION OF LYASE ACTIVITY,0.0038653,0.20353,0.2157,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.00076864,0.20351,0.23384,1,1
2,GO CELL CYCLE CHECKPOINT,0.00076864,0.2034,0.28174,1,1
2,GO DEFINITIVE HEMOPOIESIS,0.038848,0.20326,0.25132,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0092139,0.20317,0.21347,1,1
2,GO REGULATION OF DOPAMINE SECRETION,0.022172,0.20289,0.26211,1,1
2,GO HISTONE H2A ACETYLATION,0.00060992,0.20256,0.24248,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.00072571,0.20219,0.25033,1,1
2,GO HISTONE DEACETYLATION,0.0083971,0.20185,0.22972,1,1
2,GO POSITIVE REGULATION OF FERTILIZATION,0.012106,0.20182,0.16704,1,1
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.00081392,0.20109,0.27243,1,1
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0017696,0.20091,0.23892,1,1
2,GO ASSOCIATIVE LEARNING,0.00042807,0.20046,0.2448,1,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0092139,0.20032,0.19187,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0057394,0.20014,0.17023,1,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00028019,0.19995,0.24786,1,1
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.015104,0.19959,0.24309,1,1
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0047188,0.19955,0.15142,1,1
2,GO FOREBRAIN DEVELOPMENT,0.00045436,0.19934,0.25818,1,1
2,GO METHYLATION,0.00086166,0.19933,0.21373,1,1
2,GO REGIONALIZATION,0.0054671,0.19931,0.21106,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00072571,0.19929,0.24214,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0011418,0.19922,0.24245,1,1
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00057531,0.1989,0.26814,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.022172,0.19856,0.1884,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.0020776,0.19853,0.28616,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0019699,0.19825,0.19051,1,1
2,GO ATP TRANSPORT,0.007293,0.1978,0.1966,1,1
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0036751,0.19769,0.22878,1,1
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0003797,0.19756,0.21484,1,1
2,GO HISTONE H2B UBIQUITINATION,0.018736,0.19675,0.17288,1,1
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.015104,0.19668,0.20864,1,1
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.010572,0.1965,0.2124,1,1
2,GO REGULATION OF DNA REPLICATION,0.00023283,0.1964,0.26739,1,1
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.011063,0.1963,0.22054,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0023095,0.19608,0.21124,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.021265,0.1956,0.2231,1,1
2,GO REGULATION OF NEURON MATURATION,0.0083971,0.1956,0.2724,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0027019,0.19486,0.24156,1,1
2,GO NEUROGENESIS,0.0016767,0.19482,0.22879,1,1
2,GO TRANSMISSION OF NERVE IMPULSE,0.0040644,0.19476,0.24093,1,1
2,GO ORGANELLE ASSEMBLY,0.00068502,0.19462,0.22267,1,1
2,GO MRNA PROCESSING,0.00048214,0.19447,0.23537,1,1
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0036751,0.19416,0.21524,1,1
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0080134,0.19413,0.22078,1,1
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.010101,0.19373,0.23071,1,1
2,GO PROTEIN MONOUBIQUITINATION,0.0012758,0.19362,0.24964,1,1
2,GO DNA CATABOLIC PROCESS,0.0013481,0.19343,0.19554,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0036751,0.19324,0.25768,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00332,0.19312,0.24146,1,1
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0019699,0.19279,0.23018,1,1
2,GO MITOPHAGY,0.010572,0.19274,0.20602,1,1
2,GO COGNITION,0.0023095,0.19273,0.20603,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0040644,0.19261,0.22112,1,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.00064645,0.19259,0.29323,1,1
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00081392,0.19242,0.21109,1,1
2,GO RNA SPLICING,0.0003797,0.19172,0.2316,1,1
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.013235,0.19165,0.27559,1,1
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0027019,0.19153,0.22611,1,1
2,GO REGULATION OF BEHAVIOR,0.0021907,0.1911,0.21612,1,1
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0047188,0.19079,0.24475,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00051151,0.19041,0.23462,1,1
2,GO GAMETE GENERATION,0.00031664,0.19006,0.22022,1,1
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015104,0.18992,0.19042,1,1
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.007293,0.18952,0.2314,1,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.00026348,0.18934,0.22381,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.00086166,0.18887,0.24228,1,1
2,GO REGULATION OF NUCLEAR DIVISION,0.00020554,0.18845,0.23313,1,1
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0029965,0.18831,0.22213,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00033648,0.18818,0.32467,1,1
2,GO RNA METHYLATION,0.0047188,0.18799,0.17762,1,1
2,GO PROTEIN TARGETING TO LYSOSOME,0.013235,0.18752,0.22406,1,1
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00028019,0.18743,0.24565,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00086166,0.18742,0.24183,1,1
2,GO MALE GAMETE GENERATION,0.00024771,0.18713,0.21992,1,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.0011418,0.18684,0.26543,1,1
2,GO SEGMENTATION,0.0080134,0.18681,0.20856,1,1
2,GO CATECHOLAMINE SECRETION,0.0017696,0.18664,0.3055,1,1
2,GO INCLUSION BODY ASSEMBLY,0.0049572,0.18558,0.25419,1,1
2,GO SEXUAL REPRODUCTION,0.00042807,0.18557,0.20712,1,1
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.01266,0.18556,0.12304,1,1
2,GO MACROMOLECULE DEACYLATION,0.0083971,0.18551,0.20207,1,1
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.00091199,0.18524,0.21239,1,1
2,GO SOMITE DEVELOPMENT,0.0060238,0.18495,0.22178,1,1
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.011574,0.18464,0.19677,1,1
2,GO MANNOSYLATION,0.0049572,0.18413,0.19467,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0015041,0.18404,0.17623,1,1
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.018736,0.18374,0.23495,1,1
2,GO TRNA TRANSPORT,0.0063209,0.18365,0.20712,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0021907,0.18359,0.23176,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0063209,0.18342,0.18794,1,1
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.015776,0.18321,0.16201,1,1
2,GO ONE CARBON METABOLIC PROCESS,0.028348,0.18317,0.15497,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0083971,0.18312,0.21493,1,1
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00024771,0.18276,0.2362,1,1
2,GO ORGANELLE LOCALIZATION,0.0023095,0.18244,0.19948,1,1
2,GO CARNITINE METABOLIC PROCESS,0.023112,0.18226,0.16686,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0092139,0.18168,0.22432,1,1
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.028348,0.18159,0.211,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008797,0.1814,0.24892,1,1
2,GO OLIGODENDROCYTE DEVELOPMENT,0.0027019,0.18138,0.2403,1,1
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.1812,0.21584,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00091199,0.18058,0.18695,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0010209,0.17996,0.19012,1,1
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0172,0.17937,0.20942,1,1
2,GO DNA METABOLIC PROCESS,0.0010798,0.17884,0.19834,1,1
2,GO LIMBIC SYSTEM DEVELOPMENT,0.00051151,0.17789,0.23845,1,1
2,GO MITOTIC CYTOKINESIS,0.00096503,0.17787,0.22193,1,1
2,GO GERM CELL DEVELOPMENT,0.00040321,0.17737,0.23508,1,1
2,GO POST EMBRYONIC DEVELOPMENT,0.0092139,0.17723,0.21817,1,1
2,GO EMBRYONIC PATTERN SPECIFICATION,0.00033648,0.17706,0.23755,1,1
2,GO CAMERA TYPE EYE DEVELOPMENT,0.0038653,0.17705,0.22412,1,1
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0013481,0.17698,0.22348,1,1
2,GO REGULATION OF CELL DIVISION,0.0036751,0.17676,0.1931,1,1
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.006955,0.17643,0.227,1,1
2,GO CELLULAR RESPONSE TO STEROL,0.015104,0.17637,0.23997,1,1
2,GO TRNA METHYLATION,0.006955,0.17588,0.17146,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0028457,0.17582,0.15293,1,1
2,GO FATTY ACID BETA OXIDATION,0.015776,0.1753,0.14433,1,1
2,GO REGULATION OF SENSORY PERCEPTION,0.0083971,0.17445,0.21658,1,1
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0023095,0.17443,0.2134,1,1
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0031545,0.17401,0.20188,1,1
2,GO RESPONSE TO UV,0.0028457,0.174,0.20034,1,1
2,GO REGULATION OF DNA RECOMBINATION,0.0060238,0.17387,0.202,1,1
2,GO POSITIVE REGULATION OF ACROSOME REACTION,0.020391,0.17387,0.15517,1,1
2,GO SYNAPTIC VESICLE RECYCLING,0.0063209,0.1738,0.21156,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE,0.0012758,0.17372,0.20419,1,1
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0010798,0.17363,0.19812,1,1
2,GO MITOTIC CELL CYCLE,0.00033648,0.17357,0.22624,1,1
2,GO SOMITOGENESIS,0.010572,0.17338,0.20619,1,1
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.012106,0.17311,0.18118,1,1
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0066311,0.17288,0.27942,1,1
2,GO NCRNA TRANSCRIPTION,0.00072571,0.17273,0.19565,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0012071,0.17263,0.2143,1,1
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011063,0.17212,0.17374,1,1
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0042727,0.17205,0.21335,1,1
2,GO FEMALE GAMETE GENERATION,0.0040644,0.17184,0.18724,1,1
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011574,0.17169,0.1921,1,1
2,GO NUCLEAR BODY ORGANIZATION,0.0021907,0.17159,0.20775,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.031957,0.17142,0.18115,1,1
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.021265,0.17133,0.25295,1,1
2,GO ACIDIC AMINO ACID TRANSPORT,0.0063209,0.17026,0.22647,1,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.00024771,0.17014,0.23384,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0016767,0.17012,0.18094,1,1
2,GO TELOMERE ORGANIZATION,0.0025648,0.16975,0.19919,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.012106,0.16955,0.20975,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.018736,0.16952,0.15856,1,1
2,GO REGULATION OF MEMBRANE POTENTIAL,0.0049572,0.16909,0.19387,1,1
2,GO CELL CYCLE PROCESS,0.00021879,0.16908,0.2401,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.00057531,0.16821,0.23178,1,1
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0096484,0.16794,0.18811,1,1
2,GO NUCLEAR EXPORT,0.00064645,0.16788,0.21759,1,1
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.011063,0.16738,0.19839,1,1
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0063209,0.16721,0.17876,1,1
2,GO DETECTION OF VISIBLE LIGHT,0.00057531,0.16678,0.1682,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.034576,0.16677,0.15352,1,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016475,0.16656,0.22274,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0047188,0.16639,0.2143,1,1
2,GO RNA SURVEILLANCE,0.0066311,0.16629,0.13674,1,1
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.015776,0.16586,0.26333,1,1
2,GO ACROSOME REACTION,0.017954,0.16519,0.17838,1,1
2,GO PEPTIDE HORMONE SECRETION,0.0031545,0.16432,0.20541,1,1
2,GO REGULATION OF CELL CYCLE,0.00045436,0.16419,0.22065,1,1
2,GO RNA DESTABILIZATION,0.02951,0.16399,0.20246,1,1
2,GO CELL CYCLE,0.00045436,0.1637,0.22206,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0020776,0.16358,0.1954,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0063209,0.16331,0.20068,1,1
2,GO PROTEIN SUMOYLATION,0.0015882,0.16312,0.21782,1,1
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0036751,0.1631,0.17731,1,1
2,GO AXIS SPECIFICATION,0.0031545,0.16307,0.2009,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00091199,0.16264,0.1987,1,1
2,GO CELL MORPHOGENESIS,0.010101,0.16261,0.20997,1,1
2,GO MECHANORECEPTOR DIFFERENTIATION,0.0023095,0.1626,0.20708,1,1
2,GO SNRNA TRANSCRIPTION,0.00068502,0.16253,0.19683,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0015882,0.16239,0.19237,1,1
2,GO DEMETHYLATION,0.0083971,0.16218,0.20403,1,1
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.010572,0.16143,0.17789,1,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.038848,0.16134,0.18518,1,1
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.035953,0.16045,0.15897,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.00010866,0.1604,0.24905,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.028348,0.16035,0.19383,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.006955,0.16019,0.16863,1,1
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00096503,0.16009,0.18395,1,1
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0066311,0.15976,0.12578,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.037377,0.15968,0.19882,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0015041,0.1596,0.24024,1,1
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.024086,0.15946,0.20258,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0083971,0.15909,0.15632,1,1
2,GO RESPONSE TO SALT,0.041938,0.15898,0.14333,1,1
2,GO NERVOUS SYSTEM PROCESS,0.010101,0.15891,0.16011,1,1
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.010101,0.15865,0.20628,1,1
2,GO MULTICELLULAR ORGANISM GROWTH,0.0027019,0.15847,0.22774,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.030713,0.15828,0.15959,1,1
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00019306,0.15824,0.18245,1,1
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0092139,0.15815,0.17322,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0038653,0.1576,0.21055,1,1
2,GO FERTILIZATION,0.0016767,0.15735,0.17489,1,1
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0019699,0.15724,0.19583,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.007293,0.15646,0.17775,1,1
2,GO NUCLEAR TRANSPORT,0.0010209,0.15614,0.19383,1,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011063,0.15543,0.18859,1,1
2,GO PHOTOTRANSDUCTION,0.0021907,0.15534,0.12707,1,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.013235,0.15528,0.16031,1,1
2,GO PROTEIN TARGETING TO VACUOLE,0.006955,0.15513,0.20825,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0025648,0.15501,0.18171,1,1
2,GO CELL CYCLE ARREST,0.00033648,0.155,0.22259,1,1
2,GO POSITIVE REGULATION OF MITOPHAGY,0.025096,0.15471,0.21872,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0023095,0.15424,0.1879,1,1
2,GO TRNA MODIFICATION,0.013834,0.15401,0.1426,1,1
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0028457,0.1535,0.20313,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00033648,0.15328,0.21393,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0036751,0.15311,0.22475,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.00029789,0.15293,0.21573,1,1
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.035953,0.15282,0.12197,1,1
2,GO DETECTION OF LIGHT STIMULUS,0.0015041,0.15241,0.13845,1,1
2,GO CIRCADIAN RHYTHM,0.0027019,0.15238,0.21112,1,1
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.02951,0.15208,0.17286,1,1
2,GO ENAMEL MINERALIZATION,0.028348,0.152,0.19641,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.00045436,0.15197,0.20577,1,1
2,GO RNA STABILIZATION,0.012106,0.15189,0.19348,1,1
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.019548,0.15182,0.15838,1,1
2,GO SEX DIFFERENTIATION,0.0054671,0.15172,0.18752,1,1
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.010572,0.1516,0.1787,1,1
2,GO DNA METHYLATION,0.014457,0.15149,0.1693,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0023095,0.15145,0.22513,1,1
2,GO HISTONE H3 ACETYLATION,0.016475,0.1506,0.18143,1,1
2,GO FOREBRAIN GENERATION OF NEURONS,0.035953,0.15046,0.18667,1,1
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00091199,0.15042,0.17156,1,1
2,GO MRNA METABOLIC PROCESS,0.00076864,0.15034,0.17532,1,1
2,GO TOR SIGNALING,0.006955,0.15028,0.19224,1,1
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0036751,0.14953,0.20193,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0021907,0.14942,0.20111,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00096503,0.14941,0.15737,1,1
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.010572,0.14886,0.18918,1,1
2,GO RNA PROCESSING,0.0018673,0.14884,0.17564,1,1
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0047188,0.14729,0.20927,1,1
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.012106,0.14708,0.17557,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.00332,0.14683,0.16296,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.0019699,0.14679,0.18062,1,1
2,GO REGULATION OF MITOTIC CELL CYCLE,0.00045436,0.14643,0.20608,1,1
2,GO RNA LOCALIZATION,0.0024341,0.14633,0.17913,1,1
2,GO REGULATION OF GLUCONEOGENESIS,0.028348,0.14624,0.18234,1,1
2,GO RNA MODIFICATION,0.012106,0.14619,0.12662,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0057394,0.14616,0.13469,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0027019,0.1456,0.16837,1,1
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0092139,0.1455,0.17136,1,1
2,GO AMINE TRANSPORT,0.006955,0.14523,0.24304,1,1
2,GO PROSTATE GLAND GROWTH,0.035953,0.14508,0.1598,1,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0016767,0.14476,0.15688,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.0096484,0.14467,0.2032,1,1
2,GO IMPORT INTO NUCLEUS,0.0060238,0.14444,0.16533,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.028348,0.14418,0.14884,1,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.024086,0.14409,0.13822,1,1
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.010101,0.14403,0.17563,1,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.045233,0.14379,0.18279,1,1
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0063209,0.14353,0.20606,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.011574,0.14352,0.17209,1,1
2,GO PEPTIDYL THREONINE MODIFICATION,0.02951,0.14333,0.18387,1,1
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.027226,0.14248,0.20506,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0096484,0.14244,0.17302,1,1
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.041938,0.14233,0.12724,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.0060238,0.14229,0.18966,1,1
2,GO OVULATION CYCLE,0.035953,0.14198,0.19139,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.045233,0.14185,0.14183,1,1
2,GO COENZYME A METABOLIC PROCESS,0.014457,0.14163,0.17846,1,1
2,GO REGULATION OF CELL AGING,0.034576,0.14135,0.16733,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.014457,0.14104,0.16565,1,1
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.023112,0.14079,0.16772,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.010572,0.13946,0.17476,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.0010209,0.13946,0.19024,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.0015882,0.13926,0.14272,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.034576,0.13906,0.14971,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.034576,0.13866,0.14771,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0038653,0.13857,0.16141,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0029965,0.13847,0.17032,1,1
2,GO SENSORY PERCEPTION OF SMELL,0.0054671,0.13798,0.12886,1,1
2,GO CELLULAR RESPONSE TO UV,0.0060238,0.13797,0.17858,1,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.023112,0.13759,0.28722,1,1
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.011063,0.13735,0.24859,1,1
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.040368,0.13701,0.19939,1,1
2,GO APOPTOTIC DNA FRAGMENTATION,0.0076456,0.13699,0.17499,1,1
2,GO RESPONSE TO AMINO ACID STARVATION,0.00332,0.13685,0.19855,1,1
2,GO DEVELOPMENTAL GROWTH,0.015776,0.13683,0.18693,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.014457,0.13571,0.17311,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0028457,0.13567,0.16179,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0060238,0.13563,0.18147,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0066311,0.1354,0.17059,1,1
2,GO PEPTIDYL SERINE MODIFICATION,0.013834,0.13499,0.18126,1,1
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.02951,0.13491,0.1873,1,1
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0057394,0.13461,0.20743,1,1
2,GO TRNA PROCESSING,0.0172,0.13448,0.11955,1,1
2,GO SINGLE FERTILIZATION,0.0011418,0.13426,0.1777,1,1
2,GO CLATHRIN COAT ASSEMBLY,0.016475,0.13406,0.17693,1,1
2,GO REGULATION OF CELL MATURATION,0.0023095,0.13396,0.17962,1,1
2,GO GOLGI LOCALIZATION,0.023112,0.13367,0.13195,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.010572,0.1334,0.12038,1,1
2,GO FEMALE SEX DIFFERENTIATION,0.011063,0.13335,0.20006,1,1
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.0063209,0.13311,0.17185,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.014457,0.13305,0.16694,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0036751,0.13299,0.17605,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.0092139,0.13147,0.15314,1,1
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0083971,0.13094,0.18167,1,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.017954,0.13055,0.17199,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0021907,0.13054,0.20767,1,1
2,GO UBIQUINONE METABOLIC PROCESS,0.0083971,0.13053,0.13395,1,1
2,GO CELLULAR RESPONSE TO ALKALOID,0.028348,0.13003,0.15904,1,1
2,GO CELLULAR RESPONSE TO RADIATION,0.0096484,0.13,0.14629,1,1
2,GO RHYTHMIC PROCESS,0.0028457,0.12982,0.20592,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0096484,0.12959,0.14941,1,1
2,GO REGULATION OF DEPHOSPHORYLATION,0.035953,0.12938,0.15757,1,1
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.007293,0.1289,0.17369,1,1
2,GO TRNA METABOLIC PROCESS,0.022172,0.12872,0.11862,1,1
2,GO REGULATION OF PROTEIN ACETYLATION,0.020391,0.12798,0.15114,1,1
2,GO INSULIN SECRETION,0.008797,0.12779,0.1892,1,1
2,GO CELLULAR RESPONSE TO STARVATION,0.011574,0.12663,0.17486,1,1
2,GO MAGNESIUM ION TRANSPORT,0.0047188,0.12651,0.19961,1,1
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.026142,0.1265,0.20069,1,1
2,GO LIPID DROPLET ORGANIZATION,0.007293,0.12555,0.1757,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.025096,0.12539,0.12997,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0092139,0.12436,0.17965,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0092139,0.1243,0.15752,1,1
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.016475,0.12398,0.15457,1,1
2,GO SNRNA METABOLIC PROCESS,0.0063209,0.12342,0.13702,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.027226,0.12282,0.12102,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.010101,0.12263,0.1414,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.01266,0.12251,0.14705,1,1
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.035953,0.12207,0.1358,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.035953,0.12206,0.1209,1,1
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.040368,0.1219,0.14512,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0021907,0.12151,0.13975,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.01266,0.12122,0.12895,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0023095,0.12109,0.14079,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0063209,0.1209,0.18469,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0029965,0.1208,0.17659,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.037377,0.12076,0.13015,1,1
2,GO REGULATION OF INSULIN SECRETION,0.0096484,0.12046,0.18576,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.012106,0.12034,0.17442,1,1
2,GO CELL CELL SIGNALING,0.030713,0.12033,0.14223,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.041938,0.12008,0.13796,1,1
2,GO PHOTOPERIODISM,0.020391,0.12001,0.18142,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.014457,0.11941,0.19421,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.021265,0.11931,0.14073,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.046961,0.11879,0.12553,1,1
2,GO RESPONSE TO RADIATION,0.0076456,0.1186,0.15235,1,1
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0018673,0.11843,0.13672,1,1
2,GO DNA MODIFICATION,0.020391,0.1181,0.13638,1,1
2,GO PROTEIN IMPORT,0.025096,0.11721,0.13082,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.035953,0.11717,0.19237,1,1
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.017954,0.11704,0.12837,1,1
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.034576,0.11618,0.1826,1,1
2,GO RESPONSE TO STARVATION,0.014457,0.11508,0.16516,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.033245,0.1149,0.14318,1,1
2,GO STRIATED MUSCLE ADAPTATION,0.028348,0.1146,0.18813,1,1
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.048745,0.11432,0.14181,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0080134,0.11415,0.14291,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.02951,0.11402,0.16014,1,1
2,GO TRANSPOSITION,0.033245,0.11346,0.15878,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.011574,0.11268,0.12279,1,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.034576,0.11177,0.11564,1,1
2,GO VESICLE LOCALIZATION,0.019548,0.11126,0.15319,1,1
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0076456,0.10993,0.2034,1,1
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.012106,0.1088,0.12191,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.014457,0.10762,0.13241,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.025096,0.10686,0.12774,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.027226,0.10637,0.13246,1,1
2,GO PROTEIN NEDDYLATION,0.016475,0.10634,0.11052,1,1
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0076456,0.10576,0.14726,1,1
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.031957,0.10503,0.18159,1,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.026142,0.10496,0.14472,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00332,0.10479,0.14452,1,1
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.013235,0.10409,0.15133,1,1
2,GO INTRACELLULAR MRNA LOCALIZATION,0.028348,0.10377,0.18142,1,1
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.043559,0.10372,0.16973,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.0029965,0.10324,0.14301,1,1
2,GO ESTABLISHMENT OF CELL POLARITY,0.015776,0.10322,0.19714,1,1
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.026142,0.10245,0.12871,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.017954,0.10115,0.18223,1,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.027226,0.10066,0.12515,1,1
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.030713,0.099341,0.13292,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.031957,0.09888,0.14412,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.037377,0.098835,0.12632,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.028348,0.097184,0.12203,1,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0063209,0.09469,0.11693,1,1
2,GO REGULATION OF ATPASE ACTIVITY,0.011574,0.094054,0.12771,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.048745,0.092442,0.12033,1,1
2,GO ORGANELLE DISASSEMBLY,0.027226,0.091837,0.13106,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.025096,0.091604,0.11727,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.018736,0.090437,0.10011,1,1
2,GO MACROAUTOPHAGY,0.048745,0.089653,0.1248,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.037377,0.089282,0.16457,1,1
2,GO PROTEIN DEPHOSPHORYLATION,0.015776,0.085337,0.14065,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.015104,0.084541,0.076801,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.023112,0.081228,0.071508,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.011063,0.079335,0.091809,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.035953,0.079033,0.095524,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.017954,0.075385,0.12411,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.020391,0.073013,0.10413,1,1
2,GO RNA CATABOLIC PROCESS,0.01266,0.067845,0.091944,1,1
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.028348,0.065361,0.075438,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.013235,0.057302,0.087028,1,1
2,GO PROTEIN TARGETING,0.008797,0.055792,0.069696,1,1
3,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.027226,0.81585,0.62653,1,1
3,GO T CELL TOLERANCE INDUCTION,0.026142,0.80233,0.5658,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00014989,0.75503,0.61569,1,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.007293,0.75103,0.64269,1,1
3,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.037377,0.7416,0.41856,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.043559,0.65557,0.46477,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012758,0.64165,0.54118,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0015041,0.62234,0.53192,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.037377,0.62094,0.46213,1,1
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00096503,0.60951,0.50831,1,1
3,GO POSITIVE T CELL SELECTION,0.030713,0.5698,0.42416,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00057531,0.56377,0.49539,1,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.007293,0.55075,0.40968,1,1
3,GO VOCALIZATION BEHAVIOR,0.00096503,0.53646,0.4594,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.026142,0.53359,0.37385,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.046961,0.53118,0.38903,1,1
3,GO SYNAPSE MATURATION,0.0015041,0.52541,0.46096,1,1
3,GO POSITIVE THYMIC T CELL SELECTION,0.035953,0.52242,0.45,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0015882,0.52212,0.43715,1,1
3,GO THYMIC T CELL SELECTION,0.026142,0.51904,0.42731,1,1
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0012071,0.51415,0.4376,1,1
3,GO PREPULSE INHIBITION,0.0063209,0.51155,0.44871,1,1
3,GO REGULATION OF SYNAPSE MATURATION,0.0034935,0.51128,0.44826,1,1
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.010572,0.50832,0.37823,1,1
3,GO REGULATION OF GLUTAMATE SECRETION,0.00057531,0.50221,0.4948,1,1
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.023112,0.49911,0.42237,1,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.027226,0.49785,0.45996,1,1
3,GO RESPONSE TO INTERLEUKIN 2,0.018736,0.4951,0.41796,1,1
3,GO INNER DYNEIN ARM ASSEMBLY,0.033245,0.49293,0.34548,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.010101,0.49257,0.46101,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,3.0304e-05,0.4905,0.47373,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.034576,0.48428,0.34372,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00068502,0.48313,0.42871,1,1
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.010572,0.48015,0.40191,1,1
3,GO MACROPHAGE PROLIFERATION,0.027226,0.47946,0.40457,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00018128,0.47283,0.47753,1,1
3,GO LONG TERM SYNAPTIC DEPRESSION,8.9327e-05,0.47222,0.42572,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00035748,0.47129,0.49432,1,1
3,GO T CELL SELECTION,0.030713,0.46968,0.40736,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0015041,0.46915,0.40725,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.034576,0.46805,0.43573,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.02951,0.46535,0.39582,1,1
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0018673,0.46468,0.44606,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0029965,0.46112,0.40727,1,1
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0013481,0.46107,0.43275,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.046961,0.45471,0.37581,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.035953,0.45424,0.33169,1,1
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00021879,0.45341,0.39932,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,0.045233,0.44505,0.37201,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00081392,0.44316,0.43016,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,1.8524e-05,0.44005,0.49279,1,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.033245,0.43904,0.35464,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0066311,0.43875,0.45095,1,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00028019,0.43832,0.38124,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.046961,0.43831,0.35268,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.0012758,0.43767,0.39209,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00017019,0.4351,0.40781,1,1
3,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.0063209,0.43107,0.3897,1,1
3,GO MICROTUBULE DEPOLYMERIZATION,0.0012758,0.431,0.41682,1,1
3,GO POSTSYNAPSE ASSEMBLY,0.0021907,0.43022,0.42492,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0014241,0.43009,0.49362,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0015882,0.42708,0.37763,1,1
3,GO NEGATIVE T CELL SELECTION,0.045233,0.42701,0.47913,1,1
3,GO MEMBRANE HYPERPOLARIZATION,0.0024341,0.427,0.43055,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0021907,0.42585,0.58018,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00068502,0.42447,0.36647,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0016767,0.42421,0.39184,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.028348,0.42413,0.35418,1,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.033245,0.42372,0.29014,1,1
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00045436,0.42255,0.40464,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,2.8267e-05,0.41979,0.43715,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0015041,0.4197,0.51677,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00010181,0.41896,0.46271,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00035748,0.41889,0.43294,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.00033648,0.41807,0.39887,1,1
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00023283,0.41481,0.46223,1,1
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.012106,0.41413,0.31146,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.046961,0.4118,0.40554,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.00060992,0.41159,0.37943,1,1
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00020554,0.41094,0.41566,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00060992,0.41091,0.42187,1,1
3,GO SYNAPTIC VESICLE BUDDING,0.00018128,0.40977,0.3979,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00026348,0.40791,0.35673,1,1
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.046961,0.40722,0.3647,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.041938,0.40349,0.32456,1,1
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0049572,0.40245,0.36731,1,1
3,GO RESPONSE TO POTASSIUM ION,0.011574,0.40233,0.30948,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.0003797,0.39805,0.439,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0010209,0.3977,0.37416,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.011063,0.39706,0.31876,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.0047188,0.3958,0.35866,1,1
3,GO FOREBRAIN NEURON DEVELOPMENT,0.0047188,0.39387,0.30268,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.00014989,0.3931,0.50064,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00091199,0.39267,0.39593,1,1
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.025096,0.39237,0.41414,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.02951,0.39212,0.33655,1,1
3,GO NEURON CELLULAR HOMEOSTASIS,0.00054254,0.38937,0.39208,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0042727,0.38687,0.33511,1,1
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00076864,0.38633,0.35682,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00029789,0.38594,0.36551,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0015041,0.38568,0.33676,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,6.8565e-05,0.38554,0.42459,1,1
3,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.027226,0.3849,0.32119,1,1
3,GO DIVALENT METAL ION EXPORT,0.0018673,0.38417,0.39715,1,1
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.013834,0.38412,0.30994,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00020554,0.38317,0.3789,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.046961,0.38195,0.30431,1,1
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0023095,0.38189,0.3449,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.041938,0.3818,0.31443,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0017696,0.38133,0.32721,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,2.4576e-05,0.38043,0.37907,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.013235,0.37869,0.30025,1,1
3,GO COLLATERAL SPROUTING,0.0019699,0.37863,0.34168,1,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0052065,0.37719,0.40382,1,1
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.00081392,0.37648,0.45434,1,1
3,GO CARDIAC CHAMBER FORMATION,0.0012758,0.37629,0.43964,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0015882,0.37579,0.36481,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0015882,0.37126,0.35701,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.034576,0.37103,0.33085,1,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.020391,0.37008,0.36222,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.02951,0.37,0.307,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0060238,0.36999,0.33497,1,1
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0029965,0.3699,0.41024,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.045233,0.36983,0.38632,1,1
3,GO RECEPTOR CLUSTERING,0.006955,0.36977,0.31911,1,1
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0036751,0.36918,0.34325,1,1
3,GO NOREPINEPHRINE SECRETION,0.00091199,0.36733,0.39769,1,1
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0025648,0.36729,0.3205,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0028457,0.36619,0.33702,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00096503,0.3649,0.35037,1,1
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00086166,0.36427,0.34322,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.041938,0.36388,0.29171,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0024341,0.36369,0.32277,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.028348,0.36212,0.29484,1,1
3,GO NEUROMUSCULAR PROCESS,0.00018128,0.36161,0.37355,1,1
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.038848,0.3616,0.26489,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.013235,0.36135,0.29413,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00035748,0.36062,0.39579,1,1
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.00051151,0.36032,0.35328,1,1
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.010101,0.35958,0.33324,1,1
3,GO T CELL LINEAGE COMMITMENT,0.041938,0.35951,0.30352,1,1
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00068502,0.35874,0.29127,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013834,0.35843,0.25763,1,1
3,GO REGULATION OF LYASE ACTIVITY,1.7249e-05,0.35754,0.36269,1,1
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0063209,0.3572,0.38502,1,1
3,GO ALANINE TRANSPORT,0.00086166,0.35551,0.38366,1,1
3,GO OLFACTORY LOBE DEVELOPMENT,0.018736,0.35496,0.2701,1,1
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0076456,0.35431,0.29183,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.022172,0.35261,0.27409,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0038653,0.35258,0.33815,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.010572,0.35226,0.34177,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.023112,0.35206,0.28163,1,1
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.00332,0.35126,0.32459,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00096503,0.34942,0.36855,1,1
3,GO LIPID GLYCOSYLATION,0.00054254,0.34927,0.34936,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0042727,0.34922,0.28972,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0060238,0.3492,0.30857,1,1
3,GO HISTONE H3 K27 METHYLATION,0.0042727,0.34774,0.33497,1,1
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00096503,0.34731,0.43444,1,1
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0036751,0.3469,0.40585,1,1
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.006955,0.34639,0.3356,1,1
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0011418,0.34549,0.32695,1,1
3,GO REGULATION OF GLIAL CELL MIGRATION,0.027226,0.34521,0.34146,1,1
3,GO REGULATION OF COLLATERAL SPROUTING,0.0049572,0.34478,0.31639,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.028348,0.34439,0.37534,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.022172,0.34403,0.26374,1,1
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0021907,0.34356,0.34094,1,1
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.011574,0.34301,0.30264,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.035953,0.3422,0.31712,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.00010866,0.34215,0.41895,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00068502,0.34159,0.43292,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00060992,0.34085,0.35796,1,1
3,GO RESPONSE TO ACETYLCHOLINE,0.00072571,0.3404,0.39229,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0057394,0.34036,0.36125,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.030713,0.34035,0.27544,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.038848,0.34005,0.33815,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,9.5377e-05,0.33953,0.39415,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0052065,0.33952,0.41517,1,1
3,GO SPINAL CORD PATTERNING,0.0076456,0.33949,0.33422,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.00057531,0.33936,0.37209,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00029789,0.3393,0.33382,1,1
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0034935,0.33873,0.35139,1,1
3,GO LOCALIZATION WITHIN MEMBRANE,0.0019699,0.33823,0.29352,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0036751,0.33785,0.31371,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.013235,0.33721,0.27581,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0029965,0.33717,0.318,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0057394,0.33693,0.31274,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,0.0012071,0.33687,0.35827,1,1
3,GO HEART VALVE FORMATION,0.0010798,0.33512,0.43739,1,1
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.026142,0.33502,0.38754,1,1
3,GO GLUTAMATE SECRETION,0.00042807,0.33461,0.36026,1,1
3,GO APOPTOTIC CELL CLEARANCE,0.041938,0.33446,0.30217,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0011418,0.3344,0.32423,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00091199,0.33293,0.39832,1,1
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0012071,0.3329,0.34032,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00040321,0.33259,0.31242,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.038848,0.33238,0.2851,1,1
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00068502,0.33182,0.31692,1,1
3,GO NEUTROPHIL EXTRAVASATION,0.030713,0.33098,0.32038,1,1
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0019699,0.33084,0.35265,1,1
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0012071,0.33069,0.30282,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.018736,0.33045,0.25825,1,1
3,GO RETROGRADE AXONAL TRANSPORT,0.0054671,0.33038,0.34199,1,1
3,GO AZOLE TRANSMEMBRANE TRANSPORT,0.0012758,0.33021,0.36091,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.023112,0.33008,0.3565,1,1
3,GO PHAGOCYTOSIS RECOGNITION,0.020391,0.32992,0.29507,1,1
3,GO MAST CELL MIGRATION,0.027226,0.32972,0.27244,1,1
3,GO RETINA LAYER FORMATION,0.020391,0.32906,0.25711,1,1
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0013481,0.32901,0.31906,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,3.248e-05,0.32827,0.42887,1,1
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0027019,0.32822,0.35941,1,1
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0010798,0.32766,0.35219,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.006955,0.3272,0.29788,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.041938,0.32649,0.28076,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00091199,0.32589,0.32576,1,1
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.046961,0.32573,0.29906,1,1
3,GO RESPONSE TO INSECTICIDE,0.0028457,0.32369,0.31222,1,1
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0003797,0.3234,0.35299,1,1
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0017696,0.32265,0.41284,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.045233,0.32158,0.27456,1,1
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0021907,0.32098,0.33023,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0003797,0.32065,0.36728,1,1
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.0034935,0.32064,0.27564,1,1
3,GO AORTIC VALVE DEVELOPMENT,0.021265,0.32063,0.25865,1,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00045436,0.32027,0.29682,1,1
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.00057531,0.31989,0.36685,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0016767,0.31966,0.39895,1,1
3,GO BASIC AMINO ACID TRANSPORT,0.00091199,0.31951,0.36525,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.0034935,0.31927,0.28118,1,1
3,GO REGULATION OF B CELL ACTIVATION,0.045233,0.31792,0.31336,1,1
3,GO MAST CELL ACTIVATION,0.028348,0.3178,0.29127,1,1
3,GO POSTSYNAPSE ORGANIZATION,0.0015041,0.31743,0.30424,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.00060992,0.3171,0.39362,1,1
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00076864,0.31679,0.30582,1,1
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.012106,0.3164,0.32649,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.007293,0.31631,0.30296,1,1
3,GO RESPONSE TO LEUCINE,0.00031664,0.3161,0.40798,1,1
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.007293,0.31594,0.30005,1,1
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0040644,0.31558,0.30034,1,1
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.041938,0.31508,0.1508,1,1
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.00091199,0.31483,0.34798,1,1
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.020391,0.31305,0.25772,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.010572,0.31206,0.2812,1,1
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00045436,0.31198,0.34838,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.0024341,0.31156,0.3645,1,1
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0038653,0.31151,0.31891,1,1
3,GO PIGMENT ACCUMULATION,0.0060238,0.31138,0.32791,1,1
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00091199,0.3113,0.32448,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,7.8298e-05,0.31047,0.32663,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.011574,0.30974,0.3078,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00048214,0.30947,0.34706,1,1
3,GO REGULATION OF VESICLE FUSION,0.0034935,0.30914,0.30204,1,1
3,GO SYNAPTIC VESICLE MATURATION,0.0042727,0.3087,0.4084,1,1
3,GO NEURON MATURATION,0.010572,0.30852,0.24968,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.025096,0.30802,0.25212,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,8.3641e-05,0.30773,0.34147,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0010209,0.3076,0.3396,1,1
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0057394,0.3074,0.29114,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0027019,0.30693,0.28333,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0013481,0.30635,0.30502,1,1
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.013235,0.30624,0.29562,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.046961,0.30605,0.27037,1,1
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.023112,0.30587,0.28171,1,1
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0012071,0.30572,0.28938,1,1
3,GO SYNAPTIC VESICLE LOCALIZATION,0.0028457,0.30529,0.30294,1,1
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0057394,0.30483,0.26248,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.040368,0.30457,0.27722,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.030713,0.30447,0.30796,1,1
3,GO MECHANOSENSORY BEHAVIOR,0.033245,0.30444,0.25875,1,1
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.00076864,0.30444,0.34019,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.00029789,0.30423,0.32363,1,1
3,GO CD40 SIGNALING PATHWAY,0.038848,0.30422,0.27723,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.017954,0.30411,0.34586,1,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,9.5377e-05,0.30379,0.34397,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0015041,0.30337,0.39492,1,1
3,GO POST ANAL TAIL MORPHOGENESIS,0.023112,0.30314,0.27135,1,1
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.0003797,0.30314,0.36665,1,1
3,GO PROTEIN KINASE C SIGNALING,0.0054671,0.30286,0.30194,1,1
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00096503,0.30226,0.33532,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0010209,0.30202,0.37043,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.0036751,0.3019,0.2732,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,4.8997e-05,0.30179,0.36507,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,0.0040644,0.30115,0.32139,1,1
3,GO MAST CELL MEDIATED IMMUNITY,0.027226,0.30088,0.29383,1,1
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.015776,0.30056,0.2741,1,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0066311,0.30054,0.34065,1,1
3,GO LEARNING,0.0052065,0.30048,0.2775,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0012758,0.29973,0.33016,1,1
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0015041,0.29961,0.3074,1,1
3,GO T CELL DIFFERENTIATION,0.045233,0.29939,0.28531,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.007293,0.2991,0.30358,1,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.00091199,0.29904,0.35602,1,1
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.00072571,0.29897,0.33039,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.025096,0.29861,0.31383,1,1
3,GO STARTLE RESPONSE,0.010572,0.29849,0.33875,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.040368,0.2983,0.28845,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.023112,0.29825,0.22916,1,1
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00040321,0.29822,0.32696,1,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.0042727,0.29805,0.32516,1,1
3,GO B CELL HOMEOSTASIS,0.040368,0.29779,0.29471,1,1
3,GO LONG TERM SYNAPTIC POTENTIATION,0.00054254,0.29761,0.32522,1,1
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0014241,0.29759,0.31725,1,1
3,GO CELL JUNCTION MAINTENANCE,0.0040644,0.29625,0.31736,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00013188,0.29616,0.33487,1,1
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.031957,0.29504,0.23675,1,1
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0029965,0.29491,0.30974,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.045233,0.29456,0.28427,1,1
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00091199,0.29453,0.37482,1,1
3,GO CARDIOBLAST DIFFERENTIATION,0.033245,0.29447,0.21541,1,1
3,GO CEREBRAL CORTEX CELL MIGRATION,0.017954,0.29378,0.25858,1,1
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0052065,0.29368,0.24946,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00048214,0.29366,0.37218,1,1
3,GO NEURON PROJECTION GUIDANCE,0.0021907,0.29364,0.3104,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0024341,0.29315,0.3669,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.038848,0.29289,0.30806,1,1
3,GO LONG TERM MEMORY,0.00014989,0.2922,0.35011,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,0.00019306,0.29218,0.39127,1,1
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0027019,0.29194,0.2563,1,1
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.0049572,0.29155,0.29642,1,1
3,GO NEUROTRANSMITTER SECRETION,0.0023095,0.29145,0.30538,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.012106,0.29119,0.34131,1,1
3,GO NEURON FATE SPECIFICATION,0.024086,0.29115,0.26131,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0027019,0.2908,0.27071,1,1
3,GO AXON EXTENSION,0.00076864,0.29077,0.32546,1,1
3,GO NEURAL CREST FORMATION,0.025096,0.2907,0.30562,1,1
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00017019,0.29048,0.28953,1,1
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0047188,0.29017,0.32007,1,1
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0019699,0.28995,0.32447,1,1
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.0015041,0.28909,0.37208,1,1
3,GO REGULATION OF AXONOGENESIS,0.00081392,0.28902,0.34222,1,1
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.013235,0.28868,0.25361,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.041938,0.28833,0.24669,1,1
3,GO RESPONSE TO GLUCAGON,0.0014241,0.28792,0.30754,1,1
3,GO LYMPHOCYTE ACTIVATION,0.035953,0.28788,0.27094,1,1
3,GO PODOSOME ASSEMBLY,0.0049572,0.28711,0.32975,1,1
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0083971,0.28688,0.30094,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.012106,0.28665,0.29588,1,1
3,GO SYNAPTIC SIGNALING,0.0013481,0.28645,0.28645,1,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.0018673,0.28615,0.29912,1,1
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0172,0.28589,0.22807,1,1
3,GO CGMP METABOLIC PROCESS,0.0028457,0.28578,0.32266,1,1
3,GO MEIOTIC SPINDLE ORGANIZATION,0.01266,0.28574,0.29534,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0019699,0.2857,0.38605,1,1
3,GO NEURON PROJECTION ORGANIZATION,0.0010798,0.28517,0.32266,1,1
3,GO RESPONSE TO PROSTAGLANDIN,0.033245,0.28505,0.23603,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0044907,0.28505,0.25082,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00332,0.28491,0.25306,1,1
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.013235,0.28462,0.30864,1,1
3,GO CHROMATIN SILENCING AT TELOMERE,0.037377,0.28458,0.21458,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0028457,0.28439,0.30079,1,1
3,GO DENDRITE MORPHOGENESIS,0.0080134,0.2843,0.28039,1,1
3,GO TORC1 SIGNALING,0.00091199,0.28363,0.32333,1,1
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00014062,0.28346,0.32061,1,1
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0083971,0.28328,0.30308,1,1
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0036751,0.28267,0.29697,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0010209,0.28261,0.29943,1,1
3,GO NEURON MIGRATION,0.0057394,0.28226,0.28502,1,1
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0019699,0.28162,0.29247,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.027226,0.28147,0.2787,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.040368,0.28139,0.27393,1,1
3,GO REGULATION OF B CELL PROLIFERATION,0.043559,0.28088,0.34872,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00086166,0.28074,0.29437,1,1
3,GO FUCOSYLATION,0.0063209,0.28026,0.24065,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.025096,0.28003,0.2601,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.015104,0.28002,0.26024,1,1
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.048745,0.27989,0.23503,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.00076864,0.27944,0.31484,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0017696,0.2791,0.32323,1,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.035953,0.27909,0.24318,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0040644,0.27861,0.2829,1,1
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.010572,0.27821,0.27238,1,1
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0031545,0.27775,0.26236,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0066311,0.27715,0.29485,1,1
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.00086166,0.27709,0.32264,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.0172,0.27691,0.2385,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.048745,0.27685,0.20446,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.013834,0.27684,0.25434,1,1
3,GO SECRETORY GRANULE LOCALIZATION,0.021265,0.27671,0.26423,1,1
3,GO POTASSIUM ION HOMEOSTASIS,0.0031545,0.27657,0.25266,1,1
3,GO MICROTUBULE POLYMERIZATION,0.0042727,0.27649,0.28109,1,1
3,GO B CELL ACTIVATION,0.045233,0.27602,0.2849,1,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0054671,0.2755,0.31579,1,1
3,GO CELL FATE SPECIFICATION,0.007293,0.2752,0.22715,1,1
3,GO ACTIVATION OF JNKK ACTIVITY,0.0040644,0.27482,0.30109,1,1
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.01266,0.27482,0.27337,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0076456,0.2745,0.29788,1,1
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0027019,0.27407,0.25244,1,1
3,GO NEURON REMODELING,0.016475,0.27394,0.32543,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0049572,0.27388,0.28127,1,1
3,GO WALKING BEHAVIOR,0.00072571,0.27385,0.31065,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.043559,0.27364,0.21551,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.043559,0.27341,0.22522,1,1
3,GO REGULATION OF TORC1 SIGNALING,0.0014241,0.27308,0.29812,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.037377,0.27282,0.18845,1,1
3,GO DENDRITE DEVELOPMENT,0.0047188,0.2724,0.28071,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0060238,0.27198,0.26285,1,1
3,GO MYOTUBE CELL DEVELOPMENT,0.007293,0.27185,0.22984,1,1
3,GO STORE OPERATED CALCIUM ENTRY,0.011574,0.27159,0.26626,1,1
3,GO NEURON RECOGNITION,0.0066311,0.2707,0.27671,1,1
3,GO PROTEIN POLYGLUTAMYLATION,0.0054671,0.27011,0.31572,1,1
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.016475,0.2699,0.27791,1,1
3,GO T CELL HOMEOSTASIS,0.021265,0.26976,0.24673,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0010209,0.26925,0.28881,1,1
3,GO NEURON PROJECTION EXTENSION,0.0015041,0.2689,0.2939,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.021265,0.26888,0.35787,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.017954,0.26874,0.33227,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0028457,0.26866,0.28407,1,1
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00068502,0.26865,0.29925,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.01266,0.26854,0.23075,1,1
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00021879,0.26844,0.32628,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.025096,0.26835,0.23334,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0038653,0.26805,0.26602,1,1
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00076864,0.268,0.32306,1,1
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0023095,0.26771,0.26888,1,1
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0020776,0.26735,0.37363,1,1
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.023112,0.26731,0.28167,1,1
3,GO LYSOSOME LOCALIZATION,0.0063209,0.26669,0.27828,1,1
3,GO NEUROTRANSMITTER TRANSPORT,0.0016767,0.26666,0.29446,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.046961,0.26654,0.21187,1,1
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0010798,0.26653,0.27662,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0080134,0.26647,0.30647,1,1
3,GO CGMP MEDIATED SIGNALING,0.006955,0.26639,0.24801,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00040321,0.26629,0.27925,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.040368,0.26607,0.26649,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.01266,0.26597,0.30905,1,1
3,GO REGULATION OF AXON GUIDANCE,0.0076456,0.26595,0.28625,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0016767,0.26589,0.24994,1,1
3,GO SPINAL CORD DEVELOPMENT,0.00332,0.26588,0.27766,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00057531,0.26559,0.33298,1,1
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.011063,0.26551,0.26504,1,1
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.033245,0.2655,0.20012,1,1
3,GO PINOCYTOSIS,0.035953,0.26518,0.23878,1,1
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0076456,0.2651,0.25149,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0063209,0.26505,0.27035,1,1
3,GO CELL CELL JUNCTION MAINTENANCE,0.010572,0.2648,0.2937,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0019699,0.26456,0.27771,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.017954,0.26429,0.27035,1,1
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0047188,0.2641,0.26336,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0080134,0.26351,0.30558,1,1
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0038653,0.26334,0.27649,1,1
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00096503,0.2632,0.2989,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.030713,0.26312,0.21758,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00086166,0.26257,0.26389,1,1
3,GO EATING BEHAVIOR,0.0003797,0.26246,0.32709,1,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0012758,0.26244,0.317,1,1
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.00072571,0.26129,0.30376,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.00054254,0.26124,0.26146,1,1
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.046961,0.26082,0.20844,1,1
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.0034935,0.26069,0.26102,1,1
3,GO ADULT BEHAVIOR,0.0052065,0.26054,0.2678,1,1
3,GO CELL PART MORPHOGENESIS,0.0036751,0.26045,0.27234,1,1
3,GO GLIAL CELL MIGRATION,0.0024341,0.26004,0.30021,1,1
3,GO RESPONSE TO NICOTINE,0.017954,0.25968,0.23429,1,1
3,GO EPITHELIAL CELL MATURATION,0.016475,0.25943,0.28053,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.008797,0.2593,0.26448,1,1
3,GO FILOPODIUM ASSEMBLY,0.0049572,0.25929,0.24893,1,1
3,GO NEURAL RETINA DEVELOPMENT,0.0017696,0.25924,0.3048,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.048745,0.25866,0.24485,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0076456,0.25858,0.24504,1,1
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0015882,0.2579,0.32409,1,1
3,GO SYNAPSE ORGANIZATION,0.0036751,0.25765,0.27724,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.017954,0.25719,0.2222,1,1
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0036751,0.25714,0.23074,1,1
3,GO NEURON CELL CELL ADHESION,0.024086,0.25714,0.39953,1,1
3,GO DNA DEAMINATION,0.034576,0.25653,0.22056,1,1
3,GO CALCINEURIN MEDIATED SIGNALING,0.0052065,0.25645,0.23928,1,1
3,GO LIPID TRANSLOCATION,0.014457,0.25633,0.27152,1,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.0044907,0.25624,0.25523,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0052065,0.25497,0.21059,1,1
3,GO MUSCLE FIBER DEVELOPMENT,0.010572,0.2548,0.23296,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.041938,0.25473,0.22624,1,1
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.038848,0.25411,0.31773,1,1
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0076456,0.25408,0.2316,1,1
3,GO EXPLORATION BEHAVIOR,0.030713,0.25399,0.22122,1,1
3,GO NEUROBLAST PROLIFERATION,0.0040644,0.2539,0.2629,1,1
3,GO MEMBRANE DEPOLARIZATION,0.021265,0.25388,0.20475,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.006955,0.25385,0.3063,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.01266,0.25381,0.27009,1,1
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00072571,0.25372,0.28608,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.016475,0.25368,0.21751,1,1
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0012071,0.25351,0.27747,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.025096,0.25306,0.27766,1,1
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00057531,0.25229,0.27821,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.023112,0.25167,0.23719,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.0015882,0.25134,0.26175,1,1
3,GO CELL MIGRATION IN HINDBRAIN,0.0060238,0.2512,0.32885,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0028457,0.25098,0.27134,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0083971,0.25071,0.26124,1,1
3,GO BEHAVIOR,0.0044907,0.25025,0.24166,1,1
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0038653,0.25011,0.23181,1,1
3,GO AXON DEVELOPMENT,0.0036751,0.25007,0.27762,1,1
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0020776,0.24986,0.30898,1,1
3,GO FEAR RESPONSE,0.048745,0.2496,0.16671,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.038848,0.24956,0.18029,1,1
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0014241,0.24939,0.26784,1,1
3,GO REGULATION OF RESPIRATORY BURST,0.034576,0.24894,0.23927,1,1
3,GO NERVE DEVELOPMENT,0.031957,0.24894,0.23168,1,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.010572,0.24881,0.2377,1,1
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0027019,0.24877,0.30476,1,1
3,GO NEURON FATE COMMITMENT,0.018736,0.24819,0.22854,1,1
3,GO REGULATION OF MRNA BINDING,0.0066311,0.24811,0.21472,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.0092139,0.24805,0.28603,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.017954,0.24798,0.2022,1,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.02951,0.24758,0.20738,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.018736,0.24751,0.2732,1,1
3,GO FOREBRAIN CELL MIGRATION,0.010572,0.24741,0.2596,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.010101,0.24738,0.24284,1,1
3,GO GDP METABOLIC PROCESS,0.0019699,0.24731,0.28832,1,1
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0027019,0.24729,0.27667,1,1
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.0044907,0.24724,0.22983,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0172,0.24712,0.22915,1,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.2763e-05,0.24705,0.28695,1,1
3,GO LOCOMOTORY BEHAVIOR,0.0054671,0.24645,0.26542,1,1
3,GO REGULATION OF GOLGI ORGANIZATION,0.0014241,0.24629,0.26022,1,1
3,GO MAINTENANCE OF CELL POLARITY,0.0038653,0.24615,0.29688,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0066311,0.24603,0.29938,1,1
3,GO RESPONSE TO ISCHEMIA,0.0083971,0.24589,0.24498,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0031545,0.2455,0.28033,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.006955,0.24549,0.25669,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00086166,0.24542,0.26531,1,1
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.0015041,0.24516,0.25858,1,1
3,GO REGULATION OF BEHAVIOR,0.008797,0.24509,0.20253,1,1
3,GO SPINDLE MIDZONE ASSEMBLY,0.0096484,0.24472,0.28833,1,1
3,GO RESPONSE TO VITAMIN A,0.0047188,0.24417,0.21528,1,1
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.027226,0.24417,0.22763,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.015104,0.24346,0.21052,1,1
3,GO ORGANIC CATION TRANSPORT,0.013834,0.24274,0.23612,1,1
3,GO CEREBELLAR CORTEX FORMATION,0.0042727,0.24269,0.26005,1,1
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.019548,0.24266,0.18432,1,1
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.028348,0.24261,0.21982,1,1
3,GO GROWTH HORMONE SECRETION,0.023112,0.24231,0.29313,1,1
3,GO FUCOSE METABOLIC PROCESS,0.037377,0.24229,0.17185,1,1
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0049572,0.24203,0.22426,1,1
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.011063,0.24201,0.27043,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.046961,0.24176,0.26093,1,1
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.020391,0.24173,0.24137,1,1
3,GO SYNAPTIC VESICLE RECYCLING,0.0023095,0.24162,0.27001,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.007293,0.24131,0.29578,1,1
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012106,0.24126,0.29319,1,1
3,GO TUBULIN DEACETYLATION,0.025096,0.24123,0.2352,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0040644,0.24099,0.29761,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.0049572,0.24098,0.2336,1,1
3,GO STEROID ESTERIFICATION,0.022172,0.2409,0.23015,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.008797,0.24071,0.19341,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.016475,0.24068,0.25692,1,1
3,GO AXO DENDRITIC TRANSPORT,0.015104,0.24045,0.23591,1,1
3,GO CHROMATIN DISASSEMBLY,0.0042727,0.24041,0.26638,1,1
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.02951,0.24009,0.21359,1,1
3,GO ASSOCIATIVE LEARNING,0.007293,0.23996,0.25636,1,1
3,GO PROTEIN DEPOLYMERIZATION,0.0014241,0.23987,0.28438,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.02951,0.23947,0.29735,1,1
3,GO NEURAL CREST CELL MIGRATION,0.011063,0.23919,0.24688,1,1
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.031957,0.23912,0.23004,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0029965,0.23904,0.23981,1,1
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.028348,0.23871,0.25815,1,1
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.0031545,0.23848,0.26268,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.010101,0.23846,0.25016,1,1
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.045233,0.23841,0.20621,1,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.046961,0.23817,0.19613,1,1
3,GO PROTEIN KINASE A SIGNALING,0.0021907,0.23815,0.25053,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.041938,0.23813,0.20735,1,1
3,GO REGULATION OF ISOTYPE SWITCHING,0.025096,0.23803,0.25111,1,1
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.00332,0.23791,0.31458,1,1
3,GO FEEDING BEHAVIOR,0.0012071,0.23786,0.25339,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.031957,0.23778,0.22063,1,1
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.00081392,0.23757,0.31719,1,1
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00072571,0.23733,0.24691,1,1
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.031957,0.23711,0.23606,1,1
3,GO RESPONSE TO PARATHYROID HORMONE,0.033245,0.23677,0.19511,1,1
3,GO NEURON DEVELOPMENT,0.0031545,0.23655,0.25571,1,1
3,GO SKELETAL MUSCLE CONTRACTION,0.0016767,0.23644,0.24538,1,1
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.00332,0.23626,0.22624,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.040368,0.23621,0.25539,1,1
3,GO METENCEPHALON DEVELOPMENT,0.00332,0.236,0.25175,1,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.011574,0.23598,0.23216,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0044907,0.23591,0.24024,1,1
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.024086,0.23547,0.21592,1,1
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.01266,0.23534,0.1792,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.030713,0.23461,0.19178,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.034576,0.23459,0.22142,1,1
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00068502,0.23424,0.25547,1,1
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0172,0.23404,0.27117,1,1
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.011574,0.23373,0.30319,1,1
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00011593,0.23371,0.27247,1,1
3,GO DEVELOPMENTAL CELL GROWTH,0.0034935,0.23337,0.26335,1,1
3,GO RHYTHMIC BEHAVIOR,0.0034935,0.23314,0.25928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.048745,0.23302,0.2105,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0092139,0.23277,0.20997,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.045233,0.23256,0.25045,1,1
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0034935,0.23235,0.25616,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0021907,0.23233,0.26487,1,1
3,GO CELLULAR RESPONSE TO PH,0.00045436,0.23231,0.32189,1,1
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0060238,0.2317,0.2608,1,1
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0010209,0.23159,0.26277,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.026142,0.23144,0.23633,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0015882,0.23125,0.25783,1,1
3,GO HEART VALVE DEVELOPMENT,0.015104,0.23124,0.25472,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.015776,0.23108,0.23293,1,1
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0031545,0.231,0.22629,1,1
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0031545,0.23092,0.31088,1,1
3,GO LEFT RIGHT PATTERN FORMATION,0.014457,0.23092,0.20749,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.030713,0.23065,0.25167,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.015104,0.23051,0.23579,1,1
3,GO EMBRYONIC HEMOPOIESIS,0.007293,0.23035,0.22468,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0083971,0.23031,0.25127,1,1
3,GO PLATELET MORPHOGENESIS,0.00054254,0.23027,0.33731,1,1
3,GO DEFINITIVE HEMOPOIESIS,0.027226,0.22967,0.25029,1,1
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.033245,0.22952,0.16948,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0021907,0.22907,0.27661,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,0.0042727,0.22907,0.28925,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00091199,0.22884,0.24931,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0013481,0.22876,0.24553,1,1
3,GO REGULATION OF INSULIN SECRETION,0.0018673,0.22873,0.25453,1,1
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00054254,0.22872,0.2416,1,1
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0042727,0.22863,0.24587,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0012071,0.22818,0.2518,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0049572,0.22817,0.2755,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.030713,0.22805,0.20488,1,1
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0023095,0.22793,0.26627,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0010209,0.2279,0.34592,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0018673,0.22787,0.28571,1,1
3,GO NEURON DIFFERENTIATION,0.0028457,0.22786,0.2477,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.01266,0.22779,0.24074,1,1
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.010101,0.22774,0.20609,1,1
3,GO ENDOTHELIUM DEVELOPMENT,0.019548,0.2277,0.20471,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.0029965,0.22741,0.26697,1,1
3,GO INSULIN SECRETION,0.0024341,0.22725,0.25357,1,1
3,GO RESPONSE TO ATP,0.0049572,0.22724,0.23704,1,1
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0042727,0.22724,0.23718,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0063209,0.22707,0.21375,1,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.033245,0.22686,0.24584,1,1
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0003797,0.22641,0.2688,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.008797,0.22619,0.29479,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.010101,0.22614,0.20835,1,1
3,GO FORELIMB MORPHOGENESIS,0.0034935,0.22604,0.28275,1,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.0012071,0.226,0.27552,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.027226,0.22597,0.22533,1,1
3,GO REGULATION OF EXOCYTOSIS,0.0010798,0.22516,0.25233,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.010101,0.22436,0.30667,1,1
3,GO RESPONSE TO IRON ION,0.0172,0.22433,0.17939,1,1
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0017696,0.22415,0.29558,1,1
3,GO REGULATION OF CELL SIZE,0.0011418,0.2241,0.2825,1,1
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.011063,0.22404,0.25472,1,1
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00045436,0.22389,0.25473,1,1
3,GO REGULATION OF NEURON DIFFERENTIATION,0.00332,0.22376,0.2516,1,1
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0016767,0.22369,0.25024,1,1
3,GO NEURON APOPTOTIC PROCESS,0.0024341,0.2236,0.21171,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.041938,0.22328,0.24213,1,1
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00020554,0.22327,0.25167,1,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.008797,0.22296,0.20075,1,1
3,GO CEREBRAL CORTEX DEVELOPMENT,0.0060238,0.22275,0.25761,1,1
3,GO PEPTIDE HORMONE SECRETION,0.0040644,0.22263,0.23172,1,1
3,GO CERAMIDE TRANSPORT,0.0027019,0.22212,0.27319,1,1
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0044907,0.22207,0.21912,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0036751,0.22206,0.26234,1,1
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.011063,0.22205,0.24319,1,1
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0054671,0.22197,0.23076,1,1
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.037377,0.22185,0.19786,1,1
3,GO SERTOLI CELL DIFFERENTIATION,0.040368,0.22173,0.19599,1,1
3,GO FOREGUT MORPHOGENESIS,0.013834,0.2214,0.23964,1,1
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0092139,0.22123,0.22732,1,1
3,GO NEURON DEATH,0.0019699,0.22071,0.21695,1,1
3,GO REGULATION OF TRANSPOSITION,0.028348,0.22054,0.19861,1,1
3,GO RESPONSE TO HYDROXYUREA,0.0060238,0.22053,0.24495,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.011063,0.22026,0.18981,1,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.0036751,0.21972,0.25905,1,1
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.021265,0.21947,0.2695,1,1
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0018673,0.21922,0.29267,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.012106,0.21922,0.2429,1,1
3,GO HINDBRAIN MORPHOGENESIS,0.0054671,0.21915,0.22231,1,1
3,GO CARDIAC CONDUCTION,0.0066311,0.21845,0.22025,1,1
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.008797,0.21843,0.17528,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.0019699,0.21818,0.24486,1,1
3,GO L AMINO ACID TRANSPORT,0.0013481,0.218,0.23531,1,1
3,GO POTASSIUM ION TRANSPORT,0.0023095,0.21797,0.25693,1,1
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.025096,0.21767,0.2267,1,1
3,GO MEMORY,0.0023095,0.21749,0.24595,1,1
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00332,0.21716,0.23949,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0036751,0.2169,0.28026,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0029965,0.21669,0.25084,1,1
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.010101,0.21635,0.21741,1,1
3,GO RESPONSE TO ACIDIC PH,0.00081392,0.2159,0.36857,1,1
3,GO RESPONSE TO DOPAMINE,0.00091199,0.21582,0.24855,1,1
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0054671,0.21559,0.23235,1,1
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.0019699,0.21532,0.23089,1,1
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0018673,0.21531,0.26527,1,1
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0080134,0.21496,0.2182,1,1
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.006955,0.21466,0.22092,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.028348,0.21411,0.23185,1,1
3,GO ENDOCYTIC RECYCLING,0.015104,0.2141,0.22078,1,1
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0015041,0.21392,0.26389,1,1
3,GO XENOBIOTIC TRANSPORT,0.011574,0.21387,0.24006,1,1
3,GO FOREBRAIN GENERATION OF NEURONS,0.020391,0.21376,0.17664,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.011063,0.21363,0.17361,1,1
3,GO REGULATION OF ION TRANSPORT,0.0015882,0.21332,0.22821,1,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.020391,0.21263,0.22515,1,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.022172,0.21258,0.20452,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.014457,0.21238,0.18937,1,1
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0011418,0.21234,0.25855,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.0018673,0.2123,0.21402,1,1
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0083971,0.21193,0.23085,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.010101,0.21161,0.22004,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0083971,0.21137,0.23799,1,1
3,GO RECEPTOR INTERNALIZATION,0.00023283,0.21128,0.26199,1,1
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0044907,0.21111,0.26239,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.013834,0.21092,0.26806,1,1
3,GO REGULATION OF PROTON TRANSPORT,0.00081392,0.21073,0.21993,1,1
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.020391,0.21057,0.20606,1,1
3,GO CALCIUM ION IMPORT,0.0015882,0.21029,0.2324,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.027226,0.2102,0.20373,1,1
3,GO RESPIRATORY SYSTEM PROCESS,0.0054671,0.2102,0.29352,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.0024341,0.21004,0.23633,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0049572,0.20999,0.27989,1,1
3,GO PROTEIN TRIMERIZATION,0.013235,0.20998,0.27594,1,1
3,GO THYROID GLAND DEVELOPMENT,0.023112,0.20981,0.20076,1,1
3,GO TRANSMISSION OF NERVE IMPULSE,0.0042727,0.20968,0.27817,1,1
3,GO REGULATION OF STEM CELL PROLIFERATION,0.0080134,0.20948,0.21393,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0049572,0.20941,0.24623,1,1
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.00072571,0.2093,0.2641,1,1
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0034935,0.20921,0.28298,1,1
3,GO INTERMEMBRANE LIPID TRANSFER,0.0052065,0.20881,0.23183,1,1
3,GO ACTIN CROSSLINK FORMATION,0.038848,0.20848,0.21728,1,1
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.011063,0.20844,0.24325,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.20831,0.23387,1,1
3,GO REGULATION OF AMINO ACID TRANSPORT,0.011063,0.20827,0.2588,1,1
3,GO REGULATION OF RNA BINDING,0.012106,0.20807,0.1812,1,1
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0040644,0.20772,0.25793,1,1
3,GO ADHERENS JUNCTION ASSEMBLY,0.0063209,0.2077,0.29519,1,1
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0015041,0.20754,0.22133,1,1
3,GO LACTATION,0.017954,0.20748,0.18706,1,1
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.034576,0.20735,0.23065,1,1
3,GO NEUROGENESIS,0.0036751,0.20717,0.23911,1,1
3,GO MOTOR NEURON AXON GUIDANCE,0.008797,0.20704,0.25916,1,1
3,GO OUTFLOW TRACT MORPHOGENESIS,0.037377,0.20658,0.19794,1,1
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0044907,0.20656,0.23722,1,1
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0034935,0.20611,0.23756,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,0.012106,0.2057,0.21433,1,1
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.0018673,0.20569,0.23504,1,1
3,GO SCHWANN CELL DEVELOPMENT,0.015776,0.20568,0.24657,1,1
3,GO PHOSPHOLIPID TRANSPORT,0.021265,0.20563,0.19858,1,1
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.007293,0.2055,0.22648,1,1
3,GO CATECHOLAMINE UPTAKE,0.019548,0.20515,0.25822,1,1
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.013834,0.20502,0.23008,1,1
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.00035748,0.20495,0.24843,1,1
3,GO POSITIVE REGULATION OF JNK CASCADE,0.019548,0.20485,0.2424,1,1
3,GO REGULATION OF STEROL TRANSPORT,0.043559,0.20469,0.1774,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.033245,0.20459,0.19893,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.006955,0.20453,0.22419,1,1
3,GO RESPONSE TO PH,0.00042807,0.20448,0.34319,1,1
3,GO CELL FATE COMMITMENT,0.0040644,0.20442,0.20625,1,1
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.041938,0.2044,0.17309,1,1
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.014457,0.20431,0.2242,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.045233,0.20422,0.19484,1,1
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.023112,0.20414,0.26567,1,1
3,GO ADULT LOCOMOTORY BEHAVIOR,0.0083971,0.20412,0.23047,1,1
3,GO CELL MORPHOGENESIS,0.0044907,0.2036,0.24766,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.017954,0.20337,0.23185,1,1
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.013834,0.20323,0.21624,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.011063,0.20318,0.20867,1,1
3,GO REGULATION OF HORMONE SECRETION,0.0096484,0.20308,0.19706,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00054254,0.20295,0.24358,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.016475,0.20288,0.23873,1,1
3,GO SECONDARY PALATE DEVELOPMENT,0.02951,0.20288,0.24186,1,1
3,GO SIGNAL RELEASE,0.0052065,0.20283,0.21006,1,1
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.007293,0.20275,0.22012,1,1
3,GO HINDBRAIN DEVELOPMENT,0.011574,0.20262,0.21251,1,1
3,GO REGULATION OF CELL MORPHOGENESIS,0.0023095,0.2026,0.26456,1,1
3,GO DENDRITE SELF AVOIDANCE,0.045233,0.20243,0.22083,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.023112,0.20223,0.19834,1,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.026142,0.20194,0.23793,1,1
3,GO HEAD DEVELOPMENT,0.008797,0.20157,0.2159,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00040321,0.20117,0.25561,1,1
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00076864,0.20111,0.24204,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.010572,0.20094,0.23107,1,1
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.020391,0.2008,0.19167,1,1
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0049572,0.20072,0.219,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.015104,0.20067,0.23325,1,1
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0083971,0.20056,0.25567,1,1
3,GO CALCIUM MEDIATED SIGNALING,0.021265,0.20034,0.21129,1,1
3,GO MITOCHONDRION LOCALIZATION,0.015104,0.2003,0.21858,1,1
3,GO DEVELOPMENTAL MATURATION,0.0036751,0.20007,0.22623,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00031664,0.19999,0.24473,1,1
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.013834,0.19994,0.22067,1,1
3,GO CELLULAR COMPONENT MAINTENANCE,0.0036751,0.19962,0.28066,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.00051151,0.19931,0.23057,1,1
3,GO APICAL PROTEIN LOCALIZATION,0.031957,0.19926,0.20006,1,1
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0047188,0.19921,0.31701,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.014457,0.19911,0.21948,1,1
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0044907,0.1984,0.23157,1,1
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.02951,0.19836,0.20868,1,1
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0038653,0.19821,0.21789,1,1
3,GO SECRETORY GRANULE ORGANIZATION,0.033245,0.19814,0.18947,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.00048214,0.19812,0.29917,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0038653,0.1978,0.26661,1,1
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.011574,0.19753,0.21234,1,1
3,GO FOREBRAIN DEVELOPMENT,0.0040644,0.19721,0.23428,1,1
3,GO IMPORT INTO CELL,0.0020776,0.19721,0.22474,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.045233,0.19705,0.21094,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.021265,0.19688,0.2024,1,1
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.016475,0.19658,0.2287,1,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.031957,0.19654,0.24434,1,1
3,GO FATTY ACID HOMEOSTASIS,0.0027019,0.1965,0.25996,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.019548,0.1965,0.25003,1,1
3,GO REGULATION OF HEMOPOIESIS,0.045233,0.19637,0.19243,1,1
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.027226,0.19627,0.2696,1,1
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.015776,0.19623,0.22607,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.014457,0.19611,0.21391,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.007293,0.19596,0.22418,1,1
3,GO EMBRYONIC EYE MORPHOGENESIS,0.037377,0.19574,0.22894,1,1
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.030713,0.19562,0.21198,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.00051151,0.19554,0.27287,1,1
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.013834,0.19554,0.25718,1,1
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0092139,0.1955,0.20965,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.028348,0.19529,0.20645,1,1
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.025096,0.19528,0.26194,1,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.00076864,0.19496,0.26832,1,1
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.030713,0.1949,0.20515,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.015104,0.19482,0.18885,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.030713,0.19449,0.24776,1,1
3,GO COLLECTING DUCT DEVELOPMENT,0.041938,0.19439,0.32703,1,1
3,GO ACIDIC AMINO ACID TRANSPORT,0.00035748,0.19434,0.29392,1,1
3,GO REGULATION OF PROTEIN TARGETING,0.0014241,0.19406,0.20077,1,1
3,GO MONOAMINE TRANSPORT,0.0057394,0.19406,0.27877,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0012758,0.19399,0.2033,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0023095,0.19383,0.2158,1,1
3,GO REGULATION OF MEMBRANE POTENTIAL,0.0021907,0.19369,0.23998,1,1
3,GO TRANSPOSITION,0.020391,0.19339,0.19354,1,1
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.016475,0.19319,0.23348,1,1
3,GO INOSITOL METABOLIC PROCESS,0.037377,0.19318,0.23984,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.019548,0.19317,0.19307,1,1
3,GO NEURAL CREST CELL DIFFERENTIATION,0.028348,0.19316,0.20242,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.041938,0.19258,0.18493,1,1
3,GO COGNITION,0.0031545,0.19253,0.23258,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,0.010572,0.19249,0.20857,1,1
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0021907,0.19217,0.30995,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.030713,0.19192,0.18902,1,1
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033245,0.19182,0.16913,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.010572,0.19158,0.1783,1,1
3,GO AMINO ACID TRANSPORT,0.00033648,0.19142,0.2521,1,1
3,GO DNA DEMETHYLATION,0.0096484,0.19136,0.20368,1,1
3,GO POSITIVE REGULATION OF DNA REPAIR,0.0076456,0.19136,0.20646,1,1
3,GO ERYTHROCYTE MATURATION,0.015776,0.1912,0.23133,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.013834,0.19112,0.20754,1,1
3,GO SENSORY PERCEPTION OF PAIN,0.013235,0.19099,0.19823,1,1
3,GO STEM CELL PROLIFERATION,0.0066311,0.19087,0.22513,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.037377,0.19084,0.19533,1,1
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.048745,0.19082,0.18978,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0063209,0.19081,0.22181,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0019699,0.19078,0.20767,1,1
3,GO HORMONE TRANSPORT,0.0057394,0.19072,0.20708,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.019548,0.19052,0.24074,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0172,0.19048,0.18825,1,1
3,GO SENSORY PERCEPTION,0.0014241,0.19028,0.18743,1,1
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.015104,0.19023,0.16975,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0044907,0.19013,0.25239,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.031957,0.1901,0.19427,1,1
3,GO LIPOPROTEIN LOCALIZATION,0.019548,0.18998,0.23156,1,1
3,GO POSITIVE REGULATION OF DNA BINDING,0.0096484,0.18959,0.1737,1,1
3,GO VISUAL BEHAVIOR,0.0042727,0.18956,0.22116,1,1
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0029965,0.18952,0.29984,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0019699,0.18946,0.22639,1,1
3,GO OVULATION CYCLE PROCESS,0.024086,0.18918,0.17841,1,1
3,GO SPLEEN DEVELOPMENT,0.0021907,0.189,0.23856,1,1
3,GO CELLULAR RESPONSE TO SALT STRESS,0.041938,0.18877,0.17893,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.025096,0.18874,0.21169,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0021907,0.1887,0.22936,1,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0010209,0.18781,0.2317,1,1
3,GO CRISTAE FORMATION,0.0092139,0.18772,0.20002,1,1
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0044907,0.18758,0.2272,1,1
3,GO DORSAL VENTRAL PATTERN FORMATION,0.019548,0.18754,0.18721,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.010101,0.18748,0.18944,1,1
3,GO CELLULAR RESPONSE TO ATP,0.0034935,0.18742,0.23643,1,1
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.023112,0.18724,0.21776,1,1
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0021907,0.1871,0.26097,1,1
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.010101,0.18705,0.21584,1,1
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.023112,0.18695,0.18456,1,1
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.028348,0.18682,0.20768,1,1
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0076456,0.18679,0.19845,1,1
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.031957,0.18658,0.2027,1,1
3,GO RESPONSE TO CATECHOLAMINE,0.0031545,0.18652,0.22354,1,1
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0031545,0.18638,0.2368,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0063209,0.18583,0.21487,1,1
3,GO REGULATION OF GLIOGENESIS,0.01266,0.18571,0.17567,1,1
3,GO CELL CELL SIGNALING,0.0034935,0.18543,0.21442,1,1
3,GO NERVOUS SYSTEM PROCESS,0.00068502,0.18535,0.2254,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0013481,0.18529,0.20662,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.0034935,0.18517,0.20175,1,1
3,GO CELL RECOGNITION,0.0060238,0.18512,0.21172,1,1
3,GO CELL JUNCTION ORGANIZATION,0.01266,0.18505,0.22441,1,1
3,GO GLYCINE METABOLIC PROCESS,0.015104,0.18491,0.21149,1,1
3,GO CELL PROJECTION ORGANIZATION,0.0066311,0.18487,0.21858,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.031957,0.18477,0.21042,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0044907,0.18462,0.22271,1,1
3,GO NADH METABOLIC PROCESS,0.0076456,0.18456,0.20054,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0015041,0.18453,0.23152,1,1
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.007293,0.18436,0.21326,1,1
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.038848,0.18422,0.14786,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00051151,0.18419,0.23285,1,1
3,GO PALLIUM DEVELOPMENT,0.011574,0.18418,0.21264,1,1
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0047188,0.18396,0.19817,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.015776,0.18354,0.22198,1,1
3,GO DENDRITE EXTENSION,0.034576,0.18332,0.19711,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.01266,0.18331,0.2541,1,1
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.00040321,0.18329,0.23186,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0080134,0.18328,0.21411,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.0060238,0.18288,0.25318,1,1
3,GO SPECIFICATION OF SYMMETRY,0.018736,0.18272,0.18568,1,1
3,GO REGULATION OF METAL ION TRANSPORT,0.0017696,0.18259,0.22223,1,1
3,GO PEPTIDYL ARGININE MODIFICATION,0.0054671,0.18257,0.18168,1,1
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.011574,0.18252,0.21823,1,1
3,GO MEMBRANE FISSION,0.022172,0.18249,0.20431,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0018673,0.18245,0.25218,1,1
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0028457,0.18239,0.26767,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.0017696,0.18223,0.22168,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.022172,0.18214,0.29101,1,1
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0044907,0.18193,0.23175,1,1
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0040644,0.18169,0.21813,1,1
3,GO POSITIVE REGULATION OF MITOPHAGY,0.0092139,0.18163,0.31067,1,1
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0028457,0.18127,0.22916,1,1
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.0083971,0.18123,0.17122,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,0.0010798,0.18116,0.20908,1,1
3,GO REGULATION OF MITOPHAGY,0.010572,0.18101,0.26529,1,1
3,GO INCLUSION BODY ASSEMBLY,0.0049572,0.18098,0.24466,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.018736,0.18085,0.23225,1,1
3,GO PROTEIN DEMETHYLATION,0.034576,0.18071,0.2294,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0027019,0.18036,0.28747,1,1
3,GO SMOOTHENED SIGNALING PATHWAY,0.020391,0.18036,0.20269,1,1
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.045233,0.18017,0.2082,1,1
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.0172,0.18009,0.19694,1,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.02951,0.1798,0.23381,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00060992,0.17976,0.26734,1,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0092139,0.1796,0.22973,1,1
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.033245,0.17956,0.16477,1,1
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.013834,0.17941,0.24125,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0020776,0.1794,0.22889,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0096484,0.17934,0.21438,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.0076456,0.1793,0.23259,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.022172,0.17929,0.20926,1,1
3,GO NEUROTRANSMITTER UPTAKE,0.020391,0.17911,0.18693,1,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.016475,0.1789,0.15109,1,1
3,GO EXOCYTIC PROCESS,0.0042727,0.17868,0.22006,1,1
3,GO DETECTION OF ABIOTIC STIMULUS,0.00042807,0.17864,0.26522,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0038653,0.17861,0.25598,1,1
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.040368,0.17844,0.20911,1,1
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.030713,0.17839,0.20209,1,1
3,GO NEUROTRANSMITTER REUPTAKE,0.030713,0.17835,0.20028,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.048745,0.17834,0.19272,1,1
3,GO MEMBRANE REPOLARIZATION,0.020391,0.17819,0.18727,1,1
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0049572,0.17818,0.23239,1,1
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0018673,0.17813,0.28327,1,1
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0066311,0.17794,0.21861,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.015776,0.17745,0.23848,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0054671,0.17718,0.2091,1,1
3,GO REGULATION OF TOR SIGNALING,0.019548,0.17709,0.18864,1,1
3,GO RESPONSE TO MISFOLDED PROTEIN,0.0092139,0.17699,0.23668,1,1
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.030713,0.17698,0.19424,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.017954,0.17673,0.22831,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.017954,0.17656,0.20471,1,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.010572,0.17647,0.19778,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0049572,0.17643,0.22144,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.011063,0.17642,0.19572,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,0.0014241,0.17638,0.20148,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,0.028348,0.1763,0.18887,1,1
3,GO RECEPTOR METABOLIC PROCESS,0.0020776,0.17621,0.21445,1,1
3,GO REGULATION OF CELL DEVELOPMENT,0.0054671,0.17587,0.2176,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.0096484,0.17568,0.23498,1,1
3,GO REGULATION OF ENDOCYTOSIS,0.007293,0.17567,0.22363,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0021907,0.17564,0.18459,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0015882,0.17561,0.22276,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,0.011574,0.17551,0.18903,1,1
3,GO CELL MATURATION,0.014457,0.17546,0.17219,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0044907,0.17514,0.19321,1,1
3,GO RECEPTOR RECYCLING,0.040368,0.17511,0.15532,1,1
3,GO TAXIS,0.037377,0.17508,0.19991,1,1
3,GO DICARBOXYLIC ACID TRANSPORT,0.00086166,0.175,0.24214,1,1
3,GO DNA DEALKYLATION,0.0038653,0.17499,0.19998,1,1
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.031957,0.17486,0.16226,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.030713,0.17484,0.20024,1,1
3,GO UV PROTECTION,0.008797,0.17479,0.25321,1,1
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.011063,0.17417,0.19042,1,1
3,GO SENSORY SYSTEM DEVELOPMENT,0.0060238,0.17399,0.2255,1,1
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0172,0.17396,0.21437,1,1
3,GO PATTERN SPECIFICATION PROCESS,0.01266,0.1736,0.18398,1,1
3,GO LIPID PHOSPHORYLATION,0.008797,0.1735,0.212,1,1
3,GO DETECTION OF VISIBLE LIGHT,0.0066311,0.17345,0.3041,1,1
3,GO NAD METABOLIC PROCESS,0.0012071,0.17337,0.21293,1,1
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00033648,0.17329,0.26591,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0019699,0.17325,0.19026,1,1
3,GO REGULATION OF HORMONE LEVELS,0.011063,0.17309,0.16998,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.030713,0.17309,0.22914,1,1
3,GO REGULATION OF GTPASE ACTIVITY,0.007293,0.17259,0.2351,1,1
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.010572,0.17249,0.21973,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.045233,0.17221,0.18102,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.012106,0.17218,0.22597,1,1
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0034935,0.17208,0.19704,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.01266,0.17189,0.16806,1,1
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.022172,0.17162,0.20082,1,1
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0023095,0.1714,0.26819,1,1
3,GO PLATELET AGGREGATION,0.031957,0.17139,0.24632,1,1
3,GO REGULATION OF ANION TRANSPORT,0.033245,0.1711,0.17511,1,1
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.031957,0.17107,0.1895,1,1
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.01266,0.17083,0.19535,1,1
3,GO PROTEIN POLYMERIZATION,0.00060992,0.17081,0.23336,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0027019,0.17065,0.19994,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.048745,0.17053,0.15445,1,1
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0049572,0.16992,0.20271,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.01266,0.16985,0.1934,1,1
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.008797,0.16955,0.20812,1,1
3,GO CELLULAR RESPONSE TO CAMP,0.025096,0.16954,0.17198,1,1
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0040644,0.16948,0.2886,1,1
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.010101,0.16946,0.22337,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.0042727,0.16935,0.19588,1,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.01266,0.16934,0.21626,1,1
3,GO MULTICELLULAR ORGANISM GROWTH,0.0038653,0.16934,0.24,1,1
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.026142,0.16932,0.2026,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.043559,0.16932,0.16241,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0036751,0.16931,0.26215,1,1
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0096484,0.16921,0.23078,1,1
3,GO CATION TRANSPORT,0.0017696,0.16904,0.206,1,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013834,0.16895,0.17969,1,1
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.011574,0.16877,0.21721,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.031957,0.16876,0.16268,1,1
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.02951,0.16872,0.18312,1,1
3,GO SULFATE TRANSPORT,0.020391,0.16866,0.20217,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0042727,0.16861,0.1989,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.043559,0.16808,0.17952,1,1
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.0023095,0.16792,0.24327,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.0036751,0.16788,0.18369,1,1
3,GO FATTY ACID BETA OXIDATION,0.037377,0.16774,0.14407,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0052065,0.16756,0.19877,1,1
3,GO CAMERA TYPE EYE DEVELOPMENT,0.0049572,0.16719,0.22667,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.007293,0.16702,0.21601,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0029965,0.16694,0.20288,1,1
3,GO ACTIVATION OF MAPKK ACTIVITY,0.030713,0.16691,0.2239,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.0042727,0.16689,0.22471,1,1
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0063209,0.16689,0.24332,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.035953,0.16674,0.19072,1,1
3,GO VIRAL RNA GENOME REPLICATION,0.025096,0.16671,0.17667,1,1
3,GO HISTONE H4 ACETYLATION,0.0080134,0.16667,0.22112,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.021265,0.1666,0.19569,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0040644,0.16638,0.21687,1,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.010101,0.16635,0.2151,1,1
3,GO DETECTION OF LIGHT STIMULUS,0.0031545,0.16626,0.31945,1,1
3,GO REGULATION OF MYELINATION,0.0172,0.16625,0.21398,1,1
3,GO VESICLE DOCKING,0.020391,0.16612,0.17766,1,1
3,GO HISTONE H3 DEACETYLATION,0.024086,0.16612,0.19941,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.012106,0.16591,0.18705,1,1
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.013235,0.16587,0.18205,1,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0052065,0.16568,0.21722,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.045233,0.16567,0.2048,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.015776,0.16567,0.1755,1,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.030713,0.16546,0.16618,1,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.031957,0.16545,0.1943,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0076456,0.16533,0.19279,1,1
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.018736,0.16519,0.20278,1,1
3,GO RESPONSE TO WATER,0.0172,0.16491,0.16549,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.045233,0.16489,0.22794,1,1
3,GO ACID SECRETION,0.0024341,0.16467,0.20072,1,1
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0036751,0.16466,0.31052,1,1
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.021265,0.1646,0.18817,1,1
3,GO MIRNA METABOLIC PROCESS,0.0038653,0.16432,0.20639,1,1
3,GO CATECHOLAMINE SECRETION,0.007293,0.16426,0.28029,1,1
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0025648,0.16426,0.24584,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.033245,0.16417,0.19806,1,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0054671,0.16413,0.17952,1,1
3,GO NOTCH SIGNALING PATHWAY,0.031957,0.16392,0.16819,1,1
3,GO METAL ION TRANSPORT,0.0025648,0.1639,0.20243,1,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.046961,0.16367,0.16959,1,1
3,GO B CELL APOPTOTIC PROCESS,0.048745,0.16358,0.19582,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.026142,0.16357,0.18449,1,1
3,GO NEGATIVE REGULATION OF CELL AGING,0.030713,0.16288,0.15494,1,1
3,GO PHAGOSOME MATURATION,0.0036751,0.16258,0.21277,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0038653,0.1624,0.18216,1,1
3,GO CELL CELL ADHESION,0.028348,0.16232,0.21757,1,1
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.030713,0.16213,0.14585,1,1
3,GO REGULATION OF TRANSPORT,0.0083971,0.16212,0.19134,1,1
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.023112,0.16175,0.17098,1,1
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.040368,0.1615,0.19473,1,1
3,GO EYE MORPHOGENESIS,0.0096484,0.16144,0.22021,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00076864,0.16143,0.21091,1,1
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0060238,0.16143,0.2184,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.014457,0.16136,0.2061,1,1
3,GO STRIATED MUSCLE CONTRACTION,0.0057394,0.16116,0.17807,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.017954,0.16113,0.17773,1,1
3,GO MUSCLE CONTRACTION,0.0096484,0.16104,0.18074,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.010572,0.16099,0.28384,1,1
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0052065,0.16075,0.18537,1,1
3,GO DENDRITIC SPINE MAINTENANCE,0.0052065,0.16074,0.28074,1,1
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0066311,0.16058,0.225,1,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.038848,0.16024,0.17899,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.018736,0.16015,0.19146,1,1
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.0066311,0.15984,0.19775,1,1
3,GO TOR SIGNALING,0.010572,0.15978,0.19296,1,1
3,GO ORGANELLE LOCALIZATION,0.018736,0.1597,0.16811,1,1
3,GO PH REDUCTION,0.008797,0.15953,0.15827,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.00057531,0.15887,0.21993,1,1
3,GO PEPTIDYL THREONINE MODIFICATION,0.019548,0.15846,0.19425,1,1
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.021265,0.15819,0.17898,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0083971,0.15807,0.20578,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.023112,0.15796,0.19095,1,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0021907,0.15793,0.2133,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.008797,0.15792,0.16493,1,1
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.024086,0.15785,0.15639,1,1
3,GO RETINAL CONE CELL DIFFERENTIATION,0.015104,0.15772,0.36469,1,1
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0019699,0.15678,0.16707,1,1
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011574,0.15674,0.19215,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00081392,0.15657,0.1712,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0012071,0.15633,0.18264,1,1
3,GO DETECTION OF MECHANICAL STIMULUS,0.041938,0.15631,0.16543,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.013834,0.15617,0.26743,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.011574,0.15614,0.161,1,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0057394,0.15613,0.18731,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.018736,0.15608,0.19952,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.025096,0.15607,0.18774,1,1
3,GO ACTION POTENTIAL,0.0092139,0.15606,0.18989,1,1
3,GO SENSORY ORGAN DEVELOPMENT,0.011063,0.15604,0.20646,1,1
3,GO REGULATION OF CELL SHAPE,0.037377,0.15603,0.21668,1,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.013235,0.15564,0.21226,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0054671,0.15563,0.23686,1,1
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.006955,0.15556,0.23399,1,1
3,GO MEMBRANE DOCKING,0.035953,0.15512,0.172,1,1
3,GO MYOFIBRIL ASSEMBLY,0.040368,0.15494,0.17836,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.006955,0.1546,0.19079,1,1
3,GO REGULATION OF SYSTEM PROCESS,0.0040644,0.15429,0.21027,1,1
3,GO HETEROCHROMATIN ORGANIZATION,0.035953,0.15415,0.18571,1,1
3,GO CELL PROJECTION ASSEMBLY,0.027226,0.15411,0.17814,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00332,0.15358,0.2,1,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.031957,0.15353,0.23874,1,1
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.026142,0.15348,0.17605,1,1
3,GO REGULATION OF PEPTIDE SECRETION,0.018736,0.15345,0.19092,1,1
3,GO LIMBIC SYSTEM DEVELOPMENT,0.015104,0.15305,0.18306,1,1
3,GO PROTEIN O LINKED MANNOSYLATION,0.030713,0.15301,0.18044,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.02951,0.15272,0.15888,1,1
3,GO POLYAMINE METABOLIC PROCESS,0.0066311,0.1526,0.14396,1,1
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.011574,0.15245,0.20161,1,1
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.00054254,0.15245,0.26328,1,1
3,GO REGIONALIZATION,0.015776,0.15231,0.16804,1,1
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0047188,0.15164,0.22491,1,1
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.011574,0.1514,0.21072,1,1
3,GO ORGANIC ACID TRANSPORT,0.006955,0.15137,0.17042,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0092139,0.15123,0.19173,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.048745,0.15084,0.16643,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.014457,0.15077,0.20574,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.033245,0.15075,0.20159,1,1
3,GO REGULATION OF SECRETION,0.010101,0.15058,0.19739,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.037377,0.15056,0.18224,1,1
3,GO ENSHEATHMENT OF NEURONS,0.025096,0.15037,0.17132,1,1
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0047188,0.15021,0.23156,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.041938,0.15017,0.14598,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.006955,0.15014,0.1682,1,1
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.024086,0.14995,0.19278,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0096484,0.14995,0.20658,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.013235,0.14994,0.20384,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.007293,0.14994,0.17386,1,1
3,GO ENDOCYTOSIS,0.017954,0.14991,0.20009,1,1
3,GO ACTIN NUCLEATION,0.035953,0.14989,0.14732,1,1
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0014241,0.1495,0.22743,1,1
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.046961,0.14945,0.2065,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.018736,0.14935,0.18972,1,1
3,GO CIRCADIAN RHYTHM,0.01266,0.14927,0.17624,1,1
3,GO REGULATION OF CELLULAR LOCALIZATION,0.0040644,0.14923,0.19007,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.016475,0.14904,0.17626,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0014241,0.14903,0.21368,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.040368,0.149,0.19483,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,0.0034935,0.1488,0.1902,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.041938,0.14857,0.21193,1,1
3,GO GLIOGENESIS,0.0172,0.14838,0.19278,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00332,0.14836,0.19752,1,1
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.007293,0.1481,0.22111,1,1
3,GO HEART PROCESS,0.017954,0.14794,0.16607,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.043559,0.14773,0.17674,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.018736,0.14772,0.17836,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.033245,0.14732,0.16849,1,1
3,GO TRANSMEMBRANE TRANSPORT,0.00332,0.1473,0.17458,1,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0172,0.14717,0.19672,1,1
3,GO MUSCLE SYSTEM PROCESS,0.0172,0.14689,0.17215,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0172,0.14682,0.17593,1,1
3,GO REGULATION OF FIBROBLAST MIGRATION,0.020391,0.14663,0.20825,1,1
3,GO LIPID MODIFICATION,0.019548,0.14647,0.15506,1,1
3,GO POLYOL METABOLIC PROCESS,0.0025648,0.14631,0.19751,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.016475,0.14628,0.18474,1,1
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.026142,0.1462,0.30247,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.019548,0.14609,0.18229,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0034935,0.14584,0.22985,1,1
3,GO PROTEIN KINASE B SIGNALING,0.028348,0.14567,0.19994,1,1
3,GO NUCLEAR BODY ORGANIZATION,0.0049572,0.14566,0.1985,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.014457,0.14565,0.19976,1,1
3,GO NEUTRAL AMINO ACID TRANSPORT,0.022172,0.14546,0.18011,1,1
3,GO LIPID IMPORT INTO CELL,0.046961,0.14529,0.1723,1,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.015776,0.14528,0.19601,1,1
3,GO AMINE TRANSPORT,0.007293,0.14477,0.2492,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.00332,0.14434,0.19176,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.011063,0.1439,0.15326,1,1
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.030713,0.14387,0.15913,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.0083971,0.14375,0.14569,1,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.022172,0.14373,0.19699,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.041938,0.14331,0.15333,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.038848,0.14303,0.19585,1,1
3,GO ION TRANSPORT,0.0040644,0.14271,0.18564,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.034576,0.14266,0.14574,1,1
3,GO SODIUM ION TRANSPORT,0.022172,0.14247,0.17179,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.011063,0.14222,0.1627,1,1
3,GO REGULATION OF PROTEIN BINDING,0.008797,0.14212,0.19457,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.045233,0.14201,0.17111,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012106,0.14153,0.18178,1,1
3,GO TRANSFERRIN TRANSPORT,0.013834,0.14149,0.15863,1,1
3,GO DEVELOPMENTAL GROWTH,0.015776,0.14109,0.1898,1,1
3,GO LYSOSOMAL TRANSPORT,0.025096,0.14087,0.20166,1,1
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.011063,0.14043,0.2206,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.034576,0.14033,0.14976,1,1
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.040368,0.14019,0.19456,1,1
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.021265,0.14007,0.1636,1,1
3,GO NUCLEOTIDE SALVAGE,0.01266,0.14,0.18438,1,1
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0096484,0.13995,0.32413,1,1
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.020391,0.13983,0.19679,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.040368,0.13981,0.1504,1,1
3,GO PORE COMPLEX ASSEMBLY,0.024086,0.13978,0.14365,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0054671,0.13976,0.17819,1,1
3,GO ADAPTIVE THERMOGENESIS,0.022172,0.13971,0.16283,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.012106,0.13966,0.18035,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.01266,0.13956,0.1657,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.024086,0.13954,0.18588,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.023112,0.1394,0.18444,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.043559,0.13928,0.1215,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.011574,0.13923,0.17842,1,1
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.026142,0.13887,0.17849,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.034576,0.13884,0.15341,1,1
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.011063,0.13867,0.20464,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.010572,0.13819,0.18304,1,1
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.038848,0.13818,0.16466,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.006955,0.13816,0.17228,1,1
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.014457,0.13813,0.17517,1,1
3,GO DEMETHYLATION,0.0172,0.13807,0.19206,1,1
3,GO RESPONSE TO ALKALOID,0.040368,0.13785,0.13383,1,1
3,GO ATP TRANSPORT,0.015776,0.1378,0.15919,1,1
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.020391,0.13755,0.18895,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.027226,0.13702,0.1868,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.046961,0.13678,0.13419,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0066311,0.13666,0.19881,1,1
3,GO LAMELLIPODIUM ASSEMBLY,0.030713,0.13665,0.17798,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.012106,0.13648,0.17259,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.046961,0.13642,0.17943,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.010101,0.13638,0.15728,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.040368,0.13604,0.17521,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0066311,0.13583,0.16765,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.038848,0.13581,0.16455,1,1
3,GO CYTOSKELETON ORGANIZATION,0.0096484,0.13577,0.19473,1,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.010101,0.13574,0.2,1,1
3,GO REGULATION OF DEPHOSPHORYLATION,0.010101,0.13539,0.1761,1,1
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.028348,0.13534,0.15013,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0038653,0.13507,0.18214,1,1
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.014457,0.13504,0.19035,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.038848,0.13489,0.17664,1,1
3,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.034576,0.13475,0.18466,1,1
3,GO PEPTIDYL SERINE MODIFICATION,0.010101,0.13398,0.1856,1,1
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.011063,0.13376,0.20183,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.034576,0.13366,0.17468,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.027226,0.13364,0.18456,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0038653,0.1335,0.19962,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.037377,0.13349,0.15965,1,1
3,GO CLATHRIN COAT ASSEMBLY,0.023112,0.13336,0.179,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.006955,0.13334,0.20756,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.020391,0.13333,0.20432,1,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.041938,0.13324,0.16385,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.048745,0.1332,0.15007,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.015776,0.13309,0.19702,1,1
3,GO CANONICAL WNT SIGNALING PATHWAY,0.027226,0.13307,0.16202,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.025096,0.13303,0.17709,1,1
3,GO SENSORY ORGAN MORPHOGENESIS,0.023112,0.13287,0.18845,1,1
3,GO APPENDAGE DEVELOPMENT,0.031957,0.13284,0.19103,1,1
3,GO EAR MORPHOGENESIS,0.043559,0.13251,0.15605,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.013834,0.13237,0.18477,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0052065,0.1323,0.15741,1,1
3,GO RHYTHMIC PROCESS,0.022172,0.13214,0.16716,1,1
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.046961,0.13211,0.13844,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.028348,0.13211,0.16719,1,1
3,GO MEMBRANE ORGANIZATION,0.011574,0.13188,0.16574,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0052065,0.13153,0.1956,1,1
3,GO CARDIAC MUSCLE CONTRACTION,0.021265,0.1315,0.15883,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.02951,0.13146,0.15169,1,1
3,GO CELL GROWTH,0.015776,0.13144,0.1916,1,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.019548,0.13136,0.15245,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0054671,0.13127,0.16459,1,1
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.037377,0.1311,0.18881,1,1
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.026142,0.13102,0.17402,1,1
3,GO DNA CATABOLIC PROCESS,0.013235,0.1309,0.15697,1,1
3,GO RRNA CATABOLIC PROCESS,0.028348,0.13076,0.1534,1,1
3,GO GLIAL CELL DEVELOPMENT,0.027226,0.13075,0.18482,1,1
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0066311,0.13054,0.20512,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.01266,0.13034,0.13992,1,1
3,GO FIBROBLAST MIGRATION,0.024086,0.13022,0.20858,1,1
3,GO REGULATION OF CELL DIFFERENTIATION,0.015104,0.12994,0.19009,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.040368,0.12959,0.15614,1,1
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.014457,0.12933,0.19007,1,1
3,GO PHAGOSOME ACIDIFICATION,0.031957,0.12932,0.15,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.010572,0.12932,0.17605,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.034576,0.12912,0.17528,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.030713,0.12826,0.17388,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.033245,0.12802,0.17096,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.017954,0.128,0.14402,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.035953,0.12792,0.1832,1,1
3,GO REGULATION OF PH,0.031957,0.12767,0.1448,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.015776,0.12727,0.17028,1,1
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0021907,0.12721,0.19233,1,1
3,GO GLUCOSE METABOLIC PROCESS,0.0083971,0.12713,0.16926,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.012106,0.12689,0.15696,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0172,0.12667,0.1722,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.0063209,0.12664,0.13997,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.037377,0.12661,0.20805,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.021265,0.12654,0.17936,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.030713,0.12648,0.22166,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.041938,0.12642,0.18552,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,0.0172,0.12625,0.16493,1,1
3,GO REGULATION OF DNA BINDING,0.015776,0.12624,0.16207,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.037377,0.12614,0.18829,1,1
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.043559,0.1261,0.19673,1,1
3,GO PROTEIN INSERTION INTO MEMBRANE,0.020391,0.12605,0.11196,1,1
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.040368,0.12594,0.15583,1,1
3,GO RESPONSE TO AMINO ACID STARVATION,0.017954,0.12555,0.17492,1,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00332,0.12527,0.14003,1,1
3,GO GMP METABOLIC PROCESS,0.0096484,0.12506,0.17078,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.034576,0.12505,0.13398,1,1
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.023112,0.12476,0.14643,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.014457,0.1247,0.1324,1,1
3,GO RESPONSE TO ALCOHOL,0.040368,0.12462,0.15898,1,1
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.016475,0.12448,0.17496,1,1
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.010572,0.12427,0.1332,1,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.027226,0.12424,0.17716,1,1
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.037377,0.12407,0.11538,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.035953,0.12405,0.17556,1,1
3,GO MEMBRANE FUSION,0.026142,0.12395,0.15605,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.037377,0.12394,0.15465,1,1
3,GO APOPTOTIC DNA FRAGMENTATION,0.0083971,0.12391,0.15037,1,1
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.015104,0.12384,0.18528,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.033245,0.12342,0.16161,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.022172,0.12333,0.14782,1,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.021265,0.12329,0.17099,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.026142,0.12323,0.12671,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.028348,0.12315,0.18372,1,1
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.021265,0.123,0.15128,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.013834,0.12249,0.16036,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.017954,0.12235,0.1663,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.025096,0.12222,0.12875,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.015776,0.12175,0.19417,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.021265,0.12171,0.16707,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.0057394,0.12163,0.15557,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.0172,0.12159,0.17457,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.031957,0.12099,0.16898,1,1
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.025096,0.12081,0.1511,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.033245,0.12076,0.18369,1,1
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.025096,0.12064,0.13708,1,1
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.0083971,0.12036,0.21817,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.023112,0.12034,0.16134,1,1
3,GO CELLULAR HOMEOSTASIS,0.008797,0.12019,0.17873,1,1
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0172,0.12002,0.19185,1,1
3,GO REGULATION OF VASCULAR PERMEABILITY,0.033245,0.11997,0.20508,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.015776,0.11997,0.16525,1,1
3,GO ESTABLISHMENT OF CELL POLARITY,0.007293,0.11975,0.21293,1,1
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.033245,0.11967,0.1767,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.035953,0.11966,0.15226,1,1
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0063209,0.11963,0.1547,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.020391,0.11959,0.17072,1,1
3,GO VITAMIN METABOLIC PROCESS,0.031957,0.11954,0.13499,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.030713,0.11953,0.19931,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.041938,0.11907,0.17817,1,1
3,GO CELL CELL SIGNALING BY WNT,0.019548,0.11886,0.16541,1,1
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.046961,0.11873,0.1147,1,1
3,GO ANION HOMEOSTASIS,0.016475,0.11873,0.18591,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.045233,0.11858,0.14617,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.015776,0.11842,0.17556,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.02951,0.11825,0.15295,1,1
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.024086,0.11821,0.15998,1,1
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.11817,0.13331,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.018736,0.11793,0.17242,1,1
3,GO PHOTOTRANSDUCTION,0.0066311,0.1176,0.30488,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.026142,0.11758,0.16766,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.025096,0.11756,0.1737,1,1
3,GO MAMMARY GLAND DEVELOPMENT,0.037377,0.1174,0.18257,1,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.020391,0.11684,0.17491,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.01266,0.11667,0.18105,1,1
3,GO MALE GAMETE GENERATION,0.048745,0.11665,0.12643,1,1
3,GO VACUOLAR TRANSPORT,0.023112,0.11661,0.17432,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.048745,0.11661,0.14547,1,1
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.030713,0.1161,0.11803,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0066311,0.11593,0.13636,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.035953,0.11589,0.17318,1,1
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.013834,0.11586,0.16557,1,1
3,GO MAINTENANCE OF LOCATION,0.02951,0.11578,0.17455,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.025096,0.11546,0.15366,1,1
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.007293,0.11494,0.1757,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.027226,0.11488,0.16723,1,1
3,GO SCHWANN CELL DIFFERENTIATION,0.043559,0.11486,0.17774,1,1
3,GO DEPHOSPHORYLATION,0.020391,0.11439,0.14527,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.0172,0.11434,0.16046,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,0.0092139,0.11423,0.16346,1,1
3,GO RESPONSE TO STARVATION,0.025096,0.11416,0.14077,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.02951,0.1139,0.17402,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.048745,0.11375,0.095685,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.038848,0.11364,0.15101,1,1
3,GO CELL CYCLE ARREST,0.031957,0.11353,0.14514,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0092139,0.11344,0.17665,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.028348,0.11342,0.16463,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.031957,0.11338,0.1411,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.027226,0.11316,0.15828,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.028348,0.113,0.14249,1,1
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.01266,0.11279,0.16121,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.031957,0.11272,0.15947,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.025096,0.11256,0.13306,1,1
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.027226,0.1124,0.17551,1,1
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.022172,0.1122,0.12585,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024086,0.11178,0.14638,1,1
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.021265,0.11161,0.11424,1,1
3,GO ANIMAL ORGAN MORPHOGENESIS,0.030713,0.11159,0.1688,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.030713,0.11126,0.15677,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.02951,0.11082,0.13335,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.031957,0.11058,0.13729,1,1
3,GO DETECTION OF STIMULUS,0.006955,0.11051,0.14357,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.013235,0.11049,0.17611,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.027226,0.11034,0.16742,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.025096,0.11008,0.1657,1,1
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.040368,0.10995,0.12652,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.038848,0.10981,0.15048,1,1
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.037377,0.10976,0.1698,1,1
3,GO POSITIVE REGULATION OF BINDING,0.0057394,0.10946,0.16656,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.016475,0.10929,0.15792,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.030713,0.1089,0.19229,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0040644,0.10874,0.19854,1,1
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.024086,0.10853,0.10244,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.020391,0.10837,0.17207,1,1
3,GO APOPTOTIC PROCESS,0.024086,0.10824,0.14964,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,0.011063,0.10788,0.15025,1,1
3,GO VESICLE LOCALIZATION,0.018736,0.10756,0.16513,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.043559,0.10746,0.15521,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.025096,0.10741,0.16362,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.019548,0.10732,0.1498,1,1
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.037377,0.10732,0.13561,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.022172,0.10685,0.16393,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.027226,0.10669,0.12897,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.026142,0.10661,0.16179,1,1
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.025096,0.10645,0.11079,1,1
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.035953,0.10636,0.15577,1,1
3,GO BIOLOGICAL ADHESION,0.048745,0.10601,0.20093,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.038848,0.10598,0.14877,1,1
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0172,0.10557,0.23054,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.033245,0.10491,0.13539,1,1
3,GO EMBRYO DEVELOPMENT,0.037377,0.10475,0.16182,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.011063,0.10474,0.18163,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.034576,0.10449,0.15528,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.030713,0.10441,0.15275,1,1
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.018736,0.10436,0.1631,1,1
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.035953,0.10434,0.13345,1,1
3,GO PROTEIN TETRAMERIZATION,0.017954,0.10427,0.15393,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.041938,0.10418,0.18678,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.018736,0.10415,0.11095,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.048745,0.10405,0.14353,1,1
3,GO RESPONSE TO PEPTIDE,0.034576,0.10384,0.16363,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.02951,0.10355,0.16303,1,1
3,GO GROWTH,0.026142,0.10343,0.16104,1,1
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.008797,0.10251,0.13587,1,1
3,GO CERAMIDE METABOLIC PROCESS,0.020391,0.10248,0.17275,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.015776,0.1021,0.14334,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0083971,0.10183,0.13059,1,1
3,GO MUSCLE CELL DEVELOPMENT,0.038848,0.10174,0.15295,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.017954,0.1017,0.12675,1,1
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.02951,0.10127,0.1745,1,1
3,GO MULTI ORGANISM PROCESS,0.048745,0.10105,0.12132,1,1
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.028348,0.10099,0.16146,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.026142,0.10087,0.14825,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.030713,0.10063,0.14834,1,1
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.040368,0.10011,0.13531,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.008797,0.099913,0.11831,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.041938,0.099629,0.14041,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0172,0.099474,0.11067,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.040368,0.099414,0.12242,1,1
3,GO ORGANELLE ASSEMBLY,0.037377,0.09923,0.14567,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.031957,0.099002,0.151,1,1
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.013235,0.09813,0.17383,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.015104,0.097948,0.1497,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.022172,0.097822,0.18062,1,1
3,GO ACTIN FILAMENT BASED MOVEMENT,0.037377,0.097283,0.16915,1,1
3,GO GLAND DEVELOPMENT,0.046961,0.096884,0.14681,1,1
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.022172,0.096672,0.14756,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.023112,0.096397,0.13618,1,1
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.038848,0.096308,0.14054,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.033245,0.096254,0.17209,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.017954,0.096018,0.15077,1,1
3,GO RESPONSE TO LIGHT STIMULUS,0.011574,0.095936,0.16025,1,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.046961,0.095484,0.13251,1,1
3,GO RESPONSE TO INSULIN,0.034576,0.095453,0.14779,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.01266,0.095372,0.15992,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.038848,0.094463,0.15038,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.048745,0.094398,0.12402,1,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.020391,0.093251,0.11205,1,1
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0083971,0.093126,0.13469,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.046961,0.092802,0.16994,1,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.035953,0.092309,0.14936,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.040368,0.092224,0.13218,1,1
3,GO REGULATION OF AUTOPHAGY,0.028348,0.091474,0.14949,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.033245,0.091388,0.14892,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.027226,0.091286,0.17516,1,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.043559,0.091192,0.21177,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.027226,0.090799,0.1402,1,1
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.033245,0.090796,0.15573,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.028348,0.090624,0.18964,1,1
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.035953,0.0899,0.13756,1,1
3,GO VACUOLE ORGANIZATION,0.038848,0.089889,0.15197,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.038848,0.089312,0.12321,1,1
3,GO PROTEIN STABILIZATION,0.043559,0.089033,0.12032,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.046961,0.088435,0.13786,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.041938,0.088398,0.1458,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.010572,0.08792,0.12595,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.017954,0.087844,0.12119,1,1
3,GO CYTOSOLIC TRANSPORT,0.02951,0.087743,0.18454,1,1
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.048745,0.087565,0.092639,1,1
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.022172,0.087504,0.12794,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.011063,0.08654,0.11907,1,1
3,GO PIGMENT METABOLIC PROCESS,0.010101,0.085906,0.12991,1,1
3,GO ATP METABOLIC PROCESS,0.0052065,0.085258,0.10567,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.034576,0.083891,0.12145,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.048745,0.082749,0.11801,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0080134,0.082631,0.11637,1,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0092139,0.08257,0.13334,1,1
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.028348,0.082506,0.13114,1,1
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.040368,0.08248,0.13176,1,1
3,GO PROTEIN DEPHOSPHORYLATION,0.0172,0.080632,0.1482,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.043559,0.080328,0.088137,1,1
3,GO SULFUR COMPOUND TRANSPORT,0.030713,0.080181,0.18097,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.038848,0.080127,0.14416,1,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.023112,0.078573,0.14281,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0047188,0.078003,0.12478,1,1
3,GO VESICLE ORGANIZATION,0.021265,0.07717,0.15488,1,1
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.015104,0.076318,0.12233,1,1
3,GO REGULATION OF GROWTH,0.040368,0.073224,0.15679,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0092139,0.072641,0.11622,1,1
3,GO AMINE METABOLIC PROCESS,0.037377,0.070855,0.11261,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.041938,0.070784,0.1206,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.013235,0.07042,0.1373,1,1
3,GO ERAD PATHWAY,0.025096,0.070051,0.14479,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.015776,0.069264,0.11961,1,1
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.012106,0.068512,0.12572,1,1
3,GO MITOCHONDRION ORGANIZATION,0.038848,0.050741,0.10291,1,1
4,GO OUTER DYNEIN ARM ASSEMBLY,0.0063209,0.67074,0.51237,1,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0010209,0.62543,0.61713,1,1
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0012071,0.62205,0.68183,1,1
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0054671,0.59026,0.44668,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0049572,0.57552,0.47969,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0027019,0.56075,0.48804,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,7.8298e-05,0.54966,0.75607,1,1
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0013481,0.54355,0.44643,1,1
4,GO LOOP OF HENLE DEVELOPMENT,0.00023283,0.54282,0.55236,1,1
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00086166,0.53949,0.49087,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00026348,0.53284,0.65768,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00332,0.5278,0.49814,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00010181,0.52556,0.62763,1,1
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00051151,0.5246,0.5198,1,1
4,GO PONS DEVELOPMENT,0.00014062,0.51956,0.6068,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0021907,0.50342,0.52035,1,1
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00021879,0.50325,0.54217,1,1
4,GO SYNAPTIC VESICLE DOCKING,0.00033648,0.4991,0.66821,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0083971,0.48659,0.36675,1,1
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00014989,0.48406,0.49094,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00048214,0.47665,0.48389,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0042727,0.47615,0.41386,1,1
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00332,0.47317,0.43356,1,1
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00013188,0.47179,0.62988,1,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0023095,0.46652,0.48021,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,8.9327e-05,0.45689,0.62103,1,1
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00042807,0.45677,0.67834,1,1
4,GO DENSE CORE GRANULE TRANSPORT,0.00068502,0.44643,0.56444,1,1
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0015041,0.44424,0.37859,1,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00028019,0.44381,0.49743,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,7.8298e-05,0.44301,0.597,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0021907,0.44081,0.44581,1,1
4,GO CELL JUNCTION MAINTENANCE,0.00019306,0.44008,0.40795,1,1
4,GO AXONEME ASSEMBLY,0.0029965,0.43844,0.3801,1,1
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0076456,0.43807,0.47816,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0040644,0.43755,0.39703,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00013188,0.43717,0.65224,1,1
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0021907,0.43122,0.42033,1,1
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0054671,0.43039,0.36751,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0031545,0.42977,0.35789,1,1
4,GO DENDRITIC TRANSPORT,0.0076456,0.4285,0.35113,1,1
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0076456,0.42661,0.45751,1,1
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0010209,0.42585,0.46655,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00014062,0.41552,0.53888,1,1
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00051151,0.4148,0.42274,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00054254,0.41325,0.47152,1,1
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,5.9985e-05,0.4125,0.42286,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0027019,0.41244,0.45802,1,1
4,GO LIPID DIGESTION,0.0010209,0.40648,0.43956,1,1
4,GO PREPULSE INHIBITION,0.0054671,0.40379,0.42828,1,1
4,GO RESPONSE TO FORSKOLIN,0.0015882,0.40074,0.421,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0024341,0.3961,0.39019,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00045436,0.39596,0.38552,1,1
4,GO NEURON REMODELING,0.007293,0.39567,0.36652,1,1
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00076864,0.3952,0.49052,1,1
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0018673,0.39098,0.48144,1,1
4,GO SYNAPTIC VESICLE CLUSTERING,0.00081392,0.39092,0.50124,1,1
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0027019,0.38974,0.62491,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0010209,0.38969,0.39991,1,1
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0023095,0.38863,0.38673,1,1
4,GO VOCALIZATION BEHAVIOR,0.0060238,0.38723,0.35745,1,1
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0028457,0.38711,0.40221,1,1
4,GO REFLEX,0.0023095,0.38421,0.38683,1,1
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00051151,0.38295,0.44356,1,1
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0012758,0.38082,0.37694,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.0029965,0.37897,0.3,1,1
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0019699,0.37796,0.39869,1,1
4,GO POSTSYNAPSE ASSEMBLY,0.0066311,0.37788,0.40449,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00081392,0.37665,0.31837,1,1
4,GO MEMBRANE DEPOLARIZATION,0.00017019,0.37604,0.3977,1,1
4,GO IRON COORDINATION ENTITY TRANSPORT,0.0025648,0.37252,0.34863,1,1
4,GO EXTRACELLULAR TRANSPORT,0.0018673,0.37087,0.35355,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00019306,0.37063,0.55426,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00086166,0.3696,0.36416,1,1
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00072571,0.36938,0.43044,1,1
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0042727,0.36937,0.31266,1,1
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.00035748,0.36923,0.48169,1,1
4,GO REGULATION OF CILIUM ASSEMBLY,0.0015041,0.36902,0.31921,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00014989,0.3689,0.53641,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00086166,0.36792,0.36009,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0054671,0.36528,0.30362,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0034935,0.36334,0.4684,1,1
4,GO ADRENAL GLAND DEVELOPMENT,0.0012071,0.36316,0.36521,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.0015882,0.36267,0.4446,1,1
4,GO INTESTINAL LIPID ABSORPTION,0.00076864,0.36199,0.45502,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00081392,0.36168,0.4078,1,1
4,GO SECRETORY GRANULE LOCALIZATION,0.0044907,0.35989,0.39039,1,1
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0011418,0.35986,0.34862,1,1
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0023095,0.35952,0.35171,1,1
4,GO GLUTAMATE SECRETION,0.00064645,0.35757,0.36777,1,1
4,GO NEURONAL ACTION POTENTIAL,0.0016767,0.35697,0.3869,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.045233,0.3564,0.26348,1,1
4,GO MICROTUBULE BUNDLE FORMATION,0.0014241,0.35586,0.35448,1,1
4,GO SYNAPTIC VESICLE BUDDING,0.0021907,0.35576,0.32837,1,1
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.043559,0.35476,0.28937,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0016767,0.35423,0.38463,1,1
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0011418,0.35303,0.36413,1,1
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00040321,0.35179,0.44272,1,1
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0036751,0.35153,0.37576,1,1
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0010798,0.35132,0.3857,1,1
4,GO SYNAPTIC VESICLE MATURATION,0.00042807,0.35107,0.51246,1,1
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0014241,0.34935,0.3573,1,1
4,GO DOSAGE COMPENSATION,0.0040644,0.34774,0.30121,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0020776,0.34736,0.39116,1,1
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0040644,0.34725,0.3814,1,1
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0040644,0.3463,0.37583,1,1
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0024341,0.34558,0.42141,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00096503,0.34439,0.33628,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.00019306,0.3425,0.49076,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0040644,0.34164,0.31374,1,1
4,GO MRNA SPLICE SITE SELECTION,0.012106,0.3405,0.28228,1,1
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0052065,0.33979,0.27748,1,1
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0036751,0.33946,0.55451,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.01266,0.33908,0.27546,1,1
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00051151,0.33904,0.39475,1,1
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0029965,0.33879,0.3735,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0016767,0.33702,0.35776,1,1
4,GO SYNAPTIC VESICLE LOCALIZATION,0.00033648,0.33698,0.37777,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.011574,0.33572,0.28282,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.046961,0.33445,0.2393,1,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.025096,0.33286,0.31694,1,1
4,GO NEURON MATURATION,0.0024341,0.33152,0.31724,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.024086,0.33106,0.26704,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0020776,0.33042,0.31589,1,1
4,GO NEUROTRANSMITTER SECRETION,0.00054254,0.3304,0.4086,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,0.00332,0.32995,0.32885,1,1
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00081392,0.32931,0.4197,1,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.010101,0.32785,0.24308,1,1
4,GO PROTEIN POLYGLUTAMYLATION,0.00042807,0.32588,0.36113,1,1
4,GO COLLECTING DUCT DEVELOPMENT,0.0012758,0.32556,0.40725,1,1
4,GO STARTLE RESPONSE,0.0016767,0.32553,0.35323,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0016767,0.32535,0.38174,1,1
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0034935,0.32533,0.29141,1,1
4,GO RETROGRADE AXONAL TRANSPORT,0.0076456,0.32525,0.33376,1,1
4,GO CHEMOSENSORY BEHAVIOR,0.00018128,0.32481,0.40855,1,1
4,GO SYNAPSE ASSEMBLY,0.00096503,0.32469,0.37653,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0021907,0.32439,0.35424,1,1
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.013834,0.32426,0.27261,1,1
4,GO REGULATION OF VESICLE FUSION,0.00081392,0.32416,0.38178,1,1
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00072571,0.3234,0.39095,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0096484,0.32332,0.33999,1,1
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0049572,0.32323,0.38434,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0025648,0.32277,0.31692,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.023112,0.32274,0.30575,1,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0025648,0.32224,0.3172,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0014241,0.32043,0.30489,1,1
4,GO LOCOMOTOR RHYTHM,0.00054254,0.3204,0.40197,1,1
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.011574,0.32016,0.29343,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0024341,0.31948,0.37323,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0017696,0.31939,0.35775,1,1
4,GO COLLATERAL SPROUTING,0.0038653,0.31917,0.35053,1,1
4,GO MICROTUBULE POLYMERIZATION,0.0015041,0.31907,0.30601,1,1
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0020776,0.31762,0.43678,1,1
4,GO NEUROTRANSMITTER TRANSPORT,0.00057531,0.31656,0.37778,1,1
4,GO PANCREATIC JUICE SECRETION,0.015776,0.31646,0.24779,1,1
4,GO FOREBRAIN NEURON DEVELOPMENT,0.0019699,0.31599,0.32282,1,1
4,GO MICROTUBULE SEVERING,0.010572,0.31592,0.25994,1,1
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0017696,0.31585,0.28042,1,1
4,GO REGULATION OF COLLATERAL SPROUTING,0.011063,0.31463,0.32534,1,1
4,GO SYNAPTIC VESICLE PRIMING,0.00048214,0.31365,0.52409,1,1
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0015041,0.31182,0.38057,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0018673,0.31181,0.26996,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0063209,0.31043,0.3879,1,1
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.010101,0.31021,0.3451,1,1
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0063209,0.31017,0.29416,1,1
4,GO HISTONE H3 K4 TRIMETHYLATION,0.0080134,0.31012,0.33843,1,1
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0057394,0.31005,0.32694,1,1
4,GO ADULT BEHAVIOR,0.0042727,0.30948,0.28426,1,1
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0010798,0.30936,0.39511,1,1
4,GO NODAL SIGNALING PATHWAY,0.0016767,0.30921,0.31791,1,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0025648,0.30879,0.44018,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00081392,0.30864,0.38979,1,1
4,GO SECONDARY HEART FIELD SPECIFICATION,0.0063209,0.30837,0.3602,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0096484,0.30835,0.26873,1,1
4,GO NEURON PROJECTION EXTENSION,0.00068502,0.30835,0.33252,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0012071,0.3082,0.41382,1,1
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0057394,0.30782,0.27396,1,1
4,GO REGULATION OF GOLGI ORGANIZATION,0.00076864,0.30702,0.34924,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,4.5779e-05,0.30629,0.37766,1,1
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00017019,0.30618,0.33529,1,1
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.0017696,0.3061,0.36353,1,1
4,GO ANTEROGRADE AXONAL TRANSPORT,0.0027019,0.30582,0.30434,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0010798,0.30565,0.35921,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.023112,0.30537,0.27329,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00081392,0.30513,0.32986,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0010798,0.30258,0.2798,1,1
4,GO PEPTIDYL ARGININE METHYLATION,1.7249e-05,0.30197,0.34315,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0076456,0.30111,0.28667,1,1
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0042727,0.30055,0.39228,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0044907,0.3001,0.36373,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0018673,0.29977,0.3421,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0024341,0.29951,0.32387,1,1
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0025648,0.29889,0.29282,1,1
4,GO DENDRITE MORPHOGENESIS,0.0044907,0.29872,0.2951,1,1
4,GO PROTEIN PALMITOYLATION,0.00013188,0.2987,0.35201,1,1
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00045436,0.29857,0.37432,1,1
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.008797,0.29824,0.27431,1,1
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0052065,0.29756,0.34056,1,1
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.015104,0.29728,0.32737,1,1
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00045436,0.29649,0.32322,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.008797,0.296,0.33974,1,1
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0049572,0.29577,0.29987,1,1
4,GO INTRACILIARY TRANSPORT,0.006955,0.29539,0.24888,1,1
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00054254,0.29473,0.48956,1,1
4,GO AXON EXTENSION,0.0015041,0.29437,0.32297,1,1
4,GO PROTEIN DEMETHYLATION,0.0018673,0.29411,0.35322,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0016767,0.2939,0.30637,1,1
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.0057394,0.29345,0.29733,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.0012758,0.29318,0.34917,1,1
4,GO CILIUM MOVEMENT,0.0018673,0.29307,0.31126,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00023283,0.29264,0.34489,1,1
4,GO SYNAPTIC VESICLE TRANSPORT,0.00029789,0.29257,0.34212,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0080134,0.29209,0.34418,1,1
4,GO PIGMENT ACCUMULATION,0.015776,0.29166,0.25977,1,1
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0025648,0.29151,0.33289,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.00040321,0.29131,0.35474,1,1
4,GO ACROSOME REACTION,0.00035748,0.29127,0.27183,1,1
4,GO AXO DENDRITIC TRANSPORT,0.00068502,0.29095,0.32302,1,1
4,GO DETECTION OF CALCIUM ION,0.0020776,0.29093,0.37192,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0013481,0.28993,0.28786,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.013834,0.28992,0.27433,1,1
4,GO REGULATION OF MICROTUBULE BINDING,0.0036751,0.28861,0.30435,1,1
4,GO POTASSIUM ION HOMEOSTASIS,0.00048214,0.28753,0.31284,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00051151,0.28698,0.31961,1,1
4,GO WATER HOMEOSTASIS,0.0023095,0.28668,0.27395,1,1
4,GO CELLULAR COMPONENT MAINTENANCE,0.00045436,0.28641,0.31159,1,1
4,GO LYSINE METABOLIC PROCESS,0.0010798,0.28608,0.31363,1,1
4,GO DOPAMINE TRANSPORT,0.00035748,0.286,0.43498,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.0029965,0.28584,0.31043,1,1
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00048214,0.28539,0.29319,1,1
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00068502,0.28519,0.33601,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0042727,0.28372,0.28115,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.008797,0.28286,0.2973,1,1
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0016767,0.28279,0.34148,1,1
4,GO REGULATION OF MITOPHAGY,0.00028019,0.28263,0.38881,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.015104,0.2817,0.23152,1,1
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.0019699,0.28124,0.31958,1,1
4,GO SYNAPTIC SIGNALING,0.00076864,0.28108,0.33114,1,1
4,GO OXIDATIVE DEMETHYLATION,0.00045436,0.28092,0.35746,1,1
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.019548,0.28075,0.23363,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015776,0.28055,0.25699,1,1
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00086166,0.28032,0.38269,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0038653,0.27957,0.35254,1,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.00076864,0.27952,0.30083,1,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.0012758,0.27928,0.30964,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0057394,0.27917,0.24568,1,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.008797,0.27916,0.24153,1,1
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.007293,0.27855,0.29322,1,1
4,GO REGULATION OF TELOMERE CAPPING,0.0038653,0.27832,0.26299,1,1
4,GO UV DAMAGE EXCISION REPAIR,0.007293,0.27817,0.25766,1,1
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0012071,0.27815,0.33818,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0172,0.27814,0.27116,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0020776,0.27782,0.34731,1,1
4,GO HISTONE H3 K9 TRIMETHYLATION,0.0042727,0.27775,0.29539,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0020776,0.27639,0.31173,1,1
4,GO LONG TERM SYNAPTIC DEPRESSION,0.0027019,0.27635,0.33584,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0023095,0.27631,0.31909,1,1
4,GO FUCOSYLATION,0.0019699,0.27593,0.29634,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00011593,0.27565,0.34952,1,1
4,GO CHROMATIN DISASSEMBLY,0.0080134,0.27525,0.25235,1,1
4,GO POSITIVE REGULATION OF ACROSOME REACTION,0.00045436,0.27484,0.2768,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0016767,0.27445,0.30742,1,1
4,GO DEVELOPMENTAL CELL GROWTH,0.00096503,0.27404,0.29703,1,1
4,GO POTASSIUM ION TRANSPORT,0.00042807,0.274,0.31467,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0017696,0.27359,0.30921,1,1
4,GO ADHERENS JUNCTION ASSEMBLY,0.0011418,0.273,0.34154,1,1
4,GO RESPONSE TO GLUCAGON,0.022172,0.27279,0.21468,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0024341,0.27203,0.2894,1,1
4,GO CGMP MEDIATED SIGNALING,0.0044907,0.2718,0.31901,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.00057531,0.27166,0.4179,1,1
4,GO AXONAL TRANSPORT,0.0015041,0.27146,0.30598,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.008797,0.27139,0.29899,1,1
4,GO MITOCHONDRION LOCALIZATION,0.0014241,0.27108,0.28815,1,1
4,GO MICROTUBULE BASED MOVEMENT,0.00076864,0.27099,0.28671,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.016475,0.27088,0.32247,1,1
4,GO REGULATION OF AXON GUIDANCE,0.0042727,0.27075,0.34193,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0016767,0.27071,0.34581,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.00026348,0.27035,0.50889,1,1
4,GO GENETIC IMPRINTING,0.0012071,0.27012,0.32365,1,1
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0014241,0.26986,0.33277,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.0027019,0.26976,0.2719,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.007293,0.26935,0.26348,1,1
4,GO BRAIN MORPHOGENESIS,0.0020776,0.26884,0.29534,1,1
4,GO CELL MIGRATION IN HINDBRAIN,0.008797,0.26877,0.29034,1,1
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0063209,0.26842,0.34808,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.0049572,0.2681,0.34991,1,1
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.008797,0.2678,0.25182,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00068502,0.26729,0.32022,1,1
4,GO SYNAPTIC VESICLE RECYCLING,0.00019306,0.2672,0.38697,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.011063,0.26691,0.30037,1,1
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.007293,0.2666,0.23461,1,1
4,GO NEGATIVE CHEMOTAXIS,0.0038653,0.26659,0.33692,1,1
4,GO NEURON PROJECTION ARBORIZATION,0.015776,0.26617,0.27326,1,1
4,GO MICROTUBULE NUCLEATION,0.0049572,0.26601,0.28802,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00014989,0.266,0.35948,1,1
4,GO ACIDIC AMINO ACID TRANSPORT,0.00064645,0.2653,0.30617,1,1
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0054671,0.26525,0.28505,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0052065,0.26479,0.31738,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.023112,0.26448,0.30697,1,1
4,GO MICROTUBULE ANCHORING,0.00332,0.26424,0.33332,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.020391,0.26384,0.23495,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0031545,0.26368,0.32329,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0020776,0.26355,0.34577,1,1
4,GO CATECHOLAMINE SECRETION,0.00029789,0.26354,0.39608,1,1
4,GO CILIUM ORGANIZATION,0.0019699,0.26345,0.27103,1,1
4,GO NON MOTILE CILIUM ASSEMBLY,0.0042727,0.26295,0.24012,1,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.0029965,0.26286,0.32026,1,1
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.007293,0.26272,0.29245,1,1
4,GO BASEMENT MEMBRANE ASSEMBLY,0.0034935,0.26267,0.40651,1,1
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0083971,0.26224,0.30427,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00051151,0.26175,0.37455,1,1
4,GO CELL PART MORPHOGENESIS,0.0024341,0.26172,0.27353,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.0080134,0.26148,0.23239,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00042807,0.2611,0.29602,1,1
4,GO DENDRITIC SPINE MORPHOGENESIS,0.0038653,0.26086,0.31856,1,1
4,GO NEURON PROJECTION ORGANIZATION,0.0040644,0.26079,0.29069,1,1
4,GO DIOL METABOLIC PROCESS,0.0023095,0.26066,0.26683,1,1
4,GO O GLYCAN PROCESSING,0.0076456,0.26066,0.26428,1,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.0057394,0.26039,0.25407,1,1
4,GO DENDRITE EXTENSION,0.00023283,0.26024,0.43094,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.0012758,0.2602,0.28445,1,1
4,GO MICROTUBULE BASED TRANSPORT,0.0010798,0.25979,0.27567,1,1
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00028019,0.25946,0.31582,1,1
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0080134,0.25928,0.30565,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0036751,0.25882,0.27664,1,1
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0031545,0.25864,0.27723,1,1
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0083971,0.2585,0.38433,1,1
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0018673,0.25799,0.28633,1,1
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.0029965,0.25773,0.29967,1,1
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.0034935,0.25728,0.2712,1,1
4,GO DENDRITE DEVELOPMENT,0.0042727,0.25694,0.26948,1,1
4,GO TELOMERE CAPPING,0.0017696,0.25692,0.25346,1,1
4,GO POSTSYNAPSE ORGANIZATION,0.0038653,0.25692,0.28132,1,1
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0060238,0.25683,0.30855,1,1
4,GO TRANSPORT ALONG MICROTUBULE,0.0014241,0.2568,0.26296,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0038653,0.25672,0.24698,1,1
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.014457,0.25658,0.23384,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0042727,0.25655,0.30345,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0020776,0.2565,0.26117,1,1
4,GO CAMP METABOLIC PROCESS,0.0015882,0.25646,0.33787,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0044907,0.25589,0.28728,1,1
4,GO HISTONE H4 K5 ACETYLATION,0.0014241,0.25579,0.28428,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00011593,0.25567,0.33353,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043559,0.25551,0.21648,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.0042727,0.25515,0.26815,1,1
4,GO SYNAPSE ORGANIZATION,0.0029965,0.25502,0.31066,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0014241,0.25492,0.32897,1,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0015041,0.25472,0.28895,1,1
4,GO NEURON PROJECTION GUIDANCE,0.0049572,0.25455,0.28182,1,1
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0028457,0.25404,0.27877,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.013834,0.25385,0.30324,1,1
4,GO FIBROBLAST ACTIVATION,0.022172,0.25356,0.21568,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00091199,0.25315,0.29186,1,1
4,GO MECHANOSENSORY BEHAVIOR,0.034576,0.25307,0.27048,1,1
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0080134,0.25295,0.23289,1,1
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.0023095,0.2527,0.26885,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00096503,0.25219,0.28822,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00040321,0.25187,0.30723,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0023095,0.25155,0.29254,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0025648,0.25154,0.28118,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0052065,0.25153,0.28308,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0017696,0.25128,0.2758,1,1
4,GO SKELETAL MUSCLE ADAPTATION,0.0028457,0.25088,0.32509,1,1
4,GO FEAR RESPONSE,0.0096484,0.25051,0.21965,1,1
4,GO AXON DEVELOPMENT,0.0042727,0.25033,0.2643,1,1
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0027019,0.24944,0.34011,1,1
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.037377,0.24925,0.26916,1,1
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.00081392,0.24921,0.3222,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.0038653,0.24919,0.318,1,1
4,GO RESPONSE TO REDOX STATE,0.0066311,0.24844,0.28527,1,1
4,GO BODY MORPHOGENESIS,0.0076456,0.24785,0.27711,1,1
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.011574,0.24747,0.21638,1,1
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.020391,0.24743,0.26831,1,1
4,GO TRANSCYTOSIS,0.014457,0.2473,0.2613,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0029965,0.24709,0.34416,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0012758,0.24701,0.34547,1,1
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.012106,0.24596,0.35137,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0019699,0.24529,0.31287,1,1
4,GO LEARNING,0.0038653,0.24521,0.28673,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.007293,0.24485,0.28287,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.0018673,0.24469,0.24828,1,1
4,GO HISTONE DEUBIQUITINATION,0.0052065,0.24467,0.2688,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.00035748,0.24442,0.37667,1,1
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.007293,0.24414,0.27337,1,1
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0014241,0.24396,0.2827,1,1
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.026142,0.24368,0.31514,1,1
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0012071,0.24364,0.31385,1,1
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.0066311,0.24348,0.29042,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0042727,0.24287,0.2504,1,1
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00096503,0.24274,0.2689,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0044907,0.24268,0.26239,1,1
4,GO SEGMENT SPECIFICATION,0.010572,0.24266,0.2969,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.012106,0.24191,0.21439,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0020776,0.24179,0.25402,1,1
4,GO HISTONE H3 K9 MODIFICATION,0.013235,0.24124,0.26042,1,1
4,GO NEURAL NUCLEUS DEVELOPMENT,0.00023283,0.24121,0.29713,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0047188,0.24117,0.34725,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00068502,0.24117,0.2382,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.014457,0.24084,0.32451,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0057394,0.24036,0.25503,1,1
4,GO REGULATION OF APPETITE,0.006955,0.23994,0.31532,1,1
4,GO REGULATION OF AXONOGENESIS,0.0066311,0.23991,0.28914,1,1
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.026142,0.23988,0.28935,1,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00332,0.2398,0.27717,1,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.017954,0.23907,0.29358,1,1
4,GO HISTONE H3 K9 METHYLATION,0.01266,0.23855,0.28022,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.01266,0.23825,0.26853,1,1
4,GO LONG TERM SYNAPTIC POTENTIATION,0.0092139,0.23809,0.29374,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.010572,0.23763,0.25516,1,1
4,GO RESPONSE TO DOPAMINE,0.0010798,0.23708,0.2396,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.00076864,0.23683,0.31224,1,1
4,GO HISTONE H2A MONOUBIQUITINATION,0.0016767,0.23676,0.29738,1,1
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.034576,0.23672,0.3093,1,1
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0028457,0.2359,0.36074,1,1
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.006955,0.23571,0.27167,1,1
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0010209,0.23528,0.2825,1,1
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0040644,0.2341,0.29521,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,0.011574,0.23344,0.20743,1,1
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0047188,0.23311,0.32559,1,1
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00026348,0.23301,0.39418,1,1
4,GO TORC1 SIGNALING,0.0023095,0.23277,0.28959,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0011418,0.23276,0.26137,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.024086,0.23273,0.2106,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.0014241,0.23247,0.27497,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.00035748,0.2321,0.2806,1,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0172,0.23154,0.21486,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0040644,0.23125,0.32962,1,1
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.018736,0.23091,0.19134,1,1
4,GO MYOTUBE CELL DEVELOPMENT,0.027226,0.23088,0.1743,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00035748,0.23072,0.31989,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0052065,0.23043,0.32265,1,1
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0015041,0.23039,0.26135,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.0052065,0.23009,0.31883,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.011063,0.23002,0.34893,1,1
4,GO VISUAL BEHAVIOR,0.00015974,0.22982,0.31884,1,1
4,GO CELL VOLUME HOMEOSTASIS,0.00096503,0.22978,0.29181,1,1
4,GO CORNIFICATION,0.040368,0.22911,0.15945,1,1
4,GO CARDIAC CONDUCTION,0.0042727,0.22897,0.29321,1,1
4,GO MONOAMINE TRANSPORT,0.0014241,0.22887,0.32107,1,1
4,GO ACTION POTENTIAL,0.0028457,0.22842,0.31776,1,1
4,GO AMINE TRANSPORT,0.0027019,0.2284,0.29736,1,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.022172,0.22807,0.22842,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.0021907,0.22783,0.28929,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.034576,0.22777,0.20428,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.031957,0.2277,0.25752,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.043559,0.22769,0.21592,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.0019699,0.22725,0.24171,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0092139,0.22685,0.23443,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.045233,0.2268,0.26009,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.0010209,0.2267,0.27399,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046961,0.22654,0.23059,1,1
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.0014241,0.22626,0.33992,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.025096,0.2262,0.19397,1,1
4,GO REGULATION OF TORC1 SIGNALING,0.00332,0.22613,0.27175,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.011574,0.22595,0.29448,1,1
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.00035748,0.2258,0.21278,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.010101,0.22577,0.25324,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,0.00060992,0.22547,0.23014,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0034935,0.22525,0.28691,1,1
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0040644,0.22515,0.29692,1,1
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00072571,0.22503,0.35136,1,1
4,GO LUTEINIZATION,0.023112,0.22466,0.33648,1,1
4,GO CELLULAR RESPONSE TO PH,0.0076456,0.22455,0.24373,1,1
4,GO CELL JUNCTION ASSEMBLY,0.0019699,0.22447,0.27811,1,1
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0019699,0.22433,0.36178,1,1
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0028457,0.22432,0.27943,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0003797,0.22407,0.31225,1,1
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.048745,0.22381,0.24928,1,1
4,GO LATERAL VENTRICLE DEVELOPMENT,0.013834,0.22361,0.30153,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.035953,0.22336,0.2872,1,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.011574,0.2232,0.30191,1,1
4,GO HEART FIELD SPECIFICATION,0.012106,0.22317,0.27276,1,1
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0096484,0.22312,0.28467,1,1
4,GO DETECTION OF VISIBLE LIGHT,0.00081392,0.2231,0.20204,1,1
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0080134,0.22303,0.23949,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.008797,0.22294,0.20234,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.00064645,0.22287,0.26697,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.015776,0.22255,0.24867,1,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0012071,0.2223,0.2807,1,1
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00072571,0.22174,0.32665,1,1
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00026348,0.2217,0.22272,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0015882,0.22123,0.25954,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.031957,0.22103,0.27144,1,1
4,GO NEURON DEVELOPMENT,0.0029965,0.22103,0.26342,1,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.043559,0.22101,0.19825,1,1
4,GO MICROTUBULE BASED PROCESS,0.0034935,0.22088,0.23003,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0044907,0.22087,0.30191,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.017954,0.22076,0.23687,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0036751,0.22008,0.27191,1,1
4,GO SODIUM ION TRANSPORT,0.00054254,0.21986,0.30944,1,1
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0063209,0.21981,0.27721,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.011574,0.21972,0.23214,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00332,0.21965,0.2795,1,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.018736,0.21962,0.2306,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00042807,0.21954,0.27749,1,1
4,GO RENAL WATER HOMEOSTASIS,0.0052065,0.21925,0.27042,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0049572,0.2191,0.27773,1,1
4,GO PROTEIN METHYLATION,0.0057394,0.21906,0.24089,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0015041,0.21856,0.23123,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.017954,0.21846,0.20831,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.023112,0.21813,0.23018,1,1
4,GO POLYOL CATABOLIC PROCESS,0.0060238,0.21726,0.26372,1,1
4,GO REGULATION OF MEMBRANE POTENTIAL,0.00096503,0.21686,0.29684,1,1
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0092139,0.2166,0.28187,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.006955,0.21655,0.2338,1,1
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.00081392,0.21618,0.20775,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00060992,0.21603,0.30337,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.017954,0.21583,0.22254,1,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0015041,0.21582,0.20842,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.013834,0.21569,0.29079,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0019699,0.21565,0.29476,1,1
4,GO DETECTION OF LIGHT STIMULUS,0.00086166,0.21546,0.19937,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.011574,0.21522,0.18441,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00076864,0.21494,0.29707,1,1
4,GO MIRNA METABOLIC PROCESS,0.00091199,0.21488,0.26672,1,1
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.00332,0.2148,0.3218,1,1
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0018673,0.21462,0.26149,1,1
4,GO PRESYNAPSE ORGANIZATION,0.0042727,0.21458,0.31855,1,1
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0049572,0.21445,0.32666,1,1
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0027019,0.21444,0.26144,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.037377,0.21413,0.17658,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0060238,0.21411,0.26782,1,1
4,GO REGULATION OF MRNA PROCESSING,0.021265,0.21411,0.19128,1,1
4,GO LOCOMOTORY BEHAVIOR,0.008797,0.2141,0.2522,1,1
4,GO MEMORY,0.0034935,0.21407,0.28415,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.017954,0.21402,0.27717,1,1
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.038848,0.21395,0.24955,1,1
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0092139,0.2139,0.24654,1,1
4,GO HISTONE H3 DEACETYLATION,0.00332,0.21386,0.27586,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0052065,0.21377,0.2992,1,1
4,GO MEMBRANE DOCKING,0.0011418,0.21357,0.24879,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.010101,0.21322,0.27439,1,1
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.017954,0.21281,0.20746,1,1
4,GO BONE CELL DEVELOPMENT,0.040368,0.21255,0.21603,1,1
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0021907,0.21222,0.28738,1,1
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.006955,0.2122,0.2594,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0020776,0.2121,0.23677,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0049572,0.21206,0.2741,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0040644,0.21201,0.28105,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.0036751,0.21198,0.30747,1,1
4,GO ADAPTATION OF SIGNALING PATHWAY,0.017954,0.21179,0.29024,1,1
4,GO THYROID GLAND DEVELOPMENT,0.0172,0.21177,0.21208,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.011063,0.2117,0.28979,1,1
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.038848,0.21162,0.16493,1,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.012106,0.21156,0.36015,1,1
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0013481,0.21137,0.30085,1,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.0047188,0.21105,0.27937,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.0016767,0.21077,0.24533,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.035953,0.21076,0.18869,1,1
4,GO HINDBRAIN DEVELOPMENT,0.014457,0.21066,0.20769,1,1
4,GO HEAD MORPHOGENESIS,0.019548,0.21039,0.28514,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.0021907,0.21037,0.2933,1,1
4,GO REGULATION OF RNA SPLICING,0.011574,0.21025,0.1977,1,1
4,GO PARTURITION,0.010101,0.21004,0.2312,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0083971,0.21004,0.21441,1,1
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.033245,0.21001,0.2019,1,1
4,GO LONG TERM MEMORY,0.017954,0.20991,0.26835,1,1
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.033245,0.20988,0.18793,1,1
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.046961,0.2097,0.24904,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.035953,0.20964,0.20199,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.007293,0.20961,0.20219,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.028348,0.20939,0.21765,1,1
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0080134,0.20933,0.25488,1,1
4,GO EXOCYTIC PROCESS,0.0013481,0.20879,0.30124,1,1
4,GO CELL PROJECTION ORGANIZATION,0.0028457,0.20875,0.2458,1,1
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0015041,0.20841,0.26311,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0040644,0.20827,0.28667,1,1
4,GO PROTEIN HETEROOLIGOMERIZATION,0.0016767,0.20804,0.25393,1,1
4,GO REGULATION OF ACROSOME REACTION,0.0063209,0.20802,0.21422,1,1
4,GO PHOSPHATE ION TRANSPORT,0.043559,0.20793,0.19732,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0038653,0.20779,0.30822,1,1
4,GO NEURON DIFFERENTIATION,0.0038653,0.20767,0.24492,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00086166,0.20761,0.3147,1,1
4,GO BEHAVIOR,0.010101,0.20749,0.22721,1,1
4,GO SPERM MOTILITY,0.0027019,0.20713,0.26011,1,1
4,GO ASSOCIATIVE LEARNING,0.0060238,0.207,0.27922,1,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0054671,0.20697,0.26463,1,1
4,GO PHOTOTRANSDUCTION,0.0010798,0.20675,0.17381,1,1
4,GO MITOPHAGY,0.00091199,0.2067,0.29474,1,1
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.025096,0.20638,0.21919,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0060238,0.20635,0.17002,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.031957,0.20625,0.20794,1,1
4,GO NEUROTRANSMITTER REUPTAKE,0.0027019,0.20624,0.29542,1,1
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0023095,0.20603,0.28464,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0023095,0.2059,0.27249,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.02951,0.2058,0.1898,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0029965,0.2058,0.40535,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0036751,0.20549,0.26446,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0096484,0.20543,0.27915,1,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.030713,0.20531,0.18154,1,1
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0040644,0.20498,0.3096,1,1
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0047188,0.20496,0.26323,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0044907,0.20494,0.26056,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0063209,0.2047,0.31761,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.013235,0.20468,0.23161,1,1
4,GO REGULATION OF NEURON DIFFERENTIATION,0.0076456,0.20433,0.23558,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.007293,0.20352,0.29709,1,1
4,GO MITOCHONDRION DISTRIBUTION,0.0096484,0.20348,0.26104,1,1
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.011574,0.20288,0.21902,1,1
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.030713,0.20288,0.19918,1,1
4,GO CRISTAE FORMATION,0.00054254,0.20247,0.23623,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0034935,0.2016,0.2734,1,1
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.006955,0.20117,0.19788,1,1
4,GO REGULATION OF HORMONE SECRETION,0.0028457,0.20097,0.22592,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0044907,0.20066,0.21641,1,1
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.046961,0.20057,0.17593,1,1
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.020391,0.20024,0.20397,1,1
4,GO RNA POLYADENYLATION,0.0057394,0.20012,0.23701,1,1
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0031545,0.19935,0.31177,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0083971,0.19919,0.21114,1,1
4,GO HISTONE MONOUBIQUITINATION,0.0066311,0.19905,0.23223,1,1
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0049572,0.19899,0.24952,1,1
4,GO MEMBRANE BIOGENESIS,0.0042727,0.19873,0.30811,1,1
4,GO AROMATIC AMINO ACID TRANSPORT,0.048745,0.19865,0.23499,1,1
4,GO SINGLE STRAND BREAK REPAIR,0.0066311,0.19849,0.26,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00013188,0.19837,0.29824,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.015104,0.19822,0.21301,1,1
4,GO RESPIRATORY SYSTEM PROCESS,0.007293,0.1982,0.29009,1,1
4,GO NOTCH SIGNALING PATHWAY,0.0014241,0.19809,0.26241,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.023112,0.19795,0.27326,1,1
4,GO RESPONSE TO LEAD ION,0.0025648,0.19707,0.25647,1,1
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.018736,0.19687,0.24635,1,1
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0012758,0.19613,0.26581,1,1
4,GO PROTEIN ACYLATION,0.0029965,0.19607,0.2271,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0016767,0.19601,0.23656,1,1
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0049572,0.19599,0.31208,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0172,0.1959,0.28802,1,1
4,GO ATP TRANSPORT,0.0017696,0.19565,0.2089,1,1
4,GO TRANSFERRIN TRANSPORT,0.00020554,0.19539,0.26967,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.013235,0.19531,0.17604,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.015776,0.19523,0.21485,1,1
4,GO PHOTOPERIODISM,0.0024341,0.19522,0.22481,1,1
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00332,0.1952,0.25671,1,1
4,GO REGULATION OF TOR SIGNALING,0.0015882,0.1952,0.22526,1,1
4,GO MEMBRANE REPOLARIZATION,0.0044907,0.19495,0.31544,1,1
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.031957,0.19475,0.25277,1,1
4,GO DICARBOXYLIC ACID TRANSPORT,0.00051151,0.1947,0.26312,1,1
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.011063,0.19462,0.26224,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0049572,0.19459,0.2401,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.008797,0.1945,0.21215,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.007293,0.19433,0.23107,1,1
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.018736,0.1943,0.23887,1,1
4,GO DEVELOPMENTAL MATURATION,0.0054671,0.19428,0.2362,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0012071,0.19403,0.237,1,1
4,GO SPERMATID DIFFERENTIATION,0.0040644,0.19402,0.19572,1,1
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0063209,0.194,0.2067,1,1
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.035953,0.19376,0.23034,1,1
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.011574,0.19369,0.35051,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0016767,0.19355,0.27408,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0066311,0.19353,0.22781,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.024086,0.19342,0.24183,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.033245,0.19321,0.21203,1,1
4,GO NUCLEOTIDE TRANSPORT,0.0017696,0.19297,0.20346,1,1
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0080134,0.19224,0.21775,1,1
4,GO GOLGI RIBBON FORMATION,0.030713,0.19206,0.27231,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.014457,0.19196,0.19943,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.034576,0.19191,0.16661,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.021265,0.19188,0.20559,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.0052065,0.19154,0.22112,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.02951,0.19138,0.21251,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0076456,0.19118,0.22222,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.0060238,0.19115,0.19529,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.012106,0.19109,0.22735,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0063209,0.19099,0.23667,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0016767,0.19093,0.30465,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.034576,0.19093,0.17816,1,1
4,GO CELL MATURATION,0.0066311,0.19017,0.19619,1,1
4,GO INSULIN SECRETION,0.0010798,0.18997,0.26234,1,1
4,GO P BODY ASSEMBLY,0.024086,0.18993,0.22509,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,0.0017696,0.18991,0.20041,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0057394,0.1898,0.29699,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.01266,0.18968,0.29046,1,1
4,GO HISTONE H3 K14 ACETYLATION,0.0040644,0.1895,0.29615,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.022172,0.18942,0.19028,1,1
4,GO CELL PROJECTION ASSEMBLY,0.0031545,0.18936,0.22779,1,1
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.023112,0.1891,0.20764,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0021907,0.18893,0.21622,1,1
4,GO SPECIFICATION OF SYMMETRY,0.00332,0.18862,0.24366,1,1
4,GO SECONDARY PALATE DEVELOPMENT,0.007293,0.18861,0.34395,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0052065,0.18848,0.23986,1,1
4,GO PEPTIDE HORMONE SECRETION,0.0010209,0.18839,0.26515,1,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0054671,0.18831,0.25844,1,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0066311,0.18822,0.23277,1,1
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0057394,0.18788,0.26565,1,1
4,GO PLASMA MEMBRANE TUBULATION,0.013834,0.18767,0.25,1,1
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.010572,0.18743,0.22732,1,1
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0092139,0.18735,0.2629,1,1
4,GO NEURON PROJECTION REGENERATION,0.006955,0.1872,0.23444,1,1
4,GO CHROMATIN SILENCING,0.038848,0.18701,0.18394,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0038653,0.18646,0.21858,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0080134,0.18642,0.23039,1,1
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0049572,0.18637,0.26014,1,1
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0017696,0.18633,0.26097,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.00033648,0.18621,0.22287,1,1
4,GO KERATINIZATION,0.018736,0.18592,0.17834,1,1
4,GO HEART PROCESS,0.013834,0.18592,0.22242,1,1
4,GO HISTONE H2A UBIQUITINATION,0.0063209,0.18582,0.22619,1,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00064645,0.18561,0.26865,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0038653,0.18551,0.21049,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0057394,0.18551,0.22732,1,1
4,GO TOOTH MINERALIZATION,0.01266,0.18486,0.28316,1,1
4,GO NUCLEAR BODY ORGANIZATION,0.0042727,0.18485,0.23172,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0172,0.18472,0.17837,1,1
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.035953,0.18467,0.16958,1,1
4,GO PHOSPHOLIPID TRANSPORT,0.046961,0.18465,0.16807,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0040644,0.18459,0.20742,1,1
4,GO REGULATION OF CELL SIZE,0.0047188,0.18452,0.26159,1,1
4,GO AMINO ACID TRANSPORT,0.0016767,0.18442,0.24163,1,1
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0066311,0.18432,0.26866,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.030713,0.18401,0.19927,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0063209,0.18393,0.27807,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.021265,0.18389,0.21608,1,1
4,GO CHLORIDE TRANSPORT,0.0066311,0.18351,0.25401,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0010798,0.18349,0.26435,1,1
4,GO HISTONE UBIQUITINATION,0.008797,0.1833,0.21715,1,1
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0036751,0.18321,0.31081,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.013235,0.18285,0.22612,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.019548,0.18267,0.20309,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.043559,0.18239,0.22004,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0036751,0.18239,0.22638,1,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0083971,0.18238,0.245,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0080134,0.18232,0.21172,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0054671,0.18217,0.22416,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.0060238,0.18202,0.21098,1,1
4,GO MRNA PROCESSING,0.021265,0.18198,0.15706,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0049572,0.18147,0.21224,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0010209,0.18075,0.20522,1,1
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0015041,0.18074,0.22982,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.012106,0.18057,0.21069,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0047188,0.18002,0.20864,1,1
4,GO METHYLATION,0.011063,0.17994,0.18109,1,1
4,GO RESPONSE TO LITHIUM ION,0.0092139,0.17979,0.23027,1,1
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.0025648,0.17961,0.22618,1,1
4,GO PANCREAS DEVELOPMENT,0.015104,0.17942,0.22862,1,1
4,GO AORTA MORPHOGENESIS,0.017954,0.17929,0.29166,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.020391,0.17928,0.20307,1,1
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0047188,0.17927,0.21482,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.016475,0.17926,0.17009,1,1
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.0028457,0.17915,0.26111,1,1
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.021265,0.17907,0.25119,1,1
4,GO HISTONE DEACETYLATION,0.0083971,0.17886,0.24159,1,1
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0054671,0.17848,0.22143,1,1
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0063209,0.17841,0.29548,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.023112,0.17834,0.22132,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0036751,0.17829,0.24977,1,1
4,GO PEPTIDYL ARGININE MODIFICATION,0.0083971,0.17828,0.14557,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0092139,0.17808,0.2371,1,1
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.01266,0.17804,0.2389,1,1
4,GO COVALENT CHROMATIN MODIFICATION,0.0096484,0.17788,0.22445,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0015882,0.1777,0.21602,1,1
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.01266,0.17729,0.22582,1,1
4,GO SKELETAL MUSCLE CONTRACTION,0.0092139,0.17722,0.28987,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0018673,0.17715,0.28156,1,1
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0052065,0.17678,0.24676,1,1
4,GO NEUROTRANSMITTER UPTAKE,0.007293,0.17654,0.22775,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.030713,0.17654,0.2348,1,1
4,GO CHROMATIN REMODELING,0.021265,0.17607,0.19443,1,1
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0060238,0.17569,0.2714,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0023095,0.17566,0.23602,1,1
4,GO ORGANELLE LOCALIZATION,0.0012071,0.17545,0.21886,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.041938,0.17512,0.14412,1,1
4,GO FACE DEVELOPMENT,0.031957,0.1748,0.24094,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.013235,0.17479,0.23858,1,1
4,GO CELL JUNCTION ORGANIZATION,0.0027019,0.17468,0.27159,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.00086166,0.17467,0.23665,1,1
4,GO POLYOL METABOLIC PROCESS,0.0020776,0.17461,0.21057,1,1
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.022172,0.17453,0.17862,1,1
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.037377,0.17451,0.2169,1,1
4,GO PROTEIN ACETYLATION,0.006955,0.17435,0.20561,1,1
4,GO AXIS SPECIFICATION,0.0047188,0.17425,0.19026,1,1
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.0044907,0.17419,0.23143,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.016475,0.17412,0.24338,1,1
4,GO REGULATION OF CYCLASE ACTIVITY,0.018736,0.17392,0.19507,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0031545,0.1737,0.25353,1,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.021265,0.17367,0.18262,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0063209,0.17362,0.20803,1,1
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0054671,0.1736,0.28264,1,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.0096484,0.17353,0.23973,1,1
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.012106,0.17352,0.26329,1,1
4,GO DIET INDUCED THERMOGENESIS,0.041938,0.17341,0.20704,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.030713,0.1734,0.22091,1,1
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0172,0.17315,0.22043,1,1
4,GO REGULATION OF TELOMERE MAINTENANCE,0.028348,0.17304,0.17516,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0015041,0.17262,0.22108,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0031545,0.17255,0.20687,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00072571,0.17253,0.20845,1,1
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0014241,0.17242,0.28931,1,1
4,GO RESPONSE TO LEPTIN,0.0057394,0.1724,0.24852,1,1
4,GO EXCRETION,0.037377,0.17226,0.19706,1,1
4,GO TOR SIGNALING,0.0016767,0.17214,0.21161,1,1
4,GO ACID SECRETION,0.0021907,0.17167,0.21679,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0031545,0.17129,0.26517,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.00332,0.17126,0.22062,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0023095,0.17115,0.19346,1,1
4,GO VASODILATION,0.038848,0.1711,0.18198,1,1
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0060238,0.17104,0.23861,1,1
4,GO INORGANIC ANION TRANSPORT,0.0063209,0.17088,0.22101,1,1
4,GO NEURAL TUBE DEVELOPMENT,0.038848,0.17086,0.18886,1,1
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.006955,0.17082,0.29329,1,1
4,GO REGULATION OF EXOCYTOSIS,0.0031545,0.17081,0.27055,1,1
4,GO MANNOSYLATION,0.019548,0.17074,0.15807,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0047188,0.17074,0.20302,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0092139,0.17038,0.23321,1,1
4,GO RESPONSE TO CALCIUM ION,0.0034935,0.17029,0.25065,1,1
4,GO UV PROTECTION,0.024086,0.17012,0.21749,1,1
4,GO RESPONSE TO PH,0.024086,0.16997,0.20903,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.01266,0.16978,0.19111,1,1
4,GO HORMONE TRANSPORT,0.0023095,0.16975,0.22932,1,1
4,GO RNA SPLICING,0.034576,0.16951,0.14209,1,1
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0096484,0.1694,0.20329,1,1
4,GO REGULATION OF PROTEIN TARGETING,0.0031545,0.16933,0.21233,1,1
4,GO REGULATION OF HISTONE MODIFICATION,0.015104,0.16932,0.19902,1,1
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.01266,0.16931,0.24811,1,1
4,GO DEMETHYLATION,0.0015041,0.16923,0.25632,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0092139,0.16874,0.18802,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0013481,0.16872,0.26508,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.034576,0.1687,0.18764,1,1
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.015104,0.16862,0.1967,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0092139,0.16859,0.22566,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0020776,0.1685,0.21635,1,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.027226,0.16816,0.27115,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.015776,0.16808,0.25549,1,1
4,GO CELLULAR RESPONSE TO SALT STRESS,0.028348,0.16804,0.20921,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.0025648,0.16782,0.24164,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.037377,0.16761,0.16557,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0018673,0.16756,0.21467,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.033245,0.16713,0.19263,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0020776,0.16691,0.2578,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.010101,0.16691,0.22515,1,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.043559,0.16661,0.19418,1,1
4,GO NERVOUS SYSTEM PROCESS,0.0019699,0.16642,0.23117,1,1
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.0021907,0.16634,0.19903,1,1
4,GO RESPONSE TO WATER,0.011063,0.1658,0.21472,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0066311,0.16561,0.19849,1,1
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.010101,0.16552,0.19785,1,1
4,GO REGULATION OF LYASE ACTIVITY,0.019548,0.16552,0.183,1,1
4,GO GERM CELL DEVELOPMENT,0.006955,0.16548,0.18495,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.019548,0.16541,0.16489,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.010101,0.16539,0.23245,1,1
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0172,0.16526,0.23684,1,1
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0080134,0.16513,0.20498,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.0034935,0.16503,0.21958,1,1
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.006955,0.16473,0.18498,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.00057531,0.16468,0.20115,1,1
4,GO RENAL SYSTEM PROCESS,0.045233,0.16452,0.19149,1,1
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.01266,0.16444,0.25525,1,1
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0015041,0.16439,0.20969,1,1
4,GO VESICLE DOCKING,0.00076864,0.16428,0.29962,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0017696,0.16409,0.24368,1,1
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.033245,0.16388,0.17649,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019548,0.16369,0.19976,1,1
4,GO REGULATION OF FERTILIZATION,0.0044907,0.16329,0.17638,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0023095,0.16316,0.21784,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.011574,0.16313,0.20999,1,1
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.048745,0.1631,0.17171,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.0014241,0.16282,0.27831,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.007293,0.16279,0.2428,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.012106,0.16266,0.25568,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.0076456,0.16264,0.18989,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00332,0.16256,0.18231,1,1
4,GO CHROMATIN ORGANIZATION,0.01266,0.16225,0.21412,1,1
4,GO SECONDARY METABOLIC PROCESS,0.0023095,0.16218,0.20842,1,1
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0036751,0.16192,0.17672,1,1
4,GO REGULATION OF HORMONE LEVELS,0.0049572,0.16183,0.19703,1,1
4,GO MRNA 3 END PROCESSING,0.041938,0.16182,0.15475,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.015776,0.16155,0.15902,1,1
4,GO VESICLE LOCALIZATION,0.00064645,0.16122,0.25714,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.007293,0.16028,0.23299,1,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.011063,0.1599,0.24946,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.020391,0.15977,0.17111,1,1
4,GO CYTOSKELETON ORGANIZATION,0.0096484,0.15972,0.20301,1,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.034576,0.15971,0.20405,1,1
4,GO ENDOCYTIC RECYCLING,0.0042727,0.15964,0.26736,1,1
4,GO PLATELET MORPHOGENESIS,0.011063,0.1595,0.26693,1,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.010101,0.15924,0.2399,1,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.0092139,0.15853,0.20173,1,1
4,GO ORGANELLE ASSEMBLY,0.0025648,0.15844,0.19462,1,1
4,GO MACROMOLECULE DEACYLATION,0.007293,0.1584,0.22717,1,1
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.012106,0.1584,0.2384,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0083971,0.15756,0.21943,1,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.014457,0.15735,0.21064,1,1
4,GO IMPORT INTO CELL,0.0049572,0.15712,0.22669,1,1
4,GO RESPONSE TO LIGHT STIMULUS,0.00332,0.15707,0.19761,1,1
4,GO ORGANIC ACID TRANSPORT,0.0060238,0.15689,0.18703,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.021265,0.15664,0.25465,1,1
4,GO MYELIN ASSEMBLY,0.013834,0.15651,0.27934,1,1
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.027226,0.15634,0.17681,1,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0054671,0.15625,0.24625,1,1
4,GO CIRCADIAN RHYTHM,0.0076456,0.15606,0.19097,1,1
4,GO SPLEEN DEVELOPMENT,0.018736,0.15605,0.21129,1,1
4,GO MIDBRAIN DEVELOPMENT,0.0063209,0.15592,0.16094,1,1
4,GO ESCRT COMPLEX DISASSEMBLY,0.018736,0.1553,0.14859,1,1
4,GO GLYCOSYLATION,0.0047188,0.1552,0.19485,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.027226,0.1551,0.23932,1,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0083971,0.15504,0.20327,1,1
4,GO MRNA METHYLATION,0.033245,0.15495,0.17297,1,1
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.015776,0.15495,0.19373,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.030713,0.15486,0.17637,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.023112,0.15463,0.18629,1,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.019548,0.15458,0.21711,1,1
4,GO SEXUAL REPRODUCTION,0.011063,0.15427,0.17594,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.010101,0.15419,0.22264,1,1
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.0172,0.15417,0.19508,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0036751,0.15416,0.21251,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.0063209,0.15411,0.18995,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.040368,0.1539,0.22165,1,1
4,GO COPII COATED VESICLE BUDDING,0.0044907,0.1538,0.20907,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.0036751,0.15374,0.25784,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.011063,0.15363,0.20811,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0028457,0.15351,0.25664,1,1
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.024086,0.15289,0.17245,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.025096,0.15287,0.15629,1,1
4,GO RESPONSE TO AXON INJURY,0.0076456,0.15283,0.19472,1,1
4,GO MYOFIBRIL ASSEMBLY,0.015104,0.1525,0.2181,1,1
4,GO ARTERY DEVELOPMENT,0.045233,0.15237,0.2163,1,1
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.035953,0.15219,0.26534,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0052065,0.15212,0.19076,1,1
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0063209,0.15186,0.25799,1,1
4,GO STRESS GRANULE ASSEMBLY,0.017954,0.15148,0.20142,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.017954,0.15148,0.20075,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0060238,0.15114,0.2295,1,1
4,GO CELLULAR PIGMENTATION,0.0042727,0.15086,0.2072,1,1
4,GO SKIN DEVELOPMENT,0.038848,0.15064,0.15532,1,1
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.034576,0.15058,0.17257,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.012106,0.15056,0.21447,1,1
4,GO SIGNAL RELEASE,0.0066311,0.15038,0.21787,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.0044907,0.15026,0.18928,1,1
4,GO ORGANELLE FUSION,0.0016767,0.15015,0.23696,1,1
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.015776,0.1501,0.23257,1,1
4,GO ARTERY MORPHOGENESIS,0.034576,0.15002,0.22386,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.026142,0.15001,0.22547,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.011574,0.14994,0.21246,1,1
4,GO MRNA CLEAVAGE,0.0015882,0.1499,0.20781,1,1
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.0096484,0.14978,0.21496,1,1
4,GO FEMALE GAMETE GENERATION,0.017954,0.14965,0.16966,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0080134,0.14964,0.24572,1,1
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0047188,0.1494,0.25313,1,1
4,GO PIGMENTATION,0.0040644,0.14939,0.22783,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,0.14925,0.16262,1,1
4,GO REGULATION OF CELL MORPHOGENESIS,0.015104,0.14862,0.21383,1,1
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.045233,0.14848,0.21853,1,1
4,GO REGULATION OF FEEDING BEHAVIOR,0.011574,0.14834,0.1965,1,1
4,GO GAMETE GENERATION,0.0096484,0.14813,0.1787,1,1
4,GO SENSORY PERCEPTION,0.0027019,0.14774,0.19867,1,1
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.020391,0.14701,0.19325,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.00332,0.14687,0.19762,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0047188,0.14686,0.23789,1,1
4,GO NEURAL TUBE FORMATION,0.02951,0.1467,0.19064,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0021907,0.14645,0.20364,1,1
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00081392,0.14642,0.20346,1,1
4,GO GLUCOSE METABOLIC PROCESS,0.006955,0.14641,0.1831,1,1
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.031957,0.14624,0.17408,1,1
4,GO HYPEROSMOTIC RESPONSE,0.046961,0.14623,0.19674,1,1
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0049572,0.14623,0.24248,1,1
4,GO MEMBRANE FUSION,0.0038653,0.14623,0.22132,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0014241,0.1462,0.19372,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.027226,0.14611,0.14082,1,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.0063209,0.14593,0.20535,1,1
4,GO CLATHRIN COAT ASSEMBLY,0.013834,0.14573,0.29374,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0052065,0.14563,0.17337,1,1
4,GO REGULATION OF ION TRANSPORT,0.0080134,0.14541,0.22299,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.014457,0.14528,0.19596,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0092139,0.14514,0.29272,1,1
4,GO PROTEIN POLYMERIZATION,0.0063209,0.14496,0.19831,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.021265,0.14492,0.2277,1,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.0021907,0.1449,0.2177,1,1
4,GO STRESS FIBER ASSEMBLY,0.010572,0.14433,0.22695,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0034935,0.14426,0.17691,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0076456,0.14403,0.32769,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0034935,0.14393,0.25166,1,1
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.027226,0.14373,0.19688,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.035953,0.1435,0.22675,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.014457,0.14313,0.18468,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.0044907,0.14273,0.24442,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.14271,0.23181,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0020776,0.14249,0.20201,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.011574,0.14233,0.2145,1,1
4,GO MALE GAMETE GENERATION,0.010101,0.14225,0.17376,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0096484,0.14217,0.19306,1,1
4,GO KETONE BODY METABOLIC PROCESS,0.020391,0.14213,0.15648,1,1
4,GO DEVELOPMENTAL INDUCTION,0.043559,0.14194,0.17714,1,1
4,GO SOMITOGENESIS,0.048745,0.14169,0.18661,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0038653,0.14154,0.17594,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.034576,0.14144,0.16189,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.0044907,0.14126,0.17373,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.023112,0.14122,0.16648,1,1
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0038653,0.14027,0.21596,1,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0054671,0.14027,0.21092,1,1
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.010101,0.14012,0.21046,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0025648,0.13994,0.16605,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0020776,0.13913,0.24021,1,1
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.0036751,0.13898,0.19776,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0060238,0.13895,0.19389,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.015104,0.13875,0.20136,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.017954,0.13869,0.17699,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0172,0.13866,0.21008,1,1
4,GO ACTIN NUCLEATION,0.013235,0.13825,0.16283,1,1
4,GO ERYTHROCYTE DEVELOPMENT,0.046961,0.13808,0.18681,1,1
4,GO REGULATION OF PROTEIN ACETYLATION,0.012106,0.13803,0.17829,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.034576,0.13796,0.1801,1,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.02951,0.13756,0.18248,1,1
4,GO FATTY ACID BETA OXIDATION,0.010572,0.13731,0.19535,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.015776,0.13724,0.30352,1,1
4,GO RETINA HOMEOSTASIS,0.0060238,0.13717,0.18381,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0038653,0.13695,0.32427,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.010101,0.13676,0.17207,1,1
4,GO HISTONE H2A ACETYLATION,0.013834,0.13662,0.21666,1,1
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.043559,0.13646,0.15973,1,1
4,GO GOLGI VESICLE BUDDING,0.0042727,0.13611,0.20971,1,1
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.0057394,0.13601,0.15205,1,1
4,GO LIPID OXIDATION,0.040368,0.1359,0.16184,1,1
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.020391,0.13587,0.20931,1,1
4,GO CARBOHYDRATE TRANSPORT,0.018736,0.13584,0.17564,1,1
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.046961,0.13529,0.18244,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.011063,0.13453,0.24871,1,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.02951,0.13445,0.14969,1,1
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.019548,0.13437,0.1787,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.00332,0.13425,0.27102,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0054671,0.13425,0.23197,1,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.020391,0.13424,0.21246,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0036751,0.13418,0.20364,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0076456,0.13416,0.16995,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00332,0.13415,0.19697,1,1
4,GO MOLTING CYCLE,0.048745,0.13414,0.1692,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0083971,0.13403,0.1707,1,1
4,GO DEPHOSPHORYLATION,0.007293,0.13374,0.20279,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.043559,0.13333,0.10915,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0025648,0.13332,0.23079,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0096484,0.13322,0.15479,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.0080134,0.1332,0.22144,1,1
4,GO COPII COATED VESICLE CARGO LOADING,0.041938,0.13284,0.20866,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.038848,0.13275,0.12171,1,1
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.012106,0.13273,0.2481,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.015776,0.1324,0.19216,1,1
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.02951,0.1324,0.16632,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0028457,0.13227,0.2317,1,1
4,GO CELL CELL SIGNALING,0.0066311,0.13198,0.21171,1,1
4,GO RESPONSE TO METAL ION,0.013834,0.13192,0.16232,1,1
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0063209,0.13186,0.19714,1,1
4,GO ORGANIC ANION TRANSPORT,0.007293,0.13167,0.17553,1,1
4,GO EPIDERMIS DEVELOPMENT,0.048745,0.1316,0.14384,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0057394,0.1312,0.17936,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0044907,0.1308,0.17499,1,1
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.034576,0.13077,0.11349,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.045233,0.13055,0.19501,1,1
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.026142,0.13019,0.1988,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0096484,0.1301,0.17254,1,1
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.0025648,0.13003,0.144,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.013834,0.12993,0.26049,1,1
4,GO IRON ION TRANSPORT,0.019548,0.12992,0.16292,1,1
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.046961,0.12973,0.15679,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.018736,0.12958,0.20821,1,1
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.038848,0.12953,0.26197,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.031957,0.12944,0.15459,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.020391,0.12921,0.15475,1,1
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.022172,0.129,0.15552,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0049572,0.12899,0.1442,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.038848,0.12887,0.24724,1,1
4,GO CALCINEURIN MEDIATED SIGNALING,0.021265,0.12871,0.20684,1,1
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.034576,0.12863,0.21221,1,1
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0024341,0.12862,0.15813,1,1
4,GO NCRNA TRANSCRIPTION,0.035953,0.12853,0.13851,1,1
4,GO RHYTHMIC PROCESS,0.015776,0.12837,0.1826,1,1
4,GO HEART FORMATION,0.031957,0.1283,0.19645,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.024086,0.12787,0.15389,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.013235,0.12762,0.13749,1,1
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.016475,0.12695,0.17932,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.013235,0.12673,0.17462,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.017954,0.12645,0.16676,1,1
4,GO MITOCHONDRIAL FUSION,0.00332,0.12643,0.19121,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0096484,0.12635,0.20971,1,1
4,GO PHAGOSOME ACIDIFICATION,0.0092139,0.12612,0.18426,1,1
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.013235,0.1256,0.19961,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0057394,0.12507,0.14433,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.008797,0.12493,0.19026,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.025096,0.12492,0.15113,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.025096,0.12461,0.17296,1,1
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.025096,0.12461,0.19655,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.0036751,0.1246,0.20859,1,1
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.028348,0.12413,0.18773,1,1
4,GO MULTI ORGANISM PROCESS,0.017954,0.12384,0.15829,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0042727,0.12362,0.17003,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014457,0.12356,0.13442,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.006955,0.1235,0.16282,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.011063,0.12348,0.166,1,1
4,GO SPERM EGG RECOGNITION,0.0012758,0.12338,0.14644,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0038653,0.12277,0.20158,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0083971,0.12276,0.17582,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.0052065,0.12272,0.21312,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.034576,0.12267,0.15239,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.010101,0.12265,0.18008,1,1
4,GO NEGATIVE REGULATION OF GROWTH,0.040368,0.12236,0.15451,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0025648,0.12196,0.19409,1,1
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.026142,0.12177,0.17819,1,1
4,GO LIPID MODIFICATION,0.018736,0.12173,0.1927,1,1
4,GO ANION TRANSPORT,0.0040644,0.12155,0.19406,1,1
4,GO LIPID PHOSPHORYLATION,0.041938,0.12111,0.18824,1,1
4,GO RETINAL CONE CELL DIFFERENTIATION,0.026142,0.12105,0.17491,1,1
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.019548,0.12081,0.16494,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.0036751,0.12074,0.20741,1,1
4,GO DETECTION OF STIMULUS,0.0052065,0.12052,0.1577,1,1
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.015104,0.12,0.11172,1,1
4,GO MITOCHONDRION MORPHOGENESIS,0.0049572,0.11986,0.16857,1,1
4,GO ORGANELLE INHERITANCE,0.0076456,0.11977,0.16768,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.022172,0.11963,0.12957,1,1
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.017954,0.11938,0.15066,1,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.026142,0.11935,0.17272,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0096484,0.11922,0.16035,1,1
4,GO CATION TRANSPORT,0.0042727,0.11796,0.21076,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.013235,0.1175,0.15401,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0042727,0.11745,0.16478,1,1
4,GO METAL ION TRANSPORT,0.006955,0.11724,0.21283,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.043559,0.11706,0.23218,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.018736,0.11651,0.14849,1,1
4,GO ION TRANSPORT,0.0049572,0.11649,0.20365,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027226,0.11587,0.21163,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.0096484,0.11575,0.15863,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.015776,0.11532,0.19451,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0080134,0.1147,0.16943,1,1
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.043559,0.11381,0.19499,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.0044907,0.11377,0.17787,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0076456,0.11371,0.15936,1,1
4,GO REGULATION OF ATPASE ACTIVITY,0.014457,0.11323,0.12215,1,1
4,GO EPITHELIUM DEVELOPMENT,0.025096,0.11279,0.16318,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.040368,0.1127,0.14809,1,1
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.028348,0.11211,0.22612,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0042727,0.11171,0.1804,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011063,0.1116,0.18746,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.026142,0.11144,0.15168,1,1
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.021265,0.11059,0.16005,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.013235,0.11016,0.16529,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.023112,0.10992,0.1664,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.013235,0.10983,0.17019,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.040368,0.10933,0.14945,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.015104,0.1091,0.14613,1,1
4,GO NEURON APOPTOTIC PROCESS,0.046961,0.10869,0.14319,1,1
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.045233,0.10842,0.14284,1,1
4,GO PEROXISOME ORGANIZATION,0.035953,0.10813,0.13186,1,1
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.016475,0.10798,0.15976,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.021265,0.10786,0.13096,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.016475,0.10765,0.12668,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.022172,0.1076,0.18343,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.010572,0.10711,0.15691,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00332,0.10649,0.1951,1,1
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.021265,0.10631,0.1706,1,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.024086,0.1062,0.23326,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.037377,0.10577,0.13247,1,1
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.027226,0.10567,0.12756,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.041938,0.10538,0.14848,1,1
4,GO PROTEIN DEPHOSPHORYLATION,0.008797,0.10532,0.1901,1,1
4,GO ERAD PATHWAY,0.011574,0.10508,0.19293,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.017954,0.10499,0.17607,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.025096,0.10463,0.14002,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.015776,0.10414,0.19737,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0076456,0.10353,0.12207,1,1
4,GO LIPID LOCALIZATION,0.048745,0.10343,0.15171,1,1
4,GO STEROID METABOLIC PROCESS,0.048745,0.10297,0.13566,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.037377,0.10261,0.15341,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.027226,0.10232,0.19749,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.030713,0.10221,0.13349,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.020391,0.10172,0.15895,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.0092139,0.10134,0.15038,1,1
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0172,0.10129,0.21856,1,1
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.033245,0.10056,0.11887,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.038848,0.099668,0.21526,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.019548,0.098679,0.095058,1,1
4,GO RNA CAPPING,0.027226,0.098554,0.10786,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.046961,0.098415,0.10341,1,1
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.013235,0.097561,0.10731,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.048745,0.097473,0.1884,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.013834,0.09729,0.16011,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0063209,0.096634,0.18206,1,1
4,GO LYTIC VACUOLE ORGANIZATION,0.031957,0.096632,0.17288,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.018736,0.096624,0.14695,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.017954,0.096054,0.15042,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.043559,0.096052,0.15213,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,0.030713,0.096017,0.12552,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.040368,0.095286,0.13629,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.048745,0.094507,0.13706,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.028348,0.093213,0.1472,1,1
4,GO PEROXISOMAL TRANSPORT,0.02951,0.092812,0.11676,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.021265,0.09273,0.22341,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.028348,0.091875,0.11652,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.026142,0.091874,0.1265,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.011574,0.091702,0.22459,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0083971,0.091457,0.15277,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.037377,0.091413,0.17386,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.033245,0.09076,0.1223,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.025096,0.090551,0.19283,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.027226,0.089769,0.11075,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.046961,0.088498,0.1522,1,1
4,GO MITOCHONDRIAL FISSION,0.018736,0.087284,0.16839,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.016475,0.086449,0.11691,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.015104,0.086255,0.13155,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.012106,0.086168,0.17801,1,1
4,GO REGULATION OF AUTOPHAGY,0.010572,0.08564,0.18918,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.028348,0.085037,0.18773,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.020391,0.083579,0.14141,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.018736,0.082219,0.12511,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.017954,0.082103,0.19058,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.013235,0.081831,0.15813,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.028348,0.078152,0.11307,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.030713,0.076407,0.12575,1,1
4,GO MITOCHONDRION ORGANIZATION,0.0028457,0.074203,0.12085,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.011574,0.074064,0.10703,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.046961,0.072046,0.22116,1,1
4,GO MITOTIC CYTOKINETIC PROCESS,0.035953,0.071951,0.10861,1,1
4,GO OXIDATION REDUCTION PROCESS,0.034576,0.070797,0.10732,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.043559,0.069408,0.13702,1,1
4,GO PIGMENT METABOLIC PROCESS,0.016475,0.068857,0.12449,1,1
4,GO PROTEIN FOLDING,0.031957,0.068181,0.10967,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.041938,0.067478,0.10112,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.026142,0.066629,0.10069,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.01266,0.059084,0.12986,1,1
5,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.00024771,1.3009,1.1349,1,1
5,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.00048214,1.2291,1.0301,1,1
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00031664,1.1883,1.0172,1,1
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00042807,1.1765,0.99978,1,1
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00024771,1.0674,0.93336,1,1
5,GO CHRONIC INFLAMMATORY RESPONSE,4.5779e-05,1.0497,0.9186,1,1
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00054254,1.049,0.78867,1,1
5,GO NATURAL KILLER CELL CHEMOTAXIS,0.00096503,1.0422,0.94012,1,1
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010181,1.016,0.90428,1,1
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.4805e-05,1.0138,0.96191,1,1
5,GO TOLERANCE INDUCTION,0.00023283,1.0037,0.88068,1,1
5,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00013188,0.98571,1.0232,1,1
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00048214,0.97908,0.83883,1,1
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.9888e-05,0.97026,0.96694,1,1
5,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.00057531,0.95327,0.7186,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,0.00033648,0.95134,0.84388,1,1
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.2763e-05,0.94918,0.80952,1,1
5,GO T CELL TOLERANCE INDUCTION,0.00014062,0.94674,0.92787,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.5779e-05,0.94272,0.92302,1,1
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00015974,0.94146,0.81221,1,1
5,GO HYPERSENSITIVITY,0.00028019,0.94002,0.84275,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00017019,0.93508,0.85707,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,3.0304e-05,0.93346,0.83287,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00015974,0.93178,0.86573,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00028019,0.93037,0.77835,1,1
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.2939e-05,0.91974,0.80347,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00013188,0.91928,0.84876,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00012367,0.91016,0.81894,1,1
5,GO T CELL CHEMOTAXIS,6.8565e-05,0.90146,0.79379,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00028019,0.89706,0.81671,1,1
5,GO LYMPHOCYTE CHEMOTAXIS,5.9985e-05,0.89535,0.79062,1,1
5,GO T HELPER 1 CELL DIFFERENTIATION,2.1347e-05,0.89161,0.83499,1,1
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00031664,0.88717,0.79154,1,1
5,GO NEGATIVE T CELL SELECTION,0.00026348,0.88464,0.83696,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00029789,0.88211,0.68702,1,1
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,8.3641e-05,0.88164,0.84156,1,1
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00029789,0.87696,0.78717,1,1
5,GO DENDRITIC CELL MIGRATION,0.00017019,0.87431,0.7788,1,1
5,GO DENDRITIC CELL CHEMOTAXIS,0.00023283,0.87034,0.78332,1,1
5,GO DETECTION OF OTHER ORGANISM,0.00024771,0.86494,0.70947,1,1
5,GO INTERLEUKIN 10 PRODUCTION,0.00011593,0.86308,0.68972,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00028019,0.86034,0.78164,1,1
5,GO SYNAPSE PRUNING,0.00028019,0.85822,0.90533,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.636e-05,0.85721,0.79172,1,1
5,GO RESPONSE TO PROTOZOAN,5.2428e-05,0.8531,0.75232,1,1
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00023283,0.84866,0.71063,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.248e-05,0.84644,0.80699,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.4576e-05,0.84421,0.76817,1,1
5,GO T CELL MEDIATED CYTOTOXICITY,3.4805e-05,0.83775,0.75652,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00014062,0.83281,0.76107,1,1
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00020554,0.82739,0.7207,1,1
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010181,0.82737,0.76827,1,1
5,GO T HELPER 2 CELL DIFFERENTIATION,2.8267e-05,0.82689,0.7744,1,1
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00042807,0.82552,0.6785,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00060992,0.82298,0.68716,1,1
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,4.8997e-05,0.8221,0.78898,1,1
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.4576e-05,0.82061,0.69872,1,1
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.8997e-05,0.81459,0.7094,1,1
5,GO POSITIVE THYMIC T CELL SELECTION,0.0014241,0.81335,0.6696,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,9.5377e-05,0.80976,0.65721,1,1
5,GO NEGATIVE REGULATION OF CELL KILLING,7.3279e-05,0.80686,0.82576,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.8565e-05,0.80677,0.73758,1,1
5,GO CYTOLYSIS,0.00024771,0.80082,0.79559,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,0.00019306,0.80074,0.72315,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.0012758,0.79535,0.6169,1,1
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00021879,0.79531,0.6606,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00020554,0.7939,0.68098,1,1
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,7.8298e-05,0.79218,0.8214,1,1
5,GO RESPONSE TO INTERLEUKIN 18,2.4576e-05,0.79218,0.72801,1,1
5,GO INTERLEUKIN 2 PRODUCTION,2.636e-05,0.78939,0.70784,1,1
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00332,0.78553,0.64199,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00033648,0.78425,0.7127,1,1
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00045436,0.78321,0.71788,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00018128,0.78252,0.66864,1,1
5,GO DETECTION OF BIOTIC STIMULUS,0.00010866,0.78214,0.63784,1,1
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00091199,0.78121,0.84217,1,1
5,GO POSITIVE T CELL SELECTION,0.00051151,0.78111,0.64842,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.4805e-05,0.77915,0.76199,1,1
5,GO T HELPER CELL LINEAGE COMMITMENT,0.00028019,0.77876,0.68925,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00013188,0.77595,0.69876,1,1
5,GO MONOCYTE CHEMOTAXIS,9.5377e-05,0.7753,0.73632,1,1
5,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00064645,0.775,0.70096,1,1
5,GO POSITIVE REGULATION OF T CELL MIGRATION,4.2763e-05,0.77482,0.69693,1,1
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.4805e-05,0.77356,0.69139,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00020554,0.77253,0.67632,1,1
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.248e-05,0.77151,0.77123,1,1
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.5779e-05,0.77139,0.68192,1,1
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.00018128,0.76988,0.65047,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0003797,0.76914,0.6674,1,1
5,GO THYMIC T CELL SELECTION,0.0012071,0.76795,0.59895,1,1
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4576e-05,0.76616,0.75957,1,1
5,GO T CELL MIGRATION,0.00020554,0.7645,0.6831,1,1
5,GO CELLULAR DEFENSE RESPONSE,0.00021879,0.76434,0.67867,1,1
5,GO INTERLEUKIN 13 PRODUCTION,0.00014062,0.76378,0.70708,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.1347e-05,0.76364,0.76708,1,1
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00033648,0.76341,0.61213,1,1
5,GO ADAPTIVE IMMUNE RESPONSE,0.00020554,0.76263,0.64639,1,1
5,GO REGULATION OF T CELL CHEMOTAXIS,2.1347e-05,0.76106,0.74015,1,1
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,5.2428e-05,0.75938,0.70564,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.9936e-05,0.75901,0.70323,1,1
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00051151,0.75836,0.67253,1,1
5,GO RESPONSE TO CHEMOKINE,6.8565e-05,0.75816,0.69891,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00014062,0.75752,0.69688,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00014062,0.75679,0.66737,1,1
5,GO RESPONSE TO PEPTIDOGLYCAN,0.00015974,0.75648,0.69474,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,8.9327e-05,0.7533,0.72359,1,1
5,GO INTERLEUKIN 4 PRODUCTION,0.00048214,0.75161,0.61435,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00010181,0.75104,0.73252,1,1
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00042807,0.74938,0.65528,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,5.9985e-05,0.74799,0.69169,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,4.8997e-05,0.7477,0.69312,1,1
5,GO LEUKOCYTE AGGREGATION,0.00026348,0.7466,0.73461,1,1
5,GO RESPONSE TO INTERLEUKIN 15,0.00011593,0.74655,0.70712,1,1
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0003797,0.74591,0.62019,1,1
5,GO T CELL EXTRAVASATION,0.00012367,0.74508,0.64895,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,7.8298e-05,0.74167,0.70471,1,1
5,GO T CELL CYTOKINE PRODUCTION,3.0304e-05,0.73949,0.66784,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00012367,0.73901,0.66917,1,1
5,GO INTERLEUKIN 12 PRODUCTION,0.00035748,0.7387,0.63796,1,1
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00040321,0.73601,0.68172,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2428e-05,0.73368,0.69845,1,1
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00042807,0.73256,0.69875,1,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.00013188,0.73249,0.70757,1,1
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,7.8298e-05,0.73193,0.63269,1,1
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00018128,0.73166,0.74469,1,1
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.7249e-05,0.7313,0.76368,1,1
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.4805e-05,0.72914,0.69462,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00021879,0.72817,0.63526,1,1
5,GO HEMIDESMOSOME ASSEMBLY,0.0028457,0.72743,0.59697,1,1
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.72721,0.64531,1,1
5,GO LYMPHOCYTE MIGRATION,0.00024771,0.72683,0.65241,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00011593,0.72588,0.66771,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.00068502,0.72447,0.7145,1,1
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,5.2428e-05,0.72309,0.72124,1,1
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00018128,0.72274,0.62133,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,7.8298e-05,0.72237,0.63685,1,1
5,GO T CELL MEDIATED IMMUNITY,3.4805e-05,0.71945,0.63212,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.00013188,0.71889,0.64307,1,1
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,8.3641e-05,0.71835,0.64746,1,1
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.248e-05,0.71784,0.65742,1,1
5,GO TYPE 2 IMMUNE RESPONSE,4.8997e-05,0.71754,0.70791,1,1
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,2.4576e-05,0.71699,0.72879,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.8267e-05,0.71686,0.66417,1,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00048214,0.71632,0.60398,1,1
5,GO CHEMOKINE SECRETION,0.00048214,0.7162,0.67957,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.2007e-06,0.71534,0.80315,1,1
5,GO REGULATION OF GLIAL CELL MIGRATION,0.00068502,0.71401,0.57522,1,1
5,GO NEUTROPHIL MIGRATION,0.00011593,0.71387,0.63742,1,1
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00010866,0.71269,0.61307,1,1
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00013188,0.71197,0.62154,1,1
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00064645,0.71192,0.59628,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00012367,0.7113,0.58561,1,1
5,GO RESPONSE TO INTERFERON GAMMA,7.3279e-05,0.71121,0.64951,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,9.5377e-05,0.71046,0.64857,1,1
5,GO MONONUCLEAR CELL MIGRATION,8.9327e-05,0.70982,0.67273,1,1
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.9327e-05,0.70973,0.67376,1,1
5,GO T CELL SELECTION,0.00051151,0.70952,0.60625,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00012367,0.70929,0.62287,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,0.00023283,0.70791,0.63586,1,1
5,GO INTERFERON GAMMA PRODUCTION,0.00020554,0.70787,0.63638,1,1
5,GO INTERLEUKIN 8 PRODUCTION,2.4576e-05,0.70617,0.62146,1,1
5,GO GLIAL CELL ACTIVATION,0.00024771,0.70601,0.65681,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,0.0013481,0.70599,0.53206,1,1
5,GO CYCLOOXYGENASE PATHWAY,0.00020554,0.70528,0.70722,1,1
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00010866,0.70503,0.62507,1,1
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0003797,0.70489,0.65295,1,1
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.9936e-05,0.70483,0.61797,1,1
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00015974,0.70278,0.67873,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.00045436,0.70194,0.56016,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00023283,0.70101,0.63761,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.00020554,0.69947,0.65667,1,1
5,GO GERMINAL CENTER FORMATION,0.00057531,0.69922,0.63994,1,1
5,GO B CELL PROLIFERATION,0.00031664,0.6991,0.63154,1,1
5,GO AMINO SUGAR CATABOLIC PROCESS,0.00057531,0.69717,0.58458,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00014062,0.697,0.59832,1,1
5,GO REGULATION OF NEUTROPHIL ACTIVATION,0.0003797,0.6968,0.66737,1,1
5,GO REGULATION OF B CELL PROLIFERATION,0.0003797,0.69358,0.60605,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,8.3641e-05,0.6927,0.65488,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.9888e-05,0.6906,0.64917,1,1
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,3.4805e-05,0.68967,0.70493,1,1
5,GO INTERLEUKIN 1 PRODUCTION,9.5377e-05,0.68926,0.63972,1,1
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00029789,0.68882,0.67345,1,1
5,GO REGULATION OF CELL KILLING,8.3641e-05,0.68822,0.64886,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014062,0.68728,0.6505,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.4139e-05,0.68624,0.61561,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00010866,0.68532,0.64416,1,1
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00010181,0.68497,0.60677,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.8997e-05,0.68372,0.64397,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00029789,0.68259,0.63096,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00015974,0.67899,0.58893,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00021879,0.6787,0.63591,1,1
5,GO IMMUNOGLOBULIN SECRETION,0.00042807,0.67491,0.53356,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,6.8565e-05,0.67432,0.58373,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.8997e-05,0.67388,0.64806,1,1
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.3279e-05,0.67353,0.59837,1,1
5,GO GRANULOCYTE MIGRATION,0.00010181,0.67295,0.60447,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,9.5377e-05,0.67213,0.61134,1,1
5,GO ALPHA BETA T CELL ACTIVATION,0.00015974,0.67127,0.60277,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00028019,0.67077,0.57233,1,1
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00096503,0.67041,0.66413,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,5.9985e-05,0.66708,0.64454,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,6.8565e-05,0.66668,0.59299,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00042807,0.66665,0.70063,1,1
5,GO INTERLEUKIN 17 PRODUCTION,0.00014989,0.66408,0.60178,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00011593,0.66306,0.61196,1,1
5,GO B CELL MEDIATED IMMUNITY,0.00017019,0.66279,0.60211,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,5.9985e-05,0.66169,0.59631,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00048214,0.66044,0.58584,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.00015974,0.66009,0.60224,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,4.2763e-05,0.65938,0.65565,1,1
5,GO INTERLEUKIN 5 PRODUCTION,0.0031545,0.65937,0.53502,1,1
5,GO ETHANOL OXIDATION,2.2907e-05,0.65936,0.75367,1,1
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00057531,0.65914,0.71826,1,1
5,GO CELLULAR RESPONSE TO ETHANOL,0.00010866,0.6588,0.56227,1,1
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0012071,0.65812,0.57086,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00014062,0.65791,0.57928,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00045436,0.65738,0.59038,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8298e-05,0.65639,0.60234,1,1
5,GO COMPLEMENT ACTIVATION,0.00040321,0.65556,0.71745,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.9327e-05,0.65532,0.59574,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.00010866,0.65487,0.61839,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00013188,0.65423,0.56715,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0014241,0.65352,0.5564,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0011418,0.65276,0.51552,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00040321,0.65186,0.56642,1,1
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.4139e-05,0.65166,0.57624,1,1
5,GO RESPONSE TO INTERFERON BETA,6.8565e-05,0.65095,0.59762,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00051151,0.65089,0.5921,1,1
5,GO RESPONSE TO LIPOTEICHOIC ACID,0.00035748,0.64947,0.60326,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00060992,0.64907,0.56514,1,1
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00010181,0.64789,0.58261,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00060992,0.64731,0.59982,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00028019,0.64711,0.58607,1,1
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00011593,0.6469,0.61838,1,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0011418,0.64651,0.52669,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00019306,0.64611,0.57093,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00031664,0.64574,0.55756,1,1
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0011418,0.64543,0.61276,1,1
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,9.5377e-05,0.64478,0.64755,1,1
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00010181,0.64411,0.59502,1,1
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00026348,0.64344,0.58714,1,1
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00026348,0.64125,0.61418,1,1
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00042807,0.64053,0.70316,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.00029789,0.64046,0.61197,1,1
5,GO NEUROINFLAMMATORY RESPONSE,0.00042807,0.64033,0.57964,1,1
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.2428e-05,0.63901,0.62689,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,0.00017019,0.63596,0.55341,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.00014062,0.63344,0.60824,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.00033648,0.63142,0.57692,1,1
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00096503,0.63054,0.50344,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00010866,0.62849,0.5657,1,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00024771,0.62753,0.59052,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,6.8565e-05,0.62699,0.57806,1,1
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00018128,0.62676,0.57891,1,1
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00026348,0.6259,0.67654,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.00048214,0.62559,0.5589,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00013188,0.6251,0.56383,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0010209,0.62406,0.648,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.8298e-05,0.62328,0.5626,1,1
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.8298e-05,0.62247,0.54026,1,1
5,GO CYTOKINE METABOLIC PROCESS,0.00011593,0.61983,0.55823,1,1
5,GO REGULATION OF PHAGOCYTOSIS,0.00021879,0.61914,0.55972,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00015974,0.6184,0.52684,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00015974,0.61836,0.55113,1,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00023283,0.61682,0.54107,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.8298e-05,0.61663,0.55228,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00010866,0.61505,0.53748,1,1
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.5779e-05,0.61407,0.64769,1,1
5,GO RESPONSE TO TYPE I INTERFERON,0.00010181,0.61285,0.56972,1,1
5,GO REGULATION OF MEMBRANE INVAGINATION,0.00081392,0.61282,0.59126,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00014989,0.61252,0.58699,1,1
5,GO REGULATION OF MYOBLAST FUSION,0.0012758,0.61248,0.56517,1,1
5,GO MACROPHAGE MIGRATION,0.00020554,0.61161,0.55347,1,1
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00014062,0.611,0.53955,1,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0003797,0.61069,0.58318,1,1
5,GO T CELL APOPTOTIC PROCESS,1.8524e-05,0.60975,0.58722,1,1
5,GO AMYLOID BETA CLEARANCE,0.00017019,0.608,0.53732,1,1
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00011593,0.60736,0.52291,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00011593,0.60636,0.55234,1,1
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00023283,0.60578,0.52699,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00013188,0.60572,0.63878,1,1
5,GO T CELL PROLIFERATION,0.00014989,0.60554,0.567,1,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00011593,0.60425,0.54484,1,1
5,GO REGULATION OF T CELL MIGRATION,9.5377e-05,0.60421,0.58438,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00020554,0.60359,0.54092,1,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.00024771,0.60346,0.56375,1,1
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,3.248e-05,0.60323,0.66142,1,1
5,GO LEUKOCYTE APOPTOTIC PROCESS,7.8298e-05,0.60308,0.55252,1,1
5,GO I KAPPAB PHOSPHORYLATION,2.4576e-05,0.60299,0.5696,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00014062,0.60277,0.51978,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.2763e-05,0.60239,0.60126,1,1
5,GO ASTROCYTE ACTIVATION,0.00029789,0.60233,0.50525,1,1
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.6059e-05,0.60133,0.61487,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00015974,0.60093,0.55079,1,1
5,GO MACROPHAGE ACTIVATION,0.00028019,0.59976,0.57228,1,1
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00015974,0.59973,0.56922,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00081392,0.59945,0.49551,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00021879,0.59926,0.57245,1,1
5,GO REGULATION OF T CELL ACTIVATION,0.00021879,0.5986,0.52934,1,1
5,GO NEUTROPHIL EXTRAVASATION,4.2763e-05,0.59815,0.63668,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00011593,0.59766,0.5396,1,1
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00011593,0.59709,0.58047,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00021879,0.597,0.52467,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00040321,0.59683,0.60952,1,1
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.00040321,0.59664,0.57575,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0003797,0.59648,0.5499,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.8267e-05,0.596,0.58093,1,1
5,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0014241,0.59331,0.61045,1,1
5,GO REGULATION OF MACROPHAGE MIGRATION,0.00026348,0.59212,0.53454,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.8565e-05,0.59196,0.58085,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,0.00014062,0.59084,0.52956,1,1
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00042807,0.59005,0.55786,1,1
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.6086e-05,0.5891,0.55557,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00010866,0.58884,0.5437,1,1
5,GO LEUKOCYTE PROLIFERATION,0.00020554,0.58708,0.54592,1,1
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.3641e-05,0.58705,0.54953,1,1
5,GO MACROPHAGE CHEMOTAXIS,0.00026348,0.58676,0.525,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00017019,0.5856,0.51813,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0017696,0.58516,0.51447,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.248e-05,0.58501,0.54883,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00021879,0.58457,0.53605,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,7.1973e-06,0.58386,0.59123,1,1
5,GO APOPTOTIC CELL CLEARANCE,0.00072571,0.58385,0.52807,1,1
5,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,3.0304e-05,0.58293,0.62366,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00014062,0.58261,0.51779,1,1
5,GO BLEB ASSEMBLY,0.00019306,0.58221,0.58625,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010181,0.58165,0.55435,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0054671,0.58066,0.48266,1,1
5,GO CELLULAR EXTRAVASATION,0.00035748,0.58055,0.55282,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00018128,0.58043,0.52025,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,3.248e-05,0.57804,0.52207,1,1
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,7.3279e-05,0.57804,0.62912,1,1
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,7.3279e-05,0.5777,0.53471,1,1
5,GO LEUKOCYTE TETHERING OR ROLLING,0.00096503,0.57734,0.51711,1,1
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,6.8565e-05,0.57561,0.60734,1,1
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,8.9327e-05,0.57523,0.51682,1,1
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,9.6689e-06,0.57491,0.60104,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014062,0.57462,0.51277,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00013188,0.57423,0.52304,1,1
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.00068502,0.57358,0.55967,1,1
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00010866,0.57269,0.57931,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00035748,0.57191,0.48373,1,1
5,GO BONE TRABECULA MORPHOGENESIS,0.0010798,0.57175,0.51618,1,1
5,GO CELL KILLING,0.00014989,0.57121,0.53053,1,1
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00048214,0.5711,0.57095,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.011063,0.56993,0.45124,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,1.8524e-05,0.56982,0.59658,1,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00045436,0.56842,0.5033,1,1
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0015882,0.56815,0.49338,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00018128,0.56719,0.54036,1,1
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00045436,0.56605,0.48459,1,1
5,GO ETHANOL METABOLIC PROCESS,7.3279e-05,0.56559,0.592,1,1
5,GO T CELL DIFFERENTIATION,0.00019306,0.5651,0.5113,1,1
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00072571,0.56499,0.58579,1,1
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0003797,0.56493,0.46975,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00014989,0.56483,0.53612,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00081392,0.56355,0.51723,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,1.7249e-05,0.56336,0.56812,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00023283,0.56289,0.52753,1,1
5,GO T CELL ACTIVATION,0.00020554,0.56184,0.51405,1,1
5,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.0021907,0.5613,0.58908,1,1
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00013188,0.55916,0.58886,1,1
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00017019,0.55882,0.56674,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00072571,0.55858,0.53352,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00023283,0.5585,0.50461,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00020554,0.55815,0.51921,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00035748,0.55776,0.54206,1,1
5,GO REGULATION OF CELL ACTIVATION,0.00026348,0.55727,0.48736,1,1
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00010181,0.55665,0.59283,1,1
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,5.2428e-05,0.55649,0.61324,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00014989,0.5564,0.51238,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.2763e-05,0.55601,0.60202,1,1
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00014062,0.55559,0.52735,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,4.5779e-05,0.55518,0.52553,1,1
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0003797,0.55483,0.61401,1,1
5,GO CD40 SIGNALING PATHWAY,0.00024771,0.55458,0.48901,1,1
5,GO MACROPHAGE DIFFERENTIATION,0.00033648,0.55342,0.48694,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,7.3279e-05,0.55324,0.51155,1,1
5,GO MACROPHAGE PROLIFERATION,0.0031545,0.55304,0.60019,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0003797,0.55302,0.48803,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00014062,0.55301,0.55056,1,1
5,GO NEUTROPHIL HOMEOSTASIS,4.5779e-05,0.55299,0.56035,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00023283,0.54961,0.49944,1,1
5,GO INTEGRIN ACTIVATION,0.00072571,0.54824,0.54308,1,1
5,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.0011418,0.54799,0.47376,1,1
5,GO INTERLEUKIN 6 PRODUCTION,0.00026348,0.5477,0.48649,1,1
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.9936e-05,0.54677,0.54393,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00064645,0.54659,0.49618,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00040321,0.54573,0.54784,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0010209,0.54435,0.52661,1,1
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00010866,0.54391,0.57298,1,1
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00035748,0.54272,0.48898,1,1
5,GO IMMUNE RESPONSE TO TUMOR CELL,5.9985e-05,0.54199,0.55515,1,1
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,9.5377e-05,0.54184,0.53639,1,1
5,GO LEUKOCYTE CHEMOTAXIS,0.00020554,0.54162,0.53458,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.7287e-05,0.54133,0.51349,1,1
5,GO REGULATION OF B CELL ACTIVATION,0.0003797,0.54064,0.54041,1,1
5,GO CYTOKINE SECRETION,0.00011593,0.53883,0.49396,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00019306,0.53815,0.55645,1,1
5,GO NATURAL KILLER CELL ACTIVATION,0.00024771,0.53777,0.50422,1,1
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00019306,0.53623,0.49692,1,1
5,GO PHAGOCYTOSIS RECOGNITION,0.0013481,0.53519,0.53121,1,1
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00051151,0.53496,0.45754,1,1
5,GO RESPONSE TO INTERFERON ALPHA,0.00013188,0.53459,0.61529,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.00012367,0.53391,0.46769,1,1
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00013188,0.53324,0.58542,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00017019,0.53312,0.4916,1,1
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00029789,0.53121,0.55322,1,1
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00013188,0.5306,0.43611,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00015974,0.52945,0.53197,1,1
5,GO RESPIRATORY BURST,0.00091199,0.52929,0.47675,1,1
5,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.0029965,0.52863,0.53459,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,4.8997e-05,0.52851,0.49456,1,1
5,GO RESPONSE TO MURAMYL DIPEPTIDE,6.4139e-05,0.52787,0.52186,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.9327e-05,0.52709,0.5634,1,1
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.8524e-05,0.52688,0.55105,1,1
5,GO PHAGOCYTOSIS,0.00021879,0.52662,0.47751,1,1
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,1.4947e-05,0.5265,0.54824,1,1
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0029965,0.52179,0.47613,1,1
5,GO ACUTE PHASE RESPONSE,0.00010866,0.52157,0.50809,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.5779e-05,0.52056,0.49305,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.00010181,0.52005,0.45472,1,1
5,GO NAD BIOSYNTHETIC PROCESS,6.8565e-05,0.51974,0.4646,1,1
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.00033648,0.51935,0.45626,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00013188,0.51928,0.43456,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,0.00018128,0.51879,0.48448,1,1
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00076864,0.51822,0.5245,1,1
5,GO MEMBRANE RAFT ORGANIZATION,0.00076864,0.5181,0.47973,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00054254,0.51752,0.50808,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00018128,0.51687,0.46183,1,1
5,GO INNATE IMMUNE RESPONSE,6.8565e-05,0.51676,0.47816,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0304e-05,0.51662,0.53567,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.00020554,0.51467,0.44521,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00018128,0.51355,0.48917,1,1
5,GO LYMPH NODE DEVELOPMENT,0.0063209,0.5135,0.40013,1,1
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0019699,0.5124,0.46589,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00023283,0.51205,0.52865,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.00023283,0.51181,0.50743,1,1
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00017019,0.51158,0.5074,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00035748,0.51151,0.41772,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00019306,0.51137,0.47482,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00019306,0.5106,0.47102,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00015974,0.51013,0.48102,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00026348,0.50982,0.48302,1,1
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00029789,0.50977,0.54692,1,1
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.9327e-05,0.50968,0.5808,1,1
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00033648,0.50907,0.47535,1,1
5,GO HUMORAL IMMUNE RESPONSE,0.00023283,0.50903,0.55992,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00031664,0.50762,0.47285,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00010866,0.50734,0.46176,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,9.5377e-05,0.50662,0.47142,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00020554,0.50593,0.52162,1,1
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00042807,0.50566,0.45659,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00068502,0.50515,0.58284,1,1
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0012071,0.50512,0.43809,1,1
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00048214,0.50389,0.4834,1,1
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,9.5377e-05,0.50383,0.54756,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,9.5377e-05,0.50374,0.45978,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00060992,0.50315,0.41383,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,5.6086e-05,0.50298,0.49867,1,1
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,9.5377e-05,0.50266,0.49539,1,1
5,GO REGULATION OF BONE DEVELOPMENT,7.3279e-05,0.50195,0.55854,1,1
5,GO ZYMOGEN INHIBITION,0.00033648,0.50123,0.48489,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00013188,0.50068,0.43483,1,1
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00023283,0.50038,0.51394,1,1
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00048214,0.50017,0.45049,1,1
5,GO REGULATION OF CELL CELL ADHESION,0.00021879,0.4995,0.45851,1,1
5,GO PEPTIDE CROSS LINKING,0.00026348,0.49936,0.51351,1,1
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.7249e-05,0.49869,0.54416,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,5.6086e-05,0.49841,0.46098,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00013188,0.49769,0.4434,1,1
5,GO B CELL HOMEOSTASIS,0.00045436,0.49723,0.43577,1,1
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,3.4805e-05,0.49631,0.59354,1,1
5,GO LYMPHOCYTE ACTIVATION,0.00020554,0.49619,0.4706,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0025648,0.49519,0.46383,1,1
5,GO CHEMOKINE PRODUCTION,9.5377e-05,0.49475,0.50273,1,1
5,GO INTERFERON ALPHA PRODUCTION,0.00010181,0.49438,0.49268,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.5377e-05,0.49369,0.46048,1,1
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,8.9327e-05,0.49343,0.47493,1,1
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00042807,0.49307,0.41884,1,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00064645,0.493,0.49137,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0034935,0.49262,0.49564,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00014062,0.49156,0.4955,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00018128,0.48994,0.47005,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00023283,0.4897,0.46525,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.00012367,0.48837,0.57332,1,1
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00024771,0.48797,0.57903,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00023283,0.48777,0.41921,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00096503,0.48758,0.55043,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00013188,0.48748,0.44876,1,1
5,GO LEUKOCYTE DIFFERENTIATION,0.00020554,0.48575,0.45376,1,1
5,GO RESPONSE TO HYDROPEROXIDE,0.00011593,0.48534,0.51343,1,1
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0054671,0.48533,0.46658,1,1
5,GO CYTIDINE TO URIDINE EDITING,0.00054254,0.48504,0.48251,1,1
5,GO THYMOCYTE APOPTOTIC PROCESS,1.2939e-05,0.48473,0.50098,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0017696,0.48471,0.41025,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0044907,0.48421,0.40901,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,0.00020554,0.48417,0.46459,1,1
5,GO TUMOR NECROSIS FACTOR SECRETION,1.2035e-05,0.48379,0.5005,1,1
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0018673,0.48369,0.39952,1,1
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00019306,0.48179,0.55805,1,1
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,8.9327e-05,0.48154,0.44459,1,1
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00014062,0.48143,0.52517,1,1
5,GO CELL CHEMOTAXIS,0.00024771,0.48087,0.47844,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,9.5377e-05,0.48031,0.43624,1,1
5,GO REGULATION OF PLATELET ACTIVATION,0.0023095,0.47964,0.48793,1,1
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00014062,0.47933,0.50243,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0047188,0.47916,0.42815,1,1
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0010798,0.47893,0.4672,1,1
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00091199,0.4775,0.46309,1,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00045436,0.47674,0.44422,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0036751,0.47659,0.42171,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00011593,0.47596,0.43925,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.5377e-05,0.47587,0.43003,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00096503,0.47557,0.43352,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.4805e-05,0.47525,0.48342,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00045436,0.47383,0.43694,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,8.3641e-05,0.47363,0.49189,1,1
5,GO IRON ION TRANSMEMBRANE TRANSPORT,3.0304e-05,0.47238,0.45636,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.00040321,0.47219,0.41998,1,1
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.4805e-05,0.47205,0.48085,1,1
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00011593,0.47196,0.47546,1,1
5,GO IMMUNE EFFECTOR PROCESS,8.3641e-05,0.47134,0.43519,1,1
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00023283,0.46996,0.44488,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00026348,0.46807,0.45498,1,1
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00020554,0.46797,0.47797,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00015974,0.46775,0.48115,1,1
5,GO MULTI ORGANISM CELLULAR PROCESS,0.00064645,0.46761,0.48639,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,0.00057531,0.46759,0.42185,1,1
5,GO CYTOKINE PRODUCTION,7.8298e-05,0.46663,0.44158,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00010181,0.46561,0.44454,1,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00033648,0.46372,0.48757,1,1
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00012367,0.46312,0.40887,1,1
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0018673,0.46273,0.46236,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,5.9985e-05,0.46224,0.49966,1,1
5,GO MITRAL VALVE DEVELOPMENT,0.00091199,0.46206,0.41833,1,1
5,GO VITAMIN D METABOLIC PROCESS,0.00035748,0.46189,0.44185,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00010866,0.4612,0.41365,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0014241,0.46094,0.42388,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,3.0304e-05,0.4608,0.48286,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,0.00013188,0.46044,0.4698,1,1
5,GO INFLAMMATORY RESPONSE,0.00020554,0.45986,0.45275,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0010209,0.45792,0.4846,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.8565e-05,0.45752,0.4602,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.0015041,0.45702,0.49812,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00024771,0.45683,0.47468,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,8.3641e-05,0.45675,0.44529,1,1
5,GO MYELOID CELL APOPTOTIC PROCESS,1.9888e-05,0.45658,0.45363,1,1
5,GO T CELL LINEAGE COMMITMENT,0.00096503,0.45555,0.45543,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.00013188,0.45539,0.4265,1,1
5,GO IMMUNOGLOBULIN PRODUCTION,0.00020554,0.45536,0.4552,1,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,7.3279e-05,0.45527,0.50581,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00060992,0.45474,0.42198,1,1
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00021879,0.45414,0.47133,1,1
5,GO MEMBRANE INVAGINATION,0.00096503,0.45401,0.41567,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00029789,0.45391,0.3917,1,1
5,GO CELL JUNCTION DISASSEMBLY,0.00051151,0.45379,0.58983,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.7249e-05,0.45366,0.48855,1,1
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.00023283,0.45297,0.51039,1,1
5,GO MONONUCLEAR CELL DIFFERENTIATION,5.9985e-05,0.45277,0.53194,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0080134,0.45257,0.47577,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00081392,0.45245,0.44083,1,1
5,GO DEFENSE RESPONSE TO VIRUS,3.9936e-05,0.45216,0.45825,1,1
5,GO OSTEOCLAST DIFFERENTIATION,0.00024771,0.45194,0.41013,1,1
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00064645,0.45165,0.4126,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.3641e-05,0.45138,0.46292,1,1
5,GO OSTEOCLAST DEVELOPMENT,0.00020554,0.45102,0.5541,1,1
5,GO LEUKOCYTE MIGRATION,0.00035748,0.45057,0.4542,1,1
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00035748,0.45042,0.52142,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.00024771,0.44951,0.42995,1,1
5,GO LIPOPROTEIN LOCALIZATION,0.00029789,0.44937,0.40613,1,1
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00018128,0.44899,0.45356,1,1
5,GO FEVER GENERATION,0.0015882,0.44863,0.36379,1,1
5,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00057531,0.44831,0.41296,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00013188,0.44806,0.43961,1,1
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00026348,0.4473,0.46099,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00020554,0.44606,0.3747,1,1
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00033648,0.445,0.44915,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00021879,0.44395,0.42285,1,1
5,GO AMINE CATABOLIC PROCESS,4.2763e-05,0.44274,0.43039,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0018673,0.44233,0.38691,1,1
5,GO B CELL ACTIVATION,0.00023283,0.44232,0.46853,1,1
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0012758,0.44206,0.40311,1,1
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00012367,0.44182,0.43394,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0012758,0.4418,0.49074,1,1
5,GO RESPONSE TO INTERLEUKIN 2,0.0012071,0.44113,0.51123,1,1
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00019306,0.43965,0.42451,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,5.2428e-05,0.43943,0.49105,1,1
5,GO SOMATIC STEM CELL DIVISION,0.00060992,0.43881,0.49427,1,1
5,GO RESPONSE TO BACTERIUM,9.5377e-05,0.4384,0.46766,1,1
5,GO OSTEOBLAST DEVELOPMENT,0.00054254,0.4378,0.36881,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,6.4139e-05,0.43771,0.41775,1,1
5,GO ACTIVATED T CELL PROLIFERATION,0.00026348,0.43769,0.41499,1,1
5,GO GRANULOCYTE DIFFERENTIATION,0.00060992,0.43724,0.42082,1,1
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,8.3641e-05,0.43612,0.48964,1,1
5,GO DEFENSE RESPONSE,8.3641e-05,0.43559,0.41292,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00026348,0.43511,0.41792,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.00023283,0.43317,0.46895,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00021879,0.43299,0.46699,1,1
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.9843e-06,0.43107,0.46203,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00010866,0.43045,0.38169,1,1
5,GO FLUID TRANSPORT,0.00015974,0.42994,0.46892,1,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00021879,0.42872,0.43865,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0015882,0.42773,0.3703,1,1
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00018128,0.4275,0.40221,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00014989,0.42692,0.45743,1,1
5,GO RETINAL METABOLIC PROCESS,0.00020554,0.42681,0.47283,1,1
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.6086e-05,0.42672,0.41127,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011593,0.42655,0.39474,1,1
5,GO RESPONSE TO TUMOR CELL,0.00026348,0.42621,0.45412,1,1
5,GO CHOLESTEROL STORAGE,0.00042807,0.42593,0.45051,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00081392,0.42574,0.40859,1,1
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00023283,0.4254,0.47517,1,1
5,GO MYOBLAST FUSION,0.00028019,0.42525,0.44972,1,1
5,GO CELL ACTIVATION,0.00018128,0.4252,0.39886,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.00060992,0.42492,0.48964,1,1
5,GO HYPOTONIC RESPONSE,0.00020554,0.42405,0.40681,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.0023095,0.42358,0.40476,1,1
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1191e-05,0.42302,0.44446,1,1
5,GO SKIN MORPHOGENESIS,0.0047188,0.42246,0.39058,1,1
5,GO ENTRY INTO HOST,0.00014062,0.42232,0.41537,1,1
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.4576e-05,0.42194,0.48036,1,1
5,GO PROSTANOID METABOLIC PROCESS,0.00021879,0.42193,0.39546,1,1
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00029789,0.42192,0.41325,1,1
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,4.8997e-05,0.42174,0.46801,1,1
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00015974,0.42102,0.47416,1,1
5,GO PINOCYTOSIS,0.00014989,0.42079,0.42585,1,1
5,GO WATER TRANSPORT,0.00091199,0.42075,0.4452,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00017019,0.42065,0.50217,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,8.3641e-05,0.41955,0.38926,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,4.8997e-05,0.41883,0.44074,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.5377e-05,0.41869,0.42559,1,1
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00031664,0.41862,0.45937,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0023095,0.41789,0.38054,1,1
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0010209,0.41779,0.37796,1,1
5,GO REGULATION OF INTEGRIN ACTIVATION,0.0019699,0.41706,0.4062,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00064645,0.41656,0.53066,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.8298e-05,0.41617,0.43179,1,1
5,GO RESPONSE TO VIRUS,4.5779e-05,0.41608,0.4308,1,1
5,GO RESPONSE TO PROSTAGLANDIN,0.00072571,0.41556,0.40775,1,1
5,GO FOAM CELL DIFFERENTIATION,0.0010209,0.41534,0.41619,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0024341,0.41531,0.41925,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,3.9936e-05,0.41485,0.45561,1,1
5,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00021879,0.41369,0.3677,1,1
5,GO ASTROCYTE DEVELOPMENT,0.00013188,0.41297,0.45119,1,1
5,GO BONE RESORPTION,0.0024341,0.41212,0.37453,1,1
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,5.6086e-05,0.41146,0.55196,1,1
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00060992,0.41143,0.36456,1,1
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00029789,0.41134,0.45754,1,1
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00068502,0.41101,0.46991,1,1
5,GO MACROPHAGE APOPTOTIC PROCESS,0.0010209,0.41083,0.44324,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00031664,0.41003,0.46344,1,1
5,GO PODOSOME ASSEMBLY,0.00010866,0.40984,0.46315,1,1
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0013481,0.40913,0.37709,1,1
5,GO RESPONSE TO INTERLEUKIN 1,1.4947e-05,0.40885,0.38562,1,1
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,2.4576e-05,0.40813,0.42658,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025648,0.40715,0.40951,1,1
5,GO BONE CELL DEVELOPMENT,0.00021879,0.4069,0.43531,1,1
5,GO REGULATION OF DEFENSE RESPONSE,7.8298e-05,0.40659,0.38257,1,1
5,GO RESPONSE TO INTERLEUKIN 4,0.00018128,0.40637,0.39457,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.8565e-05,0.40475,0.38555,1,1
5,GO TRANSCYTOSIS,0.0034935,0.40449,0.39199,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00019306,0.40281,0.4055,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010181,0.40244,0.38923,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.5779e-05,0.40179,0.4009,1,1
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00035748,0.40165,0.43982,1,1
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00021879,0.40153,0.48991,1,1
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0020776,0.40128,0.3443,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0012758,0.39995,0.47628,1,1
5,GO HETEROTYPIC CELL CELL ADHESION,0.00018128,0.39994,0.43289,1,1
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00048214,0.39978,0.37749,1,1
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026348,0.39929,0.37509,1,1
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00018128,0.39899,0.40182,1,1
5,GO ETHANOL CATABOLIC PROCESS,0.00051151,0.39894,0.38941,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00072571,0.39838,0.39076,1,1
5,GO SYNCYTIUM FORMATION,0.00028019,0.39817,0.42669,1,1
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013188,0.3973,0.4564,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00054254,0.39702,0.34343,1,1
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00010181,0.3968,0.40384,1,1
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00064645,0.3967,0.50559,1,1
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00020554,0.39625,0.46095,1,1
5,GO ERK1 AND ERK2 CASCADE,0.00076864,0.39586,0.36479,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,4.2763e-05,0.39529,0.40903,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,6.4139e-05,0.39527,0.38423,1,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00064645,0.39454,0.375,1,1
5,GO SEQUESTERING OF METAL ION,0.00014989,0.39418,0.456,1,1
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00024771,0.39404,0.44228,1,1
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00028019,0.39368,0.41842,1,1
5,GO MUCUS SECRETION,0.00012367,0.39365,0.44589,1,1
5,GO NK T CELL DIFFERENTIATION,0.026142,0.39358,0.35592,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00015974,0.39336,0.44938,1,1
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.00010181,0.39323,0.33412,1,1
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,4.8997e-05,0.39289,0.46143,1,1
5,GO REGULATION OF FIBRINOLYSIS,0.0034935,0.39247,0.42798,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,0.008797,0.39131,0.36996,1,1
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00045436,0.39121,0.38789,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00076864,0.39108,0.49045,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00014989,0.39091,0.43265,1,1
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00035748,0.39033,0.46104,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,6.8565e-05,0.39015,0.36635,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00015974,0.38993,0.39696,1,1
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.00045436,0.38943,0.42365,1,1
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0015882,0.38926,0.40159,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.9327e-05,0.3891,0.38624,1,1
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.0010209,0.38807,0.40753,1,1
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0066311,0.38801,0.37972,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00051151,0.38768,0.39402,1,1
5,GO REGULATION OF PODOSOME ASSEMBLY,0.00012367,0.38695,0.45807,1,1
5,GO ETHER BIOSYNTHETIC PROCESS,0.00026348,0.38694,0.37971,1,1
5,GO B CELL DIFFERENTIATION,0.00012367,0.3864,0.46659,1,1
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0012071,0.3862,0.34103,1,1
5,GO RESPONSE TO CYTOKINE,6.8565e-05,0.38489,0.37771,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00068502,0.38465,0.41345,1,1
5,GO COLLAGEN CATABOLIC PROCESS,0.0020776,0.38452,0.40625,1,1
5,GO HYALURONAN CATABOLIC PROCESS,0.00064645,0.3842,0.43518,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,6.8565e-05,0.38404,0.40468,1,1
5,GO PROGRAMMED NECROTIC CELL DEATH,0.00064645,0.38372,0.35408,1,1
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00031664,0.38303,0.3346,1,1
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00033648,0.38204,0.65519,1,1
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00031664,0.38093,0.40458,1,1
5,GO STORE OPERATED CALCIUM ENTRY,0.00035748,0.38056,0.37519,1,1
5,GO STEROL HOMEOSTASIS,0.00024771,0.3805,0.35988,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00048214,0.38022,0.44228,1,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00012367,0.38002,0.32854,1,1
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00020554,0.37975,0.34446,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0031545,0.37938,0.30005,1,1
5,GO CELL ADHESION MOLECULE PRODUCTION,0.00081392,0.37903,0.45277,1,1
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00018128,0.37901,0.42236,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00086166,0.37879,0.36315,1,1
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0016767,0.37869,0.41934,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.2763e-05,0.37863,0.41731,1,1
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00029789,0.37841,0.4028,1,1
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00048214,0.3783,0.3514,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00010866,0.37829,0.48338,1,1
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0013481,0.37766,0.42989,1,1
5,GO MYOBLAST MIGRATION,0.0044907,0.37736,0.31376,1,1
5,GO SKELETAL MUSCLE TISSUE REGENERATION,8.9843e-06,0.37676,0.40872,1,1
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00045436,0.37619,0.38268,1,1
5,GO ACTIN FILAMENT SEVERING,0.0013481,0.37599,0.42551,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0042727,0.37571,0.45068,1,1
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010866,0.37545,0.40287,1,1
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0047188,0.37495,0.34797,1,1
5,GO T CELL HOMEOSTASIS,0.00054254,0.37484,0.34929,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.008797,0.37454,0.31265,1,1
5,GO NIK NF KAPPAB SIGNALING,2.4576e-05,0.37439,0.35695,1,1
5,GO REGULATION OF STEROL TRANSPORT,0.00091199,0.37426,0.34991,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00010181,0.37422,0.38882,1,1
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0012758,0.37381,0.40651,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.0012758,0.37372,0.31653,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00028019,0.37344,0.35291,1,1
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.0014241,0.37328,0.36274,1,1
5,GO PSEUDOPODIUM ORGANIZATION,0.00040321,0.37315,0.38768,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00015974,0.3728,0.34179,1,1
5,GO REGULATION OF LIPASE ACTIVITY,0.00013188,0.37253,0.37998,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.636e-05,0.37237,0.40062,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0013481,0.37217,0.37483,1,1
5,GO REGULATION OF HEMOPOIESIS,0.00010181,0.37198,0.36919,1,1
5,GO RETINOL METABOLIC PROCESS,1.9888e-05,0.37165,0.39101,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00021879,0.37002,0.39799,1,1
5,GO PROTEIN NITROSYLATION,0.00013188,0.36994,0.37585,1,1
5,GO VAGINA DEVELOPMENT,0.0044907,0.36992,0.33797,1,1
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0044907,0.36978,0.36275,1,1
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00072571,0.3693,0.35699,1,1
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.36913,0.35064,1,1
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.00051151,0.36909,0.35211,1,1
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00048214,0.36891,0.41984,1,1
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00029789,0.36829,0.38062,1,1
5,GO DIET INDUCED THERMOGENESIS,0.0011418,0.36805,0.34593,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0020776,0.36804,0.33879,1,1
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00012367,0.36804,0.39235,1,1
5,GO RESPONSE TO INTERLEUKIN 7,0.00064645,0.36725,0.36024,1,1
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,3.7287e-05,0.36706,0.51387,1,1
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.36594,0.34309,1,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.0304e-05,0.36523,0.40416,1,1
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,7.8298e-05,0.36514,0.39572,1,1
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,7.8298e-05,0.36477,0.38338,1,1
5,GO PYROPTOSIS,0.00086166,0.36451,0.40789,1,1
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,8.9843e-06,0.3645,0.39308,1,1
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,8.9327e-05,0.36379,0.40074,1,1
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00019306,0.36369,0.37403,1,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00019306,0.36329,0.44755,1,1
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00060992,0.36273,0.36943,1,1
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0047188,0.36266,0.35785,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0016767,0.3625,0.37595,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0010798,0.36249,0.39176,1,1
5,GO COLLAGEN METABOLIC PROCESS,0.0027019,0.36174,0.38093,1,1
5,GO REGULATION OF CHEMOTAXIS,0.00040321,0.36171,0.38537,1,1
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0019699,0.36089,0.37753,1,1
5,GO INTERFERON BETA PRODUCTION,9.5377e-05,0.36085,0.39826,1,1
5,GO MOVEMENT IN HOST ENVIRONMENT,8.9327e-05,0.35982,0.36483,1,1
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00068502,0.35955,0.39496,1,1
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0025648,0.35922,0.34185,1,1
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.3279e-05,0.35903,0.42469,1,1
5,GO MAST CELL ACTIVATION,0.0083971,0.35893,0.34092,1,1
5,GO RESPONSE TO FUNGUS,0.0024341,0.35837,0.37142,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0021907,0.35789,0.39818,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0052065,0.35748,0.34525,1,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00086166,0.35628,0.31729,1,1
5,GO PROSTATE GLAND GROWTH,0.00035748,0.3561,0.39392,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.00081392,0.35583,0.33202,1,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00029789,0.35578,0.39006,1,1
5,GO MAST CELL MEDIATED IMMUNITY,0.010572,0.35537,0.32367,1,1
5,GO INTERACTION WITH SYMBIONT,8.9843e-06,0.35537,0.38143,1,1
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0021907,0.35371,0.40379,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00021879,0.3533,0.36353,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00068502,0.35325,0.4295,1,1
5,GO ZYMOGEN ACTIVATION,0.0016767,0.35312,0.37112,1,1
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.00057531,0.35308,0.43191,1,1
5,GO TRABECULA FORMATION,0.0063209,0.35272,0.3273,1,1
5,GO LYMPHANGIOGENESIS,0.00091199,0.35256,0.43366,1,1
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0031545,0.35213,0.39584,1,1
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0028457,0.35159,0.43711,1,1
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0013481,0.35147,0.38357,1,1
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00045436,0.35067,0.42572,1,1
5,GO GLYCOLIPID CATABOLIC PROCESS,0.00086166,0.35055,0.42596,1,1
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0010209,0.35036,0.37839,1,1
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.00086166,0.35001,0.38746,1,1
5,GO MYELOID CELL DEVELOPMENT,7.3279e-05,0.34956,0.38845,1,1
5,GO COLLAGEN FIBRIL ORGANIZATION,0.012106,0.3481,0.43171,1,1
5,GO REGULATION OF BONE REMODELING,0.0083971,0.34799,0.30233,1,1
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00020554,0.34769,0.3358,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0024341,0.34766,0.42604,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.8298e-05,0.34737,0.38445,1,1
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,4.2763e-05,0.34728,0.38395,1,1
5,GO GAP JUNCTION ASSEMBLY,0.010101,0.34563,0.39516,1,1
5,GO PROTEIN TRIMERIZATION,0.0015882,0.34538,0.41212,1,1
5,GO RESPONSE TO ANGIOTENSIN,0.00081392,0.34408,0.32,1,1
5,GO RENAL ABSORPTION,0.0021907,0.34367,0.42817,1,1
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0066311,0.34356,0.37697,1,1
5,GO ENDODERMAL CELL DIFFERENTIATION,0.0021907,0.34286,0.42034,1,1
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0023095,0.34275,0.34683,1,1
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0015041,0.34268,0.398,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.6086e-05,0.34237,0.39047,1,1
5,GO BONE REMODELING,0.0025648,0.34227,0.33118,1,1
5,GO REGULATION OF RECEPTOR BINDING,0.00035748,0.34186,0.38703,1,1
5,GO REGULATION OF CELL ADHESION,0.0003797,0.34156,0.3809,1,1
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00033648,0.34151,0.38105,1,1
5,GO RESPONSE TO PROSTAGLANDIN E,0.00332,0.34034,0.37066,1,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.00081392,0.33999,0.36898,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.006955,0.33998,0.30226,1,1
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0014241,0.3393,0.36557,1,1
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00026348,0.33911,0.35896,1,1
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00031664,0.33896,0.38154,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00019306,0.33869,0.33402,1,1
5,GO LIPOXYGENASE PATHWAY,0.041938,0.33859,0.3021,1,1
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00018128,0.33842,0.32645,1,1
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0028457,0.33814,0.30158,1,1
5,GO RESPONSE TO MANGANESE ION,0.00024771,0.33755,0.33523,1,1
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0020776,0.33743,0.38062,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0003797,0.33674,0.39815,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00045436,0.33662,0.35585,1,1
5,GO MODULATION BY HOST OF VIRAL PROCESS,3.0304e-05,0.33639,0.35733,1,1
5,GO LAMELLIPODIUM MORPHOGENESIS,0.0003797,0.33593,0.34589,1,1
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00024771,0.3359,0.39922,1,1
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00057531,0.33566,0.40232,1,1
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00076864,0.33536,0.34029,1,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.00033648,0.33515,0.38667,1,1
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00060992,0.33482,0.34269,1,1
5,GO DRUG CATABOLIC PROCESS,0.0016767,0.33475,0.27974,1,1
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0012758,0.33464,0.40737,1,1
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00081392,0.33447,0.39859,1,1
5,GO TYPE I INTERFERON PRODUCTION,0.00013188,0.33412,0.35029,1,1
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,7.3279e-05,0.33402,0.40841,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00035748,0.33371,0.38246,1,1
5,GO LIVER MORPHOGENESIS,0.00035748,0.33333,0.35516,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00081392,0.33201,0.38541,1,1
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.0020776,0.3317,0.34213,1,1
5,GO NOTOCHORD DEVELOPMENT,0.0018673,0.33149,0.32237,1,1
5,GO EPIDERMIS MORPHOGENESIS,0.0010798,0.33125,0.35813,1,1
5,GO DETERMINATION OF ADULT LIFESPAN,0.0042727,0.33112,0.2657,1,1
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0015882,0.33107,0.35521,1,1
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00017019,0.33097,0.3197,1,1
5,GO SERTOLI CELL DEVELOPMENT,0.00014989,0.33071,0.36796,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0031545,0.33027,0.35131,1,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00018128,0.32945,0.37048,1,1
5,GO CORNIFICATION,0.0018673,0.32874,0.31114,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00029789,0.32864,0.36331,1,1
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00054254,0.32864,0.30669,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0015041,0.32848,0.33885,1,1
5,GO TRANSEPITHELIAL TRANSPORT,0.0027019,0.32791,0.32073,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.006955,0.32743,0.38907,1,1
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.0018673,0.32732,0.32979,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00086166,0.32724,0.32453,1,1
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00040321,0.32706,0.38806,1,1
5,GO CELLULAR RESPONSE TO SALT STRESS,9.5377e-05,0.32699,0.40704,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.007293,0.32678,0.31469,1,1
5,GO REGULATION OF LIPID STORAGE,0.00048214,0.32669,0.32966,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0023095,0.32665,0.35317,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.00015974,0.32632,0.31988,1,1
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0049572,0.32572,0.49681,1,1
5,GO LYMPH VESSEL DEVELOPMENT,0.0018673,0.32567,0.41592,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.00033648,0.32516,0.34526,1,1
5,GO REGULATION OF PLATELET AGGREGATION,0.0057394,0.32504,0.34434,1,1
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00014062,0.32388,0.34822,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00051151,0.3232,0.30144,1,1
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.0025648,0.32311,0.27226,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0012758,0.32307,0.34233,1,1
5,GO REGULATION OF VIRAL LIFE CYCLE,5.9985e-05,0.32252,0.36929,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00060992,0.32224,0.31541,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00096503,0.32199,0.31606,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00028019,0.32181,0.4012,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0015882,0.32173,0.35746,1,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00014062,0.32153,0.4005,1,1
5,GO SUPEROXIDE METABOLIC PROCESS,0.00057531,0.3213,0.32502,1,1
5,GO LUNG MORPHOGENESIS,0.00096503,0.32117,0.34831,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0017696,0.32065,0.37676,1,1
5,GO RECEPTOR BIOSYNTHETIC PROCESS,7.3279e-05,0.32049,0.32879,1,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00051151,0.32016,0.40623,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,6.8565e-05,0.32011,0.34064,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.00040321,0.31984,0.3164,1,1
5,GO CHOLESTEROL EFFLUX,0.0044907,0.31977,0.28003,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00023283,0.31905,0.42583,1,1
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00012367,0.31884,0.40751,1,1
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0034935,0.31783,0.33582,1,1
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0034935,0.31691,0.28565,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0018673,0.31687,0.34529,1,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00029789,0.31678,0.38189,1,1
5,GO P38MAPK CASCADE,0.00048214,0.31666,0.3614,1,1
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,6.4139e-05,0.31658,0.31436,1,1
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00051151,0.31576,0.39647,1,1
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00014062,0.31553,0.42449,1,1
5,GO CELL AGGREGATION,0.013235,0.31516,0.27143,1,1
5,GO RESPONSE TO THYROID HORMONE,0.0023095,0.31484,0.28892,1,1
5,GO RESPONSE TO DSRNA,0.00033648,0.31472,0.3039,1,1
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0036751,0.31462,0.35774,1,1
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00010181,0.31456,0.36642,1,1
5,GO BRONCHUS DEVELOPMENT,0.00072571,0.31425,0.43012,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00051151,0.31411,0.41053,1,1
5,GO CELLULAR RESPONSE TO VIRUS,0.00018128,0.31399,0.37994,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0010209,0.31392,0.31568,1,1
5,GO STEROID ESTERIFICATION,0.0066311,0.31356,0.24762,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00031664,0.31338,0.31993,1,1
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0044907,0.31299,0.30438,1,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0057394,0.31258,0.37301,1,1
5,GO REGULATION OF CALCIUM ION IMPORT,0.0025648,0.31143,0.32064,1,1
5,GO RIG I SIGNALING PATHWAY,7.3279e-05,0.31131,0.32567,1,1
5,GO O GLYCAN PROCESSING,0.0015041,0.31106,0.27905,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00057531,0.31106,0.33599,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.00064645,0.31095,0.35902,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00033648,0.31027,0.34952,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0040644,0.31013,0.33807,1,1
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0015041,0.30962,0.30114,1,1
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0018673,0.30944,0.27085,1,1
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.013235,0.30924,0.34249,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0066311,0.30909,0.34744,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,0.00045436,0.30887,0.38018,1,1
5,GO REGULATION OF TISSUE REMODELING,0.0057394,0.30872,0.30846,1,1
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.015776,0.3086,0.28174,1,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,8.9327e-05,0.30837,0.28748,1,1
5,GO PRIMARY MIRNA PROCESSING,0.0017696,0.30819,0.37954,1,1
5,GO AMYLOID FIBRIL FORMATION,0.0025648,0.30797,0.33504,1,1
5,GO REGULATION OF ISOTYPE SWITCHING,0.00042807,0.30779,0.37014,1,1
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00048214,0.30733,0.33841,1,1
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.00060992,0.30664,0.40905,1,1
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0080134,0.30662,0.29995,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00020554,0.30629,0.32114,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.00014989,0.30624,0.35001,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.00051151,0.30619,0.35637,1,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.2428e-05,0.30614,0.40599,1,1
5,GO MUSCLE CELL FATE COMMITMENT,0.00028019,0.30552,0.35865,1,1
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0010798,0.30546,0.35917,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00029789,0.30477,0.27936,1,1
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0015882,0.30468,0.34837,1,1
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00054254,0.3046,0.35879,1,1
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.00072571,0.30454,0.33758,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0040644,0.30421,0.35382,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00040321,0.30384,0.31561,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.0013481,0.3029,0.30219,1,1
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.010572,0.30276,0.35056,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00028019,0.30268,0.3182,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00060992,0.3024,0.35284,1,1
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.0016767,0.30231,0.32629,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0011418,0.30206,0.29304,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.030713,0.30194,0.32143,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0054671,0.30142,0.36005,1,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00010181,0.30084,0.26938,1,1
5,GO CERAMIDE TRANSPORT,0.019548,0.30061,0.2363,1,1
5,GO REGULATION OF PINOCYTOSIS,0.0016767,0.30037,0.32327,1,1
5,GO PLATELET DEGRANULATION,0.0034935,0.29996,0.37291,1,1
5,GO FC RECEPTOR SIGNALING PATHWAY,0.00012367,0.29936,0.30488,1,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0044907,0.29932,0.44179,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018128,0.29896,0.32339,1,1
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0029965,0.29862,0.36038,1,1
5,GO REGULATION OF SYMBIOTIC PROCESS,4.2763e-05,0.29858,0.32875,1,1
5,GO TONGUE DEVELOPMENT,0.0034935,0.29848,0.2558,1,1
5,GO RESPONSE TO DEXAMETHASONE,0.00012367,0.29841,0.28758,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0012071,0.29798,0.3797,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00096503,0.29763,0.37639,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,0.00015974,0.29759,0.33342,1,1
5,GO RESPONSE TO MINERALOCORTICOID,0.02951,0.29747,0.22619,1,1
5,GO CELLULAR RESPONSE TO X RAY,0.00081392,0.29728,0.35418,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0029965,0.297,0.34218,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.0024341,0.29692,0.3869,1,1
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00042807,0.29666,0.37656,1,1
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0083971,0.29632,0.26211,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.2428e-05,0.29631,0.36096,1,1
5,GO RESPONSE TO INACTIVITY,0.0044907,0.29562,0.26542,1,1
5,GO NECROTIC CELL DEATH,0.00091199,0.29506,0.29348,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00026348,0.29499,0.3378,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.00013188,0.2949,0.32657,1,1
5,GO TISSUE REMODELING,0.0018673,0.29487,0.35463,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0012758,0.29427,0.33992,1,1
5,GO INTERACTION WITH HOST,5.6086e-05,0.29417,0.30811,1,1
5,GO CALCIUM MEDIATED SIGNALING,0.0015041,0.29415,0.30289,1,1
5,GO KERATINOCYTE PROLIFERATION,0.0018673,0.29407,0.30466,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00023283,0.29389,0.30496,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00031664,0.29377,0.35046,1,1
5,GO STEM CELL DIVISION,0.0014241,0.29374,0.32422,1,1
5,GO REGULATION OF ODONTOGENESIS,0.0049572,0.29374,0.32334,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00068502,0.29369,0.32908,1,1
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0040644,0.29335,0.34027,1,1
5,GO DECIDUALIZATION,0.0080134,0.29291,0.30178,1,1
5,GO EPITHELIAL CELL CELL ADHESION,0.0092139,0.29274,0.30654,1,1
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00045436,0.29253,0.28746,1,1
5,GO CELLULAR RESPONSE TO DSRNA,0.00081392,0.29226,0.35268,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00086166,0.29175,0.32879,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,0.0054671,0.29124,0.26182,1,1
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.00010866,0.29091,0.34748,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0014241,0.28977,0.33151,1,1
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00076864,0.28977,0.36669,1,1
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0038653,0.2897,0.35944,1,1
5,GO ARTERY MORPHOGENESIS,0.0003797,0.28959,0.37238,1,1
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00051151,0.28933,0.3541,1,1
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00026348,0.28905,0.35188,1,1
5,GO MANGANESE ION TRANSPORT,0.00026348,0.28901,0.29256,1,1
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.016475,0.28896,0.2735,1,1
5,GO ARGININE METABOLIC PROCESS,0.00076864,0.28889,0.295,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.0083971,0.28869,0.31673,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0011418,0.28795,0.36548,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.8267e-05,0.28742,0.33039,1,1
5,GO URETER DEVELOPMENT,0.024086,0.28734,0.21688,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00064645,0.28612,0.32685,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.0028457,0.28602,0.37264,1,1
5,GO REGULATION OF CELL FATE COMMITMENT,0.00033648,0.28567,0.34495,1,1
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0012758,0.28516,0.33832,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,9.5377e-05,0.28515,0.34116,1,1
5,GO BARBED END ACTIN FILAMENT CAPPING,0.0010798,0.28504,0.29885,1,1
5,GO TERPENOID METABOLIC PROCESS,8.9327e-05,0.28499,0.28117,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.00054254,0.28465,0.32152,1,1
5,GO ICOSANOID METABOLIC PROCESS,0.00091199,0.28446,0.31273,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0049572,0.28408,0.34154,1,1
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0083971,0.28398,0.25449,1,1
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,1.1191e-05,0.28383,0.33022,1,1
5,GO COPPER ION TRANSPORT,0.00064645,0.28383,0.31424,1,1
5,GO RUFFLE ORGANIZATION,0.00033648,0.28348,0.32293,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.00040321,0.28342,0.27035,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0042727,0.28317,0.30829,1,1
5,GO PLATELET ACTIVATION,0.010572,0.28316,0.30413,1,1
5,GO RESPONSE TO GROWTH HORMONE,9.5377e-05,0.28301,0.30215,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0012758,0.28297,0.36086,1,1
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.00024771,0.28291,0.36569,1,1
5,GO PULMONARY VALVE DEVELOPMENT,0.0054671,0.28264,0.37834,1,1
5,GO SEQUESTERING OF CALCIUM ION,0.0040644,0.28258,0.28253,1,1
5,GO GLIAL CELL PROLIFERATION,0.00076864,0.28227,0.32869,1,1
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.0020776,0.2822,0.29822,1,1
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0010209,0.28207,0.31059,1,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.021265,0.28163,0.27911,1,1
5,GO RESPONSE TO NITRIC OXIDE,0.0027019,0.2816,0.25594,1,1
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0024341,0.28101,0.40516,1,1
5,GO RESPONSE TO STEROL,0.0003797,0.28094,0.31807,1,1
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0013481,0.28092,0.28586,1,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00045436,0.28082,0.34175,1,1
5,GO ACTIN FILAMENT BASED TRANSPORT,0.0018673,0.28067,0.33047,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0013481,0.28064,0.29133,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0028457,0.2804,0.30095,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0015041,0.28038,0.24127,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,0.00051151,0.27988,0.3243,1,1
5,GO B CELL APOPTOTIC PROCESS,0.00042807,0.27924,0.32948,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.024086,0.27912,0.26705,1,1
5,GO ENDODERM DEVELOPMENT,0.0027019,0.27899,0.31788,1,1
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0010209,0.27893,0.30156,1,1
5,GO BEHAVIORAL RESPONSE TO PAIN,0.0047188,0.27871,0.28848,1,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.0013481,0.27868,0.29769,1,1
5,GO RESPONSE TO INTERLEUKIN 12,0.00024771,0.27853,0.28685,1,1
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0024341,0.27839,0.24036,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0016767,0.27826,0.29623,1,1
5,GO PEPTIDYL TYROSINE MODIFICATION,0.00040321,0.27807,0.3151,1,1
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00076864,0.27797,0.35527,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0015882,0.27758,0.36076,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0024341,0.2775,0.31596,1,1
5,GO INTRACELLULAR STEROL TRANSPORT,0.0003797,0.27748,0.30639,1,1
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,7.8298e-05,0.27732,0.32282,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00029789,0.27722,0.28082,1,1
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0096484,0.27668,0.30917,1,1
5,GO HEPATOCYTE DIFFERENTIATION,0.035953,0.27655,0.20581,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0015041,0.27637,0.3181,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,0.0017696,0.27617,0.32574,1,1
5,GO REGULATION OF AMYLOID BETA FORMATION,0.00035748,0.27589,0.32862,1,1
5,GO SALIVA SECRETION,0.0025648,0.27499,0.32787,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00072571,0.27485,0.33428,1,1
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0010209,0.27458,0.3153,1,1
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0060238,0.27416,0.31899,1,1
5,GO GLOMERULUS DEVELOPMENT,0.0054671,0.27405,0.34851,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0057394,0.27401,0.32284,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00026348,0.27398,0.30062,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.006955,0.27395,0.25645,1,1
5,GO ENDODERM FORMATION,0.0014241,0.27352,0.39361,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.045233,0.27335,0.19603,1,1
5,GO ARACHIDONIC ACID SECRETION,0.0052065,0.27327,0.23947,1,1
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0057394,0.27318,0.27625,1,1
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00024771,0.27287,0.25803,1,1
5,GO TRACHEA DEVELOPMENT,0.0014241,0.27272,0.3541,1,1
5,GO DRUG METABOLIC PROCESS,0.00064645,0.27238,0.29836,1,1
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00010866,0.27191,0.33902,1,1
5,GO TRABECULA MORPHOGENESIS,0.010572,0.27155,0.29166,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.00096503,0.27126,0.3001,1,1
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0027019,0.27116,0.27166,1,1
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0042727,0.2707,0.30403,1,1
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0012758,0.2701,0.31385,1,1
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00018128,0.26945,0.32013,1,1
5,GO REGULATION OF PROTEIN MATURATION,0.00018128,0.26938,0.32459,1,1
5,GO COAGULATION,0.0057394,0.26875,0.28402,1,1
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0044907,0.26857,0.26536,1,1
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00051151,0.26834,0.37237,1,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0027019,0.26831,0.32096,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.0028457,0.26825,0.29781,1,1
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00020554,0.26818,0.26708,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00029789,0.26795,0.33911,1,1
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0040644,0.26771,0.30053,1,1
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0080134,0.2677,0.22927,1,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0018673,0.26766,0.34529,1,1
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0092139,0.26752,0.39537,1,1
5,GO LYMPH VESSEL MORPHOGENESIS,0.0025648,0.26728,0.38779,1,1
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00060992,0.26728,0.29421,1,1
5,GO REGULATION OF DNA METHYLATION,0.0012758,0.26728,0.25064,1,1
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.006955,0.26682,0.36148,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00028019,0.26637,0.30541,1,1
5,GO ISOPRENOID METABOLIC PROCESS,6.8565e-05,0.26631,0.25002,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.00035748,0.26619,0.35767,1,1
5,GO HEAD MORPHOGENESIS,0.033245,0.26618,0.23897,1,1
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0044907,0.26596,0.27675,1,1
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0096484,0.26586,0.28861,1,1
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00015974,0.26586,0.2929,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0038653,0.26536,0.24878,1,1
5,GO REGULATION OF CELL SHAPE,0.00040321,0.26534,0.32528,1,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0019699,0.26515,0.28923,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.008797,0.26481,0.24979,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0172,0.26457,0.24739,1,1
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.248e-05,0.26449,0.29978,1,1
5,GO WOUND HEALING,0.0021907,0.26422,0.30143,1,1
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00042807,0.26382,0.32452,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.5377e-05,0.26375,0.29887,1,1
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0054671,0.26358,0.32057,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,0.0049572,0.26313,0.21247,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.008797,0.26289,0.25577,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.0003797,0.26285,0.27957,1,1
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0023095,0.26235,0.26127,1,1
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0052065,0.26222,0.37812,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0054671,0.26208,0.26099,1,1
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0017696,0.26207,0.37673,1,1
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00015974,0.26159,0.32074,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1347e-05,0.26151,0.30684,1,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.0012071,0.26133,0.28721,1,1
5,GO REPLACEMENT OSSIFICATION,0.00332,0.26099,0.3246,1,1
5,GO ARTERY DEVELOPMENT,0.0003797,0.2608,0.37109,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.0013481,0.26034,0.33998,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016767,0.26018,0.28109,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.030713,0.25919,0.27271,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.0049572,0.25915,0.24407,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00081392,0.25906,0.28248,1,1
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0014241,0.25889,0.26786,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0040644,0.25869,0.26251,1,1
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00051151,0.25844,0.347,1,1
5,GO HIPPO SIGNALING,0.0054671,0.25837,0.29328,1,1
5,GO FOREGUT MORPHOGENESIS,0.0020776,0.25804,0.34463,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00040321,0.2577,0.31083,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0013481,0.25769,0.30455,1,1
5,GO REGULATION OF WOUND HEALING,0.0031545,0.25762,0.32132,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0172,0.25751,0.25702,1,1
5,GO SULFATION,0.013834,0.25742,0.25299,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00035748,0.25732,0.28764,1,1
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0029965,0.25705,0.31959,1,1
5,GO AMINO SUGAR METABOLIC PROCESS,0.0011418,0.25699,0.30697,1,1
5,GO CELL CELL RECOGNITION,7.3279e-05,0.25656,0.29326,1,1
5,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.0092139,0.25653,0.24606,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0025648,0.25633,0.32519,1,1
5,GO RESPONSE TO AMYLOID BETA,0.02951,0.25601,0.24922,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00042807,0.25555,0.29955,1,1
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0014241,0.25524,0.33613,1,1
5,GO VIRAL GENOME REPLICATION,0.00018128,0.25515,0.31729,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.007293,0.25505,0.26545,1,1
5,GO AMELOGENESIS,0.0010798,0.255,0.32005,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00026348,0.25477,0.2628,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0042727,0.25474,0.30626,1,1
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0018673,0.25468,0.32582,1,1
5,GO VIRAL LIFE CYCLE,5.6086e-05,0.25462,0.30163,1,1
5,GO PEPTIDE CATABOLIC PROCESS,0.0042727,0.25451,0.31409,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00045436,0.25407,0.30022,1,1
5,GO PROSTAGLANDIN TRANSPORT,0.0066311,0.25381,0.31101,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0080134,0.25337,0.29915,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00072571,0.25337,0.30061,1,1
5,GO GLAND MORPHOGENESIS,0.0017696,0.2528,0.32774,1,1
5,GO CELLULAR OXIDANT DETOXIFICATION,0.00026348,0.25257,0.25869,1,1
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0014241,0.25222,0.29995,1,1
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00081392,0.25188,0.33174,1,1
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00064645,0.25184,0.31118,1,1
5,GO MATERNAL PLACENTA DEVELOPMENT,0.0042727,0.25153,0.2658,1,1
5,GO PLATELET AGGREGATION,0.006955,0.25144,0.33785,1,1
5,GO EPIBOLY,0.00064645,0.25133,0.32935,1,1
5,GO PROSTATE GLAND DEVELOPMENT,0.0010798,0.25106,0.32245,1,1
5,GO MRNA TRANSCRIPTION,0.0024341,0.251,0.29848,1,1
5,GO TISSUE MIGRATION,0.0020776,0.251,0.30431,1,1
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.010101,0.25089,0.24803,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,0.0042727,0.2508,0.28723,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.021265,0.25044,0.26042,1,1
5,GO FACE DEVELOPMENT,0.008797,0.25035,0.27803,1,1
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.00042807,0.25024,0.26495,1,1
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.006955,0.2502,0.31974,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0021907,0.24999,0.281,1,1
5,GO RESPONSE TO X RAY,0.0015882,0.24993,0.26632,1,1
5,GO HEAT GENERATION,0.015776,0.24975,0.23933,1,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0038653,0.24966,0.31719,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.013235,0.2496,0.26909,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.018736,0.24955,0.3239,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.00018128,0.24954,0.28405,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.019548,0.24936,0.22877,1,1
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.0020776,0.24893,0.25027,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0010209,0.24864,0.31709,1,1
5,GO FEMALE GENITALIA DEVELOPMENT,0.0038653,0.24862,0.22371,1,1
5,GO ODONTOGENESIS,0.0015882,0.24837,0.27198,1,1
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0012071,0.24832,0.24984,1,1
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.011063,0.24818,0.25194,1,1
5,GO RESPONSE TO RETINOIC ACID,0.00068502,0.24809,0.28786,1,1
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0057394,0.24793,0.28963,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.0015882,0.24746,0.34159,1,1
5,GO FIBROBLAST APOPTOTIC PROCESS,0.00064645,0.24739,0.28458,1,1
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00081392,0.24715,0.27793,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00014062,0.24707,0.30341,1,1
5,GO ENAMEL MINERALIZATION,0.0038653,0.24706,0.35564,1,1
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00086166,0.24691,0.30213,1,1
5,GO PROTEIN KINASE B SIGNALING,0.00086166,0.24689,0.29266,1,1
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0012071,0.24688,0.26788,1,1
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.018736,0.24687,0.22185,1,1
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0013481,0.24673,0.27375,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.012106,0.2466,0.22678,1,1
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.010572,0.2466,0.34037,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.025096,0.24637,0.21354,1,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.00060992,0.24635,0.31089,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.008797,0.24605,0.24193,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.021265,0.2458,0.29457,1,1
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0047188,0.24576,0.35179,1,1
5,GO MUSCLE CELL PROLIFERATION,0.00091199,0.24556,0.30738,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0010209,0.24522,0.2491,1,1
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,8.9327e-05,0.24509,0.27495,1,1
5,GO PROTEIN DEGLYCOSYLATION,0.00091199,0.24469,0.32709,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0021907,0.24424,0.26403,1,1
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00051151,0.24422,0.28238,1,1
5,GO AMYLOID BETA FORMATION,0.00042807,0.24418,0.28927,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00012367,0.24416,0.26225,1,1
5,GO RESPONSE TO FATTY ACID,0.00054254,0.24388,0.25967,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00018128,0.24373,0.30233,1,1
5,GO CELL MATRIX ADHESION,0.0066311,0.24367,0.31058,1,1
5,GO CELL SUBSTRATE ADHESION,0.0066311,0.24362,0.31502,1,1
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0019699,0.24359,0.25025,1,1
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0014241,0.24325,0.37835,1,1
5,GO REGULATION OF TRANSPOSITION,0.043559,0.24316,0.18357,1,1
5,GO REGULATION OF GASTRULATION,0.00054254,0.24288,0.3085,1,1
5,GO FIBROBLAST ACTIVATION,0.010101,0.24284,0.26658,1,1
5,GO CELL REDOX HOMEOSTASIS,0.00048214,0.24258,0.27675,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,0.0017696,0.24252,0.29912,1,1
5,GO ENDODERMAL CELL FATE COMMITMENT,0.011574,0.2425,0.2398,1,1
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00081392,0.24238,0.30165,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,6.4139e-05,0.24201,0.2835,1,1
5,GO ERBB2 SIGNALING PATHWAY,0.00035748,0.24192,0.27144,1,1
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00015974,0.24186,0.23445,1,1
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.006955,0.24175,0.24157,1,1
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.012106,0.2417,0.27197,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0025648,0.24167,0.28115,1,1
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0042727,0.24155,0.23453,1,1
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0172,0.24144,0.27712,1,1
5,GO CELL CELL JUNCTION MAINTENANCE,0.0034935,0.24121,0.30835,1,1
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.022172,0.2405,0.22609,1,1
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.011574,0.23997,0.23165,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00072571,0.23975,0.26222,1,1
5,GO PANCREATIC JUICE SECRETION,0.0083971,0.23952,0.26266,1,1
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0172,0.23936,0.1885,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0015041,0.23929,0.34745,1,1
5,GO TISSUE REGENERATION,0.00054254,0.23919,0.24905,1,1
5,GO PROTEIN DEMANNOSYLATION,0.0016767,0.23908,0.3031,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.0014241,0.23876,0.25862,1,1
5,GO RESPONSE TO LIPID,0.00068502,0.23873,0.26221,1,1
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00018128,0.23847,0.30667,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.006955,0.23835,0.25068,1,1
5,GO BLOOD VESSEL MORPHOGENESIS,0.0014241,0.23794,0.33962,1,1
5,GO RESPONSE TO ANTIBIOTIC,0.00015974,0.23791,0.25511,1,1
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0076456,0.2379,0.31817,1,1
5,GO KERATINOCYTE MIGRATION,0.0066311,0.23728,0.27757,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0019699,0.23717,0.2714,1,1
5,GO MEGAKARYOCYTE DEVELOPMENT,0.0023095,0.23711,0.30168,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.021265,0.23691,0.23858,1,1
5,GO MESODERMAL CELL DIFFERENTIATION,0.0015041,0.23655,0.29686,1,1
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.045233,0.23655,0.26653,1,1
5,GO NEPHRON TUBULE FORMATION,0.0012758,0.2363,0.34234,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0029965,0.23623,0.32562,1,1
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.028348,0.23606,0.30014,1,1
5,GO TOOTH MINERALIZATION,0.015776,0.23586,0.28585,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00011593,0.23567,0.29468,1,1
5,GO SECRETION BY TISSUE,0.00091199,0.23563,0.24141,1,1
5,GO RESPONSE TO UV C,0.0044907,0.23559,0.24614,1,1
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.0017696,0.23502,0.25446,1,1
5,GO AORTA DEVELOPMENT,0.00068502,0.23499,0.34206,1,1
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0036751,0.23484,0.28965,1,1
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00051151,0.23447,0.28793,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0019699,0.23438,0.26468,1,1
5,GO VASCULATURE DEVELOPMENT,0.00096503,0.23435,0.33268,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00013188,0.23407,0.33261,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00035748,0.23407,0.3187,1,1
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0054671,0.23369,0.22247,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00045436,0.23354,0.26041,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,8.3641e-05,0.23352,0.26828,1,1
5,GO REGULATION OF BONE MINERALIZATION,0.010572,0.23302,0.28141,1,1
5,GO GENITALIA DEVELOPMENT,0.0063209,0.2328,0.23161,1,1
5,GO HYALURONAN METABOLIC PROCESS,0.0076456,0.23244,0.30283,1,1
5,GO CELL CELL ADHESION,0.0027019,0.23219,0.26801,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.043559,0.23219,0.24583,1,1
5,GO PROSTAGLANDIN SECRETION,0.037377,0.23186,0.24704,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0010798,0.23149,0.28561,1,1
5,GO GLIAL CELL MIGRATION,0.033245,0.23113,0.22362,1,1
5,GO KERATINIZATION,0.013834,0.23095,0.1926,1,1
5,GO STEROL TRANSPORT,0.0013481,0.23077,0.26735,1,1
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0019699,0.23072,0.34537,1,1
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0049572,0.23037,0.30018,1,1
5,GO PIGMENT ACCUMULATION,0.037377,0.23001,0.27801,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0031545,0.22992,0.29858,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.028348,0.22945,0.18737,1,1
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.00031664,0.22941,0.30162,1,1
5,GO ASTROCYTE DIFFERENTIATION,0.0034935,0.22933,0.27211,1,1
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00042807,0.22863,0.24518,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.0052065,0.22819,0.30313,1,1
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00017019,0.22782,0.27611,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00086166,0.22781,0.25521,1,1
5,GO MALE GENITALIA DEVELOPMENT,0.0047188,0.22779,0.26849,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00091199,0.22777,0.24601,1,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0020776,0.22772,0.26728,1,1
5,GO EXOCYTOSIS,0.00332,0.22751,0.23406,1,1
5,GO BONE DEVELOPMENT,0.00086166,0.22746,0.30106,1,1
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00031664,0.22727,0.25536,1,1
5,GO ERBB SIGNALING PATHWAY,0.00068502,0.22719,0.2587,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0054671,0.22701,0.20957,1,1
5,GO TRANSITION METAL ION HOMEOSTASIS,0.00023283,0.227,0.2415,1,1
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0015882,0.22646,0.27284,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0042727,0.22643,0.29227,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0010209,0.22633,0.2671,1,1
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0013481,0.22612,0.25358,1,1
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.010101,0.22592,0.29204,1,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.0076456,0.22579,0.2396,1,1
5,GO REGULATION OF RECEPTOR RECYCLING,0.00076864,0.22577,0.25867,1,1
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00054254,0.22552,0.29294,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.02951,0.22486,0.23673,1,1
5,GO RESPONSE TO WOUNDING,0.0042727,0.22485,0.2711,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.00054254,0.2247,0.27314,1,1
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0003797,0.22459,0.2698,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.008797,0.22455,0.29629,1,1
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0020776,0.22448,0.25768,1,1
5,GO RESPONSE TO SALT STRESS,0.013235,0.22441,0.21003,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0031545,0.22388,0.2698,1,1
5,GO AORTA MORPHOGENESIS,0.0054671,0.22378,0.32229,1,1
5,GO REGULATION OF NUCLEASE ACTIVITY,0.0057394,0.22363,0.21628,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00060992,0.2235,0.26453,1,1
5,GO DETOXIFICATION,0.00076864,0.22331,0.21521,1,1
5,GO RESPONSE TO ATP,0.0015041,0.22328,0.28111,1,1
5,GO FATTY ACID TRANSPORT,0.00068502,0.22311,0.25383,1,1
5,GO RESPONSE TO ISCHEMIA,0.0092139,0.22302,0.25218,1,1
5,GO TRANSPOSITION,0.031957,0.22296,0.17507,1,1
5,GO PARAXIAL MESODERM DEVELOPMENT,0.021265,0.22283,0.21555,1,1
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.013235,0.22269,0.30293,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.048745,0.22253,0.15666,1,1
5,GO EMBRYO IMPLANTATION,0.0015041,0.22215,0.30611,1,1
5,GO PIGMENT GRANULE LOCALIZATION,0.00051151,0.22206,0.24255,1,1
5,GO ESTROUS CYCLE,0.026142,0.22202,0.24656,1,1
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0044907,0.22201,0.25944,1,1
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.0014241,0.22194,0.26081,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00091199,0.22155,0.2494,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00017019,0.22125,0.25498,1,1
5,GO RESPONSE TO GAMMA RADIATION,0.00042807,0.22101,0.26061,1,1
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0010798,0.22095,0.24274,1,1
5,GO PLASMA MEMBRANE FUSION,0.030713,0.22081,0.22248,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0012758,0.22077,0.26521,1,1
5,GO TROPHOBLAST CELL MIGRATION,0.0019699,0.22064,0.28013,1,1
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.048745,0.22049,0.16468,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0014241,0.22042,0.2795,1,1
5,GO BLASTODERM SEGMENTATION,0.0011418,0.22037,0.2758,1,1
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.0034935,0.22031,0.23245,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0014241,0.22001,0.22673,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00068502,0.2198,0.26849,1,1
5,GO RESPONSE TO ESTROGEN,0.0014241,0.21959,0.2667,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0031545,0.21926,0.25546,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.008797,0.21916,0.2596,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00040321,0.21913,0.24327,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0023095,0.21902,0.31734,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.0017696,0.21879,0.22164,1,1
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.013834,0.21814,0.2527,1,1
5,GO COPPER ION HOMEOSTASIS,0.0015882,0.21742,0.22557,1,1
5,GO HEMOGLOBIN METABOLIC PROCESS,6.4139e-05,0.21704,0.29804,1,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,7.8298e-05,0.21691,0.25949,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0016767,0.21686,0.33021,1,1
5,GO LIVER REGENERATION,0.00021879,0.21683,0.25598,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0066311,0.21662,0.25621,1,1
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.018736,0.21649,0.22847,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00096503,0.21643,0.23192,1,1
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00068502,0.21631,0.25829,1,1
5,GO REGULATION OF BIOMINERALIZATION,0.0172,0.21615,0.25652,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0019699,0.21615,0.25242,1,1
5,GO LIPID STORAGE,0.0036751,0.21606,0.24286,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0012071,0.21606,0.24779,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.015776,0.21604,0.23989,1,1
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020776,0.21594,0.23543,1,1
5,GO PULMONARY VALVE MORPHOGENESIS,0.0172,0.21591,0.34328,1,1
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0054671,0.2158,0.23663,1,1
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00017019,0.21576,0.23607,1,1
5,GO LEFT RIGHT AXIS SPECIFICATION,0.011574,0.21553,0.26997,1,1
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0010798,0.21526,0.27513,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0014241,0.21523,0.23546,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00086166,0.21475,0.24503,1,1
5,GO EPIDERMIS DEVELOPMENT,0.0023095,0.21463,0.22084,1,1
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0025648,0.21458,0.28559,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00014989,0.21453,0.26133,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023283,0.21435,0.2529,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0021907,0.21383,0.28237,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.0092139,0.21351,0.23754,1,1
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0040644,0.21318,0.33636,1,1
5,GO REGULATION OF MAPK CASCADE,0.0021907,0.21308,0.25039,1,1
5,GO HEPARIN METABOLIC PROCESS,0.01266,0.21292,0.27098,1,1
5,GO PHOSPHOLIPID HOMEOSTASIS,0.0015041,0.21284,0.31093,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0044907,0.21276,0.33243,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.012106,0.21249,0.22548,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0017696,0.21198,0.24317,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.0010798,0.21192,0.26682,1,1
5,GO BICARBONATE TRANSPORT,0.048745,0.21173,0.17459,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0015882,0.21173,0.24882,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0038653,0.21154,0.26636,1,1
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00076864,0.21147,0.27265,1,1
5,GO LIPID HOMEOSTASIS,0.00096503,0.21147,0.24443,1,1
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.011063,0.21118,0.24103,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0063209,0.211,0.28366,1,1
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00332,0.21083,0.34274,1,1
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.00068502,0.21059,0.23734,1,1
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.013235,0.21047,0.19437,1,1
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.014457,0.21033,0.28376,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.015104,0.2103,0.23976,1,1
5,GO TISSUE HOMEOSTASIS,0.00051151,0.21017,0.25271,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0080134,0.21008,0.21868,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.0096484,0.2099,0.20401,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.0080134,0.20989,0.25544,1,1
5,GO CELLULAR RESPONSE TO ATP,0.0031545,0.20953,0.25365,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.00096503,0.20915,0.23537,1,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.011574,0.20913,0.27765,1,1
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00024771,0.20897,0.24635,1,1
5,GO MYELOID CELL HOMEOSTASIS,0.00014989,0.20892,0.26434,1,1
5,GO REGULATION OF CELL MATRIX ADHESION,0.0060238,0.20887,0.28814,1,1
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.010572,0.20853,0.28769,1,1
5,GO REGULATION OF LIPID LOCALIZATION,0.0020776,0.20852,0.24526,1,1
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0025648,0.20843,0.25057,1,1
5,GO MRNA MODIFICATION,0.031957,0.20821,0.16323,1,1
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00018128,0.20786,0.29617,1,1
5,GO RNA DECAPPING,0.00091199,0.2078,0.25368,1,1
5,GO PERICARDIUM DEVELOPMENT,0.0015041,0.20767,0.31558,1,1
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00012367,0.20747,0.21038,1,1
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.02951,0.20725,0.22806,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0027019,0.20714,0.24143,1,1
5,GO INTRACELLULAR LIPID TRANSPORT,0.00091199,0.20675,0.24628,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0021907,0.20635,0.19855,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.0054671,0.20633,0.23302,1,1
5,GO RECEPTOR RECYCLING,0.0063209,0.20633,0.20792,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00072571,0.20586,0.31186,1,1
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.023112,0.20584,0.21049,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00048214,0.20576,0.22533,1,1
5,GO PLATELET MORPHOGENESIS,0.0047188,0.20573,0.28631,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.019548,0.20573,0.19371,1,1
5,GO POSITIVE REGULATION OF CELL AGING,0.016475,0.20547,0.15987,1,1
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.041938,0.20537,0.20778,1,1
5,GO BIOLOGICAL ADHESION,0.0054671,0.20525,0.26656,1,1
5,GO MYOTUBE DIFFERENTIATION,0.0057394,0.2051,0.24332,1,1
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0025648,0.20491,0.24105,1,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0024341,0.20477,0.24636,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00040321,0.2046,0.23034,1,1
5,GO INTERMEMBRANE LIPID TRANSFER,0.0012758,0.20456,0.26963,1,1
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0017696,0.20445,0.24353,1,1
5,GO ERYTHROCYTE DEVELOPMENT,0.00029789,0.20444,0.27477,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.0023095,0.20438,0.20947,1,1
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.00031664,0.20416,0.29257,1,1
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0034935,0.20349,0.28759,1,1
5,GO CELLULAR RESPONSE TO CAMP,0.00042807,0.20323,0.25757,1,1
5,GO CELLULAR IRON ION HOMEOSTASIS,0.0010798,0.20307,0.23103,1,1
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.045233,0.20281,0.15127,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.014457,0.20279,0.24287,1,1
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.027226,0.20274,0.26469,1,1
5,GO ERYTHROCYTE MATURATION,0.0038653,0.20234,0.27593,1,1
5,GO LAMELLIPODIUM ORGANIZATION,0.00086166,0.20229,0.25066,1,1
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.021265,0.20216,0.25689,1,1
5,GO SEQUESTERING OF TRIGLYCERIDE,0.0049572,0.20216,0.28738,1,1
5,GO RESPONSE TO VITAMIN,0.008797,0.20209,0.22278,1,1
5,GO OSTEOBLAST PROLIFERATION,0.0083971,0.20205,0.28396,1,1
5,GO TUBE MORPHOGENESIS,0.0021907,0.20199,0.27791,1,1
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0096484,0.20195,0.25163,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.023112,0.20183,0.28463,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0066311,0.20152,0.2493,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0063209,0.20145,0.264,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0027019,0.20138,0.26465,1,1
5,GO IRON ION HOMEOSTASIS,0.00029789,0.20122,0.27438,1,1
5,GO BILE ACID METABOLIC PROCESS,0.00332,0.20075,0.19557,1,1
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0042727,0.20073,0.29931,1,1
5,GO GENITALIA MORPHOGENESIS,0.012106,0.20073,0.28559,1,1
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.015104,0.20053,0.15143,1,1
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.012106,0.20042,0.27551,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.020391,0.20016,0.1905,1,1
5,GO REGULATION OF PROTEIN IMPORT,7.8298e-05,0.20011,0.24963,1,1
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0010209,0.19999,0.19804,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0044907,0.19997,0.224,1,1
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.015776,0.19977,0.23832,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0024341,0.19953,0.30074,1,1
5,GO FIBROBLAST PROLIFERATION,0.00045436,0.1994,0.27601,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0025648,0.19902,0.20538,1,1
5,GO BIOMINERALIZATION,0.020391,0.19901,0.21773,1,1
5,GO PROTEIN HOMOTETRAMERIZATION,0.00017019,0.19896,0.25961,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.015776,0.1989,0.26675,1,1
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.034576,0.19889,0.22838,1,1
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.016475,0.19885,0.16921,1,1
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0029965,0.19881,0.21497,1,1
5,GO REGULATION OF HAIR CYCLE,0.0028457,0.19848,0.26706,1,1
5,GO ETHER METABOLIC PROCESS,0.0012758,0.19825,0.22677,1,1
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.013834,0.19825,0.1981,1,1
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0052065,0.19808,0.23648,1,1
5,GO MAINTENANCE OF LOCATION IN CELL,0.0034935,0.19806,0.22119,1,1
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0172,0.19799,0.23702,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.011574,0.19791,0.20744,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0066311,0.19776,0.22624,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0016767,0.1972,0.27732,1,1
5,GO EMBRYONIC HEMOPOIESIS,0.0031545,0.19699,0.29015,1,1
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.028348,0.19684,0.22657,1,1
5,GO MUSCLE CELL MIGRATION,0.0019699,0.19676,0.27737,1,1
5,GO XENOBIOTIC TRANSPORT,0.024086,0.19673,0.21275,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.021265,0.19667,0.21271,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0023095,0.19644,0.24614,1,1
5,GO ANIMAL ORGAN REGENERATION,0.0012758,0.1963,0.22784,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.0031545,0.19622,0.23547,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0015882,0.19603,0.28839,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0096484,0.19599,0.25268,1,1
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0092139,0.1959,0.1845,1,1
5,GO TAXIS,0.0066311,0.19573,0.24653,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.011574,0.19572,0.23422,1,1
5,GO PSEUDOURIDINE SYNTHESIS,0.026142,0.19555,0.11531,1,1
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0083971,0.19527,0.28374,1,1
5,GO TOXIN TRANSPORT,0.0031545,0.19482,0.20795,1,1
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00013188,0.1948,0.26483,1,1
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.025096,0.19463,0.20619,1,1
5,GO SEGMENT SPECIFICATION,0.020391,0.19457,0.22854,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0012071,0.19434,0.23219,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0015041,0.19427,0.24808,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0015041,0.19425,0.24847,1,1
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0080134,0.19387,0.24186,1,1
5,GO RESPONSE TO IONIZING RADIATION,0.0012758,0.19378,0.21143,1,1
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0042727,0.19374,0.22914,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0011418,0.19367,0.31676,1,1
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0018673,0.19363,0.20483,1,1
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0042727,0.19358,0.2638,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0036751,0.19353,0.20889,1,1
5,GO PLACENTA DEVELOPMENT,0.0027019,0.19292,0.22642,1,1
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.0015041,0.19261,0.24309,1,1
5,GO SKIN DEVELOPMENT,0.0017696,0.1925,0.23645,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.00054254,0.19246,0.23249,1,1
5,GO ESTROGEN METABOLIC PROCESS,0.00068502,0.19239,0.19454,1,1
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.012106,0.19204,0.17575,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.040368,0.19184,0.19235,1,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0029965,0.1916,0.22024,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00081392,0.19126,0.23571,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0054671,0.1912,0.24895,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.00021879,0.19118,0.2217,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00051151,0.19111,0.25222,1,1
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0021907,0.19098,0.20572,1,1
5,GO HEART VALVE DEVELOPMENT,0.025096,0.19075,0.28295,1,1
5,GO METAL ION HOMEOSTASIS,0.019548,0.1907,0.1899,1,1
5,GO RESPONSE TO NUTRIENT,0.0025648,0.19033,0.22623,1,1
5,GO NCRNA CATABOLIC PROCESS,0.037377,0.19032,0.1374,1,1
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.007293,0.19002,0.23083,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.035953,0.1896,0.18439,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.00060992,0.18941,0.19908,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0013481,0.18916,0.21325,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00054254,0.18889,0.24037,1,1
5,GO RNA DESTABILIZATION,0.011063,0.18863,0.24012,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0066311,0.18856,0.28401,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00015974,0.18818,0.24053,1,1
5,GO STEROL METABOLIC PROCESS,0.0010798,0.18792,0.21659,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0024341,0.18788,0.2241,1,1
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0010798,0.18773,0.21802,1,1
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.026142,0.18762,0.20317,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.038848,0.18756,0.21481,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.008797,0.18756,0.22138,1,1
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0015041,0.18741,0.18584,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.015104,0.1872,0.27013,1,1
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.013235,0.18704,0.21021,1,1
5,GO LIPID EXPORT FROM CELL,0.017954,0.18697,0.18885,1,1
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.014457,0.18676,0.24658,1,1
5,GO FORMATION OF PRIMARY GERM LAYER,0.0031545,0.18656,0.2857,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.010572,0.18649,0.24964,1,1
5,GO ZINC ION HOMEOSTASIS,0.031957,0.18634,0.2016,1,1
5,GO GTP METABOLIC PROCESS,0.0010798,0.18617,0.18532,1,1
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0054671,0.18614,0.22274,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0044907,0.18559,0.19392,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.00332,0.18555,0.19532,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,0.0092139,0.18548,0.21137,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0092139,0.18539,0.20604,1,1
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0014241,0.18533,0.32029,1,1
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.006955,0.18524,0.22239,1,1
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0042727,0.18519,0.23298,1,1
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0003797,0.18512,0.28384,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.015104,0.18488,0.1997,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.00332,0.18482,0.24653,1,1
5,GO AUTOPHAGOSOME MATURATION,0.00012367,0.1848,0.2386,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0049572,0.18477,0.23259,1,1
5,GO PHOSPHOLIPID TRANSPORT,0.019548,0.18472,0.1974,1,1
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0013481,0.1845,0.22466,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.0020776,0.18438,0.19158,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0044907,0.18436,0.2315,1,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.00024771,0.18386,0.23909,1,1
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.015776,0.18368,0.23526,1,1
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00081392,0.18367,0.20275,1,1
5,GO MYOBLAST PROLIFERATION,0.0038653,0.18345,0.29596,1,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.043559,0.18296,0.16801,1,1
5,GO RESPONSE TO CAMP,0.012106,0.18293,0.21078,1,1
5,GO CARDIOLIPIN METABOLIC PROCESS,0.0015041,0.18292,0.19894,1,1
5,GO HEME METABOLIC PROCESS,8.3641e-05,0.18278,0.22313,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0031545,0.18275,0.27255,1,1
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.019548,0.18267,0.13922,1,1
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.0011418,0.18263,0.21324,1,1
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.00026348,0.18221,0.25065,1,1
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.027226,0.1819,0.2607,1,1
5,GO PROTEIN PROCESSING,0.0036751,0.18152,0.23001,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,0.021265,0.18144,0.16921,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0066311,0.18091,0.26743,1,1
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.018736,0.18085,0.19766,1,1
5,GO DNA METHYLATION,0.022172,0.18073,0.1456,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.0003797,0.18059,0.24223,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.010101,0.18045,0.21776,1,1
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.012106,0.18035,0.22745,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.023112,0.1803,0.21055,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0076456,0.18019,0.18458,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.00076864,0.17994,0.22883,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0038653,0.17982,0.21967,1,1
5,GO NEUROBLAST DIVISION,0.015776,0.17973,0.22173,1,1
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,6.8565e-05,0.17957,0.25874,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0018673,0.17941,0.23598,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.017954,0.17925,0.22264,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.015104,0.17924,0.27022,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,0.0076456,0.17882,0.21849,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0028457,0.17875,0.20433,1,1
5,GO REGULATION OF ANOIKIS,0.048745,0.17872,0.21299,1,1
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0028457,0.17819,0.19451,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00086166,0.17802,0.19488,1,1
5,GO RESPONSE TO UV B,0.0080134,0.17801,0.20689,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014457,0.17778,0.26392,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.011063,0.17777,0.18554,1,1
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00023283,0.17776,0.22709,1,1
5,GO AXIS ELONGATION,0.013235,0.17769,0.25619,1,1
5,GO MAINTENANCE OF LOCATION,0.0047188,0.17768,0.21001,1,1
5,GO PORE COMPLEX ASSEMBLY,0.0052065,0.17763,0.19174,1,1
5,GO CELL MOTILITY,0.007293,0.1776,0.23297,1,1
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.011574,0.17708,0.20572,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0010209,0.17708,0.25009,1,1
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.00057531,0.17688,0.2144,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.0010798,0.17687,0.21293,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0013481,0.17673,0.22799,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,0.0047188,0.17665,0.25475,1,1
5,GO ENDOCYTOSIS,0.011574,0.1766,0.21227,1,1
5,GO RESPONSE TO KETONE,0.007293,0.17654,0.19948,1,1
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.021265,0.17651,0.23231,1,1
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038848,0.17607,0.21796,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00081392,0.17601,0.22202,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.0080134,0.17601,0.23308,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.011063,0.17596,0.21058,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0066311,0.17559,0.22024,1,1
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.023112,0.17553,0.20286,1,1
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.017954,0.17539,0.2252,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,0.0063209,0.17535,0.21633,1,1
5,GO LAMELLIPODIUM ASSEMBLY,0.0044907,0.17508,0.21587,1,1
5,GO LIPID CATABOLIC PROCESS,0.00332,0.17472,0.19165,1,1
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00096503,0.17471,0.24352,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00091199,0.1745,0.21814,1,1
5,GO LIPID OXIDATION,0.011063,0.17438,0.15671,1,1
5,GO REGULATION OF OSSIFICATION,0.011063,0.1739,0.24216,1,1
5,GO SYMBIOTIC PROCESS,8.9327e-05,0.17382,0.20712,1,1
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.02951,0.17376,0.22984,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0063209,0.17353,0.22427,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0014241,0.17326,0.22709,1,1
5,GO REGULATION OF PROTEOLYSIS,0.00042807,0.17326,0.22548,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00332,0.17301,0.20452,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.020391,0.17257,0.17745,1,1
5,GO BONE MORPHOGENESIS,0.0060238,0.17233,0.26588,1,1
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0044907,0.17223,0.14653,1,1
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.025096,0.17206,0.16796,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.015104,0.17166,0.2327,1,1
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0083971,0.17163,0.22846,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.0080134,0.1714,0.21831,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0012758,0.17124,0.20213,1,1
5,GO RUFFLE ASSEMBLY,0.0028457,0.17118,0.23285,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0027019,0.17103,0.19389,1,1
5,GO DNA METHYLATION OR DEMETHYLATION,0.012106,0.17046,0.14777,1,1
5,GO NEGATIVE REGULATION OF CELL DEATH,0.00029789,0.17046,0.21548,1,1
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0063209,0.17037,0.22965,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0083971,0.17029,0.24074,1,1
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0031545,0.17027,0.17697,1,1
5,GO MESODERMAL CELL FATE COMMITMENT,0.013235,0.1699,0.16706,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,0.028348,0.16981,0.18148,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00091199,0.1697,0.24312,1,1
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0047188,0.16923,0.2548,1,1
5,GO ION HOMEOSTASIS,0.020391,0.16912,0.17579,1,1
5,GO REGULATION OF LIPID TRANSPORT,0.0044907,0.16906,0.21684,1,1
5,GO OLIGOPEPTIDE TRANSPORT,0.0096484,0.1689,0.23721,1,1
5,GO JNK CASCADE,0.0017696,0.16879,0.24493,1,1
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.011063,0.16875,0.22401,1,1
5,GO NADPH REGENERATION,0.015776,0.16872,0.15464,1,1
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.006955,0.16871,0.17592,1,1
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0023095,0.1684,0.1815,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0038653,0.16816,0.20694,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0025648,0.16812,0.2023,1,1
5,GO STEROID METABOLIC PROCESS,0.0017696,0.16802,0.18471,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.0052065,0.16796,0.21242,1,1
5,GO CORONARY VASCULATURE DEVELOPMENT,0.007293,0.16784,0.28856,1,1
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.013834,0.16767,0.17513,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0092139,0.16755,0.20084,1,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0054671,0.16735,0.23037,1,1
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.045233,0.1671,0.12782,1,1
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0031545,0.16698,0.22055,1,1
5,GO BLASTOCYST FORMATION,0.00021879,0.16644,0.20753,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023095,0.16578,0.19454,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.045233,0.16562,0.15141,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0014241,0.16553,0.21246,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0057394,0.16518,0.24976,1,1
5,GO GALACTOSE METABOLIC PROCESS,0.018736,0.16503,0.20979,1,1
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0036751,0.16494,0.17059,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00332,0.16492,0.20457,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0054671,0.16468,0.24044,1,1
5,GO REGENERATION,0.0028457,0.1644,0.20751,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0080134,0.1643,0.22369,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0021907,0.1642,0.22632,1,1
5,GO LIPID LOCALIZATION,0.0044907,0.16416,0.21542,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.010572,0.16415,0.19622,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0038653,0.16379,0.18946,1,1
5,GO RRNA MODIFICATION,0.014457,0.16378,0.10921,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0044907,0.16333,0.18459,1,1
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.013834,0.16328,0.17542,1,1
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0015041,0.16313,0.22238,1,1
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.031957,0.16307,0.17491,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0012071,0.16288,0.23197,1,1
5,GO FAT CELL DIFFERENTIATION,0.0063209,0.16285,0.22829,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0047188,0.16281,0.21635,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.017954,0.1626,0.21403,1,1
5,GO RESPONSE TO STEROID HORMONE,0.008797,0.1624,0.19249,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0066311,0.16214,0.23866,1,1
5,GO TETRAPYRROLE METABOLIC PROCESS,0.0010209,0.16185,0.1846,1,1
5,GO VESICLE CARGO LOADING,0.0020776,0.16183,0.218,1,1
5,GO VITAMIN METABOLIC PROCESS,0.00068502,0.16167,0.19432,1,1
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0066311,0.16105,0.18208,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.040368,0.1609,0.17275,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0092139,0.16081,0.18728,1,1
5,GO RRNA METHYLATION,0.018736,0.16066,0.12592,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.021265,0.16048,0.16136,1,1
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.013235,0.16037,0.24801,1,1
5,GO ANION HOMEOSTASIS,0.007293,0.15981,0.21614,1,1
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0083971,0.15966,0.14141,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.011574,0.15918,0.24592,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.0016767,0.15916,0.2149,1,1
5,GO ACETYL COA METABOLIC PROCESS,0.0066311,0.15906,0.2224,1,1
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0034935,0.1589,0.18799,1,1
5,GO OSTEOBLAST DIFFERENTIATION,0.0066311,0.15886,0.216,1,1
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.033245,0.15862,0.20877,1,1
5,GO GASTRULATION,0.0025648,0.15835,0.25267,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.0092139,0.15815,0.18441,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0020776,0.15795,0.15008,1,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.019548,0.15793,0.20768,1,1
5,GO THIOESTER METABOLIC PROCESS,0.0031545,0.15781,0.17753,1,1
5,GO SECRETION,0.017954,0.1577,0.18287,1,1
5,GO PIGMENT GRANULE ORGANIZATION,0.0063209,0.15704,0.24563,1,1
5,GO ER NUCLEUS SIGNALING PATHWAY,0.0060238,0.15692,0.18863,1,1
5,GO REGULATION OF URINE VOLUME,0.043559,0.15686,0.2214,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.0027019,0.15674,0.1935,1,1
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0052065,0.15648,0.17559,1,1
5,GO TUBE DEVELOPMENT,0.008797,0.15635,0.23495,1,1
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.006955,0.15627,0.18452,1,1
5,GO EPITHELIAL CELL PROLIFERATION,0.013235,0.15601,0.21891,1,1
5,GO MYOFIBRIL ASSEMBLY,0.033245,0.15591,0.1967,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.037377,0.15575,0.15213,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0083971,0.15563,0.19534,1,1
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0003797,0.15563,0.19747,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.008797,0.1555,0.18283,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.035953,0.15548,0.16957,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.01266,0.15542,0.19521,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.015104,0.15537,0.16738,1,1
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0016767,0.15535,0.1761,1,1
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.007293,0.15516,0.19781,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0076456,0.15479,0.2041,1,1
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0047188,0.15478,0.22279,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.027226,0.15472,0.18459,1,1
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.027226,0.15447,0.19277,1,1
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.048745,0.15441,0.18731,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0076456,0.1544,0.22829,1,1
5,GO RESPONSE TO VITAMIN A,0.016475,0.15436,0.20083,1,1
5,GO REGULATION OF CELLULAR PH,0.045233,0.1543,0.13518,1,1
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.033245,0.15419,0.20225,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.046961,0.15405,0.15436,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0096484,0.15367,0.1583,1,1
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.021265,0.15362,0.19049,1,1
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0025648,0.15357,0.20571,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0029965,0.15355,0.32489,1,1
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00332,0.15352,0.24798,1,1
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.013235,0.15327,0.16213,1,1
5,GO ENDOCYTIC RECYCLING,0.040368,0.15298,0.19122,1,1
5,GO PROTEIN MATURATION,0.0036751,0.15277,0.1858,1,1
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00091199,0.15265,0.20515,1,1
5,GO DEFINITIVE HEMOPOIESIS,0.048745,0.15239,0.24557,1,1
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00014989,0.15189,0.22288,1,1
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042727,0.15188,0.16281,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.010101,0.15172,0.22018,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0049572,0.15168,0.15864,1,1
5,GO VACUOLAR ACIDIFICATION,0.008797,0.15157,0.18455,1,1
5,GO NADP METABOLIC PROCESS,0.0054671,0.15147,0.17645,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00072571,0.15131,0.23404,1,1
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0019699,0.15128,0.18083,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.011574,0.15093,0.14584,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.016475,0.1509,0.21852,1,1
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.010572,0.15083,0.22829,1,1
5,GO PROTEIN TARGETING TO LYSOSOME,0.043559,0.15083,0.19738,1,1
5,GO LIPID METABOLIC PROCESS,0.0017696,0.15052,0.18407,1,1
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0023095,0.15008,0.21126,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.038848,0.15008,0.12185,1,1
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0044907,0.14977,0.18174,1,1
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0076456,0.14947,0.18688,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0013481,0.14935,0.20507,1,1
5,GO VITAMIN TRANSPORT,0.0172,0.14924,0.18173,1,1
5,GO REGULATION OF CELL DEATH,0.00076864,0.14922,0.20551,1,1
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00086166,0.14915,0.22479,1,1
5,GO CELLULAR PIGMENTATION,0.0018673,0.14885,0.20609,1,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0038653,0.14874,0.19151,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.037377,0.1485,0.2502,1,1
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00031664,0.14841,0.19534,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.046961,0.14826,0.20587,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0096484,0.14821,0.18564,1,1
5,GO DNA MODIFICATION,0.024086,0.14818,0.1253,1,1
5,GO CARTILAGE DEVELOPMENT,0.012106,0.14805,0.23364,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.013235,0.1477,0.21353,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014457,0.14764,0.25094,1,1
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0029965,0.1474,0.18825,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00072571,0.14733,0.21653,1,1
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0015041,0.14723,0.21081,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036751,0.14706,0.20538,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.038848,0.14695,0.21341,1,1
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.011063,0.14695,0.1685,1,1
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.008797,0.14634,0.22185,1,1
5,GO CARDIAC SEPTUM DEVELOPMENT,0.016475,0.14623,0.23496,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.013834,0.14615,0.18958,1,1
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.011063,0.14611,0.29527,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0012071,0.14603,0.21441,1,1
5,GO RECEPTOR CATABOLIC PROCESS,0.0066311,0.146,0.23402,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.011574,0.14597,0.18723,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0023095,0.14596,0.19193,1,1
5,GO RNA MODIFICATION,0.019548,0.14591,0.12541,1,1
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.01266,0.14584,0.20583,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0096484,0.14584,0.17994,1,1
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0012071,0.14564,0.18079,1,1
5,GO SELECTIVE AUTOPHAGY,0.0036751,0.14563,0.20382,1,1
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00026348,0.14562,0.18536,1,1
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.030713,0.14558,0.27315,1,1
5,GO SEGMENTATION,0.031957,0.14556,0.17633,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0011418,0.14549,0.2083,1,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0172,0.14504,0.13216,1,1
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.02951,0.14504,0.17012,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0057394,0.14491,0.21564,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.013235,0.14479,0.20826,1,1
5,GO DIGESTIVE SYSTEM PROCESS,0.028348,0.14406,0.15965,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.019548,0.14379,0.19535,1,1
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0066311,0.14366,0.17211,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011063,0.14358,0.15593,1,1
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.022172,0.14353,0.10778,1,1
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.025096,0.14342,0.25172,1,1
5,GO VIRAL RELEASE FROM HOST CELL,0.0031545,0.14339,0.16447,1,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.025096,0.14303,0.12715,1,1
5,GO REGULATION OF TELOMERASE ACTIVITY,0.0083971,0.14296,0.13987,1,1
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.011574,0.14271,0.19248,1,1
5,GO COBALAMIN METABOLIC PROCESS,0.034576,0.14266,0.18308,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0052065,0.14218,0.21379,1,1
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.040368,0.14204,0.16592,1,1
5,GO POSITIVE REGULATION OF SIGNALING,0.013834,0.14201,0.18041,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0027019,0.14195,0.18993,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0083971,0.14134,0.19911,1,1
5,GO STEM CELL DIFFERENTIATION,0.0052065,0.14111,0.18429,1,1
5,GO GLYCOSIDE METABOLIC PROCESS,0.0019699,0.14098,0.1701,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.0096484,0.14077,0.17012,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.016475,0.1407,0.2332,1,1
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0049572,0.14046,0.19264,1,1
5,GO RESPONSE TO ALCOHOL,0.017954,0.14042,0.17713,1,1
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0003797,0.14002,0.22784,1,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.011063,0.13995,0.21001,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0060238,0.13979,0.25366,1,1
5,GO MUSCLE ADAPTATION,0.012106,0.1395,0.19949,1,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.026142,0.1392,0.17177,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0025648,0.13913,0.1967,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0172,0.13911,0.19735,1,1
5,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.018736,0.13898,0.15771,1,1
5,GO FIBROBLAST MIGRATION,0.013834,0.13881,0.22817,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0054671,0.13874,0.18107,1,1
5,GO FOLIC ACID METABOLIC PROCESS,0.028348,0.13856,0.14192,1,1
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0019699,0.13848,0.14746,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0080134,0.13847,0.17806,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.015776,0.13839,0.17303,1,1
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.011574,0.13807,0.15018,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0019699,0.13784,0.16521,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.00096503,0.13784,0.19468,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.037377,0.13772,0.16179,1,1
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0052065,0.13751,0.17123,1,1
5,GO POSITIVE REGULATION OF TRANSLATION,0.0015882,0.13733,0.16112,1,1
5,GO AUTOPHAGY OF NUCLEUS,0.015776,0.137,0.18741,1,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0057394,0.13672,0.23915,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.021265,0.13672,0.14487,1,1
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.011574,0.13607,0.21849,1,1
5,GO CELLULAR RESPONSE TO UV,0.0172,0.13604,0.15442,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0034935,0.13556,0.20269,1,1
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0019699,0.13545,0.18428,1,1
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.0021907,0.13544,0.16532,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.037377,0.13509,0.10834,1,1
5,GO SARCOMERE ORGANIZATION,0.02951,0.13464,0.16524,1,1
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.014457,0.13392,0.13849,1,1
5,GO CHEMICAL HOMEOSTASIS,0.038848,0.13388,0.15562,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.035953,0.13378,0.26345,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.030713,0.13377,0.15882,1,1
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0044907,0.13355,0.1469,1,1
5,GO URONIC ACID METABOLIC PROCESS,0.015776,0.13346,0.1284,1,1
5,GO KETONE BODY METABOLIC PROCESS,0.031957,0.13339,0.13375,1,1
5,GO NUCLEOTIDE SALVAGE,0.028348,0.13337,0.16606,1,1
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.034576,0.13322,0.19733,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.013235,0.13302,0.2011,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0014241,0.13284,0.18288,1,1
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0027019,0.13215,0.18676,1,1
5,GO RESPONSE TO WATER,0.025096,0.13209,0.19662,1,1
5,GO CELLULAR KETONE METABOLIC PROCESS,0.00051151,0.13208,0.1586,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.018736,0.13203,0.16092,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035953,0.13174,0.18259,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.0024341,0.13172,0.16635,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.011574,0.13153,0.14683,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.045233,0.13139,0.17609,1,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.034576,0.13134,0.15503,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.014457,0.13106,0.20508,1,1
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.013834,0.13099,0.21825,1,1
5,GO PROTEIN TETRAMERIZATION,0.0028457,0.13097,0.19154,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0083971,0.13076,0.17352,1,1
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.023112,0.13049,0.22544,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.011574,0.13049,0.18369,1,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0060238,0.13044,0.22239,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.038848,0.13035,0.1802,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.02951,0.1303,0.15894,1,1
5,GO COPII COATED VESICLE CARGO LOADING,0.016475,0.13026,0.19528,1,1
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.023112,0.13,0.20358,1,1
5,GO MICROVILLUS ORGANIZATION,0.02951,0.12989,0.15836,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0031545,0.12972,0.19795,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0047188,0.1296,0.18923,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0076456,0.12942,0.16644,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.0042727,0.12925,0.20131,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0019699,0.12923,0.20009,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,0.035953,0.12916,0.15457,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.037377,0.12862,0.18873,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0052065,0.12856,0.19057,1,1
5,GO HEART MORPHOGENESIS,0.038848,0.12853,0.20156,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.011063,0.12853,0.24525,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00068502,0.12849,0.17633,1,1
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0025648,0.12773,0.14313,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0031545,0.12769,0.1783,1,1
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.046961,0.12767,0.16728,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00096503,0.12761,0.20487,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.01266,0.12759,0.19971,1,1
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.015104,0.12735,0.16937,1,1
5,GO CELLULAR HOMEOSTASIS,0.023112,0.12728,0.14544,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.021265,0.12702,0.14542,1,1
5,GO RESPONSE TO HORMONE,0.015776,0.12641,0.17412,1,1
5,GO REGULATION OF GENE SILENCING,0.028348,0.12611,0.14444,1,1
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0092139,0.12591,0.12733,1,1
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0083971,0.12567,0.2293,1,1
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0013481,0.12551,0.16968,1,1
5,GO NEURAL TUBE FORMATION,0.048745,0.12439,0.17605,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.038848,0.12429,0.12196,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.008797,0.12409,0.20562,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.016475,0.12405,0.15846,1,1
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.008797,0.12375,0.18692,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.011574,0.12375,0.17767,1,1
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0010209,0.12333,0.17637,1,1
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.048745,0.12297,0.083935,1,1
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.01266,0.12284,0.18691,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.007293,0.12282,0.16464,1,1
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.018736,0.12213,0.13766,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.037377,0.12198,0.15158,1,1
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0034935,0.12154,0.14436,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.046961,0.12138,0.18507,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,0.041938,0.12124,0.15277,1,1
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.015776,0.12094,0.18431,1,1
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0028457,0.1209,0.18585,1,1
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00045436,0.1205,0.16858,1,1
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023095,0.12036,0.17098,1,1
5,GO GOLGI VESICLE BUDDING,0.01266,0.12002,0.16282,1,1
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0042727,0.11984,0.14498,1,1
5,GO CELLULAR RESPONSE TO RADIATION,0.025096,0.1198,0.13506,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02951,0.11977,0.15939,1,1
5,GO LIPID MODIFICATION,0.0172,0.11934,0.15865,1,1
5,GO NUCLEOSIDE METABOLIC PROCESS,0.0036751,0.11921,0.14129,1,1
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.021265,0.11918,0.11721,1,1
5,GO AUTOPHAGOSOME ORGANIZATION,0.0047188,0.11889,0.19645,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.010101,0.11863,0.18575,1,1
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.035953,0.1186,0.13782,1,1
5,GO REGULATION OF PROTEIN SUMOYLATION,0.045233,0.1185,0.16803,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.010572,0.11834,0.16449,1,1
5,GO APOPTOTIC PROCESS,0.0029965,0.11829,0.18324,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0038653,0.11827,0.20318,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0057394,0.11824,0.1937,1,1
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.016475,0.11726,0.1647,1,1
5,GO CELL RECOGNITION,0.037377,0.11695,0.16742,1,1
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0172,0.11691,0.16584,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.0066311,0.11654,0.14411,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,0.031957,0.1154,0.17684,1,1
5,GO SPERM EGG RECOGNITION,0.020391,0.11519,0.13339,1,1
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0066311,0.11507,0.21155,1,1
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.027226,0.11479,0.16674,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.034576,0.11471,0.1194,1,1
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0040644,0.11471,0.18363,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.027226,0.11454,0.18627,1,1
5,GO IRON ION TRANSPORT,0.0076456,0.1144,0.18837,1,1
5,GO MULTI ORGANISM LOCALIZATION,0.011063,0.11427,0.1311,1,1
5,GO GOLGI TO ENDOSOME TRANSPORT,0.023112,0.11394,0.19635,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0044907,0.1139,0.17118,1,1
5,GO HOMEOSTATIC PROCESS,0.013235,0.11363,0.16587,1,1
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0027019,0.11361,0.15702,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.046961,0.11321,0.17066,1,1
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.015104,0.11307,0.12332,1,1
5,GO HORMONE METABOLIC PROCESS,0.037377,0.1129,0.14501,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.028348,0.11255,0.17128,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.023112,0.11157,0.16699,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.037377,0.11137,0.19991,1,1
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.023112,0.1112,0.15535,1,1
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.02951,0.1111,0.14451,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.015104,0.11097,0.18794,1,1
5,GO REGULATION OF ORGAN GROWTH,0.0057394,0.11058,0.20979,1,1
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.038848,0.11005,0.11271,1,1
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.045233,0.10988,0.1897,1,1
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.015776,0.10981,0.15312,1,1
5,GO PROTEIN IMPORT,0.034576,0.10978,0.13119,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.020391,0.10941,0.21277,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.035953,0.10935,0.15473,1,1
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.038848,0.10824,0.11481,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.023112,0.10813,0.14475,1,1
5,GO RESPONSE TO PEPTIDE,0.034576,0.10793,0.15824,1,1
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.019548,0.10764,0.12921,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.048745,0.10668,0.19999,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.021265,0.10661,0.16674,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.006955,0.10656,0.18645,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.013235,0.10642,0.17467,1,1
5,GO NUCLEOBASE METABOLIC PROCESS,0.018736,0.10627,0.11797,1,1
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0063209,0.1061,0.15483,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.041938,0.10564,0.15217,1,1
5,GO ORGANIC ACID METABOLIC PROCESS,0.0052065,0.10531,0.14871,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.038848,0.10531,0.20657,1,1
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0021907,0.10472,0.14371,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.021265,0.10452,0.16704,1,1
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.034576,0.10437,0.13233,1,1
5,GO TUBE FORMATION,0.035953,0.10427,0.1741,1,1
5,GO MALE SEX DIFFERENTIATION,0.038848,0.10397,0.16954,1,1
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.014457,0.10393,0.12349,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.0025648,0.10376,0.16865,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.027226,0.10341,0.15898,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0066311,0.10247,0.15251,1,1
5,GO COPII COATED VESICLE BUDDING,0.012106,0.1023,0.16002,1,1
5,GO PROTEOLYSIS,0.0060238,0.10184,0.16809,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.019548,0.10082,0.16845,1,1
5,GO AGING,0.0096484,0.10045,0.17523,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.043559,0.10044,0.15781,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.033245,0.10016,0.13428,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.030713,0.098971,0.15352,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.024086,0.098637,0.16043,1,1
5,GO MOLTING CYCLE,0.048745,0.098031,0.17849,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.016475,0.097685,0.16406,1,1
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.038848,0.097663,0.12597,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.035953,0.09715,0.15904,1,1
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.013235,0.097036,0.15075,1,1
5,GO RNA CATABOLIC PROCESS,0.020391,0.096524,0.079588,1,1
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.031957,0.09637,0.13196,1,1
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.038848,0.096062,0.20523,1,1
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.010101,0.095865,0.091395,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.026142,0.095815,0.17203,1,1
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.024086,0.095469,0.12963,1,1
5,GO PROTEIN DESTABILIZATION,0.0172,0.094451,0.16473,1,1
5,GO TISSUE MORPHOGENESIS,0.024086,0.094081,0.17668,1,1
5,GO CELLULAR RESPONSE TO DRUG,0.027226,0.092781,0.15258,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.020391,0.092777,0.16599,1,1
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.020391,0.092265,0.13,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.033245,0.092142,0.12828,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.037377,0.091883,0.1544,1,1
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.040368,0.091417,0.10238,1,1
5,GO VIRION ASSEMBLY,0.015104,0.09134,0.11468,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.037377,0.091116,0.12009,1,1
5,GO THYMUS DEVELOPMENT,0.017954,0.090892,0.15814,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.016475,0.090703,0.16839,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.019548,0.089789,0.13735,1,1
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.014457,0.089033,0.14003,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.030713,0.088968,0.16256,1,1
5,GO HORMONE BIOSYNTHETIC PROCESS,0.024086,0.088537,0.13527,1,1
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.020391,0.088152,0.15193,1,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.014457,0.087931,0.13447,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.030713,0.087546,0.1928,1,1
5,GO RESPONSE TO DRUG,0.028348,0.087432,0.15461,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.027226,0.08741,0.13092,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.010572,0.085219,0.1509,1,1
5,GO REGULATION OF CATABOLIC PROCESS,0.017954,0.084932,0.14509,1,1
5,GO REGULATION OF VACUOLE ORGANIZATION,0.0038653,0.084817,0.18151,1,1
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.041938,0.084006,0.12084,1,1
5,GO OXIDATION REDUCTION PROCESS,0.008797,0.08107,0.11821,1,1
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.013235,0.080952,0.087553,1,1
5,GO VACUOLE ORGANIZATION,0.016475,0.080916,0.16604,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.021265,0.080567,0.12787,1,1
5,GO PEROXISOME ORGANIZATION,0.020391,0.079527,0.10599,1,1
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.026142,0.07932,0.13773,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0172,0.078516,0.143,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.045233,0.077561,0.172,1,1
5,GO ENDOSOME ORGANIZATION,0.033245,0.077163,0.13521,1,1
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.031957,0.076016,0.15982,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.033245,0.074572,0.14618,1,1
5,GO MACROMOLECULE CATABOLIC PROCESS,0.041938,0.073332,0.11576,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY,0.048745,0.072151,0.11048,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.033245,0.071672,0.14423,1,1
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0172,0.070498,0.16254,1,1
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.030713,0.069177,0.11954,1,1
5,GO PIGMENT METABOLIC PROCESS,0.046961,0.068242,0.10938,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.046961,0.066016,0.14775,1,1
5,GO PEPTIDE METABOLIC PROCESS,0.045233,0.06307,0.069228,1,1
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.017954,0.062496,0.086708,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.037377,0.04782,0.12539,1,1
6,GO NATURAL KILLER CELL CHEMOTAXIS,0.00086166,1.1928,0.95197,1,1
6,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.0017696,0.93552,0.80544,1,1
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0011418,0.93216,0.9212,1,1
6,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00054254,0.91742,0.92058,1,1
6,GO T CELL TOLERANCE INDUCTION,0.0028457,0.85507,0.72141,1,1
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00054254,0.83541,0.79509,1,1
6,GO EOSINOPHIL MIGRATION,0.00026348,0.83429,0.73977,1,1
6,GO TOLERANCE INDUCTION,0.0014241,0.81154,0.75442,1,1
6,GO REGULATION OF TOLERANCE INDUCTION,0.0014241,0.80737,0.74338,1,1
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0019699,0.79525,0.7033,1,1
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,8.9327e-05,0.79175,0.7796,1,1
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00045436,0.76134,0.79569,1,1
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0010209,0.74979,0.7088,1,1
6,GO LYMPHOCYTE CHEMOTAXIS,0.0011418,0.74852,0.6213,1,1
6,GO CHRONIC INFLAMMATORY RESPONSE,0.0019699,0.74687,0.6721,1,1
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00068502,0.72649,0.75018,1,1
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00035748,0.72267,0.67419,1,1
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00015974,0.69823,0.72311,1,1
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.4947e-05,0.69313,0.73708,1,1
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00023283,0.6923,0.64299,1,1
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0017696,0.69056,0.59799,1,1
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0010209,0.68945,0.63681,1,1
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00033648,0.68923,0.68657,1,1
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020554,0.68655,0.62972,1,1
6,GO MONOCYTE CHEMOTAXIS,0.00081392,0.68296,0.61321,1,1
6,GO CYTOLYSIS,0.0015041,0.68099,0.62353,1,1
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00091199,0.67066,0.5656,1,1
6,GO OPSONIZATION,0.0023095,0.67009,0.49287,1,1
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00031664,0.66251,0.61201,1,1
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0019699,0.66062,0.61891,1,1
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00060992,0.65572,0.59886,1,1
6,GO NEUTROPHIL CHEMOTAXIS,0.00081392,0.65519,0.55555,1,1
6,GO INTERLEUKIN 10 PRODUCTION,0.00086166,0.64899,0.55994,1,1
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00332,0.64854,0.5396,1,1
6,GO DENDRITIC CELL CHEMOTAXIS,0.0010209,0.64849,0.65556,1,1
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00020554,0.64752,0.6259,1,1
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0025648,0.64361,0.63696,1,1
6,GO CELLULAR DEFENSE RESPONSE,0.00051151,0.64349,0.62444,1,1
6,GO NEUTROPHIL MIGRATION,0.00091199,0.63646,0.53397,1,1
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00020554,0.63587,0.64594,1,1
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0040644,0.63323,0.60973,1,1
6,GO ADHESION OF SYMBIONT TO HOST,0.0015882,0.6221,0.60019,1,1
6,GO DENDRITIC CELL MIGRATION,0.00091199,0.61191,0.62269,1,1
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00048214,0.61174,0.54283,1,1
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0011418,0.6112,0.59546,1,1
6,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00051151,0.60904,0.5801,1,1
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00042807,0.60836,0.53132,1,1
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0013481,0.59287,0.55213,1,1
6,GO PLASMINOGEN ACTIVATION,0.00026348,0.59221,0.51744,1,1
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0010209,0.59126,0.58065,1,1
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00031664,0.59071,0.53659,1,1
6,GO LYMPHOCYTE MIGRATION,0.0010209,0.59008,0.54757,1,1
6,GO REGULATION OF T CELL CHEMOTAXIS,0.00076864,0.59008,0.58142,1,1
6,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0012758,0.58851,0.53342,1,1
6,GO RESPONSE TO CHEMOKINE,0.0021907,0.58701,0.52736,1,1
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00048214,0.58697,0.53829,1,1
6,GO CYCLOOXYGENASE PATHWAY,0.00026348,0.58601,0.60198,1,1
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00040321,0.58472,0.60245,1,1
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00086166,0.58317,0.58943,1,1
6,GO INTERLEUKIN 12 PRODUCTION,0.00072571,0.58264,0.56744,1,1
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.00048214,0.58207,0.54711,1,1
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00026348,0.57952,0.56116,1,1
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00035748,0.57852,0.53969,1,1
6,GO MONONUCLEAR CELL MIGRATION,0.00096503,0.5744,0.5382,1,1
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00054254,0.57408,0.5391,1,1
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00064645,0.57239,0.49395,1,1
6,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00040321,0.57116,0.58353,1,1
6,GO GRANULOCYTE MIGRATION,0.00060992,0.56816,0.51555,1,1
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0029965,0.56524,0.48254,1,1
6,GO GRANULOCYTE CHEMOTAXIS,0.00081392,0.5648,0.52692,1,1
6,GO REGULATION OF MYOBLAST FUSION,0.00048214,0.56397,0.54736,1,1
6,GO NK T CELL DIFFERENTIATION,0.0011418,0.56371,0.52046,1,1
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0018673,0.56307,0.51939,1,1
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00072571,0.56008,0.51803,1,1
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0024341,0.55634,0.46234,1,1
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.9985e-05,0.55629,0.55928,1,1
6,GO T CELL MIGRATION,0.00091199,0.5525,0.57338,1,1
6,GO FIBRINOLYSIS,0.00051151,0.55065,0.49333,1,1
6,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00011593,0.54997,0.62158,1,1
6,GO RESPONSE TO INTERLEUKIN 15,0.0010798,0.54315,0.58213,1,1
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00045436,0.54306,0.47062,1,1
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00051151,0.54293,0.56016,1,1
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00072571,0.54269,0.51719,1,1
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0027019,0.54189,0.48288,1,1
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0016767,0.53366,0.53717,1,1
6,GO REGULATION OF B CELL PROLIFERATION,0.00086166,0.53326,0.54982,1,1
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00064645,0.53268,0.50435,1,1
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00068502,0.53129,0.54055,1,1
6,GO T CELL CYTOKINE PRODUCTION,0.0015041,0.53013,0.47667,1,1
6,GO REGULATION OF PLATELET ACTIVATION,0.00019306,0.52938,0.53396,1,1
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00096503,0.52785,0.55301,1,1
6,GO CELL ADHESION MEDIATED BY INTEGRIN,8.9327e-05,0.52754,0.56491,1,1
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0023095,0.526,0.5229,1,1
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00040321,0.52567,0.51493,1,1
6,GO POSITIVE REGULATION OF CELL KILLING,0.0010798,0.52378,0.50131,1,1
6,GO GLYCINE TRANSPORT,0.0047188,0.52275,0.38788,1,1
6,GO NAD BIOSYNTHETIC PROCESS,0.00035748,0.52233,0.42167,1,1
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0034935,0.51537,0.50386,1,1
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00026348,0.51165,0.51258,1,1
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00096503,0.50978,0.58763,1,1
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0015882,0.50886,0.4951,1,1
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00024771,0.50885,0.50852,1,1
6,GO RESPIRATORY BURST,0.00086166,0.50863,0.48826,1,1
6,GO MAST CELL ACTIVATION,0.00057531,0.50554,0.44107,1,1
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00057531,0.50425,0.51382,1,1
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0012758,0.50143,0.48515,1,1
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,6.8565e-05,0.50121,0.56666,1,1
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0020776,0.50101,0.41785,1,1
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0013481,0.49909,0.49409,1,1
6,GO REGULATION OF T CELL MIGRATION,0.00031664,0.49795,0.50873,1,1
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00081392,0.49159,0.46977,1,1
6,GO B CELL PROLIFERATION,0.00072571,0.49016,0.56532,1,1
6,GO HISTAMINE SECRETION,0.00057531,0.48776,0.44018,1,1
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00081392,0.48726,0.50247,1,1
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00021879,0.48666,0.56876,1,1
6,GO MATURE B CELL DIFFERENTIATION,0.0012071,0.48559,0.53757,1,1
6,GO MYELOID LEUKOCYTE MIGRATION,0.00051151,0.48449,0.46996,1,1
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00086166,0.48357,0.49245,1,1
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00076864,0.48333,0.48532,1,1
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0010798,0.48314,0.46835,1,1
6,GO VASCULAR WOUND HEALING,0.00018128,0.48203,0.44515,1,1
6,GO DEFENSE RESPONSE TO FUNGUS,0.00017019,0.4811,0.45634,1,1
6,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0010209,0.47913,0.54662,1,1
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0023095,0.47835,0.49374,1,1
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0023095,0.47094,0.41898,1,1
6,GO MAST CELL MEDIATED IMMUNITY,0.00081392,0.47046,0.43254,1,1
6,GO T CELL LINEAGE COMMITMENT,0.0012758,0.46922,0.43303,1,1
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0021907,0.46843,0.44179,1,1
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00072571,0.46801,0.43075,1,1
6,GO LEUKOCYTE TETHERING OR ROLLING,0.0003797,0.46704,0.51061,1,1
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00076864,0.4661,0.44394,1,1
6,GO HUMORAL IMMUNE RESPONSE,0.00042807,0.46598,0.49301,1,1
6,GO LEUKOCYTE CHEMOTAXIS,0.00054254,0.46592,0.48296,1,1
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00010866,0.46491,0.4882,1,1
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00068502,0.4644,0.44717,1,1
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0019699,0.46425,0.46258,1,1
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0038653,0.46356,0.37801,1,1
6,GO RESPONSE TO FUNGUS,0.00012367,0.45682,0.44236,1,1
6,GO LYMPH NODE DEVELOPMENT,0.0010798,0.45606,0.46073,1,1
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00064645,0.45338,0.5656,1,1
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0017696,0.45321,0.37741,1,1
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0012758,0.45255,0.41625,1,1
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00045436,0.45165,0.51423,1,1
6,GO INTERLEUKIN 8 PRODUCTION,0.0010798,0.4512,0.43914,1,1
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00076864,0.45119,0.45219,1,1
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00068502,0.44763,0.4261,1,1
6,GO NEGATIVE REGULATION OF COAGULATION,0.00040321,0.44709,0.42212,1,1
6,GO INTEGRIN ACTIVATION,0.0010798,0.44676,0.51254,1,1
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.011063,0.44424,0.40161,1,1
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012758,0.44187,0.42343,1,1
6,GO REGULATION OF MAST CELL ACTIVATION,0.0015882,0.44178,0.40301,1,1
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00054254,0.43834,0.45408,1,1
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00020554,0.43805,0.46196,1,1
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00064645,0.43715,0.48579,1,1
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00054254,0.43684,0.50987,1,1
6,GO ELASTIC FIBER ASSEMBLY,0.011574,0.43651,0.45987,1,1
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0020776,0.4332,0.42028,1,1
6,GO CYTIDINE TO URIDINE EDITING,0.0096484,0.43144,0.35901,1,1
6,GO ACUTE INFLAMMATORY RESPONSE,0.00051151,0.42941,0.42124,1,1
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00091199,0.42807,0.4526,1,1
6,GO BLEB ASSEMBLY,0.0047188,0.42641,0.37874,1,1
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0016767,0.42184,0.42527,1,1
6,GO REGULATION OF COAGULATION,0.00021879,0.42044,0.40984,1,1
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00091199,0.41745,0.43115,1,1
6,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00054254,0.41649,0.41919,1,1
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00064645,0.41646,0.40349,1,1
6,GO NEGATIVE REGULATION OF ANOIKIS,0.0018673,0.41619,0.39835,1,1
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0040644,0.41472,0.4135,1,1
6,GO REGULATION OF PLATELET AGGREGATION,0.00031664,0.4127,0.43089,1,1
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00068502,0.41236,0.4343,1,1
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00057531,0.41041,0.39984,1,1
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00011593,0.41023,0.46433,1,1
6,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00045436,0.40807,0.42734,1,1
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,6.4139e-05,0.40797,0.42383,1,1
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0014241,0.40777,0.37662,1,1
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00054254,0.40769,0.42105,1,1
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0010798,0.40716,0.43949,1,1
6,GO CELL CHEMOTAXIS,0.00035748,0.40555,0.44224,1,1
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.022172,0.4023,0.26035,1,1
6,GO DEFENSE RESPONSE TO BACTERIUM,0.0003797,0.40198,0.40356,1,1
6,GO ACUTE PHASE RESPONSE,0.0011418,0.40154,0.4095,1,1
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0028457,0.40089,0.4318,1,1
6,GO ZYMOGEN INHIBITION,0.00068502,0.39954,0.44619,1,1
6,GO PROTEIN ACTIVATION CASCADE,0.0016767,0.39885,0.43765,1,1
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00035748,0.39711,0.42394,1,1
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00091199,0.39701,0.38076,1,1
6,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00033648,0.39667,0.41942,1,1
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00048214,0.39356,0.36253,1,1
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00072571,0.39343,0.36384,1,1
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0010798,0.39323,0.37689,1,1
6,GO LIVER MORPHOGENESIS,0.0011418,0.39064,0.35624,1,1
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0016767,0.38737,0.45028,1,1
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00028019,0.38723,0.38214,1,1
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0015882,0.3868,0.42512,1,1
6,GO HISTAMINE TRANSPORT,0.00076864,0.38275,0.40466,1,1
6,GO INTESTINAL ABSORPTION,0.00035748,0.38236,0.4161,1,1
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00081392,0.38159,0.45916,1,1
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00057531,0.37963,0.35057,1,1
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0015041,0.37946,0.39222,1,1
6,GO PLATELET DEGRANULATION,0.00010866,0.37808,0.41347,1,1
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.033245,0.37773,0.33723,1,1
6,GO REGULATION OF INTEGRIN ACTIVATION,0.0012758,0.3763,0.43271,1,1
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00072571,0.37403,0.41778,1,1
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0023095,0.37038,0.38773,1,1
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0021907,0.37016,0.37156,1,1
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.00021879,0.36934,0.35272,1,1
6,GO KERATAN SULFATE CATABOLIC PROCESS,0.0011418,0.36927,0.49087,1,1
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0083971,0.36802,0.30392,1,1
6,GO REGULATION OF STEM CELL DIVISION,0.0038653,0.36707,0.36633,1,1
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0011418,0.3664,0.38523,1,1
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00057531,0.36611,0.34737,1,1
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00060992,0.36059,0.37621,1,1
6,GO REGULATION OF BONE DEVELOPMENT,0.00054254,0.36055,0.45355,1,1
6,GO REGULATION OF BONE REMODELING,0.0003797,0.35694,0.39305,1,1
6,GO HETEROTYPIC CELL CELL ADHESION,0.00042807,0.35568,0.39438,1,1
6,GO REGULATION OF TISSUE REMODELING,0.00040321,0.35478,0.38245,1,1
6,GO RESPONSE TO INTERLEUKIN 6,0.00072571,0.35444,0.40678,1,1
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0023095,0.35389,0.36691,1,1
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0010798,0.35165,0.34103,1,1
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0010798,0.3503,0.35853,1,1
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0031545,0.34964,0.3496,1,1
6,GO RESPONSE TO THYROID HORMONE,0.00029789,0.34949,0.33665,1,1
6,GO REGULATION OF WOUND HEALING,0.00051151,0.34947,0.3282,1,1
6,GO VITAMIN BIOSYNTHETIC PROCESS,0.00023283,0.34899,0.41251,1,1
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0012758,0.34868,0.40958,1,1
6,GO POSITIVE REGULATION OF WOUND HEALING,0.00035748,0.34723,0.34276,1,1
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0080134,0.34584,0.34255,1,1
6,GO MYELOID LEUKOCYTE ACTIVATION,0.00064645,0.34577,0.37571,1,1
6,GO LIPOXYGENASE PATHWAY,0.0027019,0.34471,0.37913,1,1
6,GO CHOLESTEROL STORAGE,0.0027019,0.34403,0.34966,1,1
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0057394,0.3435,0.32547,1,1
6,GO IMMUNOLOGICAL MEMORY PROCESS,0.0015882,0.34296,0.34968,1,1
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0018673,0.34283,0.35657,1,1
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0019699,0.34249,0.3451,1,1
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00035748,0.34215,0.40941,1,1
6,GO PLATELET ACTIVATION,0.0016767,0.34213,0.32767,1,1
6,GO PROSTANOID METABOLIC PROCESS,0.0017696,0.34095,0.29646,1,1
6,GO NEGATIVE REGULATION OF WOUND HEALING,0.0020776,0.34074,0.31357,1,1
6,GO REGULATION OF INFLAMMATORY RESPONSE,0.00076864,0.34024,0.37557,1,1
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0016767,0.33985,0.36049,1,1
6,GO STEROID CATABOLIC PROCESS,0.00021879,0.33971,0.35696,1,1
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0034935,0.33719,0.346,1,1
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00035748,0.33697,0.35145,1,1
6,GO POSITIVE REGULATION OF COAGULATION,0.00048214,0.33667,0.36196,1,1
6,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0020776,0.33647,0.36874,1,1
6,GO TRABECULA FORMATION,0.0047188,0.33407,0.30459,1,1
6,GO RELAXATION OF CARDIAC MUSCLE,0.0013481,0.33388,0.32531,1,1
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00081392,0.33367,0.35345,1,1
6,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0010209,0.33353,0.32798,1,1
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.011574,0.33254,0.32776,1,1
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0054671,0.33103,0.32753,1,1
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00023283,0.33079,0.35718,1,1
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0018673,0.32897,0.32086,1,1
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0024341,0.32867,0.32996,1,1
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0010209,0.32846,0.33934,1,1
6,GO GLYCOLIPID CATABOLIC PROCESS,0.00060992,0.32817,0.39566,1,1
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0031545,0.3277,0.3683,1,1
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00068502,0.32493,0.28251,1,1
6,GO LUTEINIZATION,0.0060238,0.32459,0.30865,1,1
6,GO PLATELET AGGREGATION,0.0015882,0.32413,0.34168,1,1
6,GO BLOOD VESSEL REMODELING,0.0031545,0.32385,0.35034,1,1
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00054254,0.32352,0.34731,1,1
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0020776,0.32346,0.3272,1,1
6,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00015974,0.32218,0.35133,1,1
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.019548,0.32208,0.28853,1,1
6,GO B CELL HOMEOSTASIS,0.0034935,0.32183,0.33392,1,1
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.017954,0.32134,0.31905,1,1
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.006955,0.32127,0.39407,1,1
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00029789,0.31788,0.30735,1,1
6,GO HYALURONAN CATABOLIC PROCESS,0.00096503,0.31753,0.33528,1,1
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0027019,0.3172,0.29857,1,1
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.046961,0.3172,0.27929,1,1
6,GO HOMOTYPIC CELL CELL ADHESION,0.00081392,0.31697,0.33444,1,1
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00060992,0.3163,0.39486,1,1
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00086166,0.31609,0.33645,1,1
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00048214,0.31576,0.36584,1,1
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0013481,0.3157,0.27595,1,1
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00072571,0.31547,0.39829,1,1
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00081392,0.31468,0.36583,1,1
6,GO PHAGOLYSOSOME ASSEMBLY,0.00031664,0.31309,0.35762,1,1
6,GO REGULATION OF RESPIRATORY BURST,0.00057531,0.31255,0.33107,1,1
6,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0042727,0.31153,0.31102,1,1
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0042727,0.30986,0.31699,1,1
6,GO POSITIVE REGULATION OF BONE RESORPTION,0.0016767,0.30939,0.32283,1,1
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00026348,0.30919,0.37099,1,1
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0003797,0.30889,0.30473,1,1
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0012071,0.3086,0.4175,1,1
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0028457,0.30675,0.29408,1,1
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.0066311,0.30611,0.31921,1,1
6,GO MYOBLAST FUSION,0.0011418,0.30534,0.37935,1,1
6,GO MAST CELL MIGRATION,0.0012071,0.3044,0.3399,1,1
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00057531,0.30416,0.37057,1,1
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00072571,0.3041,0.35082,1,1
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0023095,0.30409,0.33211,1,1
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00096503,0.30316,0.32309,1,1
6,GO DNA DEAMINATION,0.015776,0.30316,0.23924,1,1
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0036751,0.30285,0.30968,1,1
6,GO LYSOSOME LOCALIZATION,0.0031545,0.30202,0.26894,1,1
6,GO GALACTOSE METABOLIC PROCESS,0.00029789,0.30155,0.39901,1,1
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0017696,0.30153,0.38468,1,1
6,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0021907,0.30144,0.38839,1,1
6,GO ADRENAL GLAND DEVELOPMENT,0.0052065,0.30043,0.32808,1,1
6,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0003797,0.29905,0.34311,1,1
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0010798,0.29888,0.29893,1,1
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0042727,0.2988,0.36722,1,1
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00035748,0.29849,0.4328,1,1
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0172,0.29835,0.29126,1,1
6,GO CELL ADHESION MOLECULE PRODUCTION,0.010572,0.29624,0.32009,1,1
6,GO BONE RESORPTION,0.00060992,0.29613,0.37516,1,1
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0049572,0.29441,0.25341,1,1
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0042727,0.29402,0.26897,1,1
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.023112,0.29349,0.27003,1,1
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0015882,0.29268,0.3377,1,1
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00060992,0.29241,0.3069,1,1
6,GO COPPER ION TRANSPORT,0.00011593,0.29238,0.35765,1,1
6,GO INTESTINAL LIPID ABSORPTION,0.008797,0.29235,0.29509,1,1
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00023283,0.29173,0.33953,1,1
6,GO REGULATION OF VASCULOGENESIS,0.008797,0.29156,0.27608,1,1
6,GO STORE OPERATED CALCIUM ENTRY,0.01266,0.29113,0.26493,1,1
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.0010209,0.29081,0.35006,1,1
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0016767,0.29072,0.36358,1,1
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.006955,0.2906,0.24409,1,1
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00064645,0.2898,0.32443,1,1
6,GO REGULATION OF LIPASE ACTIVITY,0.0060238,0.28958,0.24489,1,1
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.023112,0.28844,0.30361,1,1
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0025648,0.28841,0.25576,1,1
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00072571,0.28827,0.28256,1,1
6,GO COLLAGEN BIOSYNTHETIC PROCESS,0.01266,0.28687,0.34105,1,1
6,GO TISSUE REMODELING,0.00072571,0.28674,0.36478,1,1
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0016767,0.28673,0.33421,1,1
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0029965,0.28658,0.30446,1,1
6,GO OSTEOBLAST PROLIFERATION,0.00091199,0.28583,0.33874,1,1
6,GO FATTY ACID DERIVATIVE TRANSPORT,0.00091199,0.28496,0.31066,1,1
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.007293,0.28433,0.26475,1,1
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.008797,0.28409,0.30029,1,1
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.00068502,0.2839,0.32991,1,1
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0042727,0.28214,0.30431,1,1
6,GO PROSTAGLANDIN SECRETION,0.0013481,0.28171,0.35268,1,1
6,GO TONIC SMOOTH MUSCLE CONTRACTION,0.027226,0.28069,0.23098,1,1
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0036751,0.28036,0.3184,1,1
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.037377,0.27965,0.25847,1,1
6,GO REGULATION OF ANOIKIS,0.0044907,0.27869,0.31164,1,1
6,GO RESPONSE TO MAGNESIUM ION,0.00332,0.27849,0.33909,1,1
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0014241,0.27828,0.28383,1,1
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.024086,0.278,0.24328,1,1
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0044907,0.2777,0.31411,1,1
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00031664,0.2775,0.31385,1,1
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00064645,0.27678,0.3167,1,1
6,GO P38MAPK CASCADE,0.0057394,0.27621,0.28447,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0020776,0.27607,0.24769,1,1
6,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00091199,0.27604,0.3683,1,1
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0066311,0.27168,0.24923,1,1
6,GO HEPATOCYTE APOPTOTIC PROCESS,0.0011418,0.27153,0.26729,1,1
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00045436,0.27125,0.32906,1,1
6,GO PHOSPHATE ION TRANSPORT,0.0024341,0.27055,0.28829,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0047188,0.27022,0.29585,1,1
6,GO REGULATION OF RESPONSE TO WOUNDING,0.0016767,0.26982,0.27361,1,1
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0060238,0.26971,0.26154,1,1
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00332,0.26953,0.32443,1,1
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0054671,0.26946,0.31391,1,1
6,GO SIGNAL PEPTIDE PROCESSING,0.00035748,0.26781,0.31018,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.010572,0.26776,0.31836,1,1
6,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0017696,0.2671,0.29656,1,1
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.015104,0.26639,0.22643,1,1
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0052065,0.26608,0.31202,1,1
6,GO HORMONE CATABOLIC PROCESS,0.0052065,0.26604,0.23891,1,1
6,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0040644,0.2643,0.28394,1,1
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.010101,0.26427,0.25624,1,1
6,GO PEPTIDYL PROLINE HYDROXYLATION,0.0054671,0.26364,0.2901,1,1
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0036751,0.26357,0.24814,1,1
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0057394,0.26351,0.3221,1,1
6,GO PULMONARY VALVE DEVELOPMENT,0.031957,0.26059,0.24456,1,1
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0066311,0.26017,0.30923,1,1
6,GO PYROPTOSIS,0.011574,0.25997,0.28281,1,1
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0031545,0.25945,0.27748,1,1
6,GO REGULATION OF CELL ADHESION,0.0012071,0.2594,0.32786,1,1
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00060992,0.25909,0.32049,1,1
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0019699,0.25883,0.32093,1,1
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0049572,0.25877,0.24679,1,1
6,GO TRABECULA MORPHOGENESIS,0.019548,0.2586,0.24696,1,1
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0092139,0.25847,0.26887,1,1
6,GO PROTEIN HYDROXYLATION,0.0044907,0.25815,0.27325,1,1
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.011574,0.25797,0.2889,1,1
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0024341,0.25742,0.28402,1,1
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.016475,0.25629,0.2773,1,1
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.011063,0.25577,0.27686,1,1
6,GO CELLULAR RESPONSE TO DSRNA,0.0052065,0.25557,0.27524,1,1
6,GO RESPONSE TO ANGIOTENSIN,0.0042727,0.25482,0.27033,1,1
6,GO REGULATION OF METANEPHROS DEVELOPMENT,0.022172,0.2543,0.27447,1,1
6,GO COLLAGEN FIBRIL ORGANIZATION,0.016475,0.25423,0.39354,1,1
6,GO PROTEIN DEGLYCOSYLATION,0.007293,0.25405,0.26714,1,1
6,GO TRIGLYCERIDE CATABOLIC PROCESS,0.01266,0.25153,0.20371,1,1
6,GO ARACHIDONIC ACID SECRETION,0.0012071,0.25101,0.26807,1,1
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0076456,0.25095,0.24189,1,1
6,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0016767,0.25029,0.26572,1,1
6,GO CELL REDOX HOMEOSTASIS,0.00021879,0.24895,0.27718,1,1
6,GO HEART INDUCTION,0.02951,0.24846,0.24771,1,1
6,GO RESPONSE TO IRON ION,0.0044907,0.24801,0.23138,1,1
6,GO SEMI LUNAR VALVE DEVELOPMENT,0.028348,0.24695,0.26356,1,1
6,GO STEROID HORMONE SECRETION,0.027226,0.24663,0.1954,1,1
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00048214,0.24644,0.32381,1,1
6,GO RESPONSE TO DIETARY EXCESS,0.0042727,0.24643,0.24183,1,1
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0012758,0.24624,0.26654,1,1
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014241,0.24495,0.27534,1,1
6,GO AMINE BIOSYNTHETIC PROCESS,0.00033648,0.24469,0.27995,1,1
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0054671,0.24419,0.28913,1,1
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0044907,0.24375,0.23223,1,1
6,GO BONE TRABECULA MORPHOGENESIS,0.034576,0.24272,0.33094,1,1
6,GO CELL CELL RECOGNITION,0.00031664,0.24257,0.25295,1,1
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0012758,0.24189,0.24264,1,1
6,GO KERATAN SULFATE METABOLIC PROCESS,0.0038653,0.2418,0.30337,1,1
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.01266,0.24148,0.24222,1,1
6,GO ANDROGEN METABOLIC PROCESS,0.0066311,0.24082,0.21411,1,1
6,GO RESPONSE TO MANGANESE ION,0.0017696,0.24046,0.26166,1,1
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0023095,0.24018,0.29439,1,1
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.015776,0.24005,0.34745,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00018128,0.23906,0.29082,1,1
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0063209,0.23886,0.27274,1,1
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.010101,0.23861,0.24339,1,1
6,GO MYELIN MAINTENANCE,0.0060238,0.23839,0.28673,1,1
6,GO ENDOTHELIAL CELL MIGRATION,0.0083971,0.23838,0.24349,1,1
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0054671,0.23827,0.24517,1,1
6,GO PANCREATIC JUICE SECRETION,0.0092139,0.23804,0.2422,1,1
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0057394,0.23801,0.23216,1,1
6,GO SEQUESTERING OF CALCIUM ION,0.0011418,0.23786,0.29915,1,1
6,GO REGULATION OF BONE MINERALIZATION,0.0047188,0.2375,0.29065,1,1
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0021907,0.23702,0.27564,1,1
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0010798,0.2366,0.33324,1,1
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0080134,0.23607,0.24683,1,1
6,GO RESPONSE TO LITHIUM ION,0.00081392,0.23584,0.27057,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0092139,0.23502,0.24886,1,1
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0066311,0.23437,0.20672,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049572,0.23409,0.23974,1,1
6,GO CELL MATRIX ADHESION,0.011063,0.23331,0.26705,1,1
6,GO LUNG ALVEOLUS DEVELOPMENT,0.0025648,0.23322,0.29256,1,1
6,GO RESPONSE TO EPINEPHRINE,0.017954,0.2322,0.21916,1,1
6,GO BONE CELL DEVELOPMENT,0.0083971,0.23151,0.30094,1,1
6,GO REGULATION OF ICOSANOID SECRETION,0.00064645,0.23102,0.28409,1,1
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0042727,0.23099,0.25046,1,1
6,GO O GLYCAN PROCESSING,0.013235,0.23073,0.21711,1,1
6,GO PROTEIN NITROSYLATION,0.0029965,0.22972,0.25023,1,1
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.019548,0.22937,0.23201,1,1
6,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0052065,0.22925,0.2412,1,1
6,GO BONE MINERALIZATION,0.0027019,0.2287,0.26827,1,1
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.011063,0.22832,0.23877,1,1
6,GO REGULATION OF NUCLEASE ACTIVITY,0.0096484,0.2281,0.19974,1,1
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0083971,0.22778,0.24022,1,1
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.030713,0.22774,0.22124,1,1
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.025096,0.22766,0.25964,1,1
6,GO RUFFLE ORGANIZATION,0.00332,0.22747,0.26417,1,1
6,GO CELLULAR RESPONSE TO X RAY,0.026142,0.22711,0.22728,1,1
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.013834,0.22672,0.21862,1,1
6,GO AMINO ACID IMPORT,0.0010798,0.22647,0.25549,1,1
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0017696,0.22597,0.30043,1,1
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0052065,0.22582,0.25542,1,1
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.041938,0.22563,0.22891,1,1
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.018736,0.22524,0.24409,1,1
6,GO RELAXATION OF MUSCLE,0.0066311,0.22415,0.21046,1,1
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0018673,0.2235,0.24955,1,1
6,GO PROTEIN DEMANNOSYLATION,0.007293,0.22316,0.27269,1,1
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00057531,0.22301,0.29809,1,1
6,GO LIPID EXPORT FROM CELL,0.0020776,0.22279,0.24236,1,1
6,GO ENDOCRINE PROCESS,0.0052065,0.2221,0.22487,1,1
6,GO PEPTIDYL TYROSINE MODIFICATION,0.0047188,0.22205,0.25961,1,1
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0010798,0.2218,0.25737,1,1
6,GO EXOCYTOSIS,0.00048214,0.22147,0.26696,1,1
6,GO REGULATION OF FATTY ACID TRANSPORT,0.00096503,0.2214,0.27938,1,1
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.016475,0.22139,0.25629,1,1
6,GO BARBED END ACTIN FILAMENT CAPPING,0.010572,0.22083,0.25725,1,1
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0015041,0.2208,0.30926,1,1
6,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00024771,0.21932,0.2323,1,1
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.015776,0.21887,0.19384,1,1
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0080134,0.21862,0.27621,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.019548,0.21862,0.2439,1,1
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0024341,0.21848,0.27004,1,1
6,GO LABYRINTHINE LAYER DEVELOPMENT,0.0044907,0.21846,0.23445,1,1
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00332,0.21844,0.23011,1,1
6,GO REGULATION OF CELL MATRIX ADHESION,0.007293,0.21834,0.26636,1,1
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0172,0.21832,0.21823,1,1
6,GO TISSUE MIGRATION,0.013235,0.21792,0.22577,1,1
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00019306,0.21774,0.24063,1,1
6,GO RESPONSE TO MUSCLE STRETCH,0.013834,0.2173,0.24867,1,1
6,GO RETINAL METABOLIC PROCESS,0.025096,0.21664,0.25784,1,1
6,GO PHOSPHOLIPID TRANSPORT,0.013834,0.21647,0.20862,1,1
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.018736,0.21587,0.22474,1,1
6,GO RESPONSE TO DEXAMETHASONE,0.0027019,0.21549,0.22732,1,1
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0021907,0.21488,0.25216,1,1
6,GO TOXIN METABOLIC PROCESS,0.0025648,0.21447,0.24958,1,1
6,GO DOPAMINE METABOLIC PROCESS,0.018736,0.2138,0.21297,1,1
6,GO EPIBOLY,0.00332,0.21298,0.28629,1,1
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0044907,0.21272,0.21454,1,1
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00024771,0.2127,0.29033,1,1
6,GO GLOMERULUS DEVELOPMENT,0.026142,0.21222,0.26382,1,1
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.010101,0.21215,0.22984,1,1
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0044907,0.21136,0.25514,1,1
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.033245,0.21116,0.22254,1,1
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00013188,0.21003,0.2725,1,1
6,GO RESPONSE TO MECHANICAL STIMULUS,0.0015882,0.20963,0.26193,1,1
6,GO VASODILATION,0.00064645,0.20803,0.25738,1,1
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.018736,0.208,0.19164,1,1
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00096503,0.20728,0.23015,1,1
6,GO INTRACELLULAR STEROL TRANSPORT,0.010101,0.20697,0.23159,1,1
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0054671,0.20692,0.23882,1,1
6,GO REGULATION OF RECEPTOR RECYCLING,0.018736,0.20421,0.19585,1,1
6,GO PLASMA MEMBRANE FUSION,0.0060238,0.20337,0.25437,1,1
6,GO REGULATION OF BIOMINERALIZATION,0.0063209,0.20232,0.26115,1,1
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0040644,0.20219,0.21072,1,1
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0042727,0.20202,0.2756,1,1
6,GO INSEMINATION,0.046961,0.2019,0.2255,1,1
6,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0052065,0.20139,0.22025,1,1
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.022172,0.19974,0.20913,1,1
6,GO ENDOTHELIAL CELL PROLIFERATION,0.015776,0.19933,0.22745,1,1
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.022172,0.19922,0.22674,1,1
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0054671,0.19878,0.24173,1,1
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0016767,0.19869,0.23861,1,1
6,GO CERAMIDE CATABOLIC PROCESS,0.0047188,0.19836,0.29786,1,1
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0038653,0.19825,0.25258,1,1
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0029965,0.19772,0.23447,1,1
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.012106,0.1977,0.30506,1,1
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.015104,0.19765,0.25949,1,1
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.026142,0.19715,0.25471,1,1
6,GO DIGESTIVE SYSTEM PROCESS,0.0047188,0.19681,0.197,1,1
6,GO REGULATION OF ENDOCRINE PROCESS,0.018736,0.19588,0.20213,1,1
6,GO POSITIVE REGULATION OF SECRETION,0.0027019,0.19566,0.20113,1,1
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0015882,0.19532,0.28492,1,1
6,GO REGULATION OF RELAXATION OF MUSCLE,0.048745,0.19472,0.27229,1,1
6,GO CERAMIDE TRANSPORT,0.012106,0.1943,0.23308,1,1
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0044907,0.19391,0.22663,1,1
6,GO LUNG CELL DIFFERENTIATION,0.0063209,0.19347,0.27905,1,1
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0057394,0.19306,0.2,1,1
6,GO ZINC ION HOMEOSTASIS,0.020391,0.19251,0.20717,1,1
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0011418,0.19244,0.20951,1,1
6,GO SMOOTH MUSCLE CELL MIGRATION,0.013834,0.19238,0.2659,1,1
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.020391,0.19217,0.22293,1,1
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.007293,0.19176,0.22111,1,1
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015776,0.19055,0.20231,1,1
6,GO REGULATION OF EXOSOMAL SECRETION,0.00035748,0.19035,0.2631,1,1
6,GO PROTEIN OXIDATION,0.0060238,0.19007,0.24794,1,1
6,GO ER NUCLEUS SIGNALING PATHWAY,0.0016767,0.18948,0.20771,1,1
6,GO REGULATION OF HORMONE METABOLIC PROCESS,0.018736,0.18913,0.24695,1,1
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0040644,0.18905,0.22336,1,1
6,GO HEAT GENERATION,0.048745,0.18871,0.18736,1,1
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00086166,0.18851,0.21734,1,1
6,GO MANGANESE ION TRANSPORT,0.023112,0.18772,0.18778,1,1
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.013834,0.18749,0.17704,1,1
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.025096,0.18748,0.20099,1,1
6,GO COPPER ION HOMEOSTASIS,0.0024341,0.1873,0.21024,1,1
6,GO RESPONSE TO HYDROGEN PEROXIDE,0.00096503,0.18698,0.22235,1,1
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0029965,0.18686,0.21478,1,1
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.013834,0.18665,0.20922,1,1
6,GO RESPONSE TO COLD,0.0066311,0.18662,0.19996,1,1
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045436,0.18659,0.24107,1,1
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.016475,0.18544,0.22291,1,1
6,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0096484,0.18514,0.264,1,1
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0052065,0.18392,0.22566,1,1
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.013235,0.18352,0.20931,1,1
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.007293,0.18346,0.24613,1,1
6,GO GLYCEROLIPID CATABOLIC PROCESS,0.011574,0.18312,0.18858,1,1
6,GO LIPID LOCALIZATION,0.0063209,0.18311,0.20331,1,1
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.016475,0.18291,0.21445,1,1
6,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.035953,0.18249,0.24195,1,1
6,GO RESPONSE TO INTERLEUKIN 12,0.0023095,0.18244,0.21069,1,1
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014241,0.1824,0.21814,1,1
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.010101,0.18127,0.18991,1,1
6,GO REGULATION OF PEPTIDE SECRETION,0.0040644,0.18076,0.20692,1,1
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0060238,0.18075,0.18745,1,1
6,GO NEUTRAL LIPID CATABOLIC PROCESS,0.021265,0.18012,0.16574,1,1
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.037377,0.18001,0.16078,1,1
6,GO RESPONSE TO STEROL,0.021265,0.17966,0.23645,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.026142,0.17933,0.15434,1,1
6,GO PHAGOSOME MATURATION,0.0012758,0.17924,0.22662,1,1
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0066311,0.1786,0.2012,1,1
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.028348,0.17832,0.21601,1,1
6,GO MODULATION BY HOST OF VIRAL PROCESS,0.010572,0.17793,0.21048,1,1
6,GO REGULATION OF AMYLOID BETA FORMATION,0.023112,0.17789,0.20505,1,1
6,GO TRIGLYCERIDE METABOLIC PROCESS,0.0083971,0.17783,0.1982,1,1
6,GO SPHINGOMYELIN METABOLIC PROCESS,0.007293,0.17697,0.23608,1,1
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.018736,0.17633,0.19066,1,1
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.008797,0.17607,0.18544,1,1
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.014457,0.17567,0.18051,1,1
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.028348,0.17456,0.21188,1,1
6,GO CORTICAL CYTOSKELETON ORGANIZATION,0.008797,0.17433,0.20527,1,1
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.020391,0.17416,0.20147,1,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00091199,0.17339,0.22275,1,1
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.011063,0.16983,0.1914,1,1
6,GO TROPHOBLAST CELL MIGRATION,0.033245,0.16963,0.21908,1,1
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0014241,0.1696,0.21627,1,1
6,GO RESPONSE TO CORTICOSTEROID,0.0042727,0.16932,0.22456,1,1
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0015041,0.1692,0.22053,1,1
6,GO RESPONSE TO GROWTH HORMONE,0.0049572,0.16891,0.20687,1,1
6,GO RESPONSE TO CAMP,0.0040644,0.16827,0.22771,1,1
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.040368,0.16716,0.15897,1,1
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012106,0.16632,0.24806,1,1
6,GO MAINTENANCE OF LOCATION IN CELL,0.0018673,0.16541,0.22806,1,1
6,GO RESPONSE TO STEROL DEPLETION,0.02951,0.1653,0.20336,1,1
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.021265,0.16464,0.17538,1,1
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.026142,0.16441,0.27138,1,1
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0060238,0.16431,0.21464,1,1
6,GO DIGESTION,0.0063209,0.16405,0.1797,1,1
6,GO REGULATION OF MAP KINASE ACTIVITY,0.021265,0.16367,0.1914,1,1
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.017954,0.16367,0.19621,1,1
6,GO PHAGOSOME ACIDIFICATION,0.0034935,0.1632,0.19828,1,1
6,GO RESPONSE TO NUTRIENT,0.0076456,0.16308,0.2144,1,1
6,GO PEPTIDE SECRETION,0.0057394,0.16167,0.19759,1,1
6,GO PLASMA MEMBRANE ORGANIZATION,0.015776,0.1614,0.20987,1,1
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.020391,0.16107,0.22679,1,1
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0096484,0.16033,0.18725,1,1
6,GO LYTIC VACUOLE ORGANIZATION,0.0023095,0.16026,0.21295,1,1
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00033648,0.15985,0.21072,1,1
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.041938,0.15928,0.19002,1,1
6,GO REGULATION OF MUSCLE CONTRACTION,0.0092139,0.15924,0.17917,1,1
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.038848,0.15895,0.17947,1,1
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0031545,0.15878,0.25445,1,1
6,GO ACTIN MEDIATED CELL CONTRACTION,0.026142,0.15862,0.15776,1,1
6,GO REGULATION OF STEROID METABOLIC PROCESS,0.0025648,0.15842,0.20255,1,1
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0018673,0.1581,0.19651,1,1
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.034576,0.15799,0.227,1,1
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.045233,0.15792,0.19506,1,1
6,GO REGULATION OF BLOOD PRESSURE,0.010572,0.15542,0.19006,1,1
6,GO RESPONSE TO OXIDATIVE STRESS,0.0066311,0.15507,0.17791,1,1
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0057394,0.1546,0.17728,1,1
6,GO STEROL METABOLIC PROCESS,0.011063,0.15418,0.16856,1,1
6,GO MUSCLE CELL MIGRATION,0.022172,0.15417,0.22726,1,1
6,GO NEGATIVE REGULATION OF SECRETION,0.0063209,0.15311,0.19675,1,1
6,GO RESPONSE TO ORGANOPHOSPHORUS,0.0076456,0.15305,0.22116,1,1
6,GO VITAMIN METABOLIC PROCESS,0.0027019,0.15292,0.17576,1,1
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.010572,0.15282,0.18166,1,1
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0047188,0.15236,0.21141,1,1
6,GO REGULATION OF TUBE SIZE,0.0172,0.15221,0.18662,1,1
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.034576,0.15216,0.18061,1,1
6,GO PROTEIN N LINKED GLYCOSYLATION,0.0011418,0.15187,0.19387,1,1
6,GO HORMONE METABOLIC PROCESS,0.015104,0.15114,0.15444,1,1
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0083971,0.15079,0.23224,1,1
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.013834,0.15058,0.17498,1,1
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.006955,0.15037,0.20823,1,1
6,GO RESPONSE TO CADMIUM ION,0.017954,0.14939,0.15877,1,1
6,GO CIRCULATORY SYSTEM PROCESS,0.035953,0.14927,0.1647,1,1
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00332,0.14917,0.14087,1,1
6,GO CELL RECOGNITION,0.011574,0.14896,0.18894,1,1
6,GO CARBOHYDRATE TRANSPORT,0.017954,0.14895,0.15713,1,1
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0018673,0.14855,0.25596,1,1
6,GO POSITIVE REGULATION OF TRANSPORT,0.0096484,0.14804,0.17911,1,1
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.030713,0.148,0.17963,1,1
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.00076864,0.14798,0.24195,1,1
6,GO AMYLOID BETA METABOLIC PROCESS,0.035953,0.14752,0.18083,1,1
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.010101,0.14751,0.18299,1,1
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0076456,0.14724,0.20629,1,1
6,GO RESPONSE TO ETHER,0.041938,0.14704,0.16927,1,1
6,GO IRON ION TRANSPORT,0.0014241,0.14701,0.2019,1,1
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0080134,0.14699,0.18094,1,1
6,GO MUSCLE ADAPTATION,0.026142,0.1466,0.17863,1,1
6,GO LIPID IMPORT INTO CELL,0.021265,0.14636,0.184,1,1
6,GO REGULATION OF VASCULAR PERMEABILITY,0.013834,0.14586,0.23077,1,1
6,GO REGULATION OF LIPID METABOLIC PROCESS,0.0076456,0.14571,0.19303,1,1
6,GO ER OVERLOAD RESPONSE,0.013235,0.14566,0.19362,1,1
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0060238,0.14543,0.2151,1,1
6,GO RESPONSE TO INORGANIC SUBSTANCE,0.0060238,0.14538,0.16705,1,1
6,GO POSITIVE REGULATION OF ION TRANSPORT,0.011574,0.14496,0.174,1,1
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.015104,0.14492,0.16581,1,1
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0023095,0.14469,0.19377,1,1
6,GO NEUTRAL AMINO ACID TRANSPORT,0.0096484,0.14457,0.20663,1,1
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00091199,0.14437,0.23046,1,1
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0027019,0.14435,0.18666,1,1
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.043559,0.14419,0.19192,1,1
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.022172,0.14414,0.19024,1,1
6,GO EMBRYONIC PLACENTA DEVELOPMENT,0.020391,0.14368,0.19224,1,1
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0031545,0.14353,0.18904,1,1
6,GO RESPONSE TO METAL ION,0.00332,0.14337,0.16894,1,1
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.027226,0.14299,0.18819,1,1
6,GO MITOCHONDRIAL DEPOLARIZATION,0.013834,0.14276,0.20979,1,1
6,GO CELLULAR LIPID CATABOLIC PROCESS,0.015776,0.14202,0.16176,1,1
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.037377,0.14186,0.14613,1,1
6,GO CHONDROCYTE DEVELOPMENT,0.024086,0.14182,0.29276,1,1
6,GO CELLULAR RESPONSE TO KETONE,0.027226,0.1416,0.16776,1,1
6,GO NEGATIVE REGULATION OF MAPK CASCADE,0.026142,0.14118,0.1842,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.045233,0.14097,0.15051,1,1
6,GO RESPONSE TO GONADOTROPIN,0.034576,0.14091,0.19006,1,1
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.011063,0.14082,0.17761,1,1
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.006955,0.14026,0.20974,1,1
6,GO STEROID METABOLIC PROCESS,0.0047188,0.14025,0.16918,1,1
6,GO RESPONSE TO KETONE,0.0083971,0.13989,0.19483,1,1
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0083971,0.13949,0.14336,1,1
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.046961,0.13897,0.15968,1,1
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.007293,0.13885,0.17141,1,1
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.015776,0.13884,0.15302,1,1
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0054671,0.13839,0.17894,1,1
6,GO MIDBODY ABSCISSION,0.006955,0.1377,0.14708,1,1
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.014457,0.13679,0.20198,1,1
6,GO RESPONSE TO CALCIUM ION,0.031957,0.13635,0.14985,1,1
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.008797,0.13602,0.26168,1,1
6,GO EXTRACELLULAR VESICLE BIOGENESIS,0.00040321,0.13581,0.23062,1,1
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.028348,0.13567,0.2395,1,1
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0012758,0.13552,0.22595,1,1
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.010101,0.13539,0.17529,1,1
6,GO BILE ACID METABOLIC PROCESS,0.02951,0.13532,0.15113,1,1
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.037377,0.13518,0.19862,1,1
6,GO RESPONSE TO ALCOHOL,0.011574,0.13479,0.18871,1,1
6,GO AMYLOID BETA FORMATION,0.034576,0.13478,0.18982,1,1
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.015776,0.13433,0.17616,1,1
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0096484,0.13421,0.23142,1,1
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.020391,0.13379,0.14908,1,1
6,GO STRIATED MUSCLE CONTRACTION,0.030713,0.13346,0.14336,1,1
6,GO GLYCOPROTEIN METABOLIC PROCESS,0.021265,0.13328,0.1662,1,1
6,GO AMINE METABOLIC PROCESS,0.00045436,0.13298,0.1682,1,1
6,GO NEUTRAL LIPID METABOLIC PROCESS,0.023112,0.13132,0.16053,1,1
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.045233,0.1308,0.13523,1,1
6,GO RESPONSE TO STEROID HORMONE,0.033245,0.13049,0.16833,1,1
6,GO REGULATION OF METAL ION TRANSPORT,0.018736,0.12945,0.16022,1,1
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.045233,0.12904,0.17112,1,1
6,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0096484,0.12897,0.19069,1,1
6,GO VESICLE BUDDING FROM MEMBRANE,0.013834,0.12874,0.15936,1,1
6,GO MEMBRANE FUSION,0.0042727,0.12829,0.17869,1,1
6,GO TRANSITION METAL ION TRANSPORT,0.0011418,0.12829,0.18317,1,1
6,GO REGULATION OF SECRETION,0.014457,0.12819,0.16287,1,1
6,GO PHOSPHOLIPID METABOLIC PROCESS,0.030713,0.12752,0.14613,1,1
6,GO NADP METABOLIC PROCESS,0.0054671,0.12747,0.18116,1,1
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0027019,0.12745,0.1492,1,1
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.045233,0.12677,0.1563,1,1
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.011574,0.12661,0.17377,1,1
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00072571,0.12634,0.17086,1,1
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.027226,0.1247,0.1162,1,1
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.025096,0.12468,0.16118,1,1
6,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0047188,0.12464,0.15157,1,1
6,GO STEROID BIOSYNTHETIC PROCESS,0.0076456,0.12451,0.14867,1,1
6,GO RESPONSE TO ETHANOL,0.0034935,0.12354,0.16613,1,1
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.041938,0.12336,0.16071,1,1
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015041,0.123,0.17319,1,1
6,GO ORGANELLE MEMBRANE FUSION,0.006955,0.1227,0.18029,1,1
6,GO FATTY ACID METABOLIC PROCESS,0.016475,0.12244,0.14608,1,1
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0083971,0.12221,0.19471,1,1
6,GO REGULATION OF MUSCLE ADAPTATION,0.022172,0.12091,0.18133,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0054671,0.12047,0.18469,1,1
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.010101,0.12021,0.15774,1,1
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.022172,0.11933,0.15976,1,1
6,GO APOPTOTIC SIGNALING PATHWAY,0.0044907,0.11865,0.17492,1,1
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.046961,0.11807,0.16339,1,1
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.027226,0.1178,0.12759,1,1
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.017954,0.1175,0.17897,1,1
6,GO ANION HOMEOSTASIS,0.040368,0.11732,0.17718,1,1
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.034576,0.11708,0.17577,1,1
6,GO ALCOHOL METABOLIC PROCESS,0.028348,0.11698,0.1482,1,1
6,GO PEPTIDYL PROLINE MODIFICATION,0.034576,0.11695,0.11809,1,1
6,GO NEGATIVE REGULATION OF TRANSPORT,0.011574,0.11687,0.1653,1,1
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.006955,0.11629,0.16054,1,1
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.037377,0.11601,0.16859,1,1
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.015104,0.11525,0.17091,1,1
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.018736,0.11479,0.15481,1,1
6,GO SPLEEN DEVELOPMENT,0.038848,0.11442,0.13412,1,1
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00332,0.11302,0.16696,1,1
6,GO COPII COATED VESICLE BUDDING,0.014457,0.11283,0.15371,1,1
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.021265,0.11241,0.15753,1,1
6,GO TEMPERATURE HOMEOSTASIS,0.035953,0.11218,0.15438,1,1
6,GO REGULATION OF PEPTIDE TRANSPORT,0.022172,0.11186,0.15465,1,1
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.043559,0.11184,0.17666,1,1
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.024086,0.11158,0.12483,1,1
6,GO NAD METABOLIC PROCESS,0.017954,0.11125,0.17558,1,1
6,GO KETONE BIOSYNTHETIC PROCESS,0.030713,0.11063,0.14665,1,1
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0044907,0.11057,0.16714,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0080134,0.11015,0.17952,1,1
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.01266,0.10944,0.14427,1,1
6,GO FAT CELL DIFFERENTIATION,0.038848,0.10902,0.17875,1,1
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.028348,0.10887,0.1468,1,1
6,GO RESPONSE TO HORMONE,0.035953,0.1084,0.15641,1,1
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.037377,0.10835,0.12909,1,1
6,GO CELLULAR LIPID METABOLIC PROCESS,0.031957,0.10818,0.14095,1,1
6,GO GOLGI VESICLE BUDDING,0.013834,0.10762,0.15635,1,1
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0057394,0.10654,0.19347,1,1
6,GO SKELETAL MUSCLE CONTRACTION,0.021265,0.10621,0.15862,1,1
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.037377,0.10572,0.13682,1,1
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.024086,0.10526,0.15198,1,1
6,GO PEROXISOMAL TRANSPORT,0.011063,0.10487,0.12041,1,1
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.019548,0.10439,0.13541,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.034576,0.10284,0.13981,1,1
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.019548,0.10278,0.16377,1,1
6,GO CELLULAR RESPONSE TO DRUG,0.0063209,0.10248,0.1659,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.015104,0.10172,0.13942,1,1
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.028348,0.10159,0.14669,1,1
6,GO ERAD PATHWAY,0.043559,0.10152,0.13631,1,1
6,GO LIPID METABOLIC PROCESS,0.033245,0.10058,0.14357,1,1
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.040368,0.1,0.15475,1,1
6,GO MEMBRANE ORGANIZATION,0.031957,0.099109,0.14377,1,1
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0054671,0.098781,0.15821,1,1
6,GO RESPONSE TO TOXIC SUBSTANCE,0.023112,0.097885,0.13483,1,1
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.019548,0.097838,0.15294,1,1
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.030713,0.096641,0.15688,1,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.011574,0.095505,0.1491,1,1
6,GO ALCOHOL BIOSYNTHETIC PROCESS,0.014457,0.094559,0.1485,1,1
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.033245,0.094439,0.15339,1,1
6,GO VESICLE TARGETING,0.017954,0.094208,0.15235,1,1
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.048745,0.093856,0.11545,1,1
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.041938,0.093843,0.14985,1,1
6,GO LIPID BIOSYNTHETIC PROCESS,0.028348,0.093413,0.13385,1,1
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.048745,0.092584,0.16888,1,1
6,GO NADPH REGENERATION,0.031957,0.089984,0.12768,1,1
6,GO MITOTIC CYTOKINETIC PROCESS,0.033245,0.089209,0.11386,1,1
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.013834,0.088045,0.13543,1,1
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.043559,0.087803,0.14036,1,1
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.02951,0.08764,0.17799,1,1
6,GO PEROXISOME ORGANIZATION,0.015776,0.086133,0.10605,1,1
6,GO VESICLE ORGANIZATION,0.016475,0.085974,0.15073,1,1
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.043559,0.085957,0.13154,1,1
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.027226,0.085601,0.10895,1,1
6,GO MEMBRANE LIPID METABOLIC PROCESS,0.037377,0.084494,0.12957,1,1
6,GO FRUCTOSE METABOLIC PROCESS,0.046961,0.084441,0.17018,1,1
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.038848,0.083789,0.12388,1,1
6,GO VIRION ASSEMBLY,0.0080134,0.083657,0.11189,1,1
6,GO ZINC ION TRANSPORT,0.030713,0.079939,0.10416,1,1
6,GO ORGANIC ACID METABOLIC PROCESS,0.028348,0.078887,0.12486,1,1
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.027226,0.078408,0.13454,1,1
6,GO PROTEOLYSIS,0.040368,0.078303,0.142,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.038848,0.075993,0.15498,1,1
6,GO MITOCHONDRIAL FISSION,0.017954,0.073754,0.15469,1,1
6,GO CELLULAR KETONE METABOLIC PROCESS,0.041938,0.07145,0.11067,1,1
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.018736,0.067508,0.12596,1,1
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.034576,0.0662,0.11964,1,1
6,GO OXIDATION REDUCTION PROCESS,0.021265,0.065826,0.11011,1,1
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.043559,0.065803,0.126,1,1
